Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42181,0.158659802130785,0.00322094915342692,0.152346741790069,0.164972862471502,0
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GCG,Pro-glucagon,41843,-0.504836038347873,0.0123304538816409,-0.52900372795589,-0.480668348739857,0
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MFGE8,Lactadherin,42137,-0.205624773281739,0.0044310373765084,-0.214309606539696,-0.196939940023783,0
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42137,0.138851651483944,0.00316781337272287,0.132642737273408,0.145060565694481,0
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPY,Pro-neuropeptide Y,42262,-0.227705512765519,0.0063975005383692,-0.240244613820722,-0.215166411710315,1.96243445296838e-265
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRSS8,Prostasin,42080,-0.148359944783346,0.00420265502696992,-0.156597148636207,-0.140122740930485,3.57002904792849e-261
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRAP1,Proline-rich acidic protein 1,39966,-0.138617064057281,0.00392245838941596,-0.146305082500536,-0.130929045614026,1.19594512428674e-259
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42185,0.0978970472374992,0.00297082198785089,0.0920742361413114,0.103719858333687,3.56783757588056e-229
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C9,Complement component C9,39990,0.190126520442775,0.00583785052192344,0.178684333419805,0.201568707465745,1.54355458683248e-222
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGSF9,Protein turtle homolog A,39958,-0.281451158041187,0.00871416356805373,-0.298530918634572,-0.264371397447802,4.97114742873636e-219
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGRP,Agouti-related protein,42296,-0.167913514722291,0.00523819324851457,-0.178180373489379,-0.157646655955202,1.79026677201439e-217
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42287,0.398544334386791,0.0129080226812065,0.373244609931626,0.423844058841956,2.03683097879026e-202
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOF,Apolipoprotein F,39990,0.080471078423567,0.00263850308429617,0.0752996123783465,0.0856425444687875,1.87855878208477e-196
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PYY,Peptide YY,39575,-0.309895564409522,0.0101784209729045,-0.329845269516415,-0.289945859302629,1.56724407781883e-195
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS15,Enteropeptidase,42070,-0.253534612085006,0.00899551238634487,-0.271165816362242,-0.23590340780777,7.30121743036227e-170
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LPL,Lipoprotein lipase,42145,0.136561043602039,0.00492584040351757,0.126906396411145,0.146215690792934,1.37174357706537e-164
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LDLR,Low-density lipoprotein receptor,42170,-0.142547403938908,0.00522853593453106,-0.152795334370589,-0.132299473507227,2.18403474053779e-159
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS4,Galectin-4,42123,-0.156353803791516,0.0057802254089603,-0.167683045593078,-0.145024561989953,5.56471633234609e-157
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADIPOQ,Adiponectin,39979,0.191110947851699,0.00705438884337215,0.17728434571869,0.204937549984709,1.09843739812058e-156
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOM,Apolipoprotein M,42199,0.0768719439798884,0.00291148003529146,0.0711654431107171,0.0825784448490596,7.32739474519682e-150
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,39736,0.083276468985761,0.00316617849626779,0.0770707591330762,0.0894821788384459,5.69630148619094e-148
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CES1,Liver carboxylesterase 1,42163,-0.226857148178743,0.00872471228931639,-0.243957584265803,-0.209756712091683,1.69143926264198e-145
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MVK,Mevalonate kinase,41913,-0.213074915715075,0.00849269378470118,-0.229720595533089,-0.196429235897061,9.06962727724624e-136
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42016,-0.0774468776568243,0.0031192236473113,-0.0835605560055545,-0.0713331993080942,4.31431711252705e-133
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INHBC,Inhibin beta C chain,42137,-0.101227035602047,0.00409108016754255,-0.10924555273043,-0.0932085184736633,3.09895729464701e-132
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42181,-0.0894160780784302,0.00361612266620197,-0.0965036785041861,-0.0823284776526743,4.46431556555428e-132
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UPB1,Beta-ureidopropionase,39958,-0.229087819538354,0.00934296670690493,-0.247400034283888,-0.21077560479282,2.02950054684231e-129
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41900,-0.20325507906088,0.00841375577102221,-0.219746040372083,-0.186764117749676,3.20177442468863e-126
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPY,Pancreatic prohormone,42089,-0.251474148216152,0.0106108017629418,-0.272271319671518,-0.230676976760786,1.09305797817825e-121
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RTN4R,Reticulon-4 receptor,42262,-0.0824232329806176,0.00348086049347131,-0.0892457195478214,-0.0756007464134138,1.63838921206369e-121
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAMDC4,Apical endosomal glycoprotein,39919,-0.137938037122256,0.00585159336492875,-0.149407160117516,-0.126468914126995,5.55200728948864e-120
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACY1,Aminoacylase-1,42145,-0.152106516497026,0.00648871070254855,-0.164824389474021,-0.13938864352003,3.72631290385691e-119
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OXT,Oxytocin-neurophysin 1,42249,-0.34909412498662,0.0149558374084577,-0.378407566307197,-0.319780683666043,3.40996811454484e-118
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOD,Apolipoprotein D,39468,0.101979150875833,0.00435918012747171,0.093435157825988,0.110523143925677,3.95225740391591e-118
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPR37,Prosaposin receptor GPR37,41900,-0.156590509764577,0.00672292819476549,-0.169767449026317,-0.143413570502836,1.1903800384219e-117
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHBG,Sex hormone-binding globulin,39990,0.112799039471582,0.00484972518112505,0.103293578116577,0.122304500826587,5.99711433191998e-117
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFASC,Neurofascin,42296,-0.0693638243560531,0.00300991159365987,-0.0752632510796265,-0.0634643976324798,2.53695936990093e-115
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLTP,Phospholipid transfer protein,42267,0.0894065895451558,0.00390178462160611,0.0817590916868078,0.0970540874035037,4.66191227384511e-114
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42230,-0.113432652734617,0.00499134768459732,-0.123215694196428,-0.103649611272806,2.99474716418854e-112
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIP,Gastric inhibitory polypeptide,39638,-0.11533994070829,0.00524826234902802,-0.125626534912385,-0.105053346504195,8.32696550801939e-105
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC39A5,Zinc transporter ZIP5,42119,-0.120178646946097,0.00548250181181512,-0.130924350497254,-0.109432943394939,1.09424606498073e-104
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPM,Carboxypeptidase M,42195,-0.0766652824843111,0.00351835212418601,-0.0835612526477156,-0.0697693123209065,1.68412225967551e-103
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL16,C-C motif chemokine 16,42310,-0.114496723529376,0.00530605326670009,-0.124896587932108,-0.104096859126644,1.38869878996043e-101
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42262,-0.071854190561504,0.00334756902950956,-0.0784154258593427,-0.0652929552636652,1.51527778744618e-100
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41843,-0.14348492934301,0.00675760425088638,-0.156729833674747,-0.130240025011272,2.04688064230816e-98
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSD,Cathepsin D,41225,-0.0905000735284675,0.00429206332357723,-0.0989125176426789,-0.0820876294142561,5.04314960469419e-97
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF21,Fibroblast growth factor 21,42247,-0.262005851050569,0.0124427674670879,-0.286393675286062,-0.237618026815077,6.82565358421673e-97
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,41913,-0.119080953257766,0.00565479524079993,-0.130164351929734,-0.107997554585799,7.21747463858401e-97
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD4,T-cell surface glycoprotein CD4,42100,-0.062983740880416,0.00300504478095408,-0.068873628651086,-0.057093853109746,5.17924696282308e-96
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCN1,CCN family member 1,42047,-0.155534066485547,0.00743277547874568,-0.170102306423889,-0.140965826547206,1.04571548871088e-95
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD300LG,CMRF35-like molecule 9,42137,0.0804128297682396,0.00386539904888968,0.0728366476324159,0.0879890119040634,1.21533716725909e-94
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTH,Parathyroid hormone,39649,-0.179775816048633,0.00864540812618097,-0.196720815975948,-0.162830816121319,3.06433685448888e-94
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL27,C-C motif chemokine 27,42145,-0.134291802625729,0.00647567934475359,-0.146984134141446,-0.121599471110012,4.53561016969678e-94
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACE2,Angiotensin-converting enzyme 2,41900,-0.116804859296387,0.00565135009508191,-0.127881505482748,-0.105728213110027,1.9440769937319e-93
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,39910,-0.185914993745818,0.00898722284826241,-0.203529950528413,-0.168300036963224,2.41692192797619e-93
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLUL1,Clusterin-like protein 1,42123,0.0954227725879962,0.00463210077128291,0.0863438550762817,0.104501690099711,7.22156111592759e-93
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",41839,-0.107973675081895,0.0052473223644305,-0.118258426916179,-0.0976889232476112,1.2355552423e-92
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSTA1,Glutathione S-transferase A1,42119,-0.179455892690832,0.00878961157477865,-0.196683531377399,-0.162228254004266,2.80491618555804e-91
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHA1,Ephrin type-A receptor 1,42162,-0.0681454228256994,0.0033414541950879,-0.0746946730480717,-0.0615961726033271,4.37321700734784e-91
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA14,Carbonic anhydrase 14,42262,0.0775806473884895,0.00380972231205758,0.0701135916568567,0.0850477031201224,7.76299994436035e-91
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCG2,Secretogranin-2,42193,-0.0695177079358635,0.00342548376988251,-0.0762316561248332,-0.0628037597468938,3.12163354050412e-90
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,41921,-0.306895225159788,0.0151539700053415,-0.336597006370257,-0.277193443949318,7.6684167690225e-90
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MUC13,Mucin-13,41839,-0.110679709341029,0.00546637417918351,-0.121393802732228,-0.099965615949829,8.52701925445793e-90
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MME,Neprilysin,42070,-0.16127762537812,0.00808049204606015,-0.177115389788398,-0.145439860967842,2.28719825307949e-87
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,39945,0.102322999946403,0.00514993373937997,0.0922291298172182,0.112416870075588,2.21195272948482e-86
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42070,-0.16538998082938,0.00834225271413921,-0.181740796149093,-0.149039165509667,3.02633232839128e-86
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NHLRC3,NHL repeat-containing protein 3,39481,-0.0667898901938342,0.00336660767272129,-0.073388441232368,-0.0601913391553005,4.51822172704132e-86
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,41843,-0.122550734450361,0.00622320062399786,-0.134748207673397,-0.110353261227326,4.10370891543868e-85
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42016,-0.0690289436599599,0.00351396789618539,-0.0759163207364832,-0.0621415665834365,1.00150670244262e-84
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NTRK3,NT-3 growth factor receptor,42249,0.0431931585399399,0.00220290618879313,0.0388754624099054,0.0475108546699744,1.93475575094624e-84
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42238,-0.0644963342793925,0.00329349919843914,-0.0709515927083332,-0.0580410758504518,3.09236651129225e-84
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FURIN,Furin,42181,-0.0663601242198571,0.00343076711325326,-0.0730844277618335,-0.0596358206778807,2.99257463035166e-82
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42194,-0.0474841121204745,0.00245567370126917,-0.0522972325749621,-0.0426709916659869,3.35335176830923e-82
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MEP1A,Meprin A subunit alpha,39930,-0.151760981119635,0.00792305619167738,-0.167290171255323,-0.136231790983948,1.65650733902145e-80
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL17RB,Interleukin-17 receptor B,41934,0.105664779892049,0.00560378145978453,0.0946813682308714,0.116648191553227,2.72986204520636e-78
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPA2,Carboxypeptidase A2,42205,-0.129359122668673,0.00691267235852671,-0.142907960491386,-0.115810284845961,3.57873874938613e-77
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42145,-0.0597546291171849,0.00322652305490567,-0.0660786143048,-0.0534306439295698,1.22412599273616e-75
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42092,-0.100428405548338,0.00547569936869238,-0.111160776310975,-0.0896960347857006,3.11655509050368e-74
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42199,0.0549799811653,0.00302642709347984,0.0490481840620796,0.0609117782685205,6.8865144829065e-73
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBP5,Retinol-binding protein 5,42070,-0.106173169178351,0.00585621351320469,-0.117651347664232,-0.0946949906924694,1.34510342636087e-72
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCLY,Selenocysteine lyase,42224,-0.0910631582974845,0.00506784744988925,-0.100996139299267,-0.0811301772957015,2.27518646027298e-71
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42070,-0.158666488966019,0.0088373893519913,-0.175987772095922,-0.141345205836117,3.01581679264206e-71
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42070,-0.148427989062779,0.00832523948897876,-0.164745458461178,-0.132110519664381,2.71358297188327e-70
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCS1,Neuronal calcium sensor 1,42262,-0.052258545062445,0.00294442925344133,-0.05802962639919,-0.0464874637257,1.07481622385231e-69
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTN3,Contactin-3,42137,-0.0520549446233892,0.00294807074378279,-0.0578331632812035,-0.046276725965575,5.30023771826793e-69
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSTA3,Glutathione S-transferase A3,41843,-0.14160946161115,0.00803265777742466,-0.157353470854903,-0.125865452367398,8.95450433029686e-69
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42070,-0.0598146157444824,0.00341476281146175,-0.0665075508549474,-0.0531216806340173,6.06510630761209e-68
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42310,0.0609688786197346,0.00348383969030471,0.0541405528267374,0.0677972044127318,7.74822263587362e-68
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42119,0.0718619594765822,0.00411125639589728,0.0638038969406236,0.0799200220125409,1.14070854567385e-67
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGF,Placenta growth factor,42296,-0.0475214665643961,0.00272600968046947,-0.0528644455381163,-0.042178487590676,2.48438781241305e-67
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DSG2,Desmoglein-2,42137,0.0489993225478733,0.00281538304066466,0.0434811717881705,0.054517473307576,4.12062160357285e-67
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42070,-0.123910327859438,0.00715190244132098,-0.137928056644427,-0.109892599074449,1.58666858646973e-66
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42070,-0.152496408112858,0.00889398536531141,-0.169928619428868,-0.135064196796847,3.30710322419336e-65
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GH1,Somatotropin,42129,0.316570959199498,0.0185089221795555,0.280293471727569,0.352848446671427,6.69246698714648e-65
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KHK,Ketohexokinase,39638,-0.112582450337512,0.00659012050733398,-0.125499086531886,-0.099665814143137,1.32794107550974e-64
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SELE,E-selectin,42310,-0.0896517119058337,0.00525506045061578,-0.0999516303890406,-0.0793517934226268,1.36352632027419e-64
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39728,-0.0865938169572168,0.00507626741056318,-0.0965433010819206,-0.0766443328325129,1.98389321564131e-64
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,41843,-0.14913510631588,0.00875404491942594,-0.166293034357955,-0.131977178273805,2.14692690527073e-64
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HGF,Hepatocyte growth factor,42296,-0.0611272293264828,0.0035949416929299,-0.0681733150446254,-0.0540811436083402,3.50934293003804e-64
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AFM,Afamin,39979,-0.0357773145126229,0.00211018621831177,-0.039913279500514,-0.0316413495247318,1.07480289947032e-63
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHI3L1,Chitinase-3-like protein 1,41907,-0.147472005543647,0.00871300758347622,-0.16454950040726,-0.130394510680033,1.34873583266776e-63
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,39958,-0.116773205628422,0.00689665221918153,-0.130290643978018,-0.103255767278826,1.57142062986531e-63
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42217,0.0563891099581427,0.00333556849386912,0.0498513957101593,0.0629268242061262,1.82029708100259e-63
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HAO1,Hydroxyacid oxidase 1,42262,-0.217387471367339,0.0128856328185567,-0.24264331169171,-0.192131631042968,3.23148598792193e-63
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42016,-0.101334071002109,0.00600735974460073,-0.113108496101527,-0.0895596459026917,3.44253409824479e-63
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMBP,Protein AMBP,42239,-0.0352786689253588,0.00210199875799305,-0.0393985864910252,-0.0311587513596924,1.3693178285027e-62
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41966,-0.0854696523767906,0.0051031171786951,-0.095471762047033,-0.0754675427065482,2.50448404979091e-62
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ELN,Elastin,39958,-0.0605900496368596,0.00363019967506152,-0.0677052409999802,-0.0534748582737391,8.3441376321389e-62
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REN,Renin,42145,-0.140522990635197,0.00846536061829206,-0.157115097447049,-0.123930883823344,2.81673698968391e-61
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39736,-0.0867415397192874,0.00522760620252363,-0.0969876478762337,-0.0764954315623411,4.23064905519675e-61
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLA,Alpha-galactosidase A,39713,-0.0680360647719248,0.00410180565081113,-0.0760756038475147,-0.059996525696335,4.68885765655428e-61
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,39966,-0.0600786607098125,0.0036232186758485,-0.0671801693144756,-0.0529771521051495,4.92396262895738e-61
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F9,Coagulation factor IX,42199,-0.0314857484259936,0.00191050071748315,-0.0352303298322605,-0.0277411670197266,1.95520164827305e-60
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRIP2,Cysteine-rich protein 2,42016,-0.0622206001179321,0.00378882843960206,-0.0696467038595522,-0.0547944963763121,5.11057844461411e-60
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD209,CD209 antigen,42171,0.066653030760403,0.00406440822912541,0.0586867906313172,0.0746192708894888,7.28901113228945e-60
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",41900,-0.156451073229534,0.00955126011246855,-0.175171543049972,-0.137730603409096,1.01769721543881e-59
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MET,Hepatocyte growth factor receptor,42158,0.0327909502248408,0.00200239269912657,0.0288662605345528,0.0367156399151289,1.06294604032806e-59
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL15,C-C motif chemokine 15,42310,-0.0742231597122095,0.0045362341073326,-0.0831141785625814,-0.0653321408618376,1.30439434777755e-59
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42296,-0.0660629835679661,0.00404642387545727,-0.0739939743638624,-0.0581319927720699,2.33191304823814e-59
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGR2,Anterior gradient protein 2 homolog,41740,-0.170576051741585,0.0104672916259446,-0.191091943328436,-0.150060160154734,3.99304628699183e-59
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39638,-0.0977900410575909,0.00601960765997009,-0.109588472071132,-0.0859916100440496,1.15376369287719e-58
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOC1,Apolipoprotein C-I,39959,0.065330691129629,0.00402753557529034,0.05743672140206,0.0732246608571981,1.62506033196996e-58
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM20A,Pseudokinase FAM20A,39958,-0.0477272235441152,0.00294541179003451,-0.0535002306525828,-0.0419542164356475,2.13283629924987e-58
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGAV,Integrin alpha-V,42262,0.0279328806052291,0.00173475533214853,0.024532760154218,0.0313330010562402,8.41232352895276e-58
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GDF15,Growth/differentiation factor 15,42310,-0.0766915259377096,0.00477109401184235,-0.0860428702009206,-0.0673401816744986,1.29970031174702e-57
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,POSTN,Periostin,39966,0.0636136532907976,0.00395521032930755,0.0558614410453548,0.0713658655362404,1.4353826017512e-57
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGA11,Integrin alpha-11,42119,0.0565530104037216,0.00352803995009635,0.0496380521015327,0.0634679687059104,2.67661389437807e-57
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL18R1,Interleukin-18 receptor 1,42296,-0.0548862058339612,0.00344421002239673,-0.0616368574778588,-0.0481355541900636,1.15465741899884e-56
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42181,-0.0618639899712846,0.00388518254954061,-0.0694789477683842,-0.054249032174185,1.42398361531475e-56
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANG,Angiogenin,42152,-0.0540722594621542,0.00341789035015194,-0.060771324548452,-0.0473731943758564,7.11703791080715e-56
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42145,0.0444843033501761,0.00282003858099683,0.0389570277314223,0.0500115789689299,1.45773195702024e-55
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GHR,Growth hormone receptor,39736,-0.0467386591575127,0.00296344729178925,-0.0525470158494196,-0.0409303024656057,1.93553025198899e-55
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HEG1,Protein HEG homolog 1,39736,-0.0454787828644557,0.00288964260160486,-0.0511424823636012,-0.0398150833653102,3.23370001835779e-55
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,39919,-0.0926972501566316,0.00589706403424015,-0.104255495663742,-0.081139004649521,4.26538520158228e-55
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD2AP,CD2-associated protein,42145,-0.103403874400076,0.00658469879385503,-0.116309884036032,-0.0904978647641202,4.36671195398683e-55
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,39929,0.0603574327664933,0.00385582207584489,0.0528000214978373,0.0679148440351492,1.17182850365721e-54
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,39990,0.0444729904548051,0.0028414004784142,0.0389038455171132,0.0500421353924969,1.19635110682314e-54
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42296,-0.0645191270344336,0.00414470977107461,-0.0726427581857398,-0.0563954958831273,3.57098214551089e-54
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42070,-0.173176500573664,0.0111440866209455,-0.195018910350717,-0.151334090796611,5.4878948752148e-54
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42181,-0.0364558362853885,0.00234713375808944,-0.0410562184512438,-0.0318554541195332,6.12181172465654e-54
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSO,Cathepsin O,42296,-0.0495076656769022,0.00319245522225698,-0.0557648779125259,-0.0432504534412785,8.81112342115463e-54
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMOT,Angiomotin,39736,-0.0622894039154938,0.0040168578959683,-0.0701624453915916,-0.0544163624393959,1.13059160816119e-53
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,39929,-0.124587544029138,0.00805715469082684,-0.140379567223159,-0.108795520835117,2.16289458018434e-53
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42249,-0.0558266236400015,0.00361755755054315,-0.0629170364390661,-0.048736210840937,2.80330708094568e-53
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPPC,C-type natriuretic peptide,42119,-0.0844988355548008,0.00548635466807909,-0.0952520907042358,-0.0737455804053658,4.50234135980816e-53
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINF1,Pigment epithelium-derived factor,39815,-0.0422137026232436,0.00274085488677274,-0.0475857782013182,-0.0368416270451691,5.55353392742929e-53
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41783,-0.0878817219261299,0.00572090975319895,-0.0990947050423998,-0.0766687388098599,8.49787640087823e-53
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFPI,Tissue factor pathway inhibitor,42152,0.0495115289534498,0.00325164164972482,0.0431383113199892,0.0558847465869105,6.32931670148033e-52
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLXNB2,Plexin-B2,42255,-0.0388390342236217,0.00255219036361034,-0.0438413273362979,-0.0338367411109454,7.16096174117022e-52
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39575,-0.109294102264012,0.00718202429629781,-0.123370869884756,-0.0952173346432684,9.09180760858409e-52
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOA1,Apolipoprotein A-I,39979,0.0434770545027689,0.00286941631914996,0.037852998517235,0.0491011104883029,2.33140603085026e-51
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TTR,Transthyretin,39862,-0.0393785638502319,0.00259883928599651,-0.044472288850785,-0.0342848388496787,2.34211331776868e-51
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MENT,Protein MENT,39736,0.0377638670123605,0.00249284534059444,0.0328778901447954,0.0426498438799256,2.49855353461325e-51
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRP,Gastrin-releasing peptide,39638,-0.0848106423277956,0.00560141770588094,-0.0957894210313222,-0.0738318636242689,2.84302955180315e-51
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,39919,-0.0844466420349133,0.00558115358287049,-0.0953857030573395,-0.0735075810124871,3.21721462824499e-51
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD248,Endosialin,39966,0.0640371564347298,0.00423716347461974,0.0557323160244751,0.0723419968449845,4.15301980872183e-51
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CKB,Creatine kinase B-type,39966,0.0905189309277143,0.006010998785391,0.0787373733083479,0.102300488547081,9.3079620083211e-51
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CST3,Cystatin-C,42184,-0.0450040209314904,0.00299157763623129,-0.0508675130985037,-0.0391405287644771,9.74388823882972e-51
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SORD,Sorbitol dehydrogenase,42204,-0.108060703094294,0.0071849169349884,-0.122143140286872,-0.093978265901717,1.02709217431375e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39958,-0.114464199408124,0.00760520026322159,-0.129370391924038,-0.0995580068922093,1.05042583352096e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTSS1,Protein MTSS 1,39930,-0.17588603450426,0.0116887107985805,-0.198795907669478,-0.152976161339042,1.10555703855019e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL13,C-X-C motif chemokine 13,42249,-0.0901338052514103,0.00599896407625127,-0.101891774840863,-0.0783758356619578,1.28029867458704e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42119,0.0558518203183592,0.00372205543649583,0.0485565916628274,0.063147048973891,1.7187425953145e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM3B,Protein FAM3B,42070,-0.0550325116974589,0.00367524670262061,-0.0622359952345953,-0.0478290281603225,2.76224608596833e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LEP,Leptin,42145,-0.108401181948214,0.00726714807111381,-0.122644792167597,-0.0941575717288306,6.39811622267391e-50
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42286,0.0933976513963098,0.00630976803691169,0.0810305060439629,0.105764796748657,3.40923516109188e-49
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39575,-0.0864637133998734,0.00586777430291596,-0.0979645510335887,-0.0749628757661582,1.11399900001375e-48
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41843,-0.126467476241416,0.00861677626948461,-0.143356357729606,-0.109578594753227,2.17388789012822e-48
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F11R,Junctional adhesion molecule A,42137,-0.0853303221495701,0.00581759490767446,-0.096732808168612,-0.0739278361305281,2.44022542278774e-48
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLAT,Tissue-type plasminogen activator,42272,-0.0783044193421299,0.00534171715615854,-0.0887741849682007,-0.0678346537160592,2.74115527905701e-48
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F7,Coagulation factor VII,42194,-0.0474285499941232,0.00323919393915223,-0.0537773701148616,-0.0410797298733849,3.52111952418717e-48
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,41997,-0.110260139700658,0.00753607806817864,-0.125030852714288,-0.0954894266870277,4.18665074206907e-48
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,39638,0.0868473341837381,0.0059309895423714,0.0752225946806901,0.098472073686786,4.21623230869008e-48
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SBSN,Suprabasin,39954,0.054272995012302,0.0037200033929347,0.04698178836215,0.061564201662454,8.85632855785857e-48
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,41930,-0.0693524793819254,0.00476452911388228,-0.0786909564451347,-0.0600140023187162,1.2404510445089e-47
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FUOM,Fucose mutarotase,39736,-0.0978718212368725,0.00676640184546948,-0.111133968853993,-0.0846096736197524,5.41918243267993e-47
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41900,-0.0839483077892877,0.00581774583759353,-0.095351089630971,-0.0725455259476044,7.59785977633069e-47
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSME1,Proteasome activator complex subunit 1,42002,-0.0545498150134638,0.00378885144944087,-0.0619759638543679,-0.0471236661725597,1.19597934094517e-46
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KYNU,Kynureninase,42296,-0.0682192237228488,0.00474748113699571,-0.0775242867513604,-0.0589141606943372,1.7490158748927e-46
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OMD,Osteomodulin,42185,0.0615618700434147,0.00428565452120536,0.0531619871818522,0.0699617529049772,1.88774367274067e-46
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH1,Cadherin-1,41697,-0.0602735416635193,0.00420791611157252,-0.0685210572422014,-0.0520260260848372,3.46634002061018e-46
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASET2,Ribonuclease T2,42258,-0.0397584716860998,0.00279853778765884,-0.0452436057499111,-0.0342733376222884,1.75069910194312e-45
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42296,0.037858988104408,0.00266677129998124,0.0326321163564448,0.0430858598523712,2.01973464637517e-45
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL23,C-C motif chemokine 23,42185,-0.0624926687755413,0.00441238323618493,-0.0711409399184637,-0.0538443976326188,3.25433264723441e-45
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AREG,Amphiregulin,42070,-0.057919768257278,0.00409462250898575,-0.06594522837489,-0.0498943081396659,4.19644461912783e-45
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPE,Carboxypeptidase E,42134,0.0576409789317802,0.00408934376596242,0.0496258651504939,0.0656560927130666,8.40471386448901e-45
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERMAP,Erythroid membrane-associated protein,39657,-0.0658505658480398,0.00467983733868255,-0.0750230470318576,-0.056678084664222,1.38455379839704e-44
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REG4,Regenerating islet-derived protein 4,42144,-0.0747262280466933,0.00532719460353746,-0.0851675294696267,-0.0642849266237599,2.16877004132943e-44
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPB1,Carboxypeptidase B,42310,-0.0907709360499722,0.00648116283804434,-0.103474015212539,-0.0780678568874053,2.91727273908886e-44
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPIND1,Heparin cofactor 2,39959,-0.0426098965115617,0.00305548051983005,-0.0485986383304286,-0.0366211546926948,7.70687180163361e-44
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42119,-0.0711972088194493,0.00511338390502736,-0.0812194412733029,-0.0611749763655957,9.11726594875921e-44
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGRN,Agrin,42185,-0.0519878324373416,0.00374442654122037,-0.0593269084581335,-0.0446487564165497,1.56899414109905e-43
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPY30,Protein dpy-30 homolog,42216,-0.087090453771348,0.00628202379620105,-0.099403220411902,-0.0747776871307939,2.08007934709192e-43
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,39736,-0.0544860306355057,0.00393342888728408,-0.0621955512545825,-0.046776510016429,2.82333025351485e-43
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA4,Kallistatin,39802,-0.0338894438076617,0.00245561078508362,-0.0387024409464256,-0.0290764466688978,5.65798335582741e-43
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAST,Gastrin,39929,-0.188549532600413,0.0137203224084361,-0.215441364520948,-0.161657700679878,1.24304112968607e-42
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL32,Interleukin-32,42119,0.0632486616161462,0.00464335360116023,0.0541476885578722,0.0723496346744202,5.65830770076002e-42
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRSS2,Trypsin-2,42217,-0.0813684917815774,0.00597455970662431,-0.093078628806561,-0.0696583547565938,5.800265246813e-42
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42070,-0.052586297812987,0.00387233239477168,-0.0601760693067395,-0.0449965263192345,9.90297810574642e-42
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42113,-0.0734640385577434,0.00541839781343018,-0.0840840982720666,-0.0628439788434203,1.32438746900291e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42070,-0.0586263279404409,0.00433016198992342,-0.0671134454406908,-0.050139210440191,1.71758067122255e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UMOD,Uromodulin,42274,0.0755665428444089,0.00562625962607681,0.0645390739772984,0.0865940117115195,7.22098709870787e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,39736,-0.107630689500184,0.00801853510101722,-0.123347018298178,-0.0919143607021902,9.22406961183586e-41
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF23,Fibroblast growth factor 23,42250,-0.0705484829945851,0.005289964137318,-0.0809168127037284,-0.0601801532854418,2.54498434095815e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41913,-0.061202819518188,0.00459157031340336,-0.0702022973324586,-0.0522033417039174,2.82918824858614e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42145,-0.0472984848491261,0.00354888698369391,-0.0542543033371662,-0.0403426663610861,2.86418513137726e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFHR4,Complement factor H-related protein 4,39945,0.102160327643061,0.00766417479267522,0.0871385450494176,0.117182110236704,3.12456329375622e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42137,-0.073861297811463,0.00556674977450082,-0.0847721273694847,-0.0629504682534414,6.27554689430387e-40
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENO3,Beta-enolase,39638,-0.0872560713843915,0.00661087981820683,-0.100213395828077,-0.0742987469407061,1.77239766770549e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD5,T-cell surface glycoprotein CD5,42239,-0.0490883197872581,0.00372606169345239,-0.0563914007064248,-0.0417852388680914,2.14596129277287e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTGR1,Prostaglandin reductase 1,39958,-0.115318720937607,0.00878263239064254,-0.132532680423267,-0.0981047614519477,4.25042991643792e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL6,C-X-C motif chemokine 6,42296,-0.103520862563196,0.0078950453801423,-0.118995151508275,-0.0880465736181174,4.82148967455269e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42123,-0.13000222359946,0.00994083562692793,-0.149486261428239,-0.110518185770681,7.60718379632002e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB6A,Ras-related protein Rab-6A,42119,0.0605997754768401,0.00463865192374147,0.0515080177063068,0.0696915332473734,9.06621921878228e-39
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42137,-0.0571166381128872,0.00441654095123837,-0.0657730583773144,-0.04846021784846,4.95964555785078e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42123,-0.0370050613159403,0.00286217562936751,-0.0426149255495006,-0.03139519708238,5.18650934067941e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASE4,Ribonuclease 4,39645,-0.0377846454158846,0.00292233405886015,-0.0435124201712505,-0.0320568706605187,5.7739339104364e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPO,Erythropoietin,42119,-0.0984844630669639,0.00762286424150658,-0.113425276980317,-0.083543649153611,5.8516087481005e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSB,Cathepsin B,42153,0.0685741434019652,0.00530863947191359,0.0581692100370145,0.0789790767669158,6.00784904339625e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,XCL1,Lymphotactin,42262,-0.0737262351036155,0.00571152461703403,-0.0849208233530022,-0.0625316468542288,6.72737236076866e-38
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PIGR,Polymeric immunoglobulin receptor,41987,-0.0496899295050585,0.00388071450791748,-0.0572961299405767,-0.0420837290695402,2.56685276736352e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HJV,Hemojuvelin,39934,-0.0565626880451015,0.00443110776587969,-0.0652476592662257,-0.0478777168239773,4.63139255475485e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HEPH,Hephaestin,39958,-0.0373029363085966,0.00293154341774718,-0.0430487614073811,-0.0315571112098122,7.6925568872101e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEMA3F,Semaphorin-3F,42145,-0.0354501034823222,0.00279124758695323,-0.0409209487527505,-0.0299792582118939,9.52313470297468e-37
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSN,Gelsolin,39943,0.0253044415825403,0.00199205739187732,0.0214000090944607,0.0292088740706199,1.0161085441935e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YES1,Tyrosine-protein kinase Yes,42070,-0.151608845209918,0.0119487009616935,-0.175028299094838,-0.128189391324999,1.1129499523816e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42016,-0.0538934029091852,0.00425005702759085,-0.0622235146832633,-0.0455632911351071,1.22852552456506e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42262,-0.0443709834066107,0.00349959226985406,-0.0512301842555247,-0.0375117825576967,1.24480434452472e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41843,-0.0906355030140217,0.00714883305005783,-0.104647215792135,-0.0766237902359083,1.27209153383468e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,39575,-0.0809718746277177,0.00639211447280634,-0.0935004189944181,-0.0684433302610172,1.6126873377938e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LSP1,Lymphocyte-specific protein 1,42119,-0.0535818453424169,0.00423298463283953,-0.0618784952227823,-0.0452851954620514,1.62432269811961e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42016,-0.096696234760963,0.00764122038223742,-0.111673026710148,-0.0817194428117776,1.70616560501612e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCHE,Cholinesterase,39806,-0.0358019625947366,0.00282783161125632,-0.041344512552799,-0.0302594126366742,1.73754778179646e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42145,-0.101640486385766,0.00803814323132506,-0.117395247119163,-0.0858857256523692,1.92084083568221e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADM,Pro-adrenomedullin,42262,-0.0345862735718862,0.00274062843092109,-0.0399579052964915,-0.0292146418472808,2.61707344480906e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GUSB,Beta-glucuronidase,42211,-0.0804896127712045,0.00638197575911874,-0.0929982852590772,-0.0679809402833318,2.89160790117629e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH2,Cadherin-2,42145,-0.0465271440143041,0.00369431284624707,-0.0537679971929484,-0.0392862908356599,3.62071415095097e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42070,-0.166170201348886,0.0132107121749758,-0.192063197211838,-0.140277205485933,4.42493095351244e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42119,-0.0863268441840378,0.00687626625503756,-0.0998043260439114,-0.0728493623241641,5.97213288503231e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM3C,Protein FAM3C,42129,-0.0399183213939321,0.00318324892510401,-0.0461574892871359,-0.0336791535007282,7.12774277475361e-36
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42217,-0.05595151920015,0.00448210111011218,-0.0647364373759699,-0.0471666010243301,1.44113378265968e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,39820,-0.0433230327899341,0.00347227031047975,-0.0501286825984744,-0.0365173829813938,1.71661680719179e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OCLN,Occludin,39934,-0.0579976864679067,0.0046579189972629,-0.067127207702542,-0.0488681652332714,2.33918236254365e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42094,-0.0882432625325168,0.00709173184199061,-0.102143056942818,-0.0743434681222152,2.3821710595396e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGR3,Anterior gradient protein 3,41827,-0.0764992881131047,0.00620092657938695,-0.0886531042087031,-0.0643454720175063,8.91827647491758e-35
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,41843,-0.144049708454736,0.011692772722682,-0.166967542991193,-0.121131873918279,1.10075138521671e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PXN,Paxillin,41839,-0.0659881498806978,0.00537201103215308,-0.0765172915037178,-0.0554590082576778,1.70754763938922e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHMP6,Charged multivesicular body protein 6,39958,-0.0737649692086666,0.00602243446621334,-0.0855689407624448,-0.0619609976548885,2.81948976514424e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GZMA,Granzyme A,42296,-0.043386148916369,0.00355160419434947,-0.050347293137294,-0.0364250046954441,3.84686307297995e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42119,-0.0354952707457261,0.00291063427995345,-0.0412001139344349,-0.0297904275570173,4.98567218772881e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42249,-0.0664924433029837,0.00545258065916207,-0.0771795013949414,-0.0558053852110261,4.98779626610885e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42056,-0.134640208822523,0.0110498469722539,-0.15629790888814,-0.112982508756905,5.6553227932572e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYH9,Myosin-9,39966,-0.145177299125147,0.0119328942400092,-0.168565771835565,-0.121788826414729,7.64056115299678e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42070,0.0248735991521585,0.00204849459990087,0.0208585497363528,0.0288886485679642,9.44977081448946e-34
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUMB,Protein numb homolog,39657,-0.10701088248992,0.00882645458415932,-0.124310733474872,-0.0897110315049673,1.28943855067341e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42185,-0.0377330949848774,0.00311798655946363,-0.0438443486414261,-0.0316218413283287,1.53803511796738e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,39929,-0.0613355705863726,0.0050665611656011,-0.0712660304709507,-0.0514051107017944,1.58143754067269e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSME2,Proteasome activator complex subunit 2,41955,-0.0445089128891148,0.00368623742556924,-0.0517339382432305,-0.0372838875349991,2.15365835282708e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42284,-0.0489354982541968,0.00406595945583303,-0.0569047787876296,-0.0409662177207641,3.40482311615331e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EGFR,Epidermal growth factor receptor,42310,0.0200684582657738,0.00167110259915267,0.0167930971714346,0.023343819360113,4.66222049542819e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACAN,Aggrecan core protein,41994,0.0343888033761767,0.00286765184457276,0.0287682057608141,0.0400094009915393,5.7737412353064e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL11,Eotaxin,42296,-0.0468059214784693,0.0039130439569488,-0.054475487634089,-0.0391363553228497,8.23454342803912e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",39934,-0.0800226396901739,0.00668746775355488,-0.0931300764871415,-0.0669152028932063,8.43168886325508e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NECTIN2,Nectin-2,42129,-0.0387358313419622,0.0032407147643793,-0.0450876322801457,-0.0323840304037788,9.17008812593265e-33
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42070,-0.121964409744035,0.0102365344627829,-0.14202801729109,-0.101900802196981,1.44744750640994e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBKS,Ribokinase,41830,-0.0616579875759301,0.00518026545741033,-0.0718113078724543,-0.0515046672794058,1.68312033237751e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFNA4,Ephrin-A4,41992,-0.0401969222513662,0.00338020302641483,-0.0468221201831393,-0.0335717243195931,1.89998056973495e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42098,0.0805614979891641,0.00677944968280834,0.0672737766108597,0.0938492193674684,2.09945568878272e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCTN1,Dynactin subunit 1,42262,-0.0792035749151245,0.00669531359258765,-0.0923263895565963,-0.0660807602736527,3.93284731061329e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,41843,-0.0441055875348963,0.00374236747606487,-0.0514406277879834,-0.0367705472818091,6.69341409182024e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42137,0.0332366546475873,0.0028213792161539,0.0277067513839257,0.038766557911249,7.05817868972143e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPA1,Carboxypeptidase A1,42310,-0.0795815378392416,0.00677269782321182,-0.0928560255727368,-0.0663070501057464,9.98339140555703e-32
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39958,-0.0941643813579189,0.00801164973986733,-0.109867214848059,-0.078461547867779,1.03479200946633e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39657,-0.0854199711566093,0.00728439871529793,-0.0996973926385932,-0.0711425496746253,1.43474223745118e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAXX,Protein PAXX,39736,-0.0571230316679825,0.0048731785270332,-0.0666744615809676,-0.0475716017549975,1.50753634057664e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42070,-0.0543319565784536,0.00464063742447729,-0.0634276059304291,-0.0452363072264781,1.65084832225341e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH17,Cadherin-17,42145,-0.0837147087468627,0.00715157422132213,-0.0977317942206541,-0.0696976232730714,1.68837975308388e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41843,-0.0597474762978342,0.00511177040662443,-0.0697665462948181,-0.0497284063008504,2.08843669913913e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42144,-0.0385842638807327,0.00330366754203401,-0.0450594522631194,-0.0321090754983461,2.30106686420883e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXLNA,Alpha-taxilin,42016,-0.106838410948624,0.00920919733188305,-0.124888437719114,-0.0887883841781329,5.70562716682174e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42070,-0.0819971250913022,0.00706976810845099,-0.0958538705838661,-0.0681403795987382,5.89888485813227e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PVR,Poliovirus receptor,42249,-0.0453947724339118,0.00391765342851399,-0.0530733731537992,-0.0377161717140244,6.67273521300531e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42145,-0.0525441031535998,0.00454175671903211,-0.0614459463229028,-0.0436422599842969,8.24698874773013e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDHR2,Cadherin-related family member 2,42070,-0.0797441979722005,0.00689939999134356,-0.0932670219552339,-0.0662213739891671,9.37765920900494e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BECN1,Beclin-1,39638,-0.0724211221177298,0.00626264149447499,-0.0846958994469008,-0.0601463447885588,9.43059818553519e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH15,Cadherin-15,42230,-0.0836880908139694,0.00724404460603325,-0.0978864182417946,-0.0694897633861442,9.94810972831332e-31
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,39919,-0.0861832750112343,0.00748055292409818,-0.100845158742467,-0.0715213912800019,1.53060352633624e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TOP2B,DNA topoisomerase 2-beta,39657,-0.0972727368575342,0.00846784821084749,-0.113869719350795,-0.0806757543642732,2.2717049322188e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCAN,Brevican core protein,42016,0.0414406393253961,0.00361222434377399,0.0343606796115991,0.0485205990391931,2.51611692591454e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42262,-0.0441667965032025,0.00385350712381859,-0.0517196704658869,-0.0366139225405181,2.83308848312492e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SARG,Specifically androgen-regulated gene protein,39915,-0.132590621549704,0.0115704774174695,-0.155268757287944,-0.109912485811464,3.09717570113221e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DTYMK,Thymidylate kinase,39958,-0.0809496270818783,0.00707572493084828,-0.0948180479463409,-0.0670812062174156,3.83747037918543e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL12B,Interleukin-12 subunit beta,42296,-0.0656330770198108,0.00574139119009181,-0.0768862037523907,-0.0543799502872308,3.98300697522902e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,41913,-0.0847170260030476,0.00741330641043277,-0.0992471065674958,-0.0701869454385994,4.20009510583041e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SULT2A1,Bile salt sulfotransferase,42119,-0.0703096631903331,0.00615475661265168,-0.0823729861511304,-0.0582463402295358,4.37801546458059e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL12A_IL12B,Interleukin-12,42070,-0.0921203322318423,0.0080696178237951,-0.107936783166481,-0.0763038812972039,4.797611790367e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39930,-0.0339028155759129,0.00297342970977017,-0.0397307378070624,-0.0280748933447634,5.95535590839188e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCXR,L-xylulose reductase,42181,-0.064711601939264,0.0056835101886325,-0.0758512819089837,-0.0535719219695443,6.72046222809773e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EEF1D,Elongation factor 1-delta,39958,-0.109279145412085,0.00959338193638728,-0.128082174007404,-0.090476116816766,6.72798062595931e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IDUA,Alpha-L-iduronidase,42262,-0.0562538739236084,0.00494177307638,-0.0659397491533132,-0.0465679986939036,6.9024461258903e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42119,-0.0452544443877571,0.00397950197592236,-0.0530542682605649,-0.0374546205149493,7.88667194545139e-30
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,39657,-0.149676587000528,0.0131900014695557,-0.175528989880857,-0.123824184120199,1.1105358079997e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK14,Kallikrein-14,42262,0.0550668445842233,0.00485749939799235,0.0455461457641583,0.0645875434042883,1.1745347264548e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42181,-0.108682539385184,0.009589374980668,-0.127477714347293,-0.0898873644230743,1.21477938808893e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MLN,Promotilin,42119,-0.105880806005085,0.00935089996783052,-0.124208569942033,-0.0875530420681371,1.3710957033409e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42217,0.0509740427528416,0.00450536302609779,0.0421435312216899,0.0598045542839932,1.51418368952709e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42119,-0.0780373037236539,0.00690609412656489,-0.0915732482117211,-0.0645013592355868,1.78345206554556e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42310,0.0297344609631891,0.0026335819112562,0.024572640417127,0.0348962815092513,1.97172089136575e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THOP1,Thimet oligopeptidase,42081,-0.0369825706528588,0.00328442863487301,-0.0434200507772099,-0.0305450905285077,2.79441739759756e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39657,-0.0548468519611263,0.0048687558821207,-0.0643896134900829,-0.0453040904321698,2.81772564144366e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,39990,-0.0256704883468389,0.00228442028321225,-0.0301479521019349,-0.0211930245917429,3.81047533441143e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42217,-0.0503542478746286,0.00448487927681981,-0.0591446112571954,-0.0415638844920617,4.00893170360704e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42231,-0.0357845391782256,0.00319739477511746,-0.0420514329374559,-0.0295176454189954,5.98195322553656e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTSS2,Protein MTSS 2,39919,-0.118237761293185,0.0105852069113684,-0.138984766839467,-0.0974907557469025,8.0798046729246e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42070,-0.0699448805370141,0.00626731818564855,-0.0822288241808853,-0.057660936893143,8.53365468067865e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EGLN1,Egl nine homolog 1,42119,-0.0652325755464668,0.00585158314581799,-0.07670167851227,-0.0537634725806635,9.78813947198194e-29
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,39657,-0.0604204296829753,0.0054298436824673,-0.0710629233006112,-0.0497779360653394,1.3080987798428e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42137,-0.0360730157784778,0.0032488571022346,-0.0424407756988576,-0.029705255858098,1.60534460250634e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42119,-0.0573671195314577,0.00517411576364263,-0.0675083864281972,-0.0472258526347181,1.91681511504794e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42070,-0.0972200281955981,0.0087749923430611,-0.114419013187998,-0.0800210432031983,2.09909406464423e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFC1,Cryptic protein,41843,-0.0555806669439911,0.00501752836903913,-0.0654150225473078,-0.0457463113406744,2.15439249437248e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFRA1,GDNF family receptor alpha-1,42247,-0.0331348140324368,0.00299351878506042,-0.0390021108511553,-0.0272675172137184,2.34556260581725e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFX1,Transcriptional repressor NF-X1,39575,-0.0787665648925741,0.00711967964208804,-0.0927211369910667,-0.0648119927940816,2.66929135262786e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOMO1,Nodal modulator 1,42137,-0.0269320477728872,0.00243765813793435,-0.0317098577232386,-0.0221542378225359,2.94910009626468e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42217,0.0446980738082417,0.00404744664371527,0.0367650783865597,0.0526310692299236,3.10464696850517e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAT,Linker for activation of T-cells family member 1,42296,-0.0873998904064452,0.00794193391738913,-0.102966080884528,-0.0718336999283625,4.74552085336871e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,39919,-0.0718439831072719,0.00653235223561113,-0.0846473934890697,-0.0590405727254741,5.40297470141668e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,41839,-0.060706957746087,0.00553282045663926,-0.0715512858411,-0.0498626296510741,6.85895727969421e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42016,-0.0667154662502317,0.0060923986232799,-0.0786565675518603,-0.0547743649486031,8.65318261060377e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFI,Complement factor I,39979,-0.0223563590807855,0.00204117478763351,-0.0263570616645471,-0.0183556564970238,8.87547305065562e-28
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGBL1,Integrin beta-like protein 1,39966,-0.0453026411864383,0.00414051530983955,-0.0534180511937238,-0.0371872311791528,1.00545027762299e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42100,-0.0228829048841962,0.00209656020525432,-0.0269921628864946,-0.0187736468818977,1.28168889293073e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TREH,Trehalase,39966,-0.0861940363747655,0.00791745524561353,-0.101712248656168,-0.070675824093363,1.82458497659789e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,39657,-0.0994761493066337,0.00913892885099461,-0.117388449854583,-0.0815638487586843,1.87479878554883e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LEPR,Leptin receptor,42145,0.0358320510403109,0.00329716384866347,0.0293696098969305,0.0422944921836913,2.13513557029922e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STC1,Stanniocalcin-1,42249,-0.0521214981128156,0.00480208763770579,-0.061533589882719,-0.0427094063429122,2.4703384765876e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A4,Protein S100-A4,42181,-0.0634557356808627,0.00587309161565853,-0.0749669952475534,-0.051944476114172,4.22443962194948e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42047,-0.0294149923659503,0.00272787824775815,-0.0347616337315563,-0.0240683510003444,5.33426411571661e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CES3,Carboxylesterase 3,42070,-0.0803303560857493,0.00745013132707615,-0.0949326134868185,-0.06572809868468,5.37206507507157e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FYB1,FYN-binding protein 1,42115,-0.104513990864898,0.00969413612964875,-0.12351449767901,-0.0855134840507865,5.44051302079768e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASPN,Asporin,39958,0.031529535995558,0.00292873355300774,0.0257892182316628,0.0372698537594532,6.74625012056349e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42123,-0.0447127035028376,0.00415524065330096,-0.0528569751833075,-0.0365684318223677,6.79079897551623e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSE,Cathepsin E,39736,-0.0601853940624378,0.00559196164988608,-0.0711456388962145,-0.0492251492286611,6.98946512446939e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100P,Protein S100-P,41900,-0.0602835372763602,0.00560630101322387,-0.071271887262279,-0.0492951872904414,7.4110405501245e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39929,-0.0788820236180484,0.00734744869863575,-0.0932830230673745,-0.0644810241687224,9.27727211799006e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42119,-0.119521059665256,0.0111390598176468,-0.141353616907843,-0.0976885024226681,9.44032380761707e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,41843,-0.0823969982743117,0.00768072377816455,-0.0974512168795142,-0.0673427796691092,9.70938136446964e-27
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARF6,ADP-ribosylation factor 6,39930,-0.122336614756251,0.0114491950446866,-0.144777037043837,-0.0998961924686654,1.59719436127761e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL16,Pro-interleukin-16,42296,-0.0470678104586537,0.00443345514933823,-0.0557573825513567,-0.0383782383659508,3.15791411500376e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCARB2,Lysosome membrane protein 2,41777,-0.0364819703360615,0.00345441387165651,-0.0432526215245083,-0.0297113191476147,5.73908050566794e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C19orf12,Protein C19orf12,41839,-0.073951577013295,0.00700497609191844,-0.0876813301534552,-0.0602218238731349,5.977980116558e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EZR,Ezrin,42249,-0.0268116490068935,0.00254826726247856,-0.0318062528413515,-0.0218170451724355,8.62991953781631e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,41992,-0.0991111843685681,0.00942015387771334,-0.117574685968886,-0.08064768276825,8.69817788279645e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42137,-0.033253927404438,0.00316305258833292,-0.0394535104775705,-0.0270543443313055,9.43361586503424e-26
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39575,-0.0823652471812294,0.00788325020766641,-0.0978164175882556,-0.0669140767742032,1.96659129447796e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPOCK1,Testican-1,42016,0.0285633521592059,0.00273533183876739,0.0232021017552218,0.03392460256319,1.98742177808989e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASE6,Ribonuclease K6,39937,-0.0353993177574984,0.00340278250767954,-0.0420687714725503,-0.0287298640424465,3.1184840480401e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BACH1,Transcription regulator protein BACH1,42119,-0.0816872201959114,0.00785616825217169,-0.0970853099701679,-0.0662891304216549,3.15686212231507e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39909,-0.0858172478684801,0.00825281024743126,-0.101992755953445,-0.0696417397835148,3.27000013420767e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,39951,0.0162551674903872,0.00156363391871443,0.0131904450097069,0.0193198899710675,3.36281446391219e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP85,Centrosomal protein of 85 kDa,41843,-0.0709760293066463,0.00683011027805086,-0.084363045451626,-0.0575890131616666,3.38280207504171e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA6,Carbonic anhydrase 6,42103,0.0680486904373987,0.00656352503816635,0.0551841813625926,0.0809131995122047,4.319437978052e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FSTL3,Follistatin-related protein 3,42084,-0.0355176809454213,0.00342899868557003,-0.0422385183691385,-0.028796843521704,4.77682691785261e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42310,-0.0545516963714256,0.00527315460214409,-0.064887079391628,-0.0442163133512232,5.43863859787464e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39958,-0.0324139888409531,0.00313348926220717,-0.0385556277948792,-0.0262723498870271,5.72781842603793e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39934,-0.108849741129895,0.0105253963475921,-0.129479517971175,-0.0882199642886143,5.89598689303419e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42137,0.0431506358670512,0.00417466470050029,0.0349682930540706,0.0513329786800317,5.97729127823423e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42129,-0.0827709843833985,0.00800895641879032,-0.0984685389642275,-0.0670734298025695,6.07213527731393e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FEN1,Flap endonuclease 1,41843,-0.0695975119665022,0.00674704432157782,-0.0828217188367947,-0.0563733050962096,7.46568526922607e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42249,-0.0735802146704758,0.00713572871537842,-0.0875662429526176,-0.0595941863883341,7.71001893094779e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA5,Plasma serine protease inhibitor,39835,-0.0326363901997326,0.00316757410583133,-0.038844835447162,-0.0264279449523032,8.7784259220256e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VEGFA,Vascular endothelial growth factor A,42253,-0.0611385494244914,0.00593719307096508,-0.072775447843583,-0.0495016510053998,8.90505774073358e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42145,-0.0937762506741464,0.00911358893186205,-0.111638884980596,-0.0759136163676967,9.67004155148504e-25
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41900,0.0237896199279245,0.00231669197708312,0.0192489036528416,0.0283303362030075,1.20406922850212e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39638,-0.0917888217639448,0.00894255402437608,-0.109316227651722,-0.0742614158761677,1.316777014233e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42185,-0.0424415168745431,0.00413766124044971,-0.0505513329058245,-0.0343317008432617,1.34806458689097e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC16A1,Monocarboxylate transporter 1,41839,-0.0593623584163978,0.00578800165636985,-0.0707068416628827,-0.0480178751699129,1.3730133785321e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IKBKG,NF-kappa-B essential modulator,42119,-0.0981114315223977,0.00957401834207116,-0.116876507472857,-0.0793463555719382,1.49064459838518e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,39575,-0.038870770509621,0.00379425180372299,-0.0463075040449181,-0.031434036974324,1.61260427015435e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42310,-0.0384534498245748,0.00375626413703103,-0.0458157275331556,-0.031091172115994,1.65582895788548e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WIF1,Wnt inhibitory factor 1,42262,0.0361538896020573,0.00353213156510254,0.0292309117344563,0.0430768674696583,1.68162585097053e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42070,-0.0394110964900872,0.00386070843334613,-0.0469780850194456,-0.0318441079607288,2.23399761196199e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSS,Cathepsin S,39358,-0.0260639145353538,0.0025564332830092,-0.0310745237700518,-0.0210533053006558,2.68015567071107e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42166,-0.0904826940292392,0.00888203362652661,-0.107891479937231,-0.073073908121247,2.7672607033849e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLSCR3,Phospholipid scramblase 3,39911,-0.0618044730167028,0.00607134481934686,-0.0737043088626226,-0.0499046371707829,3.10718978729121e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CBS,Cystathionine beta-synthase,39638,-0.0554379664403448,0.00545170305011181,-0.066123304418564,-0.0447526284621257,3.48776812434632e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42070,-0.0651936869490179,0.00641554748610146,-0.0777681600217767,-0.052619213876259,3.5876062593586e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42189,0.0365578173925743,0.00360874001440452,0.0294846869643415,0.0436309478208072,4.93168063557937e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42119,-0.10614115984674,0.0104808055119099,-0.126683538650084,-0.0855987810433969,5.0975659813573e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42083,-0.0336025735281591,0.00331951755835115,-0.0401088279425274,-0.0270963191137908,5.33667071537806e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42137,0.0553232090110141,0.00546529114649872,0.0446112383638766,0.0660351796581515,5.33691513089337e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42070,0.0453425885161825,0.00448282485423023,0.0365562518018912,0.0541289252304737,5.78821184040438e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42123,0.0367140354286027,0.00363744062606764,0.0295846518015102,0.0438434190556953,7.18052763858515e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,39919,-0.0845611295943311,0.00838036642200148,-0.100986647781454,-0.0681356114072082,7.68437809849018e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39929,-0.088598817514526,0.00879208451193557,-0.10583130315792,-0.0713663318711323,8.78395811431354e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL3A1,Collagen alpha-1(III) chain,39966,-0.0249870668146898,0.00248138096796991,-0.0298505735119108,-0.0201235601174688,9.44663067845082e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42119,-0.06310797011424,0.00627066000757775,-0.0753984637290923,-0.0508174764993876,9.66004199315712e-24
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APLP1,Amyloid-like protein 1,42145,0.053636138238522,0.00533485991261991,0.0431798128097869,0.064092463667257,1.06925326234276e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42144,-0.0366425313261321,0.00364788296973556,-0.0437923819468138,-0.0294926807054504,1.17098697745064e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HYAL1,Hyaluronidase-1,42077,-0.0242909588068903,0.00241857611273864,-0.0290313679878581,-0.0195505496259226,1.18848911545738e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL9,C-X-C motif chemokine 9,42185,-0.068388611331292,0.00681105116368852,-0.0817382716121215,-0.0550389510504625,1.21895236923299e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41913,-0.0648379729047401,0.00645939935251717,-0.0774983956356738,-0.0521775501738065,1.26191573815763e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTDH,Protein LYRIC,39657,-0.100837980684369,0.0100467925591582,-0.120529694100319,-0.0811462672684187,1.32482842154826e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42119,-0.0910774025979921,0.00909393846760959,-0.108901521994507,-0.0732532832014773,1.57895155082336e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42032,-0.0302109882718343,0.00301704760600644,-0.0361244015796069,-0.0242975749640616,1.60887425746471e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42119,-0.03962849030025,0.00396581442789332,-0.0474014865789209,-0.0318554940215791,1.98165197534613e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCAN,Neurocan core protein,42249,0.0392714312718166,0.00393100722783463,0.0315666571052607,0.0469762054383724,2.02530295785195e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUCB2,Nucleobindin-2,42231,-0.0392120857480467,0.00393198238711837,-0.0469187712267987,-0.0315054002692947,2.41520349165903e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSNL1,Visinin-like protein 1,39929,-0.0406372951527417,0.0040812903328665,-0.04863662420516,-0.0326379661003233,2.92963275275222e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42129,-0.0526985785813208,0.00529743191106694,-0.063081545127012,-0.0423156120356295,3.09355415062831e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42137,-0.0303719323071873,0.0030559739103771,-0.0363616411715264,-0.0243822234428482,3.39723038355064e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42259,-0.0847726731342317,0.00854639643638145,-0.101523610149539,-0.068021736118924,4.11560812785205e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HLA_E,,42119,-0.0304943864468935,0.00307529604110955,-0.0365219666874682,-0.0244668062063187,4.25631294738335e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42216,-0.059862933091063,0.00604753809631556,-0.0717161077598415,-0.0480097584222845,5.04251899205206e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YTHDF3,YTH domain-containing family protein 3,41913,-0.0887490982785525,0.00896577831286457,-0.106322023771767,-0.0711761727853379,5.06693071555533e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASAH2,Neutral ceramidase,42016,-0.0551326934458136,0.0055729085691209,-0.0660555942412905,-0.0442097926503366,5.35246413244444e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42119,-0.107607363651007,0.0109041263890747,-0.128979451373593,-0.0862352759284207,6.81266733313364e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39930,-0.0535151382784236,0.00542352369256147,-0.064145244715844,-0.0428850318410031,7.13903806846568e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,41839,-0.0303872552071382,0.00308179473340794,-0.0364275728846178,-0.0243469375296587,7.41988259553035e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TDRKH,Tudor and KH domain-containing protein,41839,-0.0879644845546466,0.00892722393065355,-0.105461843458728,-0.0704671256505656,7.93076930170039e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39638,-0.0392594100347593,0.00398411677509387,-0.0470682789139432,-0.0314505411555753,8.18201567974554e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCR,Breakpoint cluster region protein,42119,-0.0951519805391759,0.00967700112240523,-0.11411890273909,-0.0761850583392617,9.69395802264294e-23
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42119,-0.0634639393870989,0.00648655440944524,-0.0761775860296116,-0.0507502927445863,1.56793668862287e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,41843,-0.0652916145134327,0.00668866023991876,-0.0784013885836734,-0.0521818404431919,1.95959336379471e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42145,-0.0642392467473341,0.00658659244509348,-0.0771489679397173,-0.0513295255549509,2.12153875761749e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP43,Centrosomal protein 43,41797,-0.0720044077371168,0.00738553614358987,-0.0864800585785529,-0.0575287568956806,2.20847855952263e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39862,-0.0299576046578997,0.00307500820293291,-0.0359846207356482,-0.0239305885801512,2.43832246047041e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42089,0.0265301996632137,0.00272470787068749,0.0211897722366663,0.0318706270897612,2.48578947154517e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTRB1,Chymotrypsinogen B,42137,-0.0595536277557855,0.00612592864811988,-0.0715604479061004,-0.0475468076054705,2.88531862618476e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,41843,-0.0677730667203734,0.00697208208058668,-0.0814383475983233,-0.0541077858424235,2.9224717746978e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42119,-0.0598918144454296,0.00617035407257262,-0.0719857084276719,-0.0477979204631873,3.3463313394578e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNST,Consortin,42145,-0.110936836444884,0.0114307032910508,-0.133341014895344,-0.0885326579944248,3.38522608943468e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42310,-0.06731875118746,0.00696413261569793,-0.0809684511142279,-0.053669051260692,4.91994754964391e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R9B,Neurabin-2,42296,-0.0960291300892788,0.0099401862757441,-0.115511895189737,-0.0765463649888204,5.20537325840581e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDC27,Cell division cycle protein 27 homolog,41843,-0.0617537436719478,0.00639546932372533,-0.0742888635464494,-0.0492186237974461,5.48542416197277e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERBIN,Erbin,42070,-0.103319564979664,0.010753712651672,-0.124396841776941,-0.0822422881823865,8.70440581634829e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TJAP1,Tight junction-associated protein 1,42181,-0.0837322522816384,0.00871920011939675,-0.100821884515656,-0.0666426200476208,9.08732698751552e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42016,-0.0528637534326534,0.00550665305525017,-0.0636567934209437,-0.042070713444363,9.39244192193712e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42070,-0.0854787601980931,0.00890632497898184,-0.102935157156898,-0.0680223632392887,9.61011421476109e-22
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42145,-0.0279317837670434,0.00291660598947301,-0.0336483315064105,-0.0222152360276763,1.1720940374239e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42129,-0.124473592483476,0.0130081727110343,-0.149969610997104,-0.0989775739698489,1.26520101578695e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS9,Galectin-9,42129,-0.0315077901470169,0.00329337042156524,-0.0379627961732848,-0.0250527841207491,1.28777356227648e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39958,-0.063018449664209,0.00659632008311176,-0.0759472370271081,-0.05008966230131,1.50962184066023e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADD1,Alpha-adducin,39736,-0.0702245735836347,0.00735760481345614,-0.0846454790180087,-0.0558036681492607,1.65294443495459e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AXIN1,Axin-1,42119,-0.0963537137302691,0.0101173623706238,-0.116183743976692,-0.0765236834838464,1.95283077071274e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFA,Protransforming growth factor alpha,42119,-0.0451745665183872,0.00474351573385737,-0.0544718573567476,-0.0358772756800267,1.95590612284358e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,41843,-0.0493203015229766,0.00517999349459635,-0.0594730887723855,-0.0391675142735678,2.00255856459611e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FMNL1,Formin-like protein 1,41839,-0.063124650380734,0.00663698349956653,-0.0761331380398844,-0.0501161627215837,2.20890784514226e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42249,0.0464758462444175,0.00488939548795445,0.0368926310880268,0.0560590614008082,2.31945672911962e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP20,Centrosomal protein 20,41843,-0.0749231489625431,0.0078928352602186,-0.0903931060725715,-0.0594531918525146,2.63497218785914e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REG1B,Lithostathine-1-beta,42310,-0.0567529523637496,0.00598321336567817,-0.0684800505604788,-0.0450258541670204,2.80692066234412e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42144,0.0327511083654127,0.003453401291611,0.0259824418338552,0.0395197748969703,2.85629224753422e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,41839,-0.0610237191634091,0.0064367538382811,-0.0736397566864401,-0.0484076816403782,2.95531147348697e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL21,C-C motif chemokine 21,42185,-0.0379759587479298,0.00401383606472302,-0.0458430774347869,-0.0301088400610726,3.53512526411072e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCN4,CCN family member 4,42262,-0.0388158247160242,0.00410732896020585,-0.0468661894780277,-0.0307654599540207,3.91671084033566e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42310,0.0317863035996408,0.00336371840696504,0.0251934155219894,0.0383791916772923,3.93814796063627e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA9,Serpin A9,42025,-0.0717244113760539,0.00759087348620026,-0.0866025234090065,-0.0568462993431014,3.98749163164079e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42145,-0.0367008413033946,0.00388702973909313,-0.0443194195920172,-0.0290822630147721,4.25140507229001e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDT,D-dopachrome decarboxylase,39966,-0.0404520909879483,0.00428377482935538,-0.0488482896534849,-0.0320558923224118,4.32389131612389e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39958,-0.0765341561651181,0.00812320731312328,-0.0924556424988398,-0.0606126698313965,5.29639448551568e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42310,-0.0392525866662767,0.00417029440879541,-0.0474263637075157,-0.0310788096250377,5.60866595423746e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42239,-0.0640292152754996,0.00680329644888109,-0.0773636763153065,-0.0506947542356926,5.66232156711749e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42115,-0.0794095952373341,0.00844658358238184,-0.0959648990588025,-0.0628542914158657,6.23836978239105e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCN1,Ficolin-1,39978,-0.0552948592319535,0.00588489353356726,-0.0668292505577454,-0.0437604679061617,6.74202601757162e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,41839,-0.065553055202819,0.00697923030010578,-0.0792323465910263,-0.0518737638146117,6.7990622278938e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39757,-0.113124084620819,0.0120432726910487,-0.136728899095275,-0.089519270146364,6.95482069722957e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INSL5,Insulin-like peptide INSL5,39930,-0.101323200383398,0.0107994456678963,-0.122490113892475,-0.0801562868743212,7.68424412885627e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41900,-0.0934555360496018,0.00998102907299782,-0.113018353032678,-0.0738927190665261,8.95188734018018e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEL1L,Protein sel-1 homolog 1,39638,-0.031048964371915,0.0033151388616615,-0.0375466365407715,-0.0245512922030584,9.01077702175995e-21
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FUS,RNA-binding protein FUS,41831,-0.0389273532564138,0.00416855721735376,-0.0470977254024271,-0.0307569811104004,1.13289211332387e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCOF1,Treacle protein,39958,-0.0318685487205927,0.00342024188621214,-0.0385722228175685,-0.0251648746236169,1.40851315977429e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ELOA,Elongin-A,42070,-0.0525542177054343,0.00564648113833253,-0.0636213207365661,-0.0414871146743025,1.50928309162753e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39662,-0.0386305836607669,0.00415188298366599,-0.0467682743087522,-0.0304928930127815,1.60171920350361e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IMMT,MICOS complex subunit MIC60,39919,-0.0437577582269124,0.004703475473687,-0.0529765701553389,-0.0345389462984858,1.61152697456584e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IDS,Iduronate 2-sulfatase,42296,0.00897348894300842,0.000965261919666954,0.00708157558046119,0.0108654023055557,1.66883126846914e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SRPK2,SRSF protein kinase 2,42119,-0.0827684327200403,0.00892461348485049,-0.100260675150347,-0.0652761902897334,2.05768919859476e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,39736,-0.0811098732904837,0.00875349206887821,-0.098266717745485,-0.0639530288354824,2.28714681409879e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ULBP2,UL16-binding protein 2,42016,-0.0382182941991904,0.00412619910674173,-0.0463056444484042,-0.0301309439499766,2.29976783337015e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFF1,Trefoil factor 1,42084,-0.078013088966628,0.00844209508554033,-0.094559595334287,-0.0614665825989689,2.80374234439552e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SORT1,Sortilin,42129,-0.0369513313724242,0.00400253817510716,-0.0447963061956342,-0.0291063565492142,3.04635050666756e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RPL14,60S ribosomal protein L14,39638,-0.0379940157779016,0.00412110664315324,-0.0460713847984819,-0.0299166467573212,3.53022340946454e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39736,-0.0214598440491019,0.00232820624987628,-0.0260231282988594,-0.0168965597993444,3.59234395104014e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39930,-0.0292017602630084,0.00316828403294907,-0.0354115969675885,-0.0229919235584282,3.59649022042415e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42070,-0.0749825791699552,0.00814189905801464,-0.0909407013236639,-0.0590244570162465,3.75510382101715e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42119,-0.0360875564848128,0.00392688018982905,-0.0437842416568777,-0.0283908713127479,4.49875765170373e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39736,-0.0280552243384076,0.00305364100045154,-0.0340403606992927,-0.0220700879775226,4.73361898199081e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,39930,-0.0598899551200578,0.00652226619974375,-0.0726735968715556,-0.0471063133685601,4.94701866808652e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39929,-0.0402666869800914,0.00439042858557033,-0.0488719270078092,-0.0316614469523735,5.47048926181646e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42296,-0.0939144399255779,0.0102573871781469,-0.114018918794746,-0.0738099610564101,6.15035225493018e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINH1,Serpin H1,39757,-0.124508942890574,0.0136032890864854,-0.151171389500086,-0.097846496281063,6.50816615531688e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39930,-0.10031757133996,0.0109710167288066,-0.121820764128421,-0.078814378551499,7.05094307284758e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDCD5,Programmed cell death protein 5,42249,-0.054922301609755,0.00600962530339411,-0.0667011672044075,-0.0431434360151026,7.17668327563129e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42070,-0.131451289053648,0.0143914860842701,-0.159658601778818,-0.103243976328479,7.53346941262171e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42137,-0.0353822649801874,0.00387461617109807,-0.0429765126755396,-0.0277880172848352,7.67873832012615e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42137,-0.044220968204375,0.00485583425975149,-0.0537384033534879,-0.0347035330552621,9.66088259781413e-20
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42189,0.0286180990516351,0.00314432043640961,0.0224552309962723,0.0347809671069979,1.01315276821693e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,39929,-0.0860647621387524,0.00945567390711846,-0.104597882996705,-0.0675316412808002,1.03562660110584e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD27,CD27 antigen,42181,-0.0407906679539162,0.00448358616208071,-0.0495784968315943,-0.032002839076238,1.04854615400072e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",39638,-0.060173598285892,0.00661354566188987,-0.0731361477831961,-0.0472110487885878,1.07244041306026e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42070,0.0231085147185278,0.00254073301899919,0.0181286780012894,0.0280883514357662,1.07453982523026e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39638,-0.0657488101347097,0.00724438112018942,-0.079947797130281,-0.0515498231391385,1.31934227144373e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42211,0.022837478659021,0.00251725815077271,0.0179036526835065,0.0277713046345355,1.32225764255034e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLO1,Lactoylglutathione lyase,41900,-0.0537385218699919,0.00592471178086618,-0.0653509569604896,-0.0421260867794941,1.35217611493008e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGR,Tyrosine-protein kinase Fgr,41839,-0.0559118128019098,0.00616641814965283,-0.0679979923752294,-0.0438256332285902,1.39162651444397e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL17,C-X-C motif chemokine 17,42296,-0.0405054038759198,0.00446886946264939,-0.0492643880227126,-0.031746419729127,1.42718988636789e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39929,-0.0828691749822159,0.00915196908339385,-0.100807034385668,-0.0649313155787639,1.59165314622157e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42070,0.0254337507392762,0.00280984590369113,0.0199264527680416,0.0309410487105109,1.59905687425847e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FST,Follistatin,42166,0.0462327189664236,0.00511122850173341,0.0362147111030261,0.056250726829821,1.69235601370174e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SH3GLB2,Endophilin-B2,39929,-0.0626851681614946,0.00692908854738495,-0.0762661817143691,-0.0491041546086201,1.7136688040533e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,39929,-0.0608740268051141,0.00674381722212693,-0.0740919085604828,-0.0476561450497453,2.05537928407236e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD72,B-cell differentiation antigen CD72,39736,-0.0413538061514172,0.00458355121691677,-0.0503375665365741,-0.0323700457662604,2.14498966795479e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,39919,-0.108668153718428,0.0120455389315179,-0.132277410024203,-0.0850588974126525,2.15486307977569e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASE1,Ribonuclease pancreatic,39990,-0.0234607214762392,0.00260944640755322,-0.0285752364350435,-0.0183462065174348,2.84377969896244e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39627,-0.0749376850085311,0.00834871190866729,-0.091301160349519,-0.0585742096675432,3.2637953527881e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FETUB,Fetuin-B,42199,-0.0302816021951723,0.00337504100912279,-0.0368966825730529,-0.0236665218172916,3.28179231505644e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPARCL1,SPARC-like protein 1,42169,0.025720522509209,0.00286818710234634,0.0200988757886102,0.0313421692298078,3.42486621701338e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFF3,Trefoil factor 3,42143,-0.0339330418573167,0.00378530300302137,-0.0413522357432386,-0.0265138479713948,3.52282188493419e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,39958,-0.0240341226328211,0.00268370842240613,-0.0292941911407371,-0.018774054124905,3.90517580322994e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCGN,Secretagogin,41913,-0.0416418214410966,0.00465436964784954,-0.0507643859508817,-0.0325192569313115,4.13671383681014e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,39601,-0.0483178816204238,0.00540392377091539,-0.058909572211418,-0.0377261910294297,4.46201017300636e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,39735,-0.0623071991950167,0.0069700665738722,-0.0759685296798062,-0.0486458687102272,4.53504211346957e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42185,-0.0260733565886261,0.00292518104790756,-0.031806711442525,-0.0203400017347273,5.5715159371669e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFHR5,Complement factor H-related protein 5,39864,0.0392266007468977,0.00440064357755488,0.0306013393348901,0.0478518621589053,5.6874538697118e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEMIP2,Cell surface hyaluronidase,39657,-0.0304464104770984,0.00341793046505283,-0.0371455541886019,-0.0237472667655948,6.01653682025696e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NIT2,Omega-amidase NIT2,39903,-0.0685771957166135,0.00769887726970503,-0.0836669951652354,-0.0534873962679917,6.02031494219268e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OSM,Oncostatin-M,42051,-0.0645171635054693,0.00724755549006416,-0.078722372265995,-0.0503119547449435,6.18357357695239e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42119,-0.0573153923743306,0.00643900804035983,-0.0699358481334359,-0.0446949366152254,6.21563286712943e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAA80,N-alpha-acetyltransferase 80,39649,-0.115530307679009,0.0129896387738035,-0.140989999675664,-0.0900706156823539,6.80871886260973e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39906,-0.103236664098196,0.0116207955967972,-0.126013423467919,-0.0804599047284735,7.43742650303498e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39966,0.0254401912937038,0.00286616189629508,0.0198225139769655,0.0310578686104422,7.96351309355394e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL14,C-C motif chemokine 14,42152,-0.0376134168335063,0.00424252989705038,-0.045928775431725,-0.0292980582352876,8.53349666107268e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLXNA4,Plexin-A4,42119,-0.0747304127689874,0.00843735433749812,-0.0912676272704837,-0.0581931982674911,9.22536784327704e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HEXIM1,Protein HEXIM1,42119,-0.0749621211059306,0.00846433239229693,-0.0915522125948326,-0.0583720296170287,9.29597322873675e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATXN3,Ataxin-3,39929,-0.0569700776462273,0.00643368735682428,-0.0695801048656029,-0.0443600504268517,9.6143050575108e-19
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNGR2,Interferon gamma receptor 2,42016,-0.0489285914260905,0.00553521895424539,-0.0597776205764114,-0.0380795622757695,1.07993052866218e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DKK4,Dickkopf-related protein 4,41992,-0.0427586683885304,0.0048378434233348,-0.0522408414982666,-0.0332764952787942,1.09107399606374e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNCA,Alpha-synuclein,39736,-0.110012333030243,0.0124496342840853,-0.13441361622705,-0.0856110498334356,1.13480832879247e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,41734,-0.019172750424421,0.00217068213807989,-0.0234272874150576,-0.0149182134337844,1.15125651771398e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42249,-0.0883364588353419,0.0100237871228092,-0.107983081596048,-0.068689836074636,1.36786540307632e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNF,Tumor necrosis factor,41880,-0.0335815669513398,0.00381597333040412,-0.0410608746789319,-0.0261022592237478,1.53187129520853e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCDH17,Protocadherin-17,42145,-0.0345564545335643,0.00393583744670224,-0.0422706959291007,-0.0268422131380279,1.82946304870959e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD63,CD63 antigen,41992,-0.0463718598102989,0.00528659749764595,-0.056733590905685,-0.0360101287149129,1.9722493690405e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BMPER,BMP-binding endothelial regulator protein,39736,-0.0213995501716886,0.00243972359978338,-0.026181408427264,-0.0166176919161131,2.02281334236497e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL25,C-C motif chemokine 25,42296,-0.0451357191042675,0.00515552337665189,-0.0552405449225052,-0.0350308932860298,2.28095603960262e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATG16L1,Autophagy-related protein 16-1,39930,-0.0795057191179334,0.00909707437266473,-0.0973359848883562,-0.0616754533475105,2.66573183835221e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COLEC12,Collectin-12,42123,-0.0250735757222936,0.00287200457547597,-0.0307027046902265,-0.0194444467543607,2.83372785363796e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP7,Matrilysin,41881,-0.0474443787725293,0.00544304179288636,-0.0581127406865865,-0.036776016858472,3.20591387070907e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42181,0.0385297067185939,0.00442447031037711,0.0298577449102548,0.0472016685269331,3.43664865499007e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL10,C-X-C motif chemokine 10,42185,-0.0601928872466602,0.00691340158783206,-0.0737431543588111,-0.0466426201345094,3.48585558053052e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41954,0.0546880296370185,0.00629125222084083,0.0423571752841705,0.0670188839898665,3.947678133241e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THBS2,Thrombospondin-2,42137,-0.0352407437426258,0.00405439098595075,-0.0431873500750893,-0.0272941374101624,3.96663860223381e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DLK1,Protein delta homolog 1,42310,-0.0526593191340689,0.00606904268954085,-0.064554642805569,-0.0407639954625689,4.52802306075935e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,41839,-0.0718281243159335,0.00830937155417544,-0.0881144925621173,-0.0555417560697496,6.03371329570314e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLA2,Src-like-adapter 2,39934,-0.0974293416434055,0.0112748785258208,-0.119528103554014,-0.0753305797327967,6.30350581206471e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASS1,Argininosuccinate synthase,39575,-0.0705369921694716,0.00816458623515175,-0.086539581190369,-0.0545344031485742,6.43438313778999e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42185,-0.0353581971690035,0.00409705182061567,-0.0433884187374103,-0.0273279756005968,6.80124385276962e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP6AP2,Renin receptor,41843,-0.0356615485442475,0.00413296283766689,-0.0437621557060746,-0.0275609413824204,6.91438625051001e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,39930,-0.0758687174620992,0.00880787217151053,-0.0931321469182598,-0.0586052880059385,8.00658026346069e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42070,-0.0254594937691362,0.00295749466957083,-0.031256183321495,-0.0196628042167774,8.21825355661043e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39919,-0.0656130137613743,0.00762053024021056,-0.0805492530321869,-0.0506767744905616,8.26903068904542e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AP3B1,AP-3 complex subunit beta-1,39930,-0.0699423795377797,0.00813407637951384,-0.0858851692416269,-0.0539995898339326,9.12172441742276e-18
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFF2,Trefoil factor 2,42166,-0.0525930044118961,0.0061313397626948,-0.0646104303467779,-0.0405755784770143,1.07160467625778e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL18BP,Interleukin-18-binding protein,42217,-0.0282552797372811,0.00329478943764593,-0.0347130670350671,-0.0217974924394951,1.08976005717047e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,39966,0.0297902891069157,0.00347550579276841,0.0229782977530896,0.0366022804607417,1.15335426873617e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41900,-0.043699716156185,0.00510194180459894,-0.053699522093199,-0.0336999102191711,1.19542603650075e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DKK1,Dickkopf-related protein 1,42249,-0.0529946251774261,0.00618794482108554,-0.0651229970267537,-0.0408662533280984,1.20405029046525e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,39929,-0.0982255260286862,0.0114791813530893,-0.120724721480741,-0.0757263305766311,1.30923331758038e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42119,0.047116743455162,0.00550974165441106,0.0363176498125164,0.0579158370978077,1.34401466579716e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39638,-0.0874249029839561,0.0102315209359975,-0.107478684018511,-0.067371121949401,1.45853902699042e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STAB2,Stabilin-2,39966,-0.0252727128602316,0.00296128067586442,-0.0310768229849259,-0.0194686027355373,1.58765072837761e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRAP,BRCA1-associated protein,39813,-0.0990436508186424,0.011622539462379,-0.121823828164905,-0.0762634734723795,1.7734272165862e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",41839,-0.0477027570246636,0.00560498221998735,-0.0586885221758388,-0.0367169918734884,1.91213653387294e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KAZN,Kazrin,39930,-0.094215215597846,0.0110685742736579,-0.115909621174216,-0.0725208100214764,1.92541121088698e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP5,Fatty acid-binding protein 5,42218,-0.0594660582790505,0.00698905048050971,-0.0731645972208496,-0.0457675193372515,1.94504944689059e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G15,Phospholipase A2 group XV,42181,-0.0245276029814941,0.00288660298732307,-0.0301853448366473,-0.0188698611263409,2.14551664758237e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSZ,Cathepsin Z,42168,-0.0287101257452301,0.00338692219491308,-0.0353484932472598,-0.0220717582432005,2.55247036155104e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39930,-0.125379939639552,0.0148046837124567,-0.154397119715967,-0.0963627595631371,2.7814689601115e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SH2B3,SH2B adapter protein 3,41843,-0.0876277185025112,0.0103526166073432,-0.107918847052904,-0.0673365899521185,2.84563559927462e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PALM2,Paralemmin-2,39929,-0.0345801362267733,0.00408565734330574,-0.0425880246196525,-0.026572247833894,2.90636561548107e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42137,-0.0442880164917242,0.00523906905556837,-0.0545565918406382,-0.0340194411428102,3.11597996750846e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL3,C-C motif chemokine 3,42119,-0.0526141305584145,0.0062245927571449,-0.0648143323624185,-0.0404139287544105,3.13746695967543e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GMPR,GMP reductase 1,42296,-0.0422373445199098,0.00499807821110978,-0.052033577813685,-0.0324411112261346,3.18485561832598e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42181,-0.0842282304369608,0.00996759126533575,-0.103764709317019,-0.0646917515569027,3.20124359249799e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ISM1,Isthmin-1,42119,-0.034967983210028,0.00414273699981333,-0.0430877477296621,-0.0268482186903938,3.47005172577469e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPL,N-acetylneuraminate lyase,39958,-0.041286095959862,0.00489704507729537,-0.0508843043113609,-0.0316878876083631,3.84644955798396e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNCG,Gamma-synuclein,42016,-0.0590269743198672,0.00700542105829901,-0.0727575995941332,-0.0452963490456011,3.94145434003227e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CMIP,C-Maf-inducing protein,39919,-0.0746412583086763,0.00885807421092456,-0.0920030837620885,-0.0572794328552642,3.99664260078452e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,39736,-0.0685513031017701,0.00813549238616598,-0.0844968681786554,-0.0526057380248848,4.0092290622401e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,QDPR,Dihydropteridine reductase,42081,-0.0371814681860315,0.00442639867674546,-0.0458572095924526,-0.0285057267796104,4.91042043761277e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42016,-0.0378651902336606,0.0045108701973859,-0.046706495820537,-0.0290238846467843,5.15679132886225e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42016,-0.0377147157596096,0.00450022013583786,-0.0465351472258518,-0.0288942842933674,5.78413587047082e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,39638,-0.0645259226266962,0.00770025923478415,-0.0796184307268732,-0.0494334145265193,5.94874593388387e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EHBP1,EH domain-binding protein 1,39958,-0.0661768840019144,0.00790349749800487,-0.0816677390980039,-0.0506860289058249,6.26907146749902e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB1,Integrin beta-1,42167,0.018532229364777,0.00221473962255888,0.0141913397045616,0.0228731190249925,6.44650516551489e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DAG1,Dystroglycan,42185,-0.041660109563728,0.00497993499334197,-0.0514207821506783,-0.0318994369767778,6.56017249113346e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSF,Cathepsin F,42181,-0.0354172844456069,0.00423382963802155,-0.0437155905361291,-0.0271189783550847,6.57620807254155e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA2,Annexin A2,39492,-0.062279532219606,0.00744289963755158,-0.0768676155092071,-0.0476914489300049,6.59607568825171e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMN,Protein amnionless,41913,-0.0413671016520923,0.00495097007694741,-0.0510710030029092,-0.0316632003012754,7.16529749753453e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39930,-0.0745835747237642,0.00892696254892041,-0.0920804213196482,-0.0570867281278802,7.31333886898904e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42310,-0.0353919347533644,0.00424151449214716,-0.0437053031579729,-0.027078566348756,7.85151912056275e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,39739,-0.0404023446160141,0.00484621531531918,-0.0499009266340397,-0.0309037625979885,8.52317440498168e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42119,-0.0301660251323204,0.00362582279764809,-0.0372726378157106,-0.0230594124489301,9.65119064327605e-17
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFBR2,TGF-beta receptor type-2,42181,-0.0298930864781146,0.00359823073805008,-0.0369456187246928,-0.0228405542315365,1.06737933857494e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFH,Complement factor H,39418,-0.0206080161463261,0.00247999619530501,-0.0254688086891239,-0.0157472236035283,1.07412640795502e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42016,-0.0488578228805503,0.00588939179434424,-0.060401030797465,-0.0373146149636356,1.17971288384359e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SYTL4,Synaptotagmin-like protein 4,39958,-0.0634993306160545,0.00767289259912705,-0.0785382001103435,-0.0484604611217655,1.41837602576585e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTN5,Contactin-5,42170,0.0321580242657783,0.00388798751444435,0.0245375687374674,0.0397784797940893,1.44972247080553e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41825,-0.0512985945566922,0.00620472548318733,-0.0634598565037394,-0.039137332609645,1.49559366057536e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42224,-0.0632819304864439,0.007665310774928,-0.0783059396053028,-0.048257921367585,1.64916389244172e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42211,-0.0287056491564722,0.0034775861899345,-0.0355217180887438,-0.0218895802242006,1.665173780032e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTBS,Di-N-acetylchitobiase,39860,-0.0240213013333136,0.00291265679192706,-0.0297301086454906,-0.0183124940211366,1.80133650021061e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39485,-0.0268252099353598,0.003254701517283,-0.0332044249092345,-0.0204459949614851,1.88809418898225e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,41913,-0.032505720704498,0.00395515998670798,-0.0402578342784456,-0.0247536071305504,2.24883856787969e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",39586,-0.0726070912621679,0.00885705098186058,-0.0899669111866147,-0.0552472713377212,2.7235174010427e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS8,Galectin-8,42249,-0.0522207452548024,0.00639072355749176,-0.0647465634274863,-0.0396949270821186,3.31660766685829e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSTB,Cystatin-B,41959,-0.0372229174923521,0.00455974450771379,-0.0461600167274711,-0.0282858182572331,3.5479383677198e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42085,-0.0546263175912909,0.00669636724403611,-0.0677511973896017,-0.0415014377929801,3.71781489046863e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HNMT,Histamine N-methyltransferase,41961,-0.0409269918556681,0.00501731434134845,-0.0507609279647111,-0.0310930557466252,3.73463861810927e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A14,Protein S100-A14,39934,-0.0445171811186575,0.00547131738465045,-0.0552409631925724,-0.0337933990447426,4.49425961460852e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42137,-0.0329915376357503,0.00405656200990664,-0.0409423991751673,-0.0250406760963332,4.55463236630324e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD80,T-lymphocyte activation antigen CD80,39958,-0.0293150733556627,0.00361245731842772,-0.036395489699781,-0.0222346570115443,5.35801241345325e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NSFL1C,NSFL1 cofactor p47,42249,-0.0535442021734568,0.00660175290110598,-0.0664836378596245,-0.040604766487289,5.46400002709953e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,39736,-0.0351550570337429,0.00433536717669817,-0.0436523767000713,-0.0266577373674145,5.64302345173021e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,41913,-0.0319657206449857,0.00394804708275896,-0.0397038929271933,-0.0242275483627782,6.14046751941141e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN8,Tetraspanin-8,39930,-0.0815285985756609,0.0100685916605509,-0.101263038230341,-0.0617941589209811,6.19287395650016e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRAF2,TNF receptor-associated factor 2,42119,-0.0588750455765993,0.00727882940688557,-0.073141551214095,-0.0446085399391036,6.55025150350543e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42040,-0.0241676354131947,0.00298875551102879,-0.0300255962148111,-0.0183096746115783,6.68011831861509e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TAX1BP1,Tax1-binding protein 1,39929,-0.0529207634921932,0.00654514632080018,-0.0657492502809615,-0.0400922767034248,6.82043170457393e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRP2,Neuropilin-2,42137,0.0237991465010891,0.00295294738552665,0.0180113696254569,0.0295869233767213,8.30220038267187e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLIN3,Perilipin-3,42145,-0.036231570445542,0.00450241194506708,-0.0450562978578735,-0.0274068430332106,9.17606745533466e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDGFC,Platelet-derived growth factor C,41843,-0.0236189570817965,0.00293519185677743,-0.0293719331210803,-0.0178659810425127,9.21721663155505e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40518,0.0263425416920244,0.00327365622064853,0.0199261754995533,0.0327589078844956,9.30008442385186e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42119,-0.0361585018908841,0.00449431079670295,-0.0449673510524219,-0.0273496527293463,9.30914860514607e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42113,-0.0365144962300761,0.00454255127731079,-0.0454178967336052,-0.0276110957265469,9.85987943941359e-16
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42262,-0.0341809161305913,0.00426272207795881,-0.0425358514033906,-0.025825980857792,1.1563689104215e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COCH,Cochlin,39958,-0.0388442104523436,0.00484431461503205,-0.0483390670978064,-0.0293493538068808,1.17515937695861e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42140,-0.0332491578036503,0.00414860155957035,-0.0413804168604082,-0.0251178987468925,1.19546873400284e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,39638,-0.0628487549925507,0.00784020224940809,-0.0782155514013905,-0.0474819585837108,1.20046164766703e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42272,-0.0165045075045031,0.00206049259518334,-0.0205430729910625,-0.0124659420179438,1.23953487989976e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA6,Corticosteroid-binding globulin,39979,0.0130050057569261,0.00162400242647501,0.00982196100103511,0.0161880505128172,1.27930295950189e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNXB,Tenascin-X,42137,0.0219570969851514,0.00274504498144476,0.0165768088215197,0.0273373851487832,1.35776846667439e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,39929,-0.0744735836860414,0.00931737854410524,-0.0927356456324876,-0.0562115217395951,1.44488751932011e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GOLGA3,Golgin subfamily A member 3,39934,-0.0656053534087605,0.00820941523756995,-0.0816958072743976,-0.0495148995431235,1.46240923672855e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42084,-0.016807300893845,0.00210454619990259,-0.0209322114456541,-0.0126823903420359,1.50394581841893e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39929,-0.0347293377202879,0.00435177909235677,-0.0432588247413072,-0.0261998506992687,1.59789936430229e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOXO1,Forkhead box protein O1,42119,-0.0725197346090717,0.00909218079460655,-0.0903404089665005,-0.0546990602516428,1.63167807256234e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42016,-0.0793233573764507,0.00995258001351143,-0.0988304142029331,-0.0598163005499683,1.7124640421799e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRTAC1,Cartilage acidic protein 1,42310,0.0258899203161949,0.00325045347863438,0.0195190314980716,0.0322608091343183,1.78147931561596e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,39513,-0.0447519476916487,0.00561886865206282,-0.0557649302496918,-0.0337389651336056,1.82249111332755e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,METAP2,Methionine aminopeptidase 2,42247,-0.0465629882908789,0.00585797304878334,-0.0580446154664942,-0.0350813611152635,2.03277012382522e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OPHN1,Oligophrenin-1,39929,-0.0909028211592203,0.0114390405259616,-0.113323340590105,-0.0684823017283356,2.09646651354164e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCF2,Neutrophil cytosol factor 2,42097,-0.069226002487362,0.0087220124064222,-0.0863211468039496,-0.0521308581707745,2.23519512824473e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNAPIN,SNARE-associated protein Snapin,39934,-0.0489461849557666,0.0061671897468986,-0.0610338768596878,-0.0368584930518453,2.27454351577328e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IMPACT,Protein IMPACT,39929,-0.0453635216401621,0.00571718595870431,-0.0565692061192226,-0.0341578371611017,2.31058237628673e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TALDO1,Transaldolase,39948,-0.0369617399304377,0.00465943643467176,-0.0460942353423943,-0.027829244518481,2.34615857898096e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GOLM2,Protein GOLM2,42249,-0.0189434286807596,0.00238878907175166,-0.0236254552613929,-0.0142614021001264,2.35831717501271e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,41900,-0.0349874318226089,0.00441407196153884,-0.0436390128672251,-0.0263358507779928,2.43596075265255e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39919,-0.0408714337974811,0.00516633668020056,-0.0509974536906742,-0.030745413904288,2.78840870628066e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATG4A,Cysteine protease ATG4A,41843,-0.04835655013424,0.00611436319628729,-0.0603407019989631,-0.036372398269517,2.80659010606012e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ESYT2,Extended synaptotagmin-2,39929,-0.0695225303187228,0.00879271879092231,-0.0867562591489305,-0.052288801488515,2.88505685011011e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCBP2,Poly(rC)-binding protein 2,39934,-0.0608954324600438,0.00771777117466386,-0.076022263962385,-0.0457686009577027,3.29192228773822e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIAE,Sialate O-acetylesterase,42147,-0.0384948231702488,0.00488332390956107,-0.0480661380329885,-0.0289235083075091,3.44162128320714e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SELP,P-selectin,42217,-0.0461541719991416,0.00585750071730387,-0.0576348734050572,-0.034673470593226,3.53522645632926e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42247,-0.0349658469542082,0.00443779174387499,-0.0436639187722031,-0.0262677751362132,3.5456522441227e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,39575,-0.0521699880621751,0.00662313157886037,-0.0651513259567414,-0.0391886501676088,3.67160396700784e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PQBP1,Polyglutamine-binding protein 1,41843,-0.0467484142345725,0.00594221650910732,-0.0583951585924228,-0.0351016698767222,3.90780648153219e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39934,-0.067419122405161,0.00856985042322422,-0.0842160292346805,-0.0506222155756415,3.96178772478818e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,39657,-0.0754135968652586,0.00958896287649011,-0.0942079641031792,-0.056619229627338,4.04642583053106e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42203,0.026459160519384,0.00336883396098626,0.019856245955851,0.0330620750829171,4.32698292517356e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42137,-0.0197768661734042,0.00252062231189022,-0.024717285904709,-0.0148364464420994,4.61502757098962e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AP2B1,AP-2 complex subunit beta,39649,-0.0402694008064463,0.00513238220064126,-0.0503288699197032,-0.0302099316931894,4.6858614015935e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42185,-0.102888007869358,0.0131567304697916,-0.128675199590149,-0.0771008161485661,5.6620298238808e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42185,-0.022651270922395,0.00289921035835776,-0.0283337232247762,-0.0169688186200138,5.99696101835984e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MBL2,Mannose-binding protein C,39826,0.090636456307375,0.0116155524360317,0.067869973532753,0.113402939081997,6.57987381954673e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMPD3,AMP deaminase 3,39929,-0.0566593375167357,0.00726255050810981,-0.0708939365126309,-0.0424247385208405,6.65041691789055e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,39934,-0.0442221783362422,0.00567023645445949,-0.0553358417869828,-0.0331085148855016,6.78652448078743e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,39990,-0.0547136912319005,0.00701974994089066,-0.0684724011160462,-0.0409549813477548,7.04242340594838e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB27B,Ras-related protein Rab-27B,39958,-0.0678405980633873,0.00870724055360896,-0.0849067895484608,-0.0507744065783137,7.21049036371453e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,41839,-0.0407246359290037,0.00523033870374109,-0.0509760997883362,-0.0304731720696711,7.41506324664325e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39934,-0.0333911858036001,0.00428773541407965,-0.0417951472151962,-0.0249872243920039,7.42381572585233e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHISA5,Protein shisa-5,39966,-0.021300634686276,0.00273601889685234,-0.0266632317241065,-0.0159380376484454,7.55989845542162e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP1,Interstitial collagenase,41693,-0.0737190653658247,0.00947074015033058,-0.0922817160604726,-0.0551564146711767,7.55996363231698e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN8,Septin-8,39906,-0.026750038955342,0.00343598965663924,-0.0334845786823549,-0.0200154992283291,7.56416292424042e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,39930,-0.0392356368939606,0.00504563143504567,-0.0491250745066501,-0.0293461992812711,8.12319915999057e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42129,-0.0254997694438693,0.00328367584643287,-0.0319357741028777,-0.0190637647848609,8.70709933874775e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUSD2,Sushi domain-containing protein 2,42137,0.0231115718355258,0.00297788065565765,0.0172749257504368,0.0289482179206148,9.0225253337689e-15
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42137,-0.0346634822625617,0.00447844824935458,-0.0434412408312967,-0.0258857236938268,1.06387254182028e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL4,C-C motif chemokine 4,42148,-0.0503970799265379,0.00653195434457429,-0.0631997104419035,-0.0375944494111723,1.28941043990747e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOA2,Apolipoprotein A-II,39990,0.0402568103082425,0.00521975949316108,0.0300260817016467,0.0504875389148382,1.3376590603211e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42070,-0.043454397423295,0.00563858628996587,-0.0545060265516281,-0.0324027682949619,1.38218283873791e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,POF1B,Protein POF1B,39657,-0.0369425907465912,0.00479639948105601,-0.0463435337294609,-0.0275416477637214,1.45220346130461e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRP1,Neuropilin-1,42230,0.0220680942439123,0.00286788152862127,0.0164470464478146,0.0276891420400099,1.5129388619685e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEMA7A,Semaphorin-7A,42272,-0.0230744496033774,0.00299869395619596,-0.0289518897575215,-0.0171970094492333,1.51355386174682e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,41839,-0.030857041680239,0.00402554254809421,-0.0387471050745036,-0.0229669782859743,1.90796265803088e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,39757,-0.0436065655718467,0.00570350555818308,-0.0547854364658856,-0.0324276946778079,2.25093278460528e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PENK,Proenkephalin-A,39736,-0.02501786524409,0.00327626338852805,-0.031439341485605,-0.018596389002575,2.42228290292702e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,39649,-0.0564412414813167,0.00739711490900802,-0.0709395867029724,-0.041942896259661,2.53725577695241e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD207,C-type lectin domain family 4 member K,41832,-0.0312361778289806,0.00410280499981439,-0.0392776756286168,-0.0231946800293444,2.85102878672052e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100G,Protein S100-G,39934,0.0393488049361219,0.00516971153903283,0.0292161703196175,0.0494814395526262,2.92616159559664e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42166,-0.0416851252202342,0.00548002569160379,-0.0524259755757776,-0.0309442748646908,2.99567710798684e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM13A,Protein FAM13A,39930,-0.0545134610511597,0.00717519263449443,-0.0685768386147688,-0.0404500834875506,3.25699979105913e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39979,0.0196129957448775,0.00258162019725344,0.0145530201582608,0.0246729713314943,3.26409617976724e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALCA,Calcitonin,41997,-0.055307298419153,0.00728441768963913,-0.0695847570908457,-0.0410298397474603,3.34392822963927e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,41843,-0.0377660122634303,0.0049816689879492,-0.0475300834798107,-0.0280019410470499,3.65694026490234e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPT2,Angiopoietin-2,42262,-0.0297017018221653,0.00392554443729562,-0.0373957689192647,-0.0220076347250659,4.08633691133438e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLF4,Krueppel-like factor 4,39586,-0.032427604182463,0.00428618477651799,-0.0408285263444383,-0.0240266820204878,4.16895496078959e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNMBP,Dynamin-binding protein,42016,-0.0481032761025729,0.00636228263145578,-0.0605733500602262,-0.0356332021449195,4.26920486234527e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,41843,-0.0449895386821047,0.00595125447780468,-0.0566539974586019,-0.0333250799056075,4.30624189377006e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,41843,-0.0250985589981987,0.00332290189542904,-0.0316114467132396,-0.0185856712831577,4.52472619073531e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42185,-0.0215600830186891,0.00285832037246896,-0.0271623909487283,-0.01595777508865,4.88701812436014e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42016,0.028852517765081,0.00383475732319172,0.0213363934116253,0.0363686421185368,5.65251007875257e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP3,Stromelysin-1,42137,0.0392600031775902,0.00521909991712007,0.0290305673400349,0.0494894390151456,5.71775840976639e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42272,-0.0262565557307753,0.00349149080501351,-0.0330998777086018,-0.0194132337529489,5.81154263857343e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42181,-0.0268787006861549,0.00357529953908039,-0.0338862877827525,-0.0198711135895574,5.91519593035397e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41843,-0.0610641911293644,0.00812803044840461,-0.0769951308082375,-0.0451332514504914,6.15870584045722e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REG1A,Lithostathine-1-alpha,42105,-0.0393429808732858,0.00523836331864893,-0.0496101729778377,-0.0290757887687339,6.25716132465356e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39410,-0.0394526525889754,0.00525279488148744,-0.0497481305566908,-0.02915717462126,6.34062977762148e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39930,-0.0854360654936673,0.0114339992693722,-0.107846704061637,-0.0630254269256977,8.47276230296845e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42185,-0.0815012345228252,0.0109155485121753,-0.102895709606689,-0.0601067594389616,8.73495827270551e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,41913,-0.0465639989735325,0.00623899342788018,-0.0587924260921777,-0.0343355718548874,8.95587913530194e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,39638,-0.0487882331158842,0.0065374077535582,-0.0616015523128583,-0.0359749139189101,9.09819480877379e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPPK1,Epiplakin,39638,-0.058383462519204,0.00782446286245706,-0.0737194097296198,-0.0430475153087881,9.18624190166739e-14
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,39657,0.0255390147067647,0.00343072799864333,0.0188147878294238,0.0322632415841056,1.04784307325493e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,41913,-0.0545749570378166,0.00733420972484787,-0.0689500080985184,-0.0401999059771148,1.05928544989387e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OGA,Protein O-GlcNAcase,39930,-0.0560877291553041,0.00754151264930873,-0.0708690939479493,-0.041306364362659,1.10266945275569e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42119,-0.0881755994730582,0.0118638764937758,-0.111428797400859,-0.0649224015452576,1.13152879175759e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42166,0.0347960703864201,0.00468306248645482,0.0256172679129686,0.0439748728598715,1.1491603929526e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42145,-0.022436888568022,0.00302046225053582,-0.0283569945790722,-0.0165167825569718,1.16581528409278e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42284,-0.0298930018542735,0.00402842958423705,-0.0377887238393782,-0.0219972798691689,1.23542989232927e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LARP1,La-related protein 1,39919,-0.0487847117555808,0.00657937138934751,-0.0616802796787019,-0.0358891438324597,1.30505182820954e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHAD,Chondroadherin,39736,0.0366859207014142,0.00495604976125547,0.0269720631693535,0.046399778233475,1.43549136476984e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F10,Coagulation factor X,39990,-0.0226639971996154,0.00306399074894134,-0.0286694190675404,-0.0166585753316904,1.49203849102908e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,39736,-0.0409260232927659,0.00553773711594369,-0.0517799880400155,-0.0300720585455163,1.56887861852429e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42016,-0.0563657648157351,0.00763200129839931,-0.0713244873605978,-0.0414070422708725,1.60899302174792e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCN2,CCN family member 2,42146,-0.0437437239167357,0.0059298795968785,-0.0553662879266176,-0.0321211599068539,1.71522166347234e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42163,-0.0396914463610984,0.005390971331298,-0.0502577501704425,-0.0291251425517544,1.90781801219184e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42105,-0.0492973063942959,0.00671007461161104,-0.0624490526330535,-0.0361455601555382,2.14715126924755e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD86,T-lymphocyte activation antigen CD86,39930,0.0235522986621548,0.00320772566594825,0.0172651563568962,0.0298394409674133,2.24229440578243e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD302,CD302 antigen,42070,-0.024027644874424,0.00327355287809528,-0.0304438085154908,-0.0176114812333573,2.25950120028322e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,39736,-0.0521497303122317,0.00710426941703529,-0.0660740983696208,-0.0382253622548425,2.27425971407116e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41768,-0.0645841148366819,0.00880291013102971,-0.0818378186935001,-0.0473304109798636,2.31776649688663e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42296,-0.0351842245280716,0.00479633347479928,-0.0445850381386782,-0.0257834109174651,2.33044781579278e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42145,-0.0256067588079746,0.00349756843642261,-0.0324619929433629,-0.0187515246725863,2.5941994264663e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AZI2,5-azacytidine-induced protein 2,39934,-0.0430424614757813,0.00588140975032877,-0.0545700245864256,-0.0315148983651369,2.67924797909999e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39930,-0.0585253969708179,0.00800413026988093,-0.0742134922997845,-0.0428373016418512,2.81139528489732e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPRR3,Small proline-rich protein 3,39929,-0.0485785058215909,0.00664393217116422,-0.0616006128770728,-0.0355563987661091,2.8153619370984e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CIT,Citron Rho-interacting kinase,39649,-0.0353240329963071,0.0048339028916868,-0.0447984826640132,-0.0258495833286009,2.90803277625431e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNC,Tenascin,42217,0.0370446474480393,0.00507350933869441,0.0271005691441982,0.0469887257518803,3.0017778481084e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,39657,-0.0747898638716907,0.0102437916281933,-0.0948676954629496,-0.0547120322804317,3.05266925910291e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NIT1,Deaminated glutathione amidase,39638,-0.0342137754252016,0.00469309027585146,-0.0434122323658704,-0.0250153184845327,3.30552720503472e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MDK,Midkine,42129,-0.0390729991104617,0.00537691897714998,-0.0496117603056757,-0.0285342379152478,3.88263377815816e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,39934,-0.0460809908875073,0.0063431983307912,-0.0585136596158581,-0.0336483221591566,3.98602110626987e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COMP,Cartilage oligomeric matrix protein,42042,0.025346039887705,0.00350215907275627,0.0184818081051027,0.0322102716703073,4.82668960711301e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLIT2,Slit homolog 2 protein,41839,-0.0392977130097952,0.00543277568309529,-0.0499459533486619,-0.0286494726709284,4.96761148502787e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RILP,Rab-interacting lysosomal protein,42224,-0.0445853041996208,0.0061644603087948,-0.0566676464048586,-0.032502961994383,4.9898128703617e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,39979,0.0202868648454221,0.00280509926669789,0.0147888702826943,0.02578485940815,5.05958013188045e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RFC4,Replication factor C subunit 4,39919,-0.0169269788239049,0.00234226695015338,-0.0215178220462055,-0.0123361356016043,5.26508431021247e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,41997,-0.0174646509777922,0.00241819980627095,-0.0222043225980832,-0.0127249793575011,5.39257039460385e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLIN1,Perilipin-1,41839,-0.025752584044015,0.00356754907737233,-0.0327449802356648,-0.0187601878523652,5.5403596402414e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THY1,Thy-1 membrane glycoprotein,42249,-0.0221593297071185,0.00307188276259411,-0.028180219921803,-0.0161384394924341,5.73638344168269e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL22,C-C motif chemokine 22,41991,-0.0392748996682113,0.00544554006034649,-0.0499481581864904,-0.0286016411499321,5.79664224552919e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL5,C-C motif chemokine 5,42217,-0.0763431160563824,0.0105935632581113,-0.0971065000422805,-0.0555797320704842,6.04038311795475e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39930,-0.0780439928479193,0.0108437127549194,-0.0992976698475613,-0.0567903158482773,6.53628028994023e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DOK2,Docking protein 2,42145,-0.0928757935432597,0.0129154140180744,-0.118190005018685,-0.0675615820678338,6.76515668422962e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP10,Caspase-10,41839,-0.053898304659172,0.00749722565281039,-0.0685928669386804,-0.0392037423796637,6.87175826822066e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLRD1,Natural killer cells antigen CD94,42296,-0.0355649442069055,0.00495628364500037,-0.0452792601511063,-0.0258506282627048,7.56211716901051e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C8B,Complement component C8 beta chain,39979,0.0228710292046388,0.00318687519595865,0.0166247538205599,0.0291173045887178,7.589416752275e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCK2,Cytoplasmic protein NCK2,42185,-0.0804485555234801,0.0112185434380616,-0.102436900662081,-0.0584602103848793,7.82821977191684e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BOC,Brother of CDO,41900,0.0175065275272609,0.00244168011893126,0.0127208344941557,0.0222922205603662,7.90335056997882e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UROD,Uroporphyrinogen decarboxylase,39736,-0.0513820903704569,0.00716620770710517,-0.065427857476383,-0.0373363232645308,7.97187623303345e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSC22D1,TSC22 domain family protein 1,39934,-0.0500522393153192,0.00698159371647316,-0.0637361629996066,-0.0363683156310318,8.01459438562358e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,41900,-0.0715518469833217,0.00998570075911039,-0.0911238204711781,-0.0519798734954654,8.16269174889158e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41900,-0.0430523012657376,0.00601191663067721,-0.0548356578618649,-0.0312689446696102,8.42005380874767e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSNAX,Translin-associated protein X,39575,-0.0297132527156838,0.00415441510894514,-0.0378559063292163,-0.0215705991021513,9.08283781356227e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41997,-0.0837447703889379,0.0117245294198839,-0.10672484805191,-0.0607646927259654,9.62408827262346e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39736,-0.0434367508982361,0.00608362504521663,-0.0553606559868607,-0.0315128458096115,9.91841720651375e-13
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STK11,Serine/threonine-protein kinase STK11,41900,-0.0545739910814062,0.00766167721691492,-0.0695908784265594,-0.0395571037362529,1.11048417262867e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL18,Interleukin-18,42069,-0.0331246792502777,0.0046514459586205,-0.0422415133291739,-0.0240078451713815,1.12277994991573e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42119,-0.0734488257273812,0.0103154787457841,-0.093667164069118,-0.0532304873856444,1.13169088634423e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42095,-0.0286660488223679,0.00402711001086886,-0.0365591844436709,-0.020772913201065,1.14814895211543e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42047,-0.0565781636841174,0.00795662637776921,-0.072173151384545,-0.0409831759836898,1.21179137294291e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39934,-0.0494019503229776,0.00695307017948934,-0.0630299678747767,-0.0357739327711785,1.27487924919674e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOA4,Apolipoprotein A-IV,39979,-0.0257521898017329,0.00362672283523847,-0.0328605665588003,-0.0186438130446655,1.31544093502798e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIMAP7,GTPase IMAP family member 7,39736,0.0241224918412801,0.00340120584625355,0.0174561283826231,0.030788855299937,1.39863223872085e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,39638,-0.0236687588632531,0.00334240317485727,-0.0302198690859733,-0.0171176486405328,1.51426630788539e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39934,-0.0631378952332662,0.00891957895033674,-0.0806202699759262,-0.0456555204906062,1.54250871214898e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42137,-0.0224408058644698,0.00317543615318429,-0.028664660724711,-0.0162169510042286,1.66066930510326e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,41843,-0.0469194168643466,0.00664349228428892,-0.0599406617415529,-0.0338981719871403,1.71742463687842e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42262,-0.0248668176016246,0.00352398722391209,-0.0317738325604923,-0.0179598026427569,1.79049187943555e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DGKA,Diacylglycerol kinase alpha,39657,-0.0412753978397,0.00585022175856187,-0.0527418324864812,-0.0298089631929187,1.82454959403001e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,39919,-0.0642614231466425,0.00911107923185098,-0.0821191384410705,-0.0464037078522146,1.85167307822435e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42212,-0.0758522253808632,0.010761711758559,-0.0969451804276388,-0.0547592703340875,1.897796971011e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NGRN,Neugrin,39929,-0.016671146594522,0.00236528423508692,-0.0213071036952924,-0.0120351894937517,1.91689015680167e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39934,-0.0364663834656552,0.00517547048469333,-0.0466103056156541,-0.0263224613156563,1.94807871018044e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42262,0.0440295572329212,0.00626426152768899,0.0317516046386508,0.0563075098271916,2.18369221306864e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42296,-0.0408040990188854,0.00580705515698746,-0.0521859271265808,-0.02942227091119,2.21560787752864e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD83,CD83 antigen,42119,-0.0254545320383621,0.00362343379371043,-0.0325564622740346,-0.0183526018026897,2.24347989127576e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACHE,Acetylcholinesterase,39736,-0.025408227974552,0.00362001784446133,-0.0325034629496962,-0.0183129929994078,2.36770281842893e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WDR46,WD repeat-containing protein 46,39919,-0.0271059466391964,0.00386995877470483,-0.0346910658376179,-0.019520827440775,2.62493641808419e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42181,-0.017966089907527,0.0025657062585869,-0.0229948741743574,-0.0129373056406967,2.63451304212079e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA2,Carbonic anhydrase 2,42103,-0.0486921402735845,0.00696806830285462,-0.0623495541471796,-0.0350347263999895,2.92123733990159e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,39757,-0.0421366546805822,0.00602977672560307,-0.0539550170627642,-0.0303182922984002,2.94528482879153e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MSTN,Growth/differentiation factor 8,41900,-0.0396065324167563,0.0056703562113967,-0.0507204305910938,-0.0284926342424187,2.9873857008532e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42181,0.0171999093274135,0.00246264108606995,0.0123731327987164,0.0220266858561106,2.99525284785852e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42129,-0.0349101068126537,0.00499956165702175,-0.0447092476604163,-0.025110965964891,3.0321543930033e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42137,-0.0264391348967473,0.0037895827256171,-0.0338667170389568,-0.0190115527545378,3.16029932628775e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VASN,Vasorin,41975,0.020091327799689,0.00288150578386983,0.0144435764633041,0.0257390791360739,3.2594882790703e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39657,-0.0326727246234607,0.00468847577162129,-0.0418621371358384,-0.0234833121110829,3.38010616486671e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STAMBP,STAM-binding protein,41997,-0.0459825169106827,0.00660878305217527,-0.0589357316929462,-0.0330293021284191,3.61715079733392e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RASSF2,Ras association domain-containing protein 2,41843,-0.0416849138013575,0.00600119516634517,-0.0534472563273941,-0.029922571275321,3.93053646737763e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDHD2,Phospholipase DDHD2,39934,-0.0487227082748038,0.00701688512969261,-0.0624758031290013,-0.0349696134206063,4.03023000595526e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42145,-0.0421370005218308,0.00607125107924171,-0.0540366526371446,-0.0302373484065171,4.08733864017172e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42181,-0.019965102651844,0.00288118753485272,-0.0256122302201554,-0.0143179750835327,4.41462356343221e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZNRD2,Protein ZNRD2,39930,-0.0510600901661547,0.00737208953903145,-0.0655093856626563,-0.036610794669653,4.55909267173132e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,39934,-0.0291194748933005,0.00420515817462554,-0.0373615849155666,-0.0208773648710345,4.60515076299156e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42249,-0.0500095095330615,0.00722904290596785,-0.0641784336287585,-0.0358405854373645,4.78942648343978e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42113,-0.0173253650385746,0.00250617837696223,-0.0222374746574205,-0.0124132554197286,4.95592325832955e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM3D,Protein FAM3D,39930,-0.0638870615203788,0.00924289372959247,-0.0820031332303801,-0.0457709898103776,5.03460839044455e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42084,-0.0140599907964107,0.00203457326695201,-0.0180477543996366,-0.0100722271931847,5.04513743570225e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42016,-0.0418280005113506,0.00605814533197368,-0.053701965362019,-0.0299540356606822,5.26754573888285e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLAU,Urokinase-type plasminogen activator,42137,0.0206985594074503,0.00300058980377493,0.0148174033920515,0.0265797154228492,5.50188453718714e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,41900,-0.0272523947130066,0.00395238057470766,-0.0349990606394336,-0.0195057287865796,5.6223369054775e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42310,0.0177459415069073,0.00257444061210383,0.0127000379071838,0.0227918451066308,5.69658392116499e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BMP10,Bone morphogenetic protein 10,39736,0.0206016804057524,0.00298875927346048,0.0147437122297699,0.026459648581735,5.75589554465975e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOBR,Apolipoprotein B receptor,39638,0.0312527933175985,0.0045374440995345,0.0223594028825109,0.0401461837526862,5.97629888397304e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,39649,-0.0577243129286973,0.00838105200716278,-0.0741511748627363,-0.0412974509946582,5.98747862518158e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39934,-0.0481866476335656,0.00699895156882631,-0.0619045927084651,-0.034468702558666,6.09102423683211e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39638,-0.0550562415797865,0.00799908753264978,-0.07073445314378,-0.0393780300157929,6.18631239452126e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42137,0.0323415320263903,0.00470118893469686,0.0231272017143845,0.0415558623383962,6.27297288512999e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYL4,Myosin light chain 4,39638,-0.037477717235279,0.00544701234620824,-0.0481538614338472,-0.0268015730367109,6.2909050272279e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,41843,-0.0280382964849688,0.00407744940485626,-0.0360300973184871,-0.0200464956514505,6.41235406334125e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SELL,L-selectin,39979,0.016874796522316,0.00245554523247865,0.0120619278666579,0.0216876651779742,6.65598101496416e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADA2,Adenosine deaminase 2,42096,-0.031644128871079,0.00461046496240433,-0.0406806401973914,-0.0226076175447665,7.01059962734073e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42070,-0.0249416501588487,0.00363876715928944,-0.032073633791056,-0.0178096665266414,7.47168409606798e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,39929,-0.0244088823534205,0.00356423641321798,-0.0313947857233277,-0.0174229789835132,7.86117390268561e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42100,-0.0342807613626678,0.00501604729927217,-0.0441122140692413,-0.0244493086560944,8.59916894741004e-12
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD160,CD160 antigen,42296,-0.034615068549066,0.00509111152984428,-0.0445936471475608,-0.0246364899505712,1.09621961723237e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD6,T-cell differentiation antigen CD6,42284,-0.0372120076293543,0.00547378980763732,-0.0479406356523235,-0.0264833796063852,1.10311696611404e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39638,-0.0351803656742065,0.00517520066675431,-0.045323758981045,-0.0250369723673681,1.11651009581497e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OTUD7B,OTU domain-containing protein 7B,39934,-0.0452899656671271,0.00668643913544962,-0.0583953863726083,-0.0321845449616458,1.32010660220901e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,USO1,General vesicular transport factor p115,42070,-0.0632769679784984,0.00935941313729831,-0.0816214177276031,-0.0449325182293937,1.42900778405523e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,JAM2,Junctional adhesion molecule B,42249,-0.0194023767177306,0.00287183158992001,-0.0250311666339738,-0.0137735868014874,1.47502607261028e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRDX1,Peroxiredoxin-1,41742,0.0650237330999553,0.00962529387266785,0.0461581571095264,0.0838893090903843,1.48330842994426e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP12,Macrophage metalloelastase,42146,-0.0387780377548309,0.00575008366014531,-0.0500482017287157,-0.0275078737809461,1.60433831083309e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPP4,Dipeptidyl peptidase 4,41948,0.0197711536739693,0.00293326899416488,0.0140219464454061,0.0255203609025325,1.64536564464622e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHCHD6,MICOS complex subunit MIC25,39919,-0.0206624515463466,0.00306735094164598,-0.0266744593919728,-0.0146504437007205,1.70402057551239e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42119,-0.0676762257906326,0.0100556358467752,-0.087385272050312,-0.0479671795309531,1.76284531675307e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C4BPB,C4b-binding protein beta chain,42181,0.0270036797565311,0.00401539505827427,0.0191335054423135,0.0348738540707487,1.8256891260648e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGAM,Integrin alpha-M,42137,0.0222965598604618,0.00331841941645752,0.0157924578042051,0.0288006619167185,1.90252701083656e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42144,0.0168473360393813,0.0025104548569222,0.0119268445198138,0.0217678275589489,2.01161586687315e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ST13,Hsc70-interacting protein,39736,-0.0385674218311508,0.00574778203040679,-0.0498330746107481,-0.0273017690515535,2.04116191314855e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OPLAH,5-oxoprolinase,39638,-0.0492334606789642,0.00733907086015814,-0.0636180395648741,-0.0348488817930542,2.06388578358269e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42070,-0.0232985207339076,0.00347439167112129,-0.0301083284093053,-0.0164887130585098,2.08314865815883e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,39934,-0.0669535412429815,0.00998416354695222,-0.0865225017950079,-0.0473845806909552,2.09579824045833e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,39930,-0.0353931850488457,0.0053029132004042,-0.045786894921638,-0.0249994751760535,2.60024929039107e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNM3,Dynamin-3,39934,-0.0389127484444284,0.00583029671377839,-0.050340130003434,-0.0274853668854227,2.60126044715606e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCARA5,Scavenger receptor class A member 5,42249,-0.0213794704940981,0.00320744162663583,-0.0276660560823044,-0.0150928849058919,2.73740363736976e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42249,-0.0453764594721082,0.00680790328584112,-0.0587199499123568,-0.0320329690318596,2.74338530703454e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SH3BP1,SH3 domain-binding protein 1,39930,-0.0347317705308755,0.00522159753766091,-0.0449661017046909,-0.0244974393570602,3.03353331109203e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39934,-0.0549996188769975,0.00827536504720898,-0.0712193343695271,-0.0387799033844679,3.14582195332327e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,41843,-0.0364065179384599,0.00548538917183516,-0.0471578807152568,-0.025655155161663,3.32599262756579e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAYN,Layilin,41997,-0.024925820302941,0.00375573746822072,-0.0322870657406537,-0.0175645748652284,3.33053891156489e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATXN2L,Ataxin-2-like protein,39934,-0.0337670797785358,0.00508901347821694,-0.043741546195841,-0.0237926133612306,3.38624978508169e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA10,Annexin A10,41839,-0.0570363623276315,0.0086041744683253,-0.073900544285549,-0.0401721803697139,3.51263163852594e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RETN,Resistin,42105,-0.0298221819942824,0.00450514032931523,-0.0386522570397402,-0.0209921069488245,3.73800096195871e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NADK,NAD kinase,42145,-0.0379605421046586,0.00574944872099511,-0.049229461597809,-0.0266916226115081,4.19442916539011e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS3BP,Galectin-3-binding protein,39979,-0.0217439732488065,0.00329292458085974,-0.0281981054272916,-0.0152898410703214,4.20174728478066e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPAG1,Sperm-associated antigen 1,39934,-0.0407987039235823,0.00618034914938647,-0.0529121882563798,-0.0286852195907849,4.25595769048068e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX7,Syntaxin-7,39657,-0.0342062216288609,0.00518417477665678,-0.0443672041911082,-0.0240452390666136,4.3520026411043e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39757,-0.0311833629542876,0.00472664987766742,-0.0404475967145158,-0.0219191291940595,4.37517398809389e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STAT2,Signal transducer and activator of transcription 2,39657,-0.0547913627449802,0.00830783901094843,-0.0710747272064391,-0.0385079982835212,4.4423522959029e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41997,-0.0672426119378031,0.0102038275746093,-0.0872421139840373,-0.0472431098915688,4.56461357052388e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ING1,Inhibitor of growth protein 1,41820,-0.0329982423678634,0.00501065849868939,-0.0428191330252946,-0.0231773517104322,4.70151483380338e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WASHC3,WASH complex subunit 3,39929,-0.0527766888520721,0.00801668214911496,-0.0684893858643374,-0.0370639918398067,4.8026207941869e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42248,-0.0215425921337304,0.00327450777094237,-0.0279606273647774,-0.0151245569026833,4.9128833615838e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42310,-0.0161337554981248,0.00245245598717877,-0.0209405692329952,-0.0113269417632544,4.92091816219472e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TADA3,Transcriptional adapter 3,39919,-0.0281174529553177,0.00427689958128726,-0.0365001761346408,-0.0197347297759947,5.10459621656038e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39657,-0.0340925929850674,0.00518619887989202,-0.0442575427896557,-0.023927643180479,5.12849365800325e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42094,-0.0468390227019597,0.00713054322977596,-0.0608148874323206,-0.0328631579715988,5.2586121543273e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42162,-0.0483668169727548,0.00737873563762612,-0.062829138822502,-0.0339044951230077,5.76957692559886e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL11,C-X-C motif chemokine 11,42249,-0.0537749895380296,0.0082061441470512,-0.0698590320662499,-0.0376909470098092,5.84103449204052e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',39929,-0.0306415492696343,0.0046775238686518,-0.0398094960521918,-0.0214736024870768,5.97065798536543e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAA4,Serum amyloid A-4 protein,39979,-0.0227576626392199,0.00347457334972627,-0.0295678264046834,-0.0159474988737564,6.01085820098676e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTD,Biotinidase,39979,-0.0141456848603563,0.00216371861545616,-0.0183865733466503,-0.00990479637406219,6.51564436935387e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,JAM3,Junctional adhesion molecule C,39736,-0.0351540151425607,0.00537774607928391,-0.0456943974579572,-0.0246136328271643,6.55340149633359e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD164,Sialomucin core protein 24,42137,-0.0185235001039167,0.00283822202456472,-0.0240864152720635,-0.0129605849357698,6.97473488095668e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42262,-0.0230148615589573,0.00352657721102686,-0.0299269528925699,-0.0161027702253447,6.98765975209251e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42100,-0.0167353831537293,0.00256449733500413,-0.0217617979303374,-0.0117089683771213,7.00564336719058e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIMAP8,GTPase IMAP family member 8,39560,-0.0345495101151347,0.00529467402320489,-0.0449270712006162,-0.0241719490296531,7.08438886188058e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42119,-0.0696893821629734,0.0106872743898454,-0.0906364399670704,-0.0487423243588765,7.24274176629985e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL15,Interleukin-15,42119,-0.0225503309610787,0.00345890068539816,-0.0293297763044591,-0.0157708856176983,7.30430407315796e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42310,0.0194368278879122,0.00298164286314134,0.0135928078761551,0.0252808478996692,7.33365322795658e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BLVRB,Flavin reductase,42137,-0.0436342352335304,0.00669535097105854,-0.0567571231368052,-0.0305113473302557,7.42203951048027e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,39966,0.0151041187896685,0.00232054333586855,0.0105558538513661,0.0196523837279708,7.89038080583373e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,41913,0.0276249064211096,0.00424524062165525,0.0193042348026653,0.0359455780395539,7.92709065137812e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINI1,Neuroserpin,39713,0.0199198047830832,0.00306215572843994,0.013917979555341,0.0259216300108255,8.09464305216962e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,39929,-0.0211439388483007,0.00325868863372788,-0.0275309685704074,-0.0147569091261941,9.03216713330898e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41913,-0.0295152757433169,0.0045496265722151,-0.0384325438248585,-0.0205980076617753,9.04150055360072e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41837,-0.0541250719100431,0.00834753769776337,-0.0704862457976593,-0.0377638980224269,9.25194909813822e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CETN2,Centrin-2,41839,-0.046368239068538,0.00716019101903923,-0.0604022134658549,-0.0323342646712211,9.76167179602879e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,39575,-0.0454647428027113,0.00702109819594255,-0.0592260952667587,-0.0317033903386639,9.85710757824051e-11
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMBS,Porphobilinogen deaminase,42262,-0.0273625657084201,0.00422936367700094,-0.035652118515342,-0.0190730129014983,1.01567433920394e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OGFR,Opioid growth factor receptor,42070,-0.0218017069320357,0.00337566578440217,-0.0284180118694639,-0.0151854019946074,1.0938288830652e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GMPR2,GMP reductase 2,39736,-0.0453178179097257,0.00702658615994339,-0.0590899267832147,-0.0315457090362366,1.16885061302245e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMB1,Laminin subunit beta-1,39638,-0.0213891577895739,0.00331825699944871,-0.0278929415084933,-0.0148853740706544,1.19708254093891e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD46,Membrane cofactor protein,42107,-0.0193976402805701,0.00301054404219043,-0.0252983066032633,-0.0134969739578768,1.20920711412566e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MATN3,Matrilin-3,41992,0.0223151352081117,0.00346357413833393,0.0155265298969772,0.0291037405192462,1.21296321383171e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39657,-0.0254177006751336,0.00394773949947991,-0.0331552700941142,-0.017680131256153,1.25623217486114e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42166,0.0530977156195492,0.00825255831250122,0.0369227013270468,0.0692727299120516,1.28384738983819e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42249,-0.0342790407309725,0.00534043267563056,-0.0447462887752084,-0.0238117926867366,1.41915451770969e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39930,-0.0342218794062639,0.00533163217106177,-0.044671878461545,-0.0237718803509828,1.42979002345976e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,39904,-0.0308896826080258,0.00481481853055233,-0.0403267269279084,-0.0214526382881433,1.45926471191702e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRSS22,Brain-specific serine protease 4,39657,-0.0234708417188802,0.00365893811687779,-0.0306423604279607,-0.0162993230097998,1.46901817054456e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEC31A,Protein transport protein Sec31A,39638,-0.0525049634500603,0.0081898879639092,-0.0685571438593223,-0.0364527830407982,1.50517978982343e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39930,-0.043424610627956,0.00678326400419673,-0.0567198080761816,-0.0301294131797304,1.59699338161586e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42070,-0.0139873996625298,0.00218593868097731,-0.0182718394772454,-0.00970295984781432,1.61777365977854e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GET3,ATPase GET3,39958,-0.0364740105419128,0.00570834801184669,-0.0476623726451323,-0.0252856484386933,1.72836974742476e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP9,Matrix metalloproteinase-9,42125,-0.0401557291118735,0.00628829934066061,-0.0524807958195683,-0.0278306624041787,1.76094127468312e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHA2,Ephrin type-A receptor 2,41614,-0.0217215784912801,0.00341028646618986,-0.0284057399650123,-0.015037417017548,1.96116642911635e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AAMDC,Mth938 domain-containing protein,39638,-0.035664811906797,0.00560229335548428,-0.0466453068835462,-0.0246843169300479,2.01578588936088e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLRX,Glutaredoxin-1,42057,-0.0372004148871021,0.00584732632076112,-0.0486611744757939,-0.0257396552984103,2.05653077558234e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42070,-0.0358739488615481,0.00564046808006591,-0.0469292662984773,-0.0248186314246189,2.08133524733873e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP8,Neutrophil collagenase,42224,-0.0478548554643545,0.00752924733061355,-0.0626121802323571,-0.0330975306963519,2.13862221319355e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HPSE,Heparanase,39866,-0.0640088304706884,0.0100741037792661,-0.08375407387805,-0.0442635870633268,2.18164524789164e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL20,C-C motif chemokine 20,42296,-0.0576804491238318,0.00909443328486619,-0.0755055383621695,-0.039855359885494,2.33333205411296e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42145,-0.04902898919339,0.00774157230006444,-0.0642024709015163,-0.0338555074852637,2.47699538793741e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOLR1,Folate receptor alpha,42110,-0.0196332238117472,0.00310203893815967,-0.0257132201305402,-0.0135532274929543,2.54326851532718e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,39736,-0.0482667205379038,0.00763213150206515,-0.0632256982819515,-0.0333077427938561,2.64391584203263e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39575,-0.0188286524539198,0.00297785863309623,-0.0246652553747884,-0.0129920495330511,2.66702345824068e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH3,Cadherin-3,42249,-0.0244657613024856,0.0038726460068402,-0.0320561474758924,-0.0168753751290788,2.73932430156722e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB33A,Ras-related protein Rab-33A,39575,-0.044410355827848,0.00702996087039278,-0.0581890791338179,-0.0306316325218782,2.76482412909725e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FIS1,Mitochondrial fission 1 protein,42125,-0.0508436761731017,0.00805820626028242,-0.0666377604432552,-0.0350495919029481,2.88565404173205e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,39638,-0.0351178020279212,0.00557890145113018,-0.0460524488721364,-0.024183155183706,3.19576023415286e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42249,-0.0156460060644161,0.00249117075176769,-0.0205287007378808,-0.0107633113909514,3.47532689136687e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CENPF,Centromere protein F,39757,-0.0357811823420029,0.00570263842146315,-0.0469583536480707,-0.0246040110359351,3.63768566022602e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42126,-0.0191923610664011,0.00305991109923199,-0.0251897868208958,-0.0131949353119064,3.66828632356904e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAP18,Chromatin complexes subunit BAP18,39929,-0.0451004141536049,0.00719386563849125,-0.0592003908050478,-0.0310004375021621,3.75894709816805e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOXO3,Forkhead box protein O3,41843,-0.0633380368426973,0.0101056051682011,-0.0831450229723714,-0.0435310507130233,3.77990256873872e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DLG4,Disks large homolog 4,39929,-0.047683347408638,0.00761436614137619,-0.0626075050457353,-0.0327591897715407,3.93108146169546e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SFRP4,Secreted frizzled-related protein 4,39736,-0.0264942298247539,0.00423155749912795,-0.0347880825230447,-0.0182003771264631,3.96330990564098e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MPO,Myeloperoxidase,42137,-0.0295893981649165,0.00472742130076868,-0.0388551439144231,-0.0203236524154099,3.98888140969596e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42185,-0.0718092203076269,0.0114790977789564,-0.0943082519543814,-0.0493101886608725,4.07735800374285e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,41843,-0.0195886200793769,0.00313203076597474,-0.0257274003806874,-0.0134498397780664,4.11615028355291e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL2,C-C motif chemokine 2,41992,-0.0339984260612213,0.00544338155093162,-0.0446674539010472,-0.0233293982213953,4.34308713144197e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42137,-0.0365857177979959,0.00586094458000191,-0.0480731691747996,-0.0250982664211921,4.44079376709068e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41843,-0.0378146222408369,0.00606057636303179,-0.0496933519123792,-0.0259358925692946,4.52507915013744e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DAB2,Disabled homolog 2,42262,-0.072690283827133,0.0116598537673359,-0.0955435972111114,-0.0498369704431546,4.67343008748587e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RRAS,Ras-related protein R-Ras,39649,-0.0865301300011413,0.0138926396451874,-0.113759703705709,-0.059300556296574,4.88080395624821e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MITD1,MIT domain-containing protein 1,42016,-0.0631515903094039,0.0101441247423887,-0.0830340748044858,-0.0432691058143219,4.94531015810912e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42070,0.0449999202243518,0.00724073409806077,0.0308080813921526,0.0591917590565509,5.2895327272944e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BSG,Basigin,42284,-0.0136437695437448,0.00219558696075637,-0.0179471199868273,-0.00934041910066236,5.30899664009173e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TTF2,Transcription termination factor 2,39649,-0.0326500384984882,0.00525786701223848,-0.0429554578424756,-0.0223446191545008,5.49752591455793e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,39638,-0.0674755724313711,0.0108723193849531,-0.0887853184258791,-0.0461658264368631,5.62354855261375e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42119,-0.0473604065874317,0.00763344317141282,-0.0623219552034008,-0.0323988579714626,5.65326378717376e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCRIB,Protein scribble homolog,39638,-0.0574274489251351,0.00926135591188389,-0.0755797065124276,-0.0392751913378427,5.81998332632298e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,39699,-0.0356116133529108,0.00574434537616445,-0.0468705302901931,-0.0243526964156285,5.86843488325671e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,41900,-0.0331424985277691,0.00534946121822148,-0.0436274425154832,-0.022657554540055,5.98201243466233e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GUCA2A,Guanylin,42083,-0.022907526787487,0.00369821198503093,-0.0301560222781476,-0.0156590312968263,6.02780085670875e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42296,-0.0434835994105162,0.00702043299715465,-0.0572436480849393,-0.029723550736093,6.0386338716232e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42224,-0.0197593616869213,0.00319343764371177,-0.0260184994685964,-0.0135002239052463,6.28804802640527e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41913,-0.0355469338639725,0.00575004468150209,-0.0468170214397166,-0.0242768462882284,6.51321402321274e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARSA,Arylsulfatase A,42137,-0.0292796354454146,0.00474143413965726,-0.0385728463591429,-0.0199864245316864,6.79394748637443e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,39929,-0.0198559025960847,0.00322091583098021,-0.0261688976248059,-0.0135429075673635,7.30304579677814e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VEGFD,Vascular endothelial growth factor D,42275,0.0249815266370764,0.00405643190740651,0.0170309200985596,0.0329321331755932,7.54947697861459e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RGCC,Regulator of cell cycle RGCC,39934,-0.0498854343175442,0.00810321051950968,-0.0657677269357832,-0.0340031416993052,7.70043083949634e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOST,Sclerostin,42129,-0.0250052066887971,0.00407300111580556,-0.032988288875776,-0.0170221245018182,8.52257794612763e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42119,-0.0393247272093339,0.00640620758581067,-0.0518808940775228,-0.026768560341145,8.56156095452702e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DSC2,Desmocollin-2,41984,-0.0226211933195743,0.00369136231587159,-0.0298562634586826,-0.0153861231804659,9.14064938891484e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COMT,Catechol O-methyltransferase,41740,-0.0536709146326706,0.00876956909870285,-0.0708592700661282,-0.036482559199213,9.6157956654856e-10
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42070,-0.0236169611314206,0.00386495403096655,-0.0311922710321151,-0.0160416512307262,1.02031317131843e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,B2M,Beta-2-microglobulin,39979,-0.0196169140707918,0.00321034264303331,-0.0259091856511371,-0.0133246424904465,1.02544829497835e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KITLG,Kit ligand,42145,0.0245303274209636,0.00401552148550097,0.0166599053093817,0.0324007495325455,1.03082287121042e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42119,-0.066867856718769,0.0109520411927378,-0.088333857456535,-0.045401855981003,1.05275025548343e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39930,-0.0941929833598747,0.0154347734050873,-0.124445139233846,-0.0639408274859037,1.07735335082883e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA1,Carbonic anhydrase 1,41890,-0.0361817774460064,0.00593127036092952,-0.0478070673534283,-0.0245564875385845,1.08894860738336e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DTNB,Dystrobrevin beta,39900,-0.029307170194753,0.004805839850588,-0.0387266163019055,-0.0198877240876005,1.10746274775249e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YJU2,Splicing factor YJU2,39919,-0.0212988198141543,0.00349740821908384,-0.0281537399235586,-0.0144438997047499,1.16656616574231e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42185,-0.0548019268797327,0.00900133956286634,-0.0724445524229508,-0.0371593013365147,1.1726585212249e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGA5,Integrin alpha-5,42137,-0.0159008337929174,0.00261323293400151,-0.0210227703435603,-0.0107788972422744,1.1983084719525e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EREG,Proepiregulin,41997,-0.0512206667181653,0.00841895132135699,-0.067721811308025,-0.0347195221283056,1.20435553982066e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,39958,-0.0310636077726127,0.00510796033283947,-0.041075210024978,-0.0210520055202473,1.22959791459223e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LPP,Lipoma-preferred partner,39575,-0.0424642061805497,0.00698548547584442,-0.0561557577132048,-0.0287726546478947,1.25016527886633e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",39950,-0.0252052719560395,0.00415047321031527,-0.0333401994482574,-0.0170703444638215,1.29667041961277e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,39958,-0.0586009117477809,0.00965204886708712,-0.0775189275272717,-0.0396828959682902,1.30895869532084e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCL2L15,Bcl-2-like protein 15,39657,-0.0363171938095979,0.0059818668803073,-0.0480416528950002,-0.0245927347241955,1.31113732736505e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42162,-0.0316813575776369,0.00522364068944162,-0.0419196933289425,-0.0214430218263313,1.35465224848606e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL19,C-C motif chemokine 19,42249,-0.0719988340630431,0.0118725220637466,-0.0952689773079864,-0.0487286908180998,1.36007204653466e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTN1,Contactin-1,42310,0.0170104777874735,0.00280634384732858,0.0115100438467095,0.0225109117282375,1.38449398064344e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42130,-0.0361319962092873,0.00596353732358794,-0.0478205293635196,-0.0244434630550549,1.40763497904979e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42145,0.0509620665132721,0.00841418143109758,0.0344702709083208,0.0674538621182234,1.42631895681964e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42295,-0.017792380405777,0.00293876891420491,-0.0235523674776186,-0.0120323933339354,1.44657597065607e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS3,Galectin-3,42196,-0.018836552080819,0.00311156384106233,-0.0249352172093012,-0.0127378869523369,1.45259625253725e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DBI,Acyl-CoA-binding protein,42085,-0.0494743286311728,0.00817881294428109,-0.0655048020019637,-0.0334438552603818,1.49526159175042e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL5A1,Collagen alpha-1(V) chain,39736,-0.0261935907160459,0.00433930692180655,-0.0346986322827867,-0.017688549149305,1.62656904353841e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41843,-0.0283483984274505,0.00470607698021124,-0.0375723093086645,-0.0191244875462364,1.74900766001055e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39638,0.021540593776918,0.00357614327697583,0.0145313529540454,0.0285498345997907,1.76217520090533e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,39575,-0.0427914616247616,0.00711015653880622,-0.0567273684408218,-0.0288555548087014,1.81825101884707e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRKL,Crk-like protein,42143,-0.0666624596894287,0.0110789766303594,-0.0883772538849331,-0.0449476654939243,1.82237138122355e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRG3,Proteoglycan 3,39966,0.031586613214923,0.00525038806621818,0.0212958526051353,0.0418773738247106,1.84223365354181e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINI2,Serpin I2,39930,-0.0366982713385695,0.00610766081219933,-0.0486692865304802,-0.0247272561466588,1.92926394811099e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LMNB2,Lamin-B2,39929,-0.0181477491326716,0.00302665370039976,-0.0240799903854551,-0.0122155078798881,2.0843016662609e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NBN,Nibrin,41913,-0.0341805748146476,0.00570358111292341,-0.0453595937959775,-0.0230015558333177,2.11552495739246e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39929,-0.0403514974205856,0.0067358740626655,-0.05355381058341,-0.0271491842577612,2.15503206221164e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD244,Natural killer cell receptor 2B4,42296,-0.0173199337664477,0.00289324568897287,-0.0229906953168346,-0.0116491722160609,2.19989592653895e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F3,Tissue factor,42174,0.0164764285590089,0.00275278635289116,0.0110809673073423,0.0218718898106756,2.21349569776307e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPT1,Angiopoietin-1,42085,-0.0525173549063766,0.00877708309656826,-0.0697204377756504,-0.0353142720371028,2.23979174943519e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAT,Catalase,39827,-0.0330993491945729,0.00553397295166028,-0.0439459361798271,-0.0222527622093188,2.28361500758606e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP2,Microtubule-associated protein 2,39929,-0.0294740843976507,0.00494465378663689,-0.039165605819459,-0.0197825629758424,2.58484405050157e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39934,-0.0374290658038675,0.00628652883321929,-0.0497506623169773,-0.0251074692907576,2.69663863419089e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41430,-0.0262650891797245,0.00441284402000543,-0.0349142634589351,-0.0176159149005139,2.71860414532745e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFAP,Glial fibrillary acidic protein,41820,0.0284589619858385,0.00478988224441848,0.0190707927867783,0.0378471311848988,2.89575155192555e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,41879,-0.0333920708181658,0.00562510830888274,-0.044417283103576,-0.0223668585327557,2.98884898901259e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42119,-0.0453499473273173,0.00764304725117242,-0.0603303199396152,-0.0303695747150193,3.03815629871263e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYZL2,Lysozyme-like protein 2,39560,-0.0226729075960293,0.00384156170233633,-0.0302023685326085,-0.0151434466594501,3.69751248114344e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,39934,-0.0226828633965658,0.00384337211161803,-0.0302158727353371,-0.0151498540577944,3.69819896980177e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,41747,-0.0243093043939057,0.00412147169367811,-0.0323873889135148,-0.0162312198742966,3.76497834930532e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,39934,-0.0476705532992832,0.00808419223005898,-0.0635155700701988,-0.0318255365283675,3.81280564112791e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD69,Early activation antigen CD69,42082,-0.0543002647214759,0.0092191026167901,-0.0723697058503845,-0.0362308235925673,3.95462815740352e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,39934,-0.0414894294795587,0.00704777375431296,-0.0553030660380121,-0.0276757929211053,4.0469672526251e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATRN,"Attractin, Isoform 2",39979,-0.0103473336761466,0.00175775974639683,-0.0137925427790843,-0.00690212457320877,4.05200449046238e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,39958,-0.0669196792467845,0.0113761117602316,-0.0892168582968385,-0.0446225001967305,4.15575539171765e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39638,0.0134400876525507,0.00228538107773434,0.00896074074019141,0.01791943456491,4.19882854683375e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAL,Galanin peptides,42185,0.0410635543178426,0.00699722660892164,0.0273489901643562,0.054778118471329,4.49877793254955e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39919,-0.0219526717164077,0.00374128492157319,-0.0292855901626912,-0.0146197532701243,4.54309199138095e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GASK1A,Golgi-associated kinase 1A,39575,-0.0264474829795581,0.00452215405926795,-0.0353109049357232,-0.0175840610233929,5.10405121549592e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REEP4,Receptor expression-enhancing protein 4,39934,-0.0385779810210365,0.0066024898786528,-0.051518861183196,-0.025637100858877,5.26972954310727e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD48,CD48 antigen,42166,-0.0188627253841129,0.00323078834998864,-0.0251950705500906,-0.0125303802181351,5.39010103563145e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACYP1,Acylphosphatase-1,39701,-0.0402016682405738,0.00688597426596851,-0.0536981778018721,-0.0267051586792755,5.42470606613019e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42166,-0.0466832782383217,0.00799895758176731,-0.0623612350985856,-0.0310053213780577,5.463428777737e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42310,-0.0199154269230984,0.00341974075858945,-0.0266181188099337,-0.0132127350362631,5.88607149209912e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYDGF,Myeloid-derived growth factor,39958,-0.0611625809372215,0.0105123747431402,-0.0817668354337763,-0.0405583264406666,6.11088007153506e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBCC,Tubulin-specific chaperone C,42016,-0.0491040231313019,0.00844328775414404,-0.0656528671294242,-0.0325551791331796,6.1738977132365e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BGN,Biglycan,41820,0.0722327409570756,0.0124233078050497,0.0478830576591782,0.096582424254973,6.22975589706745e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX8,Syntaxin-8,42119,-0.0292090795899369,0.00502537029819436,-0.0390588053743978,-0.0193593538054759,6.30010858535895e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOE,Apolipoprotein E,39979,-0.0427938847043704,0.00736581852318321,-0.0572308890098095,-0.0283568803989314,6.42261309352179e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,39638,-0.0260284154698937,0.00448290308679537,-0.0348149055200126,-0.0172419254197747,6.56872606386483e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHB4,Ephrin type-B receptor 4,42310,-0.0154626325746498,0.00266555040349666,-0.0206871113655032,-0.0102381537837963,6.74091629859344e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCN3,CCN family member 3,42299,-0.0206740671275983,0.00356969558522287,-0.0276706704746351,-0.0136774637805614,7.12705463170403e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39657,-0.0339231116846576,0.00585844750056817,-0.0454056687857712,-0.022440554583544,7.21046823775698e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPR,Nucleoprotein TPR,39575,-0.0298958080534317,0.00516643814698669,-0.0400220268215256,-0.0197695892853378,7.38162281513901e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39657,-0.0272009260513725,0.00470820155561668,-0.0364290011003812,-0.0179728510023638,7.79343583840028e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAMR1,Inactive serine protease PAMR1,42137,-0.0160443700998086,0.00277829112884271,-0.0214898207123403,-0.0105989194872769,7.86868324992195e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42310,0.0142474133133854,0.00246755621918638,0.00941100312378008,0.0190838235029907,7.91373261516546e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PEPD,Xaa-Pro dipeptidase,39990,0.016093051459076,0.00278980843995071,0.0106250269167726,0.0215610760013794,8.20548964703007e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,39934,-0.0724528899600947,0.0125608300432312,-0.0970721168448278,-0.0478336630753616,8.22372536944965e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OPTC,Opticin,42070,0.0275363031122499,0.00477484056580016,0.0181776156032816,0.0368949906212182,8.24870787013192e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42310,-0.0434755917986488,0.00754942357842401,-0.0582724620123599,-0.0286787215849378,8.65324765955672e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,A1BG,Alpha-1B-glycoprotein,39979,-0.0100138851190824,0.00174403081848898,-0.0134321855233208,-0.00659558471484396,9.6069137143897e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,39929,-0.0324624112534425,0.00565640534861142,-0.0435489657367209,-0.0213758567701641,9.76493900109104e-09
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,39649,-0.0441425373455535,0.00770063119147466,-0.0592357744808438,-0.0290493002102631,1.01656022470002e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CX3CL1,Fractalkine,42016,0.0201020178340978,0.00350970301457854,0.0132229999255239,0.0269810357426717,1.0407419794936e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PROC,Vitamin K-dependent protein C,42199,-0.015450772213003,0.00269775903370463,-0.0207383799190641,-0.010163164506942,1.04224150917351e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42145,-0.0485060384062183,0.00847473412806145,-0.0651165172972187,-0.0318955595152179,1.06496383292524e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42185,-0.0172570067553919,0.00301651681665456,-0.0231693797160348,-0.0113446337947489,1.08234628569054e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPING1,Plasma protease C1 inhibitor,39959,0.0111608598831476,0.0019525715875337,0.00733381957158155,0.0149879001947137,1.1182008365642e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42016,-0.0473471621609447,0.00829206336196294,-0.0635996063503921,-0.0310947179714974,1.15413333074035e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39640,-0.016197896261767,0.00283657254599266,-0.0217575784519126,-0.0106382140716214,1.15636810265616e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AZU1,Azurocidin,41751,-0.0451116389086369,0.00790145630126356,-0.0605984932591135,-0.0296247845581604,1.15906647418403e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UROS,Uroporphyrinogen-III synthase,39649,-0.0398285505695129,0.0069814590488466,-0.0535122103052523,-0.0261448908337736,1.19400339179136e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,39872,-0.0378211777396115,0.00663559653605551,-0.0508269469502803,-0.0248154085289427,1.23000997595591e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42249,-0.0277285468589603,0.00487094371487414,-0.0372755965401136,-0.018181497177807,1.27662168648249e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINE2,Glia-derived nexin,39958,-0.0389893482326753,0.00685286344158082,-0.0524209605781737,-0.0255577358871769,1.30564362852961e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39657,-0.0219196332665085,0.0038534597107176,-0.029472414299515,-0.014366852233502,1.31567822933622e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39757,-0.0299646251417,0.00527302283254275,-0.0402997498934838,-0.0196295003899162,1.35964486130977e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOL1,Apolipoprotein L1,39990,0.0320991913010021,0.00565024639705341,0.0210247083627774,0.0431736742392268,1.37171800224243e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,41963,-0.0700833253137625,0.0123433397257645,-0.0942762711762609,-0.0458903794512642,1.39257597991346e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRSF1,G-rich sequence factor 1,39486,-0.0499012301310774,0.00878992773718119,-0.0671294884959525,-0.0326729717662023,1.40509498042995e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCRL6,Fc receptor-like protein 6,42119,-0.0409067326083036,0.00721015130125137,-0.0550386291587563,-0.0267748360578509,1.42785883255531e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MGLL,Monoglyceride lipase,42166,-0.0520027435664576,0.00916832476943663,-0.0699726601145534,-0.0340328270183618,1.44021384655835e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPEP1,Dipeptidase 1,41997,0.0273201867495661,0.00482170213281886,0.0178696505692411,0.036770722929891,1.49103547471389e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OGN,Mimecan,42137,-0.0257513532650766,0.00454649725264703,-0.0346624878802648,-0.0168402186498884,1.50895233919272e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCARF1,Scavenger receptor class F member 1,42310,-0.025260227071016,0.00446436176401799,-0.0340103761284912,-0.0165100780135407,1.56034805105866e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUB1,NEDD8 ultimate buster 1,42119,-0.0499119775654452,0.00883833136487177,-0.0672351070405939,-0.0325888480902966,1.66350093220059e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSDE1,Cold shock domain-containing protein E1,39575,-0.0720191836869231,0.0127524594120956,-0.0970140041346304,-0.0470243632392157,1.66870720302943e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42106,-0.0203532975625123,0.00360535410861323,-0.0274197916153942,-0.0132868035096304,1.68215637794024e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42135,0.0314295058989824,0.00557273629692021,0.0205069427570187,0.042352069040946,1.73585176298258e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42070,-0.0204206588358554,0.00362229459117712,-0.0275203562345625,-0.0133209614371482,1.76008622403456e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD300C,CMRF35-like molecule 6,42249,-0.0208526481845258,0.00370558031297421,-0.0281155855979553,-0.0135897107710964,1.86584800547325e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42217,-0.0255606698486877,0.00454268800381066,-0.0344643383361566,-0.0166570013612188,1.87232716953134e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDCP1,CUB domain-containing protein 1,42016,-0.033074448107213,0.00588163703329521,-0.0446024566924716,-0.0215464395219544,1.91038734171044e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS5,Transmembrane protease serine 5,41946,0.0227428636943661,0.00404520563981375,0.0148142606403311,0.030671466748401,1.9234670158693e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42070,-0.0268155350710665,0.00477003273669441,-0.0361647992349876,-0.0174662709071455,1.92879550449127e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OLFM4,Olfactomedin-4,39347,-0.0735804752418019,0.0130907184321144,-0.0992382833687462,-0.0479226671148576,1.94799331334827e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL13,C-C motif chemokine 13,42275,-0.0401730490325325,0.00715919728189555,-0.0542050757050477,-0.0261410223600172,2.04605331993228e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLXNB3,Plexin-B3,42099,-0.0283724890518075,0.00505885978899141,-0.0382878542382307,-0.0184571238653844,2.08124870558921e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDA,Cytidine deaminase,39946,-0.0282337203349362,0.00503389024100477,-0.0381001452073055,-0.0183672954625668,2.08588856286606e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCRG1,Scrapie-responsive protein 1,39958,-0.0161689601328282,0.00288743203381954,-0.0218283269191145,-0.0105095933465418,2.19620277878562e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TP53,Cellular tumor antigen p53,41843,-0.0261621899344163,0.00467941440224568,-0.0353338421628178,-0.0169905377060148,2.30347558890514e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNX15,Sorting nexin-15,39736,-0.0319176514222536,0.00570832462905412,-0.0431059676951997,-0.0207293351493076,2.30523562654003e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39736,-0.0619634363058514,0.011083888025193,-0.0836878568352298,-0.0402390157764731,2.31872355839685e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STK24,Serine/threonine-protein kinase 24,41839,-0.0365353144172127,0.00654265321688924,-0.0493589147223156,-0.0237117141121098,2.39435931289723e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THTPA,Thiamine-triphosphatase,39897,-0.0518295942652895,0.00928187889102073,-0.0700220768916901,-0.0336371116388888,2.40540316177096e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,39930,-0.0240071362879047,0.0042996050298905,-0.0324343621464901,-0.0155799104293194,2.41059242181639e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42170,-0.0158231750006499,0.00283626777980242,-0.0213822598490626,-0.0102640901522371,2.46714416757392e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42185,-0.01581992492897,0.0028372642164993,-0.0213809627933087,-0.0102588870646314,2.51140272741844e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F12,Coagulation factor XII,39979,-0.0242687346235994,0.00435302546538885,-0.0328006645357615,-0.0157368047114372,2.52964623370975e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH5,Cadherin-5,42310,0.0177718991955111,0.00319269485648746,0.0115142172767957,0.0240295811142266,2.64897549441687e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42181,0.0144753127116248,0.00260184362948433,0.00937569919783553,0.0195749262254141,2.69443106027943e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAS2,Growth arrest-specific protein 2,39757,-0.0306473213659363,0.00551722243224524,-0.0414610773331369,-0.0198335653987356,2.84224129194356e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RLN2,Prorelaxin H2,39709,-0.0302560914751342,0.00544909220793189,-0.0409363122026807,-0.0195758707475877,2.88081741594946e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,39919,-0.0419700670582522,0.00757307644725535,-0.0568132968948727,-0.0271268372216317,3.05711485396959e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,41913,-0.0346568419073689,0.0062631597600918,-0.0469326350371488,-0.022381048777589,3.19934843359596e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGA,Fibrinogen alpha chain,39735,0.018145107596186,0.00328088229686738,0.011714578294326,0.0245756368980461,3.2642014275822e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42072,-0.0156309998928532,0.00282720371312805,-0.0211723191705842,-0.0100896806151222,3.28455733510415e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],41874,-0.0274932755769544,0.00498325720910291,-0.0372604597067961,-0.0177260914471127,3.51034322606809e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42181,-0.0352173386203433,0.00639776958609758,-0.0477569670090946,-0.0226777102315921,3.76659914539199e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,39736,0.0174205685762048,0.00316457627436213,0.011217999078455,0.0236231380739545,3.77636520832309e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBC1D17,TBC1 domain family member 17,41839,-0.0249263677959113,0.00453436112316564,-0.0338137155973159,-0.0160390199945066,3.92974308559072e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFRAL,GDNF family receptor alpha-like,39574,0.036756830238628,0.00668811462712926,0.0236481255694547,0.0498655349078014,3.97537369371342e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD226,CD226 antigen,39657,-0.0247389800270758,0.00450230029079915,-0.0335634885970421,-0.0159144714571094,3.99952387999152e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",39713,-0.0500774339804602,0.00911457275486391,-0.0679419965799935,-0.0322128713809269,4.01098829744959e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KEL,Kell blood group glycoprotein,41839,-0.0209329749788466,0.00381087232351729,-0.0284022847329405,-0.0134636652247527,4.02544049501246e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,39649,-0.0253058793945239,0.00460965457053851,-0.0343408023527794,-0.0162709564362684,4.1138340556308e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,41900,-0.0443307502363403,0.00807993102889141,-0.0601674150529675,-0.0284940854197131,4.17411895816082e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TF,Serotransferrin,39979,-0.0124001954477065,0.00226153299149012,-0.0168328001110272,-0.00796759078438589,4.26876710962847e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASC3,Protein CASC3,39649,-0.0249984528439758,0.00456108344017892,-0.0339381763867265,-0.0160587293012252,4.32668133311292e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CR2,Complement receptor type 2,42217,-0.0268686516056364,0.00490587154646886,-0.0364841598367153,-0.0172531433745574,4.40678872566805e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PARK7,Parkinson disease protein 7,42137,-0.0291325271296165,0.00532167005161959,-0.0395630004307909,-0.018702053828442,4.47015448805952e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,39657,-0.0337663066330429,0.00616945200552347,-0.0458584325638689,-0.0216741807022169,4.51765276982823e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39575,-0.0217658443525926,0.00397751374576788,-0.0295617712942977,-0.0139699174108876,4.54188450124848e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DHPS,Deoxyhypusine synthase,39919,-0.023294542492485,0.00426125774817239,-0.0316466076789029,-0.0149424773060671,4.68511234021041e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RWDD1,RWD domain-containing protein 1,42249,-0.0357780695487809,0.00654859272183048,-0.0486133112835686,-0.0229428278139932,4.75087119304271e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX4,Syntaxin-4,42070,-0.033882872135373,0.00620640871305167,-0.0460474332129543,-0.0217183110577918,4.86380736380504e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39930,-0.0512092623761278,0.00938393808512295,-0.0696017810229687,-0.0328167437292868,4.94109032078329e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42119,-0.0235683502399881,0.00432931824794091,-0.0320538140059523,-0.0150828864740239,5.30377888610569e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39930,-0.0174765555980342,0.00321032142850027,-0.0237687855978948,-0.0111843255981737,5.32238080736465e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42016,-0.0136859528774949,0.00251501787334037,-0.0186153879092421,-0.00875651784574781,5.37033966538699e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPI,Glucose-6-phosphate isomerase,39990,-0.0274822577404146,0.00506122553721055,-0.0374022597933473,-0.0175622556874819,5.75236295420336e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42119,-0.0136937046132655,0.0025226273768741,-0.0186380542719387,-0.00874935495459227,5.78588077932806e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39934,-0.0611963654156027,0.0112724706582536,-0.0832904079057797,-0.0391023229254257,5.78930741019861e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39934,-0.0273681716064618,0.00504501585506492,-0.037256402682389,-0.0174799405305345,5.92141818141311e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42016,-0.0598692307898015,0.0110412293452023,-0.081510040306398,-0.038228421273205,5.98443847691226e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,39575,-0.0207453036127139,0.00382579405571604,-0.0282438599619173,-0.0132467472635104,6.00228490660374e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39713,0.0281548118555405,0.00519537518915752,0.0179718764847917,0.0383377472262892,6.11143558005793e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LACRT,Extracellular glycoprotein lacritin,39895,-0.0260217602270146,0.0048095012222443,-0.0354483826226135,-0.0165951378314158,6.41356371660784e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CST5,Cystatin-D,41846,-0.0319064146519091,0.00590717781645498,-0.0434844831721608,-0.0203283461316573,6.73040275325428e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRAP2,GRB2-related adapter protein 2,42145,-0.0733588711119109,0.0135830806171914,-0.0999817091216059,-0.0467360331022158,6.74818763279537e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PF4,Platelet factor 4,39914,-0.0555625565826932,0.0102913537548921,-0.0757336099422818,-0.0353915032231046,6.83850261248519e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39934,0.0146509581978102,0.00271716968989451,0.00932530560561697,0.0199766107900034,7.10795982928206e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RALY,RNA-binding protein Raly,39919,-0.0273755980579606,0.00508689663010308,-0.0373459154529626,-0.0174052806629586,7.53032778418556e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDHR5,Cadherin-related family member 5,42145,-0.0218906113972628,0.00407318104697579,-0.0298740462493354,-0.0139071765451903,7.81418901978312e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LPO,Lactoperoxidase,41647,-0.0346867144562369,0.00647153909324535,-0.0473709310789977,-0.022002497833476,8.46915548230575e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,41843,-0.0511282490857584,0.00953919074252522,-0.0698250629411078,-0.032431435230409,8.47062182146678e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,39639,-0.0483120411276017,0.00901349712586106,-0.0659784954942894,-0.0306455867609141,8.49140170728695e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41839,-0.0362477072967928,0.00677646479723149,-0.0495295782993665,-0.0229658362942191,8.98840038898919e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACE,Angiotensin-converting enzyme,39990,-0.0152896091332525,0.00285873101115874,-0.0208927219151236,-0.00968649635138136,9.04572445433303e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42162,0.0369244006664115,0.00691672748027849,0.0233676148050657,0.0504811865277574,9.52706098312428e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41843,-0.0366305530994653,0.00686281851033733,-0.0500816773797264,-0.0231794288192041,9.57713376606336e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,39649,-0.0365060705929167,0.00684029527389768,-0.0499130493297562,-0.0230990918560772,9.64123585032619e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42057,-0.0265560072789281,0.00497652764245103,-0.0363100014581322,-0.0168020130997241,9.64259404032707e-08
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOXJ3,Forkhead box protein J3,39657,-0.025504136530535,0.00478722220477272,-0.0348870920518895,-0.0161211810091804,1.01504641188026e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GTPBP2,GTP-binding protein 2,39649,-0.0461895806093486,0.00867863054655548,-0.0631996964805973,-0.0291794647380998,1.04515172220062e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42181,0.0166101998921241,0.00312275568111284,0.0104895987571429,0.0227308010271052,1.05945591124514e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNPEP,Aspartyl aminopeptidase,39929,-0.0319448394863379,0.006009513399678,-0.0437234857497068,-0.020166193222969,1.08259618605964e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,39919,-0.0325127455829108,0.00612932562301294,-0.0445262238040161,-0.0204992673618054,1.15139756513065e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COMMD1,COMM domain-containing protein 1,39638,-0.0342227061559046,0.00645588704418427,-0.0468762447625058,-0.0215691675493035,1.17387065903222e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42296,-0.0196000936834795,0.00369831341360492,-0.0268487879741451,-0.0123513993928138,1.17767337570964e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DBNL,Drebrin-like protein,42185,-0.0516046517143289,0.00974028271279929,-0.0706956058314155,-0.0325136975972423,1.18864117045256e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL8,Interleukin-8,42035,-0.0377657301607607,0.00713976407092652,-0.0517596677397767,-0.0237717925817447,1.2458102585825e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42070,-0.0322694304125388,0.00611790019378158,-0.0442605147923507,-0.0202783460327269,1.35111292007375e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD70,CD70 antigen,42119,0.024425323382864,0.00464449936096597,0.0153221046353707,0.0335285421303574,1.47066470769038e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",39966,-0.0240691440915112,0.00457694855718561,-0.0330399632635949,-0.0150983249194274,1.47650806687581e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGA4,Pepsin A-4,39990,-0.041707208091957,0.00793170544219503,-0.0572533507586593,-0.0261610654252547,1.48034295745128e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MINK1,Misshapen-like kinase 1,39929,-0.0517438751779166,0.00984121477091729,-0.0710326561289145,-0.0324550942269187,1.48382386794006e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42070,-0.0481226001494937,0.00915996890325426,-0.0660761391998721,-0.0301690610991154,1.51447276240891e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42181,-0.0138550350270469,0.0026379609281543,-0.0190254384462293,-0.00868463160786442,1.52582754562699e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,39661,-0.0151559737196064,0.00288977180032718,-0.0208199264482476,-0.0094920209909651,1.59431113217062e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42248,-0.0231203519852034,0.00440946009175567,-0.0317628937650445,-0.0144778102053622,1.6003931156551e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,39929,-0.021382516349235,0.00408263655038063,-0.029384483987981,-0.0133805487104889,1.65748786612415e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,39657,-0.0280235760957794,0.00535187395436533,-0.0385132490463354,-0.0175339031452233,1.66909402241138e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL7,C-C motif chemokine 7,42119,-0.0308785032892982,0.00590348285156981,-0.042449329678375,-0.0193076769002214,1.71523254078702e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42145,-0.0193558401914385,0.00370190353482965,-0.0266115711197047,-0.0121001092631724,1.73322796227917e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GBP1,Guanylate-binding protein 1,39911,-0.0356512601073392,0.00682520993144726,-0.0490286715729758,-0.0222738486417025,1.78724315820107e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,41843,-0.0333861786660901,0.00639427815916711,-0.0459189638580577,-0.0208533934741226,1.80401503985529e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RTBDN,Retbindin,42070,-0.0164478457850883,0.00315316062746608,-0.0226280406149218,-0.0102676509552548,1.85234292379018e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42145,-0.0368599781102374,0.00706699155306536,-0.0507112815542455,-0.0230086746662293,1.85728180236026e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,39930,-0.0416424582649466,0.00798563697919224,-0.0572943067441634,-0.0259906097857298,1.87390767434679e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRDX2,Peroxiredoxin-2,39819,-0.0332212316484007,0.00637712889499149,-0.045720404282584,-0.0207220590142174,1.92776262348211e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,39649,-0.0258894989589564,0.00497452193898314,-0.0356395619593634,-0.0161394359585495,1.98094896833403e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPP1,Osteopontin,42286,0.024030550344838,0.00462371956565294,0.0149680599961582,0.0330930406935177,2.05185810389948e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATOX1,Copper transport protein ATOX1,42181,-0.03879882674124,0.00747412924499238,-0.0534481200614251,-0.024149533421055,2.12091031832195e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VCAN,Versican core protein,42249,0.0164149576401255,0.00316479214649099,0.0102119650330032,0.0226179502472479,2.17068426431417e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DENR,Density-regulated protein,39657,-0.0314970406712908,0.00607924276618777,-0.0434123564930188,-0.0195817248495627,2.24491151636948e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDCD6,Programmed cell death protein 6,42145,0.0384564423915701,0.00742769323271321,0.0238981636554523,0.053014721127688,2.28171704904925e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL17C,Interleukin-17C,41913,-0.038365195846749,0.00744236816284599,-0.0529522374459271,-0.0237781542475709,2.57303940812919e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42016,-0.0198012907316937,0.00384560790637439,-0.0273386822281875,-0.0122638992351999,2.65491331015202e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD36,Platelet glycoprotein 4,39657,-0.0253111205815354,0.0049225227762958,-0.0349592652230752,-0.0156629759399957,2.76624792756956e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERI1,3'-5' exoribonuclease 1,39757,-0.0186887662167415,0.00363600936268397,-0.0258153445676021,-0.0115621878658809,2.79519144252836e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EGF,Pro-epidermal growth factor,42081,-0.0561751946015365,0.0109348950598225,-0.0776075889187885,-0.0347428002842845,2.82692837485159e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,39575,-0.0375164866246834,0.00731409655568317,-0.0518521158738224,-0.0231808573755444,2.95722424216366e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,39575,-0.0236726743094566,0.00462450056670987,-0.0327366954202079,-0.0146086531987053,3.1241268350734e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPON1,Spondin-1,42144,-0.017532898273526,0.00342891630251263,-0.0242535742264507,-0.0108122223206012,3.20987250833163e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMS,Spermine synthase,39586,-0.03475697912139,0.0067968549329367,-0.0480788147899459,-0.021435143452834,3.21255903590399e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF19,Fibroblast growth factor 19,42185,-0.041721503260103,0.00816437867095168,-0.0577236854551683,-0.0257193210650377,3.26207439536247e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN1,Tetraspanin-1,41900,-0.0391112534548192,0.00765638551381383,-0.0541177690618943,-0.0241047378477441,3.29538666802721e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APP,Amyloid-beta precursor protein,42112,-0.0354485711892447,0.00695337763513825,-0.0490771913541156,-0.0218199510243737,3.47834790381852e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C2,Complement C2,42199,-0.0121105391024115,0.00237578741850236,-0.0167670824426761,-0.00745399576214684,3.48818260840535e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BID,BH3-interacting domain death agonist,42119,-0.0354655988215911,0.00695890473981753,-0.0491050521116334,-0.0218261455315487,3.50782072366187e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DOK1,Docking protein 1,39929,-0.0737741873524457,0.0144964755081915,-0.102187279348501,-0.0453610953563903,3.65511335554289e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42217,0.0174985935112934,0.00344169585911534,0.0107528696274273,0.0242443173951595,3.73894239826907e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APRT,Adenine phosphoribosyltransferase,42002,-0.0250872607827812,0.0049439181707338,-0.0347773403974194,-0.0153971811681429,3.9399022882433e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NGF,Beta-nerve growth factor,42016,0.00648023163180399,0.0012796165971678,0.00397218310135509,0.00898828016225289,4.15565333870114e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,39919,-0.0279186579687459,0.00551305967137824,-0.0387242549246473,-0.0171130610128446,4.16804321777497e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTN,Pleiotrophin,41900,-0.0265014607031752,0.00523390302805332,-0.0367599106381597,-0.0162430107681907,4.17305157497333e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BOLA1,BolA-like protein 1,39586,-0.0291654475600065,0.00576670402436671,-0.0404681874477652,-0.0178627076722477,4.31510483049745e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39919,-0.0279937524264975,0.005537239219661,-0.038846741297033,-0.0171407635559619,4.3587873702979e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCTN3,Tectonic-3,39958,-0.0162374284876375,0.00321310564804612,-0.0225351155578079,-0.00993974141746714,4.40536561911374e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,41843,-0.0240553148116949,0.00476120096890682,-0.0333872687107522,-0.0147233609126375,4.42190911047246e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42262,-0.0284936650751014,0.00564347045779773,-0.039554867172385,-0.0174324629778179,4.49938466868222e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOD3,Extracellular superoxide dismutase,39990,0.0324371545006231,0.00642677987821856,0.0198406659393147,0.0450336430619314,4.55287413616058e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSL,Cathepsin L1,42145,-0.0129922581775102,0.00257568035746079,-0.0180405916781333,-0.00794392467688702,4.61305984855108e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UBXN1,UBX domain-containing protein 1,39736,-0.0367358143064218,0.00728604753991009,-0.0510164674846455,-0.022455161128198,4.68085416089857e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASAH1,Acid ceramidase,39876,-0.0251636020687631,0.00499515357361423,-0.0349541030730469,-0.0153731010644792,4.78695798945687e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EHD3,EH domain-containing protein 3,39638,-0.0628639467196033,0.0124960259918547,-0.0873561576636386,-0.038371735775568,4.96342782306836e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMSB10,Thymosin beta-10,42137,-0.0401522171511228,0.00799026369266812,-0.0558131339887523,-0.0244913003134933,5.09476901800427e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39638,-0.0247713214626408,0.00493619613519454,-0.0344462658876221,-0.0150963770376595,5.29427024440962e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42137,-0.0405191365507714,0.00807587968086803,-0.0563478607252728,-0.0246904123762701,5.30664765022892e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42145,-0.0356480148070347,0.0071138582470115,-0.0495911769711773,-0.0217048526428922,5.48121086280017e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICA1,Islet cell autoantigen 1,41913,-0.0420303826191606,0.00839477946959324,-0.0584841503795633,-0.0255766148587579,5.60711367483261e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD200,OX-2 membrane glycoprotein,42119,0.0143067723814568,0.00285757897651955,0.00870591758747846,0.0199076271754351,5.60958981042689e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42070,-0.0364190794492626,0.00728457787558587,-0.0506968520854109,-0.0221413068131142,5.8208745718717e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42284,-0.0271535941970072,0.00546137177394562,-0.0378578828739407,-0.0164493055200738,6.70902763679359e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD93,Complement component C1q receptor,41654,0.0164852349634968,0.00331579454085278,0.00998627766342531,0.0229841922635682,6.72007003416035e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLB1,Beta-galactosidase,42016,-0.022486254915164,0.00452825282651436,-0.0313616304551321,-0.0136108793751958,6.92709895401271e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VWC2,Brorin,41973,-0.0213373553709543,0.00429689906078104,-0.0297592775300852,-0.0129154332118235,6.92778814047558e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42144,-0.0181286978572865,0.00365207373474271,-0.0252867623773822,-0.0109706333371907,6.99151484797146e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA9,Carbonic anhydrase 9,42262,-0.024385365408553,0.00491498823924207,-0.0340187423574675,-0.0147519884596386,7.08184469840463e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YWHAQ,14-3-3 protein theta,39736,-0.0389369800198659,0.00784722884313105,-0.0543175485524027,-0.023556411487329,7.08475185088933e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39657,-0.0177127934448266,0.00357689760919355,-0.024723512758846,-0.0107020741308073,7.45402837527179e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,41843,-0.0270043920509696,0.0054613788085297,-0.0377086945156878,-0.0163000895862514,7.72310500599474e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FKBPL,FK506-binding protein-like,39930,-0.0310120345018628,0.00627689295463131,-0.0433147446929402,-0.0187093243107855,7.89685217390719e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MIF,Macrophage migration inhibitory factor,42105,-0.0347654431669736,0.00703853217472294,-0.0485609662294305,-0.0209699201045166,7.9340340853422e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEXN,Nexilin,39990,-0.0362712574287249,0.00738340809419605,-0.0507427372933492,-0.0217997775641007,9.11558505148202e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB10,Ras-related protein Rab-10,39958,-0.0277238926172387,0.00564935094217817,-0.0387966204639079,-0.0166511647705695,9.35506680007323e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,39930,0.0260846214075792,0.0053153664276575,0.0156665032093705,0.0365027396057879,9.35771094502401e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39934,-0.0406016278840743,0.00828582007447278,-0.0568418352300409,-0.0243614205381076,9.70964214236361e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNLR1,Interferon lambda receptor 1,42119,-0.0187363887036015,0.0038248636742551,-0.0262331215051415,-0.0112396559020615,9.76506452322119e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPBP,Platelet basic protein,39908,-0.0442902464198994,0.00904586820180737,-0.0620201480954418,-0.026560344744357,9.90658128197554e-07
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42230,0.00988944766715097,0.00202265589254254,0.00592504211776759,0.0138538532165343,1.02328882602272e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP3,"Fatty acid-binding protein, heart",39958,-0.0280836505832505,0.00574560058041358,-0.0393450277208611,-0.0168222734456399,1.0333546371574e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39929,-0.0188226632413677,0.00385138177578156,-0.0263713715218996,-0.0112739549608359,1.03655559896521e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,41839,-0.0350775991951628,0.00718795189401534,-0.0491659849074328,-0.0209892134828927,1.07291803202311e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNX9,Sorting nexin-9,42145,-0.0348873967840752,0.00715271811505849,-0.0489067242895899,-0.0208680692785606,1.08658426019598e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,39757,-0.0352791365768676,0.00724562458816494,-0.0494805607696709,-0.0210777123840643,1.13687501747431e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKAP12,A-kinase anchor protein 12,39736,0.0109463605510773,0.00224905128773576,0.00653822002711522,0.0153545010750394,1.14800588613679e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NXPH3,Neurexophilin-3,39657,0.0154241520689363,0.00317211140844803,0.00920681370837813,0.0216414904294944,1.175529179735e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPRY2,Protein sprouty homolog 2,41913,-0.0473544767284087,0.00974947892213481,-0.0664634554157929,-0.0282454980410244,1.20454746594541e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB37,Ras-related protein Rab-37,41913,-0.0413961145793471,0.00852701717054804,-0.0581090682336212,-0.0246831609250729,1.21937615259533e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42137,-0.0271024022003941,0.00559566514020225,-0.0380699058751905,-0.0161348985255977,1.2900667882602e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VEGFC,Vascular endothelial growth factor C,42181,-0.028203289619272,0.00582635032897728,-0.0396229362640674,-0.0167836429744765,1.30842918188663e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA12,Serpin A12,41751,-0.0551411847631479,0.0114097258638061,-0.0775042474562079,-0.032778122070088,1.36130841354759e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,39929,-0.0240045495586656,0.00497486045145964,-0.0337552760435265,-0.0142538230738047,1.41707670465656e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TWF2,Twinfilin-2,39966,-0.0433729261089626,0.00899555361251344,-0.0610042111894889,-0.0257416410284363,1.44259788369446e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD274,Programmed cell death 1 ligand 1,42016,-0.0170930345655383,0.00354577233541636,-0.0240427483429544,-0.0101433207881223,1.44638028594051e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42016,-0.0401399152405654,0.00833530095466488,-0.0564771051117086,-0.0238027253694223,1.4832148519864e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTGES2,Prostaglandin E synthase 2,39579,-0.0283964030212168,0.00589731849194288,-0.0399551472654248,-0.0168376587770087,1.49061866975392e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42119,-0.0245957255558862,0.00511929441307661,-0.0346295426055164,-0.014561908506256,1.56793165832156e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",39638,-0.0446144557927883,0.00928742157951533,-0.0628178020886383,-0.0264111094969382,1.5776971969906e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PKLR,Pyruvate kinase PKLR,42143,-0.031395045789799,0.00655044046652228,-0.0442339091041827,-0.0185561824754154,1.66204144262201e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42100,0.00877017742064924,0.00183088229522561,0.00518164812200704,0.0123587067192914,1.68439035371618e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42070,-0.0524161939146713,0.0109685569717754,-0.0739145655793512,-0.0309178222499915,1.78234103292513e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41843,-0.0491326550592659,0.010287784704317,-0.0692967130797273,-0.0289685970388045,1.80889695800945e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPARC,SPARC,42181,-0.0351089779291079,0.00735294234564731,-0.0495207449265767,-0.0206972109316392,1.81745099044539e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,39807,-0.0283044945695237,0.00592947199952526,-0.0399262596885932,-0.0166827294504542,1.8331645196558e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,39958,-0.0300083280880907,0.00628914825799551,-0.0423350586737619,-0.0176815975024195,1.85186697972708e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCRLB,Fc receptor-like B,41843,-0.0308959610218443,0.00648833973816341,-0.0436131069086446,-0.018178815135044,1.93937951612726e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39657,-0.0188263045795474,0.00395437788427064,-0.0265768852327179,-0.011075723926377,1.95199504020503e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42016,-0.0467940485466152,0.00983172197075979,-0.0660642236093044,-0.027523873483926,1.96101540963922e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42070,-0.0584955856386957,0.0122948519432211,-0.0825934954474091,-0.0343976758299823,1.97814081428441e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADA,Adenosine deaminase,42296,-0.0177535321785781,0.00373441070486851,-0.0250729771601204,-0.0104340871970358,2.01422102780506e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB8,Serpin B8,42296,-0.0290833309821923,0.00614760259886492,-0.0411326320759675,-0.017034029888417,2.25824246432271e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HS1BP3,HCLS1-binding protein 3,39638,-0.0457113182514473,0.00966235341525951,-0.0646495309453559,-0.0267731055575386,2.26334598119433e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBP2,Retinol-binding protein 2,42070,0.0387923094662029,0.00820119212381806,0.0227179729035195,0.0548666460288863,2.26706861683533e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBC1D23,TBC1 domain family member 23,42070,-0.0448093615200035,0.00947800449607392,-0.0633862503323084,-0.0262324727076986,2.29353455335085e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BST2,Bone marrow stromal antigen 2,42249,-0.0253604743874394,0.00536438325191318,-0.0358746655611893,-0.0148462832136896,2.29498350402852e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCDH7,Protocadherin-7,39930,-0.0174319369913775,0.00369009041021086,-0.0246645141953908,-0.0101993597873643,2.34044186110483e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC39A14,Zinc transporter ZIP14,41839,-0.0167464691211185,0.00355314039618912,-0.0237106242976492,-0.00978231394458783,2.46405418245675e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IST1,IST1 homolog,39850,-0.0490817671181839,0.0104157361567054,-0.0694966099853264,-0.0286669242510414,2.47907528980393e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,41839,-0.0189783907166139,0.00403138238310034,-0.0268799001874906,-0.0110768812457372,2.53112901705916e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39638,-0.0214950520789307,0.00456956035698738,-0.030451390378626,-0.0125387137792355,2.5825263122002e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,39934,0.0221943967535938,0.00471896914337625,0.0129452172325764,0.0314435762746113,2.59101283336302e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,39649,-0.0333123142286736,0.00708466239670914,-0.0471982525262236,-0.0194263759311237,2.60701264949896e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRN,Progranulin,42077,-0.0124102271085274,0.0026402120132338,-0.0175850426544657,-0.00723541156258919,2.62137985577507e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,39952,-0.0235810428836733,0.00502303868942321,-0.0334261987149428,-0.0137358870524038,2.70285707542963e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSTP1,Glutathione S-transferase P,41759,0.0345736173363118,0.00736611582935873,0.0201360303107687,0.0490112043618549,2.71142438039063e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41913,-0.0355286787848818,0.00757602100058251,-0.0503776799460235,-0.0206796776237401,2.76428342082794e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,39929,-0.0195047748515356,0.00416234309262691,-0.0276629673130843,-0.0113465823899868,2.81829222358955e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBCB,Tubulin-folding cofactor B,42016,-0.049204298066623,0.0105083310598907,-0.0698006269440087,-0.0286079691892372,2.86301937376043e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC3B,Tetranectin,39726,0.0103489463523002,0.00221736960323732,0.00600290192995504,0.0146949907746453,3.08871135867905e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42145,-0.0404321237556888,0.00868222097890587,-0.0574492768743443,-0.0234149706370333,3.24076794607154e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL19,Interleukin-19,41756,-0.0360321521475734,0.00773802335969215,-0.05119867793257,-0.0208656263625768,3.24766871070894e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,39757,-0.0365016586264804,0.00785594178427442,-0.0518993045236583,-0.0211040127293026,3.41683660646772e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42070,-0.0219757112334898,0.00473301639788674,-0.0312524233733479,-0.0126989990936318,3.46518226736531e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL12,Stromal cell-derived factor 1,41913,0.0192258220897993,0.00414658176889909,0.0110985218227571,0.0273531223568415,3.57645500840296e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,39657,-0.0434565444456341,0.00937275347607078,-0.0618271412587328,-0.0250859476325353,3.58459311075589e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CIAPIN1,Anamorsin,42181,-0.0298508649226925,0.0064485266537416,-0.042489977164026,-0.0172117526813589,3.70662439728893e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,41839,-0.0245120307154264,0.00529746745125027,-0.034895066919877,-0.0141289945109759,3.74298460547872e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LXN,Latexin,41960,0.0332566924764397,0.00720094035879649,0.0191428493731986,0.0473705355796808,3.90352932975366e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39560,-0.0328277465080637,0.00710781416147325,-0.0467590622645513,-0.0188964307515762,3.90843424716357e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39958,-0.0195911472584295,0.00424733377354725,-0.0279159214545821,-0.0112663730622769,4.02057266766963e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBCA,Tubulin-specific chaperone A,39736,-0.041015523925606,0.00889386201264893,-0.0584474934703979,-0.0235835543808141,4.03903998927539e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39958,-0.0431843294734563,0.00937233907811535,-0.0615541140665624,-0.0248145448803502,4.11705530188681e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPART,Spartin,39736,-0.0378142378186147,0.00823354312949824,-0.0539519823524312,-0.0216764932847981,4.42334249130099e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PODXL,Podocalyxin,42070,0.0073040288327456,0.00159303452178102,0.00418168117005481,0.0104263764954364,4.58119785199639e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LIPF,Gastric triacylglycerol lipase,39638,-0.0304538712866206,0.00664956722285174,-0.04348702304341,-0.0174207195298312,4.70452345345551e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,39638,-0.0439791797749355,0.00960891917172358,-0.0628126613515137,-0.0251456981983573,4.77041043674172e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42185,-0.0614006190591803,0.0134260948420534,-0.0877157649496049,-0.0350854731687557,4.84506185913462e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",39575,0.0224899400731913,0.00492666609608806,0.0128336745248587,0.0321462056215239,5.05065902701032e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39757,-0.0322173378378474,0.00706504917632227,-0.046064834223439,-0.0183698414522557,5.16734693639451e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41843,-0.0404046224942964,0.00886896406662872,-0.0577877920648887,-0.0230214529237041,5.26697902349308e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL5,C-X-C motif chemokine 5,42101,-0.0537936656422509,0.0118457369485709,-0.0770113100614499,-0.0305760212230519,5.64234103924331e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CETN3,Centrin-3,39930,-0.037677135864231,0.00832084291080126,-0.0539859879694014,-0.0213682837590605,6.01399268130345e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42262,0.0126388919846111,0.00279351711389872,0.00716359844136959,0.0181141855278526,6.10877193504609e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD300E,CMRF35-like molecule 2,42232,-0.0198901815729689,0.00439943819945932,-0.0285130804439091,-0.0112672827020286,6.2045356251111e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",41900,-0.0439255202263157,0.00975818752393331,-0.063051567773225,-0.0247994726794064,6.80802002108565e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUDC,Nuclear migration protein nudC,42296,-0.0300057106515254,0.00667769131268974,-0.0430939856243973,-0.0169174356786535,7.06605211383124e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42120,-0.0346014274139361,0.00770382684896515,-0.0497009280379078,-0.0195019267899644,7.13226954154756e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,41728,-0.0584623137827785,0.0130211806945657,-0.0839838279441273,-0.0329407996214297,7.19022265065174e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDHR1,Cadherin-related family member 1,41839,-0.0195378178050237,0.00435684518929508,-0.028077234376042,-0.0109984012340053,7.37357763548073e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,39596,-0.0197098036229303,0.00439814144094674,-0.0283301608471859,-0.0110894463986746,7.49065426527553e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OBP2B,Odorant-binding protein 2b,41979,0.0269638018930308,0.00601828496811235,0.0151679633555306,0.038759640430531,7.51516185946108e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39919,-0.0396025314211177,0.0088693374908321,-0.0569864329031486,-0.0222186299390868,8.08038125983761e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,39930,-0.0304137318389404,0.00681231676436368,-0.0437658726970932,-0.0170615909807876,8.10236841762137e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HDGF,Hepatoma-derived growth factor,42243,-0.0429074235020398,0.00961747760400825,-0.0617576796058959,-0.0240571673981836,8.20770238638703e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX3,Syntaxin-3,39929,-0.0179255038837303,0.00402701925173032,-0.0258184616171217,-0.0100325461503389,8.61644168333755e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39919,-0.0174999349101484,0.00393155032566274,-0.0252057735484474,-0.00979409627184945,8.62270493414855e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,39575,-0.0286272990842234,0.00643711237060667,-0.0412440393306125,-0.0160105588378344,8.78411807411282e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42246,-0.0132201086488378,0.00297408011874215,-0.0190493056815724,-0.00739091161610321,8.8540410938058e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDCD1,Programmed cell death protein 1,42232,-0.0196286473102654,0.00441786071201358,-0.028287654305812,-0.0109696403147188,8.940364847295e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,41843,-0.0173984897263882,0.00391736457486155,-0.0250765242931168,-0.00972045515965952,9.01095541026783e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP7,Caspase-7,39929,-0.0396536500284247,0.00893103047899474,-0.0571584697672543,-0.022148830289595,9.08161756995587e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCL2L1,Bcl-2-like protein 1,39929,-0.0467475912697179,0.010529948950387,-0.0673862912124765,-0.0261088913269594,9.1025809077511e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCRL2,Fc receptor-like protein 2,42229,-0.023343314730233,0.00526611953001317,-0.0336649090090588,-0.0130217204514072,9.37719733800139e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAG6,Large proline-rich protein BAG6,41900,-0.0171957832058829,0.00388152415436534,-0.0248035705484389,-0.00958799586332678,9.49143292777636e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,39638,-0.0245830013619067,0.00555382787178758,-0.0354685039906104,-0.0136974987332031,9.67759775868587e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,39657,-0.0411705166771099,0.00930926818803272,-0.0594166823256541,-0.0229243510285658,9.84836985043964e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,39575,-0.0262561626878186,0.00593712363278654,-0.0378929250080802,-0.014619400367557,9.85630823085357e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,39638,-0.0241208197312607,0.00545583681912723,-0.0348142598967501,-0.0134273795657714,9.91365563061613e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42185,-0.0115587691153466,0.00261498842759143,-0.0166841464334258,-0.00643339179726745,9.93746771132115e-06
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GGH,Gamma-glutamyl hydrolase,41933,-0.0157888223830686,0.00357553331868745,-0.022796867687696,-0.00878077707844122,1.01431498613634e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLMP,CXADR-like membrane protein,42262,-0.0102887404954495,0.00233022847759838,-0.0148559883115424,-0.00572149267935669,1.01627761037611e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39958,-0.0418096153156437,0.0094690369407602,-0.0603689277195337,-0.0232503029117537,1.01753610924619e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL2A1,Collagen alpha-1(II) chain,39638,-0.0368103179403851,0.00833726372433731,-0.0531513548400862,-0.0204692810406839,1.018969717312e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTF1,Cardiotrophin-1,41900,-0.0392252092278356,0.00888679867025395,-0.0566433346215334,-0.0218070838341379,1.02336909361924e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GNAS,Neuroendocrine secretory protein 55,39934,-0.0404210032941793,0.00915747260776999,-0.0583696496054085,-0.0224723569829502,1.02420725409379e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,39930,-0.042147377098371,0.00956862256915993,-0.0609018773339244,-0.0233928768628175,1.06878669932905e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNR,Tenascin-R,42016,0.0193583883431102,0.00440011917669007,0.0107341547567977,0.0279826219294227,1.09329996304396e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,39958,-0.012468479342116,0.00283486486828119,-0.0180248144839471,-0.00691214420028484,1.10114492477901e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,41843,0.0175594056076734,0.00400271373321316,0.00971408669057558,0.0254047245247712,1.15879296750079e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AIF1,Allograft inflammatory factor 1,41843,-0.0240987415883878,0.00550061786636293,-0.0348799526064592,-0.0133175305703165,1.189910459267e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,39934,-0.0530057769972348,0.0120993693898928,-0.0767205410014247,-0.0292910129930448,1.19268015949185e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSV,Cathepsin L2,42200,0.0184591832296839,0.00421429086519144,0.0101991731339086,0.0267191933254591,1.19490309347972e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCN5,CCN family member 5,42137,-0.0174668137638488,0.00399257189663069,-0.0252922546812449,-0.00964137284645261,1.22437497537338e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UNC5D,Netrin receptor UNC5D,39657,0.0120751572969194,0.00276085461213434,0.0066638822571361,0.0174864323367027,1.23274964680915e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRYM,Ketimine reductase mu-crystallin,39586,-0.0349685020119792,0.00800457489736382,-0.0506574688108122,-0.0192795352131461,1.26212996609813e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39657,-0.0373409478605938,0.0085486722482368,-0.0540963454671379,-0.0205855502540497,1.2650812042971e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,41900,-0.0237520473995968,0.00545008045335579,-0.0344342050881742,-0.0130698897110195,1.3217503784455e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC4A1,Band 3 anion transport protein,39966,-0.0219102520296255,0.00502910362386079,-0.0317672951323926,-0.0120532089268583,1.33201657181743e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NID1,Nidogen-1,42189,-0.0164958541545436,0.0037885462862306,-0.0239214048755556,-0.00907030343353163,1.34568918167096e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIF22,Kinesin-like protein KIF22,39575,-0.0571992399466147,0.0131478498786038,-0.082969025708678,-0.0314294541845513,1.37077742342064e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF6,SLAM family member 6,41843,-0.0176903335522305,0.00406914409855745,-0.0256658559854031,-0.00971481111905785,1.38767976858609e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,39889,0.0125270504580113,0.00288557142910741,0.00687133045696081,0.0181827704590618,1.42894594223634e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDN1,Endothelin-1,39638,-0.0134929532229571,0.00310853645782709,-0.0195856846802982,-0.00740022176561602,1.43351477885577e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTA,Lymphotoxin-alpha,42119,-0.018262274863695,0.0042079964832299,-0.0265099479708256,-0.0100146017565644,1.43584380723112e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,39757,-0.0328863456946369,0.00758140007292495,-0.0477458898375698,-0.018026801551704,1.452029269295e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,39929,-0.0316252583756599,0.00729658707493037,-0.0459265690425234,-0.0173239477087964,1.47517592911035e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CILP,Cartilage intermediate layer protein 1,39966,-0.0252159119786143,0.00583490413372022,-0.036652324080706,-0.0137794998765227,1.56244709886837e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39958,-0.0280895051375617,0.00650614615326636,-0.0408415515979638,-0.0153374586771597,1.59231060636254e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TLR3,Toll-like receptor 3,42296,-0.02773104033006,0.0064304586523628,-0.0403347392886911,-0.0151273413714289,1.62584179338889e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39736,-0.0195551837760798,0.00454040510050764,-0.0284543777730748,-0.0106559897790848,1.66958331218016e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD7,T-cell antigen CD7,39636,-0.02035940142859,0.00473153483213793,-0.0296332096995803,-0.0110855931575997,1.70016461165397e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HRG,Histidine-rich glycoprotein,39925,-0.0141325236460378,0.00328500178456544,-0.020571127143786,-0.00769392014828951,1.70578856369544e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIF1C,Kinesin-like protein KIF1C,39575,-0.0158624514943562,0.00368966875810837,-0.0230942022602486,-0.0086307007284638,1.72932449111597e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NTF3,Neurotrophin-3,42119,-0.0155422268668538,0.00361810578109757,-0.022633714197805,-0.00845073953590254,1.75374603565078e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42119,0.0200865783091929,0.00468661933344474,0.0109008044156412,0.0292723522027446,1.83226513491821e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PI3,Elafin,41966,-0.0253438582715448,0.00591352234941976,-0.0369343620764075,-0.0137533544666821,1.83401850001886e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42093,-0.0403287499163596,0.00941464088675554,-0.0587814460544005,-0.0218760537783187,1.85149372433266e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC1,Sialoadhesin,42185,-0.0187227400395177,0.00437173788049916,-0.027291346285296,-0.0101541337937393,1.85927073365637e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,39657,-0.0408832376333628,0.00956307299646334,-0.059626860706431,-0.0221396145602947,1.9264129317223e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PROS1,Vitamin K-dependent protein S,39979,-0.0114521626739184,0.00268095487870317,-0.0167068342361766,-0.00619749111166014,1.95588488045136e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BIN2,Bridging integrator 2,42137,-0.0400268286261876,0.00938442547468483,-0.0584203025565699,-0.0216333546958053,2.01042818890879e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42262,0.0238377449253166,0.00559094386412597,0.0128794949516297,0.0347959948990035,2.02478594165981e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,39649,-0.0281188845634351,0.00659609437684516,-0.0410472295420516,-0.0151905395848185,2.03412262696857e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39930,0.0325281964240134,0.00764523231598178,0.0175435410846891,0.0475128517633377,2.11008874423653e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RSPO3,R-spondin-3,42262,-0.0125840668075535,0.0029585778165632,-0.0183828793280173,-0.00678525428708957,2.11933611355389e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPEP2,Dipeptidase 2,42070,0.0134529625868629,0.00316678361444581,0.00724606670254907,0.0196598584711766,2.16993990985644e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DGCR6,Protein DGCR6,39586,-0.0188065739859776,0.0044302179882719,-0.0274898012429905,-0.0101233467289646,2.20323863159696e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARSB,Arylsulfatase B,42070,-0.0247985249876484,0.00584426608098597,-0.0362532865063809,-0.0133437634689159,2.21805912830096e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42310,-0.0102161372001547,0.00240819868910473,-0.0149362066308,-0.00549606776950945,2.22760877568806e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41843,-0.0299776842753313,0.00707099575544527,-0.0438368359560041,-0.0161185325946586,2.25509183277878e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMOX1,Heme oxygenase 1,42007,0.0219413080637642,0.00518414034673866,0.0117803929841564,0.032102223143372,2.32758926201032e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATXN10,Ataxin-10,41839,-0.032649106665646,0.00772713417314943,-0.0477942896450189,-0.0175039236862732,2.40269372634256e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BMP6,Bone morphogenetic protein 6,41886,-0.0177648994477723,0.00421100130342326,-0.0260184620024819,-0.00951133689306273,2.4735830508683e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,39575,-0.0292827917281858,0.00694308357411168,-0.0428912355334447,-0.0156743479229269,2.48954852160349e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,39575,-0.0196961571463362,0.00467236247403693,-0.0288539875954486,-0.0105383266972238,2.51266365062357e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VNN1,Pantetheinase,39990,-0.0326598208559559,0.00774849811648024,-0.0478468771642572,-0.0174727645476546,2.51719336753117e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39934,0.0187084670913697,0.00443916971580917,0.0100076944483837,0.0274092397343557,2.52376090498395e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42042,0.00963665387522361,0.00228883293306625,0.00515054132641377,0.0141227664240335,2.56700783120631e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42017,-0.0259634633709185,0.00617213604499902,-0.0380608500191166,-0.0138660767227204,2.60971216352509e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PADI4,Protein-arginine deiminase type-4,41814,-0.0323692114447276,0.00769719895424807,-0.0474557213950538,-0.0172827014944014,2.62426867578368e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDF1,Endothelial differentiation-related factor 1,39934,-0.0294984038834076,0.00703058432049151,-0.043278349151571,-0.0157184586152443,2.74071407395406e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PROCR,Endothelial protein C receptor,39575,0.0153602413717305,0.00366500710452102,0.00817682744686932,0.0225436552965917,2.79837500365928e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PKN3,Serine/threonine-protein kinase N3,39757,-0.0326718583914162,0.00779583800934321,-0.0479517008897288,-0.0173920158931035,2.79946779941921e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42093,-0.0180735916348656,0.00431466598677882,-0.026530336968952,-0.00961684630077908,2.82124253631055e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUSD1,Sushi domain-containing protein 1,41900,-0.0214266665479621,0.0051167338142148,-0.0314554648238231,-0.0113978682721011,2.8377689129277e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFNA1,Ephrin-A1,42113,-0.0129606714492023,0.0030962721198874,-0.0190293648041816,-0.00689197809422296,2.85842129654307e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ELOB,Elongin-B,39575,-0.017371243595605,0.00415101950164817,-0.0255072418188355,-0.00923524537237464,2.87623431612638e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNG,Interferon gamma,41913,-0.0501722853618298,0.0119931956949485,-0.0736789489239289,-0.0266656217997307,2.89027815158155e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PARD3,Partitioning defective 3 homolog,39757,-0.0328467656779797,0.0078568363700195,-0.048246164963218,-0.0174473663927415,2.92882533123108e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,39929,0.0134946794234656,0.00323331929973097,0.00715737359599288,0.0198319852509383,3.02023442411934e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMED8,Protein TMED8,39930,-0.0455681183083681,0.0109319527289737,-0.0669947456571566,-0.0241414909595797,3.09103961609377e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F2R,Proteinase-activated receptor 1,42166,-0.0250874917903219,0.00602538844238777,-0.036897253137402,-0.0132777304432419,3.15162024911112e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCN2,Ficolin-2,42116,-0.0177360457531661,0.00426383441205149,-0.026093161200787,-0.00937893030554517,3.20709404889017e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,39930,-0.0254770345751086,0.00613367235637866,-0.0374990323936108,-0.0134550367566065,3.2963526528699e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CACYBP,Calcyclin-binding protein,39713,-0.0455587420935537,0.0109885342695748,-0.0670962692619203,-0.0240212149251872,3.40808298612373e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,39627,-0.0249508652880321,0.0060231205035469,-0.0367561814749841,-0.0131455491010802,3.46080736465989e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCTN2,Dynactin subunit 2,42070,-0.0413432506545997,0.00998743892000081,-0.0609186309378013,-0.0217678703713981,3.50144372841883e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF2,Fibroblast growth factor 2,42119,-0.0300543569210741,0.00726268788082158,-0.0442892251674844,-0.0158194886746638,3.5218214610773e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUSD5,Sushi domain-containing protein 5,39695,0.0150771459935165,0.00364356296588379,0.00793576258038431,0.0222185294066488,3.52898146239392e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NID2,Nidogen-2,42137,-0.0317289895832493,0.00766824318753285,-0.0467587462308137,-0.0166992329356849,3.52905737368562e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42016,0.0489681001223849,0.0118439699808048,0.0257539189600076,0.0721822812847623,3.57996480337961e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAX,Protein max,41839,-0.0462033772369077,0.0111770487849056,-0.0681103928553228,-0.0242963616184926,3.59055073493251e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,39560,-0.0332131229245892,0.00804273328402545,-0.0489768801612791,-0.0174493656878993,3.66119306640644e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA1,Alpha-1-antitrypsin,39795,0.00355496861089177,0.000860957350494368,0.00186749220392281,0.00524244501786073,3.66848053734603e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39757,-0.0461035118098046,0.011170030205701,-0.0679967710129785,-0.0242102526066306,3.69507990096092e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TEK,Angiopoietin-1 receptor,42181,-0.00960580162669184,0.00232951897015157,-0.0141716588081889,-0.00503994444519477,3.75357065445263e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42296,0.0120586849601582,0.0029330606927109,0.00630988600244479,0.0178074839178715,3.957365550051e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNX18,Sorting nexin-18,39930,-0.0189623890910305,0.00462619398604634,-0.0280297293036813,-0.00989504887837965,4.17980599352107e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNX2,Sorting nexin-2,39919,-0.037002348976939,0.0090374266057435,-0.0547157051241963,-0.0192889928296817,4.2630453222897e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCDHB15,Protocadherin beta-15,39919,-0.0171923944137935,0.00421455125521553,-0.0254529148740159,-0.00893187395357102,4.54822221178043e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSPN,Persephin,42119,-0.0370470504700782,0.00908641040775441,-0.0548564148692768,-0.0192376860708795,4.58435578025073e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,39929,-0.0144230804879032,0.0035378604675531,-0.0213572870043073,-0.00748887397149914,4.59755000706664e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRDX6,Peroxiredoxin-6,42262,0.0257211672647759,0.00632230025673172,0.0133294587615817,0.0381128757679701,4.76184766896445e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,39911,-0.0173189388662793,0.00425891812210327,-0.0256664183856017,-0.00897145934695689,4.80455633057464e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,39919,-0.0238300570327354,0.00586314404719181,-0.0353218193652313,-0.0123382947002395,4.84853859881277e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39958,-0.0423311129069787,0.0104157597618862,-0.0627460020402757,-0.0219162237736818,4.85343737696356e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEMA4C,Semaphorin-4C,42070,0.0118870639983739,0.00293163595344697,0.00614105752961782,0.0176330704671299,5.04693458909503e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,41843,-0.0241824386319256,0.00596441169867409,-0.0358726855613268,-0.0124921917025244,5.05388240911282e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39930,-0.0514691373359492,0.0126940379562564,-0.0763494517302117,-0.0265888229416867,5.05580065019371e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UNC79,Protein unc-79 homolog,39560,-0.0238930898185985,0.00589837898127303,-0.0354539126218937,-0.0123322670153034,5.13969870052359e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD59,CD59 glycoprotein,41638,-0.0100374441586076,0.00248593371779239,-0.0149098742454807,-0.00516501407173454,5.42875726764904e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPTXR,Neuronal pentraxin receptor,42145,0.0144920796634501,0.00359490135242888,0.00744607301268948,0.0215380863142107,5.57758119891943e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,39757,-0.030247919207587,0.00750770102032879,-0.0449630132074314,-0.0155328252077425,5.64055533441393e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42070,-0.0138914833608326,0.00345069577195764,-0.0206548470738696,-0.00712811964779563,5.71158395986481e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NT5E,5'-nucleotidase,42181,-0.0227679209969663,0.00565898486224458,-0.0338595313269657,-0.0116763106669669,5.76937145537159e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPD52L2,Tumor protein D54,39736,-0.0463640234828233,0.0115253050036503,-0.068953621289978,-0.0237744256756687,5.78897101477464e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP2,Caspase-2,42119,-0.0288474923337356,0.00718246970447605,-0.0429251329545087,-0.0147698517129625,5.94197143607135e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTRC,Chymotrypsin-C,42122,0.027596495479584,0.00687302953393415,0.0141253575930731,0.0410676333660949,5.9719532117648e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,39736,-0.014014109660408,0.00349357541637251,-0.0208615174764981,-0.00716670184431787,6.07556196523716e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,41839,-0.0267529927193041,0.00667149543352665,-0.0398291237690164,-0.0136768616695919,6.10405294738256e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCL2,Apoptosis regulator Bcl-2,39930,-0.0226302882011067,0.005645134861186,-0.0336947525290313,-0.0115658238731822,6.14158374669558e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRNN,Cornulin,41749,0.0284401439501853,0.0070962379804375,0.0145315175085278,0.0423487703918428,6.1630770656597e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42123,-0.126050176670181,0.0314858577483775,-0.187762457857001,-0.064337895483361,6.27745573714871e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,39586,-0.0419304418497934,0.0104755764177019,-0.0624625716284891,-0.0213983120710976,6.30389354757094e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LCN15,Lipocalin-15,39934,-0.0256542388906672,0.00642111119982838,-0.0382396168423308,-0.0130688609390036,6.50221334500439e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYO9B,Unconventional myosin-IXb,41913,-0.0276442462323397,0.00692450603448375,-0.0412162780599278,-0.0140722144047515,6.58050827475818e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,39929,0.029940191916797,0.00751275955531201,0.0152151831883855,0.0446652006452085,6.78328040595357e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,39575,-0.0162626680714532,0.00408115301808836,-0.0242617279869064,-0.00826360815599997,6.79674423261457e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALB1,Calbindin,42070,-0.0189644116118091,0.00476391299104531,-0.0283016810742579,-0.00962714214936035,6.90302586552731e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,39934,-0.0359190725134726,0.00902251040567017,-0.0536031929085861,-0.018234952118359,6.90393340479812e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DKK3,Dickkopf-related protein 3,42310,0.0123109721675437,0.00310024065344632,0.0062345004867889,0.0183874438482985,7.19451839932961e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39958,-0.0304663253308488,0.00767916775533413,-0.0455174941313037,-0.0154151565303938,7.31076872811321e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSPB6,Heat shock protein beta-6,42262,-0.0169897422850489,0.00428307776881258,-0.0253845747119215,-0.00859490985817622,7.32424094875007e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42062,-0.018961250588048,0.00478111730136016,-0.0283322404987139,-0.00959026067738213,7.35096990929575e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CST7,Cystatin-F,42148,-0.0393638978285296,0.00992868657931631,-0.0588241235239895,-0.0199036721330696,7.38771957754452e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSPB1,Heat shock protein beta-1,41949,-0.0292001458303999,0.00737631288617458,-0.043657719087302,-0.0147425725734977,7.57693772589556e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCTN6,Dynactin subunit 6,41839,-0.0301031176377732,0.00760484866319233,-0.0450086210176301,-0.0151976142579162,7.58442507778933e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,41913,-0.0130559335351517,0.0033008471308836,-0.0195255939116835,-0.00658627315861982,7.68256484057382e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDK1,Cyclin-dependent kinase 1,39560,-0.0152384060380459,0.00385713906909835,-0.0227983986134787,-0.00767841346261313,7.84107816600197e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42310,-0.0136004521474144,0.00344281707681289,-0.0203483736179677,-0.00685253067686111,7.84163163829778e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42310,-0.012906381892518,0.00326900582509949,-0.019313633309713,-0.00649913047532299,7.91654243217871e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTN4,Contactin-4,42137,0.00975199085507005,0.00247232778224414,0.00490622840187153,0.0145977533082686,8.03842488207042e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LPA,Apolipoprotein(a),39775,0.0758987410668326,0.0192514424169529,0.038165913929605,0.11363156820406,8.11296689129562e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCRL5,Fc receptor-like protein 5,42137,-0.0245203125195726,0.00622046702246616,-0.0367124278836063,-0.012328197155539,8.12532503348759e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42123,0.0164828716941495,0.00418267016347058,0.00828483817374721,0.0246809052145519,8.16346166300207e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,39966,-0.00965322600831769,0.00245090529477625,-0.0144570003860791,-0.00484945163055625,8.24353616367668e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,39966,0.0213606446677248,0.00543118350934545,0.0107155249894078,0.0320057643460419,8.44036002061685e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FSTL1,Follistatin-related protein 1,39638,-0.00966049422150305,0.00245986262820737,-0.0144818249727895,-0.00483916347021662,8.64456466345839e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DMD,Dystrophin,39638,-0.0213794006137613,0.00544513200049062,-0.0320518593347229,-0.0107069418927996,8.67751172851402e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP10,Stromelysin-2,42124,0.0237828047460833,0.00605972106265956,0.0119057514632706,0.035659858028896,8.72549112471812e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCRL1,Fc receptor-like protein 1,42145,-0.0189306906127306,0.00482386724356709,-0.0283854704101221,-0.00947591081533911,8.73829911030845e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD22,B-cell receptor CD22,42296,-0.0175318205804111,0.00448639051136446,-0.0263251459826854,-0.00873849517813677,9.35967031315394e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSAP,Prosaposin,39886,-0.0117753711029926,0.0030154188844809,-0.0176855921165751,-0.00586515008941001,9.47533382753354e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39929,-0.0407446303012285,0.0104562170406847,-0.0612388157009705,-0.0202504449014865,9.80777723537853e-05
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCDH9,Protocadherin-9,39930,-0.0139033790872498,0.00358170677862868,-0.020923524373362,-0.00688323380113759,0.000104285038794529
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSC,Dipeptidyl peptidase 1,42123,-0.0180677353266643,0.00466409412654441,-0.0272093598146913,-0.00892611083863722,0.00010765951801961
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39736,-0.035667648752961,0.00920770222560971,-0.053714745115156,-0.017620552390766,0.000107820025877617
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39958,-0.0121351417264533,0.0031411348547616,-0.018291766041786,-0.00597851741112058,0.000112487753365991
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MICALL2,MICAL-like protein 2,39649,-0.0279815991890074,0.00724380024830043,-0.0421794476756763,-0.0137837507023386,0.000112719035653996
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CST1,Cystatin-SN,38503,-0.0435418540272504,0.0113005378954956,-0.0656909083024218,-0.021392799752079,0.000117378378744414
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LACTB2,Endoribonuclease LACTB2,42145,-0.0267172754389731,0.00693835041811799,-0.0403164422584843,-0.0131181086194618,0.000118338635571763
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42181,0.0111888075968865,0.00290758625622772,0.00548993853468018,0.0168876766590928,0.000119561355901256
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42181,-0.0338493742518981,0.0088033774554433,-0.051103994064567,-0.0165947544392293,0.000121080792405516
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,39736,-0.0337980153710945,0.00880068384684841,-0.0510473557109174,-0.0165486750312716,0.000123522189580849
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39919,-0.0438582868004927,0.0114217266557631,-0.0662448710457884,-0.021471702555197,0.000123755221385974
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBP7,Retinoid-binding protein 7,39930,-0.025304428303443,0.00660569064831964,-0.0382515819741495,-0.0123572746327365,0.000128467858096086
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRH,Corticoliberin,41830,-0.034521404918832,0.00902563576872844,-0.0522116510255397,-0.0168311588121243,0.000131470246204768
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,39930,-0.0355740790080015,0.00930103997745804,-0.0538041173638193,-0.0173440406521838,0.00013161116318794
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNU13,NHP2-like protein 1,39575,-0.0254564371011986,0.00667652283940299,-0.0385424218664285,-0.0123704523359688,0.000138137212146495
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD101,Immunoglobulin superfamily member 2,39930,-0.0174173557478611,0.00457330517664172,-0.0263810338940789,-0.00845367760164335,0.000140559809894218
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL10,Interleukin-10,41913,-0.0307614973383427,0.00807794535581585,-0.0465942702357418,-0.0149287244409437,0.000140676123127541
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42247,-0.0113579264046247,0.00298499142891128,-0.0172085096052908,-0.00550734320395858,0.000142416650284632
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAX,Apoptosis regulator BAX,41814,-0.0367658354702563,0.00966727310674706,-0.0557136907594805,-0.0178179801810321,0.000143525954743892
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TREML2,Trem-like transcript 2 protein,42137,-0.0137558111217032,0.00362570157743938,-0.0208621862134844,-0.00664943602992206,0.000148901597259846
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ROBO1,Roundabout homolog 1,42144,-0.00955739943475337,0.00251923124682202,-0.0144950926785245,-0.00461970619098222,0.000149018831696036
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42166,-0.0476357078294164,0.0125620756180017,-0.0722573760406998,-0.023014039618133,0.000150071494983577
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,39958,-0.0129662865656263,0.00342356614035049,-0.0196764762007132,-0.00625609693053933,0.000153039727798269
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LEFTY2,Left-right determination factor 2,42247,-0.0204805748168119,0.00542499192728367,-0.0311135589942878,-0.00984759063933586,0.000160539630214154
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42181,-0.0285448478056471,0.00756181688530752,-0.0433660089008499,-0.0137236867104444,0.000160775007387354
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD300A,CMRF35-like molecule 8,39736,-0.0122100231440201,0.00323691445593247,-0.0185543754776477,-0.00586567081039246,0.000162706009190517
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGT,Angiotensinogen,39990,-0.00868784638468888,0.00230533500659898,-0.0132063029976229,-0.00416938977175489,0.000165005220876374
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCGB2A2,Mammaglobin-A,39575,0.0124180169269305,0.00329543167911732,0.00595897083586052,0.0188770630180004,0.000165255296476371
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42145,-0.0243957265915229,0.0064766114230236,-0.0370898849806492,-0.0117015682023967,0.000166091752804724
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C9orf40,Uncharacterized protein C9orf40,39930,-0.0309797933966216,0.00822462363009893,-0.0471000557116155,-0.0148595310816277,0.000166248668381949
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SATB1,DNA-binding protein SATB1,39934,-0.011672500959207,0.00309949984541904,-0.0177475206562283,-0.00559748126218566,0.000166769061652552
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,39915,-0.034938827506398,0.00927893586785936,-0.0531255418074023,-0.0167521132053936,0.000167130108468991
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",39929,0.0235648660845518,0.00626644504493795,0.0112826337964734,0.0358470983726302,0.00017043824840435
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMOTL2,Angiomotin-like protein 2,39882,-0.0194360222053665,0.00516954030088453,-0.0295683211951002,-0.00930372321563279,0.000170962702584139
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,39736,-0.0476429491391793,0.0126799020172989,-0.0724955570930852,-0.0227903411852734,0.000172592057565761
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42016,-0.0119086959936352,0.0031717929446267,-0.0181254101651036,-0.0056919818221669,0.000174377511006102
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42119,-0.0326331640625532,0.00869259188752077,-0.0496706441620939,-0.0155956839630125,0.000174669638805026
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39575,-0.0182878804228749,0.00488607944584936,-0.0278645961367397,-0.00871116470901015,0.00018287065976991
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP3,Caspase-3,42310,-0.0346420173107665,0.00925619893805856,-0.0527841672293613,-0.0164998673921717,0.000182887871533454
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39736,-0.0235859590401778,0.00630411738709198,-0.0359420291188781,-0.0112298889614775,0.000183947802914936
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZBP1,Z-DNA-binding protein 1,39657,-0.01634807560646,0.00437350040154176,-0.0249201363934818,-0.00777601481943814,0.000186436577296524
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42005,-0.0400790991838149,0.0107314640941033,-0.0611127688082573,-0.0190454295593724,0.000188696688589921
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,39990,-0.0160651613611441,0.00432072660638912,-0.0245337855096667,-0.00759653721262141,0.000201640017744341
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALB2,Calretinin,41839,-0.0115158024061375,0.00309853153763296,-0.0175889242198981,-0.00544268059237694,0.000202805087366078
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CERT,Ceramide transfer protein,41839,-0.0240009726370687,0.00646371584804092,-0.0366698556992289,-0.0113320895749085,0.000205507215331337
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42137,-0.0125445851165908,0.00337916846250716,-0.0191677553031049,-0.00592141493007678,0.000206184386505429
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42070,-0.0123746204855903,0.00333807150423562,-0.0189172406338921,-0.00583200033728846,0.000210472848562068
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAFB2,Scaffold attachment factor B2,39934,-0.0106885252375469,0.00288531838414575,-0.0163437492704725,-0.00503330120462121,0.000212854636015504
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB44,Ras-related protein Rab-44,39919,-0.0175620058144513,0.00474769167748997,-0.0268674815023317,-0.008256530126571,0.000217422050484786
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS1,Galectin-1,42145,-0.0136319741664643,0.0036856416322252,-0.0208558317656257,-0.00640811656730295,0.000217588420371329
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,41900,-0.0434570281001876,0.0117702705424414,-0.0665267583633727,-0.0203872978370024,0.000223298485868929
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNL1,Interferon lambda-1,41839,-0.0176629293061897,0.00478984841238125,-0.027051032194457,-0.00827482641792249,0.000227305999283118
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SWAP70,Switch-associated protein 70,39930,-0.0142967368239045,0.0038783621291897,-0.0218983265971163,-0.00669514705069265,0.000228616269150164
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42070,-0.0183256286526825,0.00497918958293227,-0.0280848402352298,-0.00856641707013526,0.000233736606692295
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCDH12,Protocadherin-12,39934,-0.00993084970880405,0.00269996580116337,-0.0152227826790843,-0.00463891673852383,0.000236029024642778
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX16,Syntaxin-16,41843,-0.0220933700868673,0.00600799488938353,-0.033869040070059,-0.0103177001036756,0.000236621984919662
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPXM1,Probable carboxypeptidase X1,42181,-0.0266086648103732,0.00723843710375816,-0.0407960015337392,-0.0124213280870072,0.000237810364252333
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXNL1,Thioredoxin-like protein 1,39570,-0.0395533951422097,0.0107625550278393,-0.0606480029967748,-0.0184587872876447,0.000238895656035507
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42070,-0.0206544278204696,0.00562237917287657,-0.0316742909993077,-0.00963456464163156,0.000240074368119515
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PMVK,Phosphomevalonate kinase,41832,-0.0418680729356612,0.0114443562999154,-0.0642990112834954,-0.019437134587827,0.000254776882327079
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42262,-0.0239201759932878,0.00655042558870383,-0.0367590101471473,-0.0110813418394283,0.000261485229394962
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42016,-0.0222094146962803,0.00609351558383951,-0.0341527052406057,-0.0102661241519548,0.000268650082293743
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCN4B,Sodium channel subunit beta-4,39638,-0.0167683786320027,0.00460550245570746,-0.0257951634451893,-0.00774159381881609,0.00027288214400243
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNX5,Sorting nexin-5,39638,-0.0114781263132849,0.0031528471921733,-0.0176577068099446,-0.00529854581662524,0.00027329049673861
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYOC,Myocilin,42137,0.0171208857150375,0.00470499349675518,0.00789909846139734,0.0263426729686777,0.000274849862965294
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,39638,-0.0283172537005401,0.0077833774193356,-0.0435726734424378,-0.0130618339586423,0.000275833961093262
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,39934,-0.0150825221032877,0.00414828288961662,-0.0232131565669362,-0.00695188763963911,0.000278296317016638
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,39958,0.0153979089262676,0.00424137235769729,0.00708481910518095,0.0237109987473543,0.000284218509206588
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,41839,-0.0275544963299095,0.00759122519669551,-0.0424332977154327,-0.0126756949443863,0.00028472917462638
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ABO,Histo-blood group ABO system transferase,39990,0.0557014616116247,0.0153483172753275,0.0256187597519829,0.0857841634712666,0.000285592693957172
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC51B,Organic solute transporter subunit beta,39575,-0.0278009041133199,0.00767888561552379,-0.0428515199197465,-0.0127502883068933,0.000295432974444709
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,41839,-0.0158417604371161,0.00437677266505364,-0.0244202348606212,-0.00726328601361095,0.000296265156775431
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGMN,Legumain,42185,-0.0137909314014731,0.003818573978913,-0.0212753364001425,-0.00630652640280361,0.000305481476979015
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DXO,Decapping and exoribonuclease protein,39929,-0.0172888572825836,0.00478937529093929,-0.0266760328528246,-0.00790168171234256,0.000307713216648757
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42249,-0.0179294426168675,0.00497669330298454,-0.0276837614907172,-0.00817512374301781,0.000316070288866782
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42249,-0.0212550185878,0.0059052295327257,-0.0328292684719424,-0.00968076870365763,0.000320137077663522
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39958,-0.0109364374599797,0.00303924382950049,-0.0168933553658007,-0.00497951955415878,0.000321533514521508
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CABP2,Calcium-binding protein 2,39649,-0.024871996203636,0.00691682423818114,-0.038428971710471,-0.011315020696801,0.000324719876908279
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRK5,G protein-coupled receptor kinase 5,41900,-0.0193593189207362,0.00540983945661876,-0.029962604255709,-0.0087560335857634,0.000346749869380068
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRL,Prolactin,42249,-0.0277103931210272,0.00774491752448848,-0.0428904314690246,-0.0125303547730298,0.000347590767096337
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,XRCC4,DNA repair protein XRCC4,41839,-0.0139088943013891,0.00388749390473818,-0.0215283823546759,-0.00628940624810226,0.000347660838631717
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBM17,Splicing factor 45,39934,-0.0291046632877436,0.00814437457603533,-0.0450676374567729,-0.0131416891187144,0.000353581193523078
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAP3,Cytosol aminopeptidase,41913,-0.0179736199591164,0.0050424710965278,-0.0278568633083109,-0.00809037660992196,0.000365901007346173
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",39929,-0.0403426919152371,0.0113185538177535,-0.0625270573980339,-0.0181583264324404,0.000366333219094705
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLU,Clusterin,39979,0.0113114351096692,0.00317821962154615,0.00508212465143873,0.0175407455678996,0.000373718282563658
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB6,Serpin B6,42216,-0.0218909731856848,0.0061627932847231,-0.0339700480237421,-0.00981189834762753,0.000383433739940045
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CYTL1,Cytokine-like protein 1,39966,0.00957799846446802,0.00269633356222255,0.00429318468251182,0.0148628122464242,0.000383526779542273
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLTA,Clathrin light chain A,41900,-0.0174674617131387,0.00492075016978582,-0.0271121320459189,-0.0078227913803585,0.000386919185468074
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPTX2,Neuronal pentraxin-2,39966,0.0128128948529109,0.00361573863368814,0.00572604713088218,0.0198997425749397,0.000396219554245801
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL18,C-C motif chemokine 18,42020,-0.0261144815363524,0.00738532489895446,-0.0405897183383032,-0.0116392447344017,0.00040760967524125
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,39919,-0.0354410762530419,0.0100233628692599,-0.0550868674767913,-0.0157952850292924,0.000408094676678195
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,39649,-0.0228770569438615,0.00647086598298491,-0.0355599542705119,-0.0101941596172111,0.000408834732578043
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39930,-0.00803701951581158,0.00227487014989305,-0.012495765009602,-0.0035782740220212,0.000412574257631845
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GZMH,Granzyme H,41900,-0.0292165901296793,0.00827675848431072,-0.0454390367589283,-0.0129941435004303,0.000417033969558886
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42181,0.0169814505838715,0.00481281927635415,0.00754832480221737,0.0264145763655257,0.000419494419792211
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STC2,Stanniocalcin-2,42113,-0.00891045067287066,0.00252542379333879,-0.0138602813078147,-0.00396062003792663,0.000419627844866611
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RCOR1,REST corepressor 1,41900,-0.0165432895949975,0.00469443078811415,-0.0257443739397012,-0.00734220525029378,0.000426472190174032
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSNK1D,Casein kinase I isoform delta,39657,-0.0239596806467904,0.0068067581884425,-0.0373009266961377,-0.0106184345974431,0.000433308915992549
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VIM,Vimentin,41900,-0.0424485921400393,0.0120782991003959,-0.0661220583768152,-0.0187751259032635,0.000442128611995163
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL34,Interleukin-34,41814,-0.0135047202393383,0.00384968418286539,-0.0210501012377545,-0.00595933924092214,0.000452976950850406
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRSS53,Serine protease 53,39929,0.0141380389767302,0.0040347386330798,0.0062299512558938,0.0220461266975666,0.000459959937943781
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,39638,-0.0212230096519061,0.00606459418373442,-0.0331096142520255,-0.00933640505178659,0.000467980508867268
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,P4HB,Protein disulfide-isomerase,42073,-0.0142039838839469,0.00406167309703202,-0.0221648631541297,-0.00624310461376414,0.000471901198916535
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39934,-0.024361546656974,0.00696942595538916,-0.0380216215295367,-0.0107014717844112,0.000475004559954059
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SYAP1,Synapse-associated protein 1,39736,-0.0216734614952902,0.0062022457033319,-0.0338298630738208,-0.00951705991675971,0.000476879317291973
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,41900,-0.0223919487662432,0.00641027741331281,-0.0349560924963363,-0.00982780503615013,0.00047894079333505
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPQ,Carboxypeptidase Q,39960,-0.013805960012844,0.00395422899582378,-0.0215562488446586,-0.00605567118102942,0.000482246112352364
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGAL,Integrin alpha-L,39657,-0.01610980476164,0.00462477357945086,-0.0251743609773637,-0.00704524854591635,0.000497056348285772
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,39934,-0.0176055595192212,0.00507344804106063,-0.0275495176797001,-0.0076616013587424,0.000522128749806521
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL17,C-C motif chemokine 17,42107,-0.0332993741514234,0.00961846812576044,-0.0521515716779139,-0.014447176624933,0.000537787144424722
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VEGFB,Vascular endothelial growth factor B,39657,-0.0107983539272496,0.00312388612931361,-0.0169211707407042,-0.00467553711379489,0.000548878249479663
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LY6D,Lymphocyte antigen 6D,42041,-0.0144365017512274,0.00417892467378736,-0.0226271941118506,-0.00624580939060418,0.00055281566115362
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UBQLN3,Ubiquilin-3,39575,-0.0205612347778258,0.0059518927229539,-0.0322269445148154,-0.00889552504083612,0.000553252402241188
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,39908,-0.0132458171279964,0.00383983424785752,-0.0207718922537971,-0.00571974200219567,0.000563506593053569
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,41843,-0.0209364209908926,0.00607848062538845,-0.0328502430166539,-0.00902259896513121,0.0005742047262677
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA3,Carbonic anhydrase 3,42287,-0.0212890385256037,0.00618598025424191,-0.0334135598239178,-0.00916451722728954,0.000580230823802372
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP1,Caspase-1,41839,-0.0249771839552972,0.00725971653972108,-0.0392062283731505,-0.0107481395374439,0.000582393390595544
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMG4,Proteasome assembly chaperone 4,39657,-0.020262456548369,0.00591757106560906,-0.0318608958369628,-0.00866401725977528,0.0006190388033222
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,39919,0.014782440050244,0.0043193103461755,0.00631659177174007,0.023248288328748,0.000622888546113565
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHA4,Ephrin type-A receptor 4,39736,-0.0105736486242477,0.00309280934109463,-0.0166355549327931,-0.00451174231570218,0.00063126877300807
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD84,SLAM family member 5,42119,-0.0114472841724089,0.00335004302594491,-0.0180133685032609,-0.00488119984155689,0.000634887139708363
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTX3,Pentraxin-related protein PTX3,42119,0.0178069686479601,0.00522770633038316,0.00756066424040909,0.0280532730555111,0.000660491851895013
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42224,-0.0245649454582609,0.00721552868022906,-0.0387073816715098,-0.0104225092450119,0.000664872211622794
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39575,0.0133761872975766,0.0039339305136819,0.00566568349076007,0.0210866911043931,0.000675741442906563
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FBLN2,Fibulin-2,39966,0.0115376308240158,0.00339408242077379,0.00488522927929919,0.0181900323687324,0.000677814889884759
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCT,Secretin,39649,-0.0172995188881421,0.0050900128036092,-0.0272759439832161,-0.00732309379306803,0.000679416156184598
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PI16,Peptidase inhibitor 16,39990,0.00867825446743096,0.00255624094565936,0.00366802221393861,0.0136884867209233,0.000688808628603899
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRGN,Neurogranin,39990,-0.0332191685368012,0.00978558314678231,-0.0523989115044946,-0.0140394255691079,0.000689369667378648
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,39657,-0.0306075737025219,0.00902826892520726,-0.0483029807959282,-0.0129121666091157,0.00070087705891248
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PKD2,Polycystin-2,39575,-0.0210016390825778,0.00619560487046825,-0.0331450246286956,-0.00885825353646004,0.000701991437394909
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRG2,Bone marrow proteoglycan,39966,0.0182836188538021,0.00541668800537261,0.00766691036327174,0.0289003273443324,0.000739487409165685
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANK2,Ankyrin-2,39575,0.0249247614222095,0.00739833656183674,0.0104240217610094,0.0394255010834095,0.000757098108213343
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CGN,Cingulin,39649,-0.0133264406485173,0.00395658395195042,-0.0210813451943402,-0.0055715361026945,0.000759278768202378
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DLL1,Delta-like protein 1,42181,-0.0108746107346228,0.00323079681243795,-0.0172069724870011,-0.00454224898224437,0.000764996703116777
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,41843,-0.0268232213021081,0.00801406217588381,-0.0425307831668404,-0.0111156594373759,0.000819128923359648
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42070,-0.0200068825558595,0.00597949442332867,-0.0317266916255837,-0.00828707348613528,0.000822355805808826
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,39757,-0.0262571744332049,0.00786298368855773,-0.0416686224627781,-0.0108457264036318,0.000842529349506878
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41843,-0.0299475429871883,0.00897070020910993,-0.0475301153970438,-0.0123649705773328,0.000845028996491816
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39929,-0.0168183741902902,0.00505027184153478,-0.0267169069996984,-0.00691984138088201,0.000870633705558919
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INSL3,Insulin-like 3,39929,0.0316059907433038,0.00951549008352907,0.0129556301795868,0.0502563513070207,0.000898083995792081
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39638,-0.0171672292268111,0.00517771666722181,-0.0273155538945658,-0.00701890455905633,0.000917420942249113
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BDNF,Brain-derived neurotrophic factor,39966,-0.0294109109993103,0.00887190284442505,-0.0467998405743834,-0.0120219814242372,0.000919095092849434
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41900,-0.0124313171737403,0.00375123627615882,-0.0197837402750116,-0.00507889407246903,0.000922418133539163
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA11,Annexin A11,42087,-0.0230624513549114,0.00696037525171271,-0.0367047868482683,-0.00942011586155452,0.000924143842052067
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,39638,-0.00865832058584098,0.00261610363890665,-0.013785883718098,-0.00353075745358393,0.00093720544201592
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TST,Thiosulfate sulfurtransferase,41809,-0.0262708008913952,0.00795292657070415,-0.0418585369699753,-0.0106830648128151,0.000958124475205477
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42199,-0.00963306296445574,0.00291790792654091,-0.0153521625004759,-0.00391396342843556,0.000964653939796125
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39930,-0.0171205068170074,0.00518691860718742,-0.0272868672870948,-0.0069541463469201,0.000967390253521868
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,39930,-0.0103472575993777,0.00313775367800287,-0.0164972548082633,-0.00419726039049206,0.000977929471639486
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,39919,-0.0100567730418451,0.00306315475346243,-0.0160605563586314,-0.00405298972505873,0.00102968154954546
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,41843,-0.0184226296206173,0.00561568843624657,-0.0294293789556606,-0.00741588028557406,0.00103867207549138
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PMS1,PMS1 protein homolog 1,39649,-0.0171402237428085,0.00522534794276352,-0.027381905710625,-0.00689854177499203,0.00104052109780819
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FRMD4B,FERM domain-containing protein 4B,39575,-0.0244204211196558,0.00744709027174832,-0.0390167180522825,-0.00982412418702907,0.00104429843639963
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB9,Serpin B9,42016,-0.0112985416167708,0.00345042283505809,-0.0180613703734846,-0.0045357128600569,0.00106102950895991
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAPG,Macrophage-capping protein,42015,-0.0202819206733521,0.00620777725880202,-0.0324491641006041,-0.00811467724610013,0.0010889785812248
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C3,Complement C3,39445,-0.0159161938187571,0.00487665327786064,-0.025474434243364,-0.00635795339415025,0.00110287292547394
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLGN,Calmegin,39649,-0.0157530112322966,0.0048289406591547,-0.0252177349242399,-0.00628828754035342,0.00110883236142421
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD300LF,CMRF35-like molecule 1,42262,-0.0206139881708511,0.00632419879592284,-0.0330094178108599,-0.00821855853084233,0.00111865435863939
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41843,-0.0149065492211634,0.0045782270197527,-0.0238798741798787,-0.00593322426244814,0.00113291507742493
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,41992,-0.00878113773432659,0.00270562796490392,-0.0140841685455383,-0.00347810692311491,0.00117529130300253
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42125,-0.0318508656292065,0.00983881551142259,-0.0511349440315948,-0.0125667872268182,0.00120971477269344
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ELAVL4,ELAV-like protein 4,39586,-0.0280826563398451,0.0086762051713709,-0.045088018475732,-0.0110772942039581,0.00121260172070689
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,39958,-0.0242931106341015,0.00751110993607697,-0.0390148861088124,-0.00957133515939067,0.00122294082850353
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LY75,Lymphocyte antigen 75,42119,-0.0130993445379099,0.00406770591787513,-0.0210720481369451,-0.00512664093887463,0.00128346984567443
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHRDL2,Chordin-like protein 2,42145,-0.0154814967608576,0.00481360301287877,-0.0249161586661,-0.00604683485561518,0.00130206549283374
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41839,-0.0377557711093804,0.0117465708107392,-0.0607790498984293,-0.0147324923203316,0.00131124281238687
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THPO,Thrombopoietin,41900,0.0131260767983934,0.00409977370289793,0.00509052034071349,0.0211616332560734,0.00136960062339632
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TK1,"Thymidine kinase, cytosolic",39757,-0.0159907174991284,0.00499675029768773,-0.0257843480825963,-0.00619708691566045,0.00137705482060899
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41973,-0.0115549465019572,0.00362971371437845,-0.018669185382139,-0.00444070762177542,0.00145873660971047
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PALM3,Paralemmin-3,39575,-0.0255555101993368,0.00802775425043946,-0.0412899085301982,-0.00982111186847547,0.0014596530574791
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GBP4,Guanylate-binding protein 4,41839,-0.0164289944357556,0.00516760365228104,-0.0265574975942265,-0.00630049127728481,0.00148007437868128
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42119,-0.0284226893475487,0.00895066077976392,-0.045965984475886,-0.0108793942192114,0.00149922022270476
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD99,CD99 antigen,42137,0.0066588940375867,0.00209700566688743,0.00254876293048733,0.0107690251446861,0.00149950158436991
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42145,0.0084152906346966,0.00265530694277985,0.0032108890268481,0.0136196922425451,0.0015318092924385
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39539,-0.0289371359262002,0.00913375703675972,-0.0468392997182493,-0.0110349721341512,0.00153833029293135
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,QSOX1,Sulfhydryl oxidase 1,39767,-0.0133295638105716,0.00420931208933069,-0.0215798155056597,-0.00507931211548344,0.00154602249902329
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,39919,-0.011782836716332,0.00372125033511126,-0.0190764873731501,-0.00448918605951393,0.00154766519141252
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39757,-0.0132575829337412,0.00418788962368952,-0.0214658465961726,-0.0050493192713097,0.00155128821801313
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPA33,Cell surface A33 antigen,42070,-0.0445550010894633,0.0140827142401691,-0.0721571210001948,-0.0169528811787319,0.00156065693727122
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42185,0.00677884055386157,0.00214309143523332,0.00257838134080426,0.0109792997669189,0.00156435394761567
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,39929,-0.0157432234744359,0.00500391718828483,-0.0255509011634742,-0.00593554578539763,0.00165846532520184
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GMFG,Glia maturation factor gamma,39958,-0.0239462287165831,0.00761519326330051,-0.0388720075126521,-0.00902044992051415,0.00166780760756489
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPT,Dermatopontin,42310,-0.00839117756043094,0.00267060051207274,-0.0136255545640935,-0.00315680055676836,0.00168122844171938
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXN,Thioredoxin,39854,-0.014306320255342,0.00455692254291326,-0.023237888439452,-0.00537475207123205,0.00169691604752511
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39930,-0.013341386460204,0.00425158484138006,-0.021674492749309,-0.00500828017109912,0.00170552925986737
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LGALS7_LGALS7B,Galectin-7,42076,-0.0145131333311825,0.00463094041148131,-0.0235897765376859,-0.00543649012467917,0.0017284056196703
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMEM106A,Transmembrane protein 106A,39919,-0.0237785102747469,0.00758847967320394,-0.0386519304342266,-0.00890509011526712,0.00173175227762068
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42076,-0.011630023350885,0.00372158864891352,-0.0189243371027555,-0.00433570959901455,0.00178172968163058
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRADD,Death domain-containing protein CRADD,41997,-0.0244116371843712,0.00784226055313698,-0.0397824678685197,-0.00904080650022271,0.00185691739401313
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A12,Protein S100-A12,41910,-0.0240468787117044,0.00773189205648151,-0.0392013871424082,-0.00889237028100068,0.00187425479769285
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,39929,-0.0182870133682305,0.00588001682961296,-0.0298118463542719,-0.00676218038218908,0.00187534196801887
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA3,Annexin A3,42224,-0.0227050509785452,0.00731517780213034,-0.0370427994707206,-0.00836730248636971,0.00191425852404614
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMTN,Smoothelin,39897,-0.0303751914533967,0.00978865332634345,-0.0495609519730299,-0.0111894309337636,0.00191976170989251
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPPB,Natriuretic peptides B,41900,-0.0456996142003467,0.0147524309041515,-0.0746143787724837,-0.0167848496282097,0.00195389905162765
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,39930,-0.0173348076191244,0.00560573850974223,-0.0283220550982192,-0.00634756014002961,0.00199072770103066
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDZD2,PDZ domain-containing protein 2,39575,-0.0192859880633429,0.00623791519545332,-0.0315123018464314,-0.00705967428025441,0.00199488411681691
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39958,0.0100743795867986,0.00327345224851517,0.0036584131797089,0.0164903459938884,0.00209171174873687
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX6,Syntaxin-6,41843,-0.0212443906129658,0.00690706900081245,-0.0347822458545582,-0.00770653537137344,0.00210404484104144
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42118,0.0156502485912569,0.00510262345373388,0.00564910662193847,0.0256513905605753,0.00216574745324314
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39919,-0.0121401305079924,0.00395904407963412,-0.0198998569040753,-0.00438040411190956,0.00217142583722874
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39934,-0.00973567843019143,0.00317852314437442,-0.0159655837931653,-0.00350577306721756,0.00219675858199077
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIL1,Nucleotide exchange factor SIL1,39638,-0.0106281048572323,0.00347199892234082,-0.0174332227450203,-0.00382298696944428,0.0022106193572256
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACRV1,Acrosomal protein SP-10,39657,-0.0343598071441844,0.0112433016951269,-0.0563966784666332,-0.0123229358217356,0.00224827590515298
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39586,-0.0102340191842596,0.00335807902595851,-0.0168158540751382,-0.00365218429338087,0.00231239042904399
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNPY4,Protein canopy homolog 4,42070,-0.0240865261162442,0.00791163335808514,-0.0395933274980911,-0.00857972473439736,0.00233560571026742
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42176,0.016395883884278,0.0053869596712871,0.00583744292855532,0.0269543248400007,0.00234193636886276
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,39919,-0.0127682341158739,0.00419949469429279,-0.0209992437166878,-0.00453722451506002,0.00236787254175531
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCP2,Non-specific lipid-transfer protein,41843,-0.0237559406412776,0.00781638811280576,-0.0390760613423769,-0.00843581994017831,0.00237632325403485
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42296,-0.0190198296305309,0.0062602627724438,-0.0312899446645207,-0.00674971459654103,0.00238457014266385
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIFBP,KIF-binding protein,42070,-0.0263947329954331,0.00869167396898872,-0.043430413974651,-0.00935905201621521,0.00239574291624057
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39638,-0.0204961448862627,0.00676051221716966,-0.0337467488319152,-0.00724554094061013,0.00243709027647543
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,39736,-0.0114645791783865,0.00378510971256963,-0.0188833942150229,-0.00404576414174998,0.00246038327938
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C2orf69,UPF0565 protein C2orf69,39649,-0.0187765007433179,0.00623495118847166,-0.0309970050727224,-0.00655599641391348,0.00260555771529794
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39958,-0.0238134429532948,0.00791400814068322,-0.0393248989090339,-0.00830198699755568,0.00262662922577945
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STXBP1,Syntaxin-binding protein 1,39934,-0.0248399110064974,0.00826229793894276,-0.0410340149668252,-0.00864580704616957,0.00264925546895884
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DAPK2,Death-associated protein kinase 2,39657,-0.0175739747725357,0.00585939124019897,-0.0290583816033256,-0.00608956794174568,0.0027121795308519
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42202,-0.0357934299413809,0.0119600232530991,-0.0592350755174552,-0.0123517843653067,0.00276967121580626
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HEPACAM2,HEPACAM family member 2,39929,0.0138103231088154,0.00461568334239066,0.00476358375772968,0.0228570624599011,0.0027771405064691
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42016,-0.0193189341356671,0.006466791138629,-0.0319938447673799,-0.00664402350395426,0.0028186407458532
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK11,Kallikrein-11,42062,-0.0101110055343922,0.00339339767644567,-0.0167620649802257,-0.00345994608855868,0.00289129681354185
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41843,0.00993580247457446,0.00334898336350659,0.00337179508210153,0.0164998098670474,0.00301442841198642
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCND2,G1/S-specific cyclin-D2,39757,0.011642224155251,0.00393233692769586,0.00393484377696713,0.0193496045335349,0.0030764910512934
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD99L2,CD99 antigen-like protein 2,42137,0.00765915156413102,0.00258735536644759,0.00258793504589374,0.0127303680823683,0.00307948251674336
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF8,SLAM family member 8,41843,-0.0167779826709931,0.00567253718969749,-0.0278961555628002,-0.00565980977918604,0.00310434408484634
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42281,-0.0161907500921148,0.00548015468032587,-0.0269318532655535,-0.00544964691867608,0.00313777540836193
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,39736,-0.0395129752121538,0.0133743721586686,-0.0657267446431443,-0.0132992057811632,0.00313953623670072
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LMOD1,Leiomodin-1,39934,0.0108374901104484,0.00367438495409962,0.00363569560041315,0.0180392846204836,0.00318969320744143
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LIF,Leukemia inhibitory factor,41839,-0.0155582849655702,0.00527587772915541,-0.0258990053147148,-0.00521756461642561,0.00319415764256665
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,39736,-0.0272909765952831,0.00926134549576377,-0.0454432137669801,-0.00913873942358609,0.0032178629466782
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRUNE2,Protein prune homolog 2,39757,-0.00900550808934951,0.00305851285491214,-0.0150001932849773,-0.00301082289372171,0.00324241111953054
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NMI,N-myc-interactor,39875,0.0226976558801557,0.00770946366934613,0.00758710708823731,0.0378082046720741,0.00324525738020487
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DSG4,Desmoglein-4,42018,0.0148369043026904,0.0050484932269983,0.00494185757777373,0.0247319510276071,0.0032996405306669
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42296,-0.00762416891378427,0.00259670073772185,-0.0127137023597191,-0.00253463546784945,0.00332921564598704
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLSTN2,Calsyntenin-2,42296,0.0123233761616639,0.00421319358417373,0.00406551673668341,0.0205812355866444,0.00345077756126946
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBC1D5,TBC1 domain family member 5,42119,-0.023981432822204,0.00819929707929841,-0.0400520550976289,-0.00791081054677911,0.00345232856493861
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LUZP2,Leucine zipper protein 2,39919,-0.0138945915129079,0.00475621173925933,-0.0232167665218562,-0.00457241650395961,0.00349199036448818
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,39934,-0.0115299266045899,0.00395120349585716,-0.0192742854564699,-0.00378556775270986,0.00352886465184219
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK3,Prostate-specific antigen,39966,0.0352630256549072,0.0120973236912299,0.0115522712200966,0.0589737800897178,0.00356446362704861
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRTAP,Cartilage-associated protein,39649,-0.0151527887215157,0.00521532255440814,-0.0253748209281557,-0.0049307565148758,0.0036746893607445
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42310,-0.00904586314345641,0.0031202317886295,-0.0151615174491702,-0.00293020883774259,0.00374829516747574
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLIC5,Chloride intracellular channel protein 5,39649,0.00963541888290801,0.00333075124750011,0.00310714643780779,0.0161636913280082,0.00382489113717068
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42145,-0.0149873997613876,0.00519641545532605,-0.0251723740538267,-0.00480242546894858,0.00393052282989828
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,41820,-0.0202569893207872,0.00702696694960004,-0.0340298445420033,-0.00648413409957117,0.00394855510539878
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCGB1A1,Uteroglobin,42165,-0.0162229133086453,0.00563747029237223,-0.0272723550816949,-0.00517347153559576,0.00401219012086742
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,39930,-0.0348716919883099,0.0121322516486643,-0.0586509052196919,-0.0110924787569279,0.00405681760233858
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TYMP,Thymidine phosphorylase,42070,-0.0201116688465177,0.00700022851776292,-0.033832116741333,-0.00639122095170235,0.00407227168634666
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,39930,-0.0146402655047961,0.00509611232486421,-0.0246286456615299,-0.00465188534806224,0.0040756828978551
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,39575,-0.0129258371256828,0.00450522099409278,-0.0217560702741046,-0.00409560397726093,0.0041245398285416
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL16,C-X-C motif chemokine 16,42295,-0.00703301900491952,0.00245267625418351,-0.0118402644631192,-0.00222577354671983,0.00414376333961997
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPL,Periplakin,39657,-0.00977506435417027,0.00341603696918622,-0.0164704968137753,-0.00307963189456527,0.00422403528632991
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42145,0.00968862033423955,0.00339510132137865,0.0030342217443374,0.0163430189241417,0.0043278056162133
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39757,-0.0212684875086513,0.00746309873663796,-0.0358961610324618,-0.00664081398484093,0.00438241283291458
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,39638,-0.0116811214209645,0.00410319823383638,-0.0197233899592838,-0.00363885288264518,0.00442379360299095
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUGT1,Protein SGT1 homolog,41843,-0.0239323201073964,0.00840973078267307,-0.0404153924414356,-0.00744924777335719,0.0044369550325067
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39638,-0.0160440582672252,0.00564614485679815,-0.0271105021865495,-0.00497761434790078,0.00449707036464274
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PER3,Period circadian protein homolog 3,39657,-0.0369347401358084,0.0130037716732417,-0.0624221326153622,-0.0114473476562547,0.00451520552927213
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL1,Growth-regulated alpha protein,42117,-0.0277658121234213,0.00978696865496784,-0.0469482706871582,-0.00858335355968431,0.00456047008487152
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MESD,LRP chaperone MESD,42137,-0.0363571838010947,0.0128191880804739,-0.0614827924388236,-0.0112315751633658,0.00457282601077641
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDIA4,Protein disulfide-isomerase A4,39966,-0.0183673614561728,0.00647648294535005,-0.0310612680290589,-0.00567345488328665,0.00457619318070214
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42144,-0.00765872484284573,0.00270145386667816,-0.0129535744215349,-0.00236387526415654,0.00458880655857096
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,39575,-0.0292575628987562,0.0103397431240013,-0.0495234594217987,-0.00899166637571368,0.0046687642443427
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOS1,"Nitric oxide synthase, brain",41839,-0.0175109884011825,0.00619288775366658,-0.029649048398369,-0.00537292840399597,0.00469692438634923
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39934,-0.0140382684541433,0.00496549369579791,-0.0237706360979072,-0.0043059008103794,0.0047044450202635
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STK4,Serine/threonine-protein kinase 4,42145,-0.0260040344226777,0.00920420589246199,-0.0440442779719032,-0.00796379087345221,0.00473152056434564
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SELENOP,Selenoprotein P,39979,0.00672872429902239,0.00238818991471758,0.00204787206617593,0.0114095765318688,0.004848258902259
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A13,Protein S100-A13,39657,-0.0106117606305809,0.00376737992309448,-0.0179958252798461,-0.00322769598131575,0.00485985158342262
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,39560,-0.0112394345252004,0.00399405994541711,-0.0190677920182179,-0.00341107703218288,0.00490106842077694
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHB6,Ephrin type-B receptor 6,41997,-0.00968919169557737,0.00344385595806608,-0.0164391493733869,-0.00293923401776786,0.00490810592108519
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCTD,Deoxycytidylate deaminase,39736,-0.0285070965560105,0.0101451179744863,-0.0483915277860037,-0.00862266532601732,0.00496383259420365
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42249,-0.0132729204200755,0.00472585762590276,-0.0225356013668449,-0.0040102394733061,0.0049832146870925
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STXBP3,Syntaxin-binding protein 3,41843,-0.0128312609956496,0.00457690156041418,-0.0218019880540614,-0.00386053393723779,0.00506275919153437
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42119,-0.0358306392985827,0.0127848717055662,-0.0608889878414924,-0.010772290755673,0.0050767623709068
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PMM2,Phosphomannomutase 2,39575,-0.0178021039513017,0.00635335519358238,-0.0302546801307232,-0.00534952777188022,0.00508757802342778
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HCG22,Protein PBMUCL2,39575,0.0172101134299197,0.00614864725360194,0.00515876481285992,0.0292614620469795,0.00513493089931405
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,39990,-0.00790495425594035,0.00283117297316382,-0.0134540532833414,-0.00235585522853926,0.00524523741389012
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARG1,Arginase-1,42015,-0.0148494599262951,0.00532122156096109,-0.0252790541857788,-0.00441986566681134,0.00526829381701219
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANPEP,Aminopeptidase N,42187,0.00800638210630807,0.00287065483356213,0.00237989863252629,0.0136328655800899,0.00529374743922936
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,39919,-0.0132128636697062,0.00473870314979131,-0.0225007218432971,-0.00392500549611519,0.00530760306929072
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLNS1A,Methylosome subunit pICln,39649,-0.00989844138143074,0.00355130846432465,-0.0168590059715071,-0.00293787679135442,0.00532455803846235
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39934,-0.0294975782507978,0.0106041552067809,-0.0502817224560884,-0.00871343404550713,0.00541643619163652
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39641,-0.0106368826324331,0.00383168360769862,-0.0181469825035224,-0.00312678276134381,0.00551191724498932
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,39636,-0.0168762426799213,0.00608339320712161,-0.0287996933658796,-0.0049527919939629,0.00554392371355904
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41820,-0.0136561630389805,0.0049484023868626,-0.0233550317172312,-0.00395729436072983,0.0057932069342005
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C7orf50,Uncharacterized protein C7orf50,39929,-0.00664748668041207,0.0024095119892075,-0.0113701301792588,-0.00192484318156537,0.00580979049090188
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42070,-0.0118864988247819,0.00431355290678536,-0.0203410625220812,-0.00343193512748259,0.00586603162540258
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,39930,0.0127152923846143,0.00461775258142888,0.00366449732501373,0.0217660874442149,0.0059043596134997
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYOM3,Myomesin-3,39736,0.0282627309012417,0.0102708033733571,0.00813195628946181,0.0483935055130216,0.00593727968000429
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42179,0.0140839953692627,0.00512520435937314,0.00403859482489136,0.0241293959136341,0.00600415170098812
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,39586,0.0180083919360831,0.00656051244602375,0.00514978754187657,0.0308669963302897,0.00606152810250787
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAGED1,Melanoma-associated antigen D1,41843,-0.0139420020481836,0.00508104999817958,-0.0239008600446156,-0.00398314405175168,0.00607917936077045
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42296,-0.0212104982598118,0.00774658767188302,-0.0363938100967025,-0.0060271864229211,0.00618856313095799
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NAA10,N-alpha-acetyltransferase 10,39575,-0.0146832726747718,0.00536808569731243,-0.0252047206415042,-0.00416182470803948,0.00624253945636309
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39930,-0.0126331612913194,0.00463165934410616,-0.0217112136057675,-0.00355510897687135,0.00639015614302333
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42137,0.00690177986235396,0.00253400556064859,0.00193512896348272,0.0118684307612252,0.0064644934073061
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42181,-0.0105917086994101,0.00389181740312325,-0.0182196708095317,-0.00296374658928858,0.00650627621826366
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAD2,Glutamate decarboxylase 2,39657,0.0130262450860388,0.00479261943628363,0.00363271099092291,0.0224197791811547,0.00657841100515706
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD40LG,CD40 ligand,42296,-0.0225732104176154,0.00833874734501802,-0.0389171552138507,-0.00622926562138004,0.00679730045257049
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SDC1,Syndecan-1,42145,-0.0115363048320501,0.00426363340515258,-0.0198930263061492,-0.0031795833579511,0.00682366512506351
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,41839,-0.020939967339538,0.00775353186526241,-0.0361368897954523,-0.00574304488362371,0.00692816322404208
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,39934,-0.0365505981579401,0.0135395526864515,-0.0630881214233851,-0.0100130748924951,0.00695378950899601
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",39649,-0.0244388895548583,0.00905737461106078,-0.0421913437925374,-0.00668643531717915,0.00698149395224005
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41843,-0.0164703857900345,0.00610841026396323,-0.0284428699074024,-0.00449790167266654,0.00701934991926971
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42185,-0.0250108020293072,0.00927721177006681,-0.0431941370986381,-0.00682746695997622,0.00702768644155592
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42262,-0.0117756800871088,0.0043715971433191,-0.0203440104880142,-0.00320734968620333,0.007075445244152
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42119,-0.0234163419984659,0.0087017894772939,-0.0404718493739619,-0.00636083462296985,0.00713300554444653
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42212,-0.0236923577988401,0.00880469669389847,-0.0409495633188811,-0.00643515227879907,0.00713514358173542
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LBP,Lipopolysaccharide-binding protein,42217,0.016490390668118,0.00616881129081982,0.00439952053811118,0.0285812607981249,0.00752237605935367
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL17A,Interleukin-17A,41877,-0.0120271105880039,0.00451069644953722,-0.0208680756290969,-0.00318614554691099,0.00767719507653332
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RYR1,Ryanodine receptor 1,39575,0.00950670178629591,0.00357420835938797,0.00250125340189549,0.0165121501706963,0.00782992051425053
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,39803,-0.0157525390133344,0.00592924449234999,-0.0273738582183403,-0.00413121980832837,0.00790090241822885
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COMMD9,COMM domain-containing protein 9,39919,-0.0111947059286764,0.00421827183520499,-0.0194625187256782,-0.00292689313167463,0.00796878735157341
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DBN1,Drebrin,39657,-0.0143272585466618,0.00540024711975841,-0.0249117429013882,-0.00374277419193527,0.00798762254203145
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42041,-0.0113613313643691,0.00428517992027992,-0.0197602840081177,-0.00296237872062045,0.00802747437830197
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42070,-0.0261615527541091,0.00987464318164299,-0.0455158533901294,-0.00680725211808885,0.00807368561044235
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39934,-0.0330781738498433,0.0124878746796969,-0.0575544082220493,-0.00860193947763727,0.0080884509677754
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,39657,0.0244616094908415,0.00924325852760221,0.00634482277674121,0.0425783962049419,0.0081462262112962
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39757,-0.0176379944543483,0.00667868331672972,-0.0307282137551385,-0.00454777515355803,0.00827918241717503
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42119,-0.033318208955983,0.0126240881448144,-0.0580614217198193,-0.00857499619214671,0.00831833614657049
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,41843,0.00840338339272071,0.00318413053837157,0.00216248753751243,0.014644279247929,0.00832126509961866
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39575,-0.0165350368994011,0.00626576963672983,-0.0288159453873916,-0.00425412841141062,0.00832813432832675
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SDC4,Syndecan-4,42145,0.0131455765197841,0.00498644483677531,0.00337214463970449,0.0229190083998637,0.00839204966854385
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42070,-0.00594844270094277,0.00225739730528007,-0.0103729414192917,-0.00152394398259384,0.00842115377461853
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,39560,-0.0408807725561323,0.0155175967605115,-0.0712952622067347,-0.0104662829055298,0.00843851575826823
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,41900,-0.00970167468505574,0.00369844437258612,-0.0169506256553245,-0.00245272371478694,0.00872133599159746
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,39560,0.0134186236814954,0.00511673269735589,0.00338982759467783,0.0234474197683129,0.00874084045635344
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FN1,Fibronectin,39979,-0.00754703582808968,0.00287862815033082,-0.0131891470027381,-0.00190492465344126,0.00875966821976106
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,39575,-0.0109088213866634,0.00417004241691426,-0.0190821045238154,-0.00273553824951145,0.00890889735315579
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SDK2,Protein sidekick-2,39736,-0.0108753753840676,0.00416666839748737,-0.0190420454431429,-0.00270870532499239,0.00906398364749321
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CR1,Complement receptor type 1,39970,0.0098041028995301,0.00375716554621027,0.00244005842895798,0.0171681473701022,0.00908090018388059
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,41820,-0.0111923251189304,0.00429801521808726,-0.0196164349463815,-0.00276821529147941,0.00922274232803775
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42159,0.00626596124449082,0.00240657866649589,0.00154906705815887,0.0109828554308228,0.00923292746204272
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL6,Interleukin-6,42070,-0.0204720444717048,0.00786492349570052,-0.0358872945232778,-0.00505679442013175,0.00925252823079618
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39736,-0.0192943161069612,0.00741726469903762,-0.0338321549170749,-0.00475647729684747,0.0093001870565068
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,39638,-0.0130305401727706,0.0050122067990618,-0.0228544654989317,-0.00320661484660947,0.00934129044450837
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHRDL1,Chordin-like protein 1,42166,-0.00886374578253663,0.00344110008485448,-0.0156083019488514,-0.00211918961622184,0.0100099841254939
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NECTIN4,Nectin-4,42181,-0.00910996230901326,0.00353910627446528,-0.0160466106069652,-0.00217331401106131,0.0100610411542412
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39649,-0.0108691011224783,0.0042238813203369,-0.0191479085103386,-0.00259029373461796,0.0100877727576293
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,39638,-0.00917772002470559,0.00356989031804834,-0.0161747050480803,-0.00218073500133084,0.0101573533679039
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MST1,Hepatocyte growth factor-like protein,39854,-0.0182952936876807,0.00712670651420735,-0.0322636384555272,-0.00432694891983433,0.0102667566938668
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDI2,Protein DDI1 homolog 2,39736,-0.0203566658774969,0.00793190872480241,-0.0359032069781096,-0.00481012477688415,0.010288174162702
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41913,-0.011600156541983,0.00452218850470405,-0.0204636460112029,-0.00273666707276305,0.0103235510173932
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42119,-0.0267679683254522,0.0104438152606037,-0.0472378462362353,-0.00629809041466898,0.0103865841945887
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD2,T-cell surface antigen CD2,39575,-0.010544146159444,0.00411990808637873,-0.0186191660087463,-0.00246912631014172,0.0105011237138545
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEZ6L,Seizure 6-like protein,42181,0.00741157035838176,0.0028974794025141,0.00173251072945412,0.0130906299873094,0.0105402669659415
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RGMB,RGM domain family member B,42249,-0.0075474738697834,0.00295127797524982,-0.013331978701273,-0.00176296903829376,0.0105577779040811
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL8,C-C motif chemokine 8,42239,-0.0163094583921341,0.00638369862287747,-0.0288215076929739,-0.00379740909129424,0.0106338011688994
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42239,-0.00822018547477566,0.00322142256491888,-0.0145341737020167,-0.00190619724753465,0.0107299093133175
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CBX2,Chromobox protein homolog 2,39575,0.01065533096576,0.0041789383409993,0.00246461181740141,0.0188460501141186,0.0107928789059687
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42249,0.00749654252351661,0.00294192576857476,0.00173036801711008,0.0132627170299232,0.0108396634913108
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42070,0.010875793369914,0.00427998515719605,0.00248702246180974,0.0192645642780182,0.0110621173871762
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,-0.0154535122760223,0.00608302011567034,-0.0273762317027362,-0.00353079284930846,0.0110825732980263
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39649,-0.013505501801933,0.00533187016674829,-0.0239559673287597,-0.00305503627510638,0.0113235703794272
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39586,-0.0157717265082079,0.00622753305263763,-0.0279776912913777,-0.00356576172503815,0.0113364518601286
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39638,-0.027262161252207,0.0107898061821506,-0.0484101813692222,-0.00611414113519174,0.011529180702815
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RSPO1,R-spondin-1,42016,0.00904989336461027,0.00358311250875998,0.0020269928474407,0.0160727938817798,0.0115579800933557
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMOX2,Heme oxygenase 2,41839,-0.012702654653833,0.00503422948182126,-0.0225697444382027,-0.00283556486946336,0.0116389493007026
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39638,0.0106597514851014,0.00422583841991617,0.00237710818206567,0.0189423947881371,0.0116657541261113
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,41839,-0.0394505724493136,0.0156761617342979,-0.0701758494485374,-0.00872529545008977,0.011861168522948
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,39919,-0.0116821052063675,0.00464418763951555,-0.020784712979818,-0.00257949743291701,0.0119026332991671
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42137,-0.0100741335649644,0.00400738559881771,-0.0179286093386471,-0.00221965779128171,0.0119522156337531
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCUN1D1,DCN1-like protein 1,39586,-0.0200159373499953,0.00798125490015969,-0.0356591969543083,-0.00437267774568231,0.0121604901129255
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",39560,-0.0252392051435322,0.0100658531232703,-0.0449682772651419,-0.00551013302192244,0.0121763540642201
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LY96,Lymphocyte antigen 96,42016,-0.0096097313733088,0.00384260066167183,-0.0171412286701856,-0.00207823407643201,0.0124017248754245
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMCN2,Hemicentin-2,39721,-0.0153598827630343,0.00614224710782532,-0.0273986870943719,-0.00332107843169664,0.0124092824679502
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACRBP,Acrosin-binding protein,39919,-0.0105569335798227,0.00422628051565441,-0.0188404433905054,-0.0022734237691401,0.0125063248955842
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42123,-0.0141846670363889,0.00568104869406398,-0.0253195224767543,-0.00304981159602348,0.0125423653131056
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41900,-0.00824337666067687,0.00330718313546183,-0.0147254556061821,-0.00176129771517168,0.0126943992489278
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RP2,Protein XRP2,42070,-0.0111716600206777,0.00448489764571867,-0.0199620594062863,-0.00238126063506908,0.0127521167270883
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRYBB1,Beta-crystallin B1,39958,-0.0174238874899262,0.00699605237433431,-0.0311361501436214,-0.00371162483623094,0.0127694015350302
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",39930,-0.0232828274891417,0.00935387154520382,-0.0416164157177412,-0.00494923926054224,0.0128205254239173
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RPS10,40S ribosomal protein S10,39575,0.0109804618358948,0.0044205281758303,0.00231622661126746,0.0196446970605222,0.0130074603343208
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRND,Prion-like protein doppel,39929,-0.012780681192555,0.00516505088873447,-0.0229041809344746,-0.00265718145063546,0.013358530196026
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NINJ1,Ninjurin-1,41843,0.014085881335976,0.00572190478756326,0.002870947952352,0.0253008147196,0.0138388694545306
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39919,-0.0140448903179558,0.00570729784179017,-0.0252311940878645,-0.00285858654804708,0.0138750630581288
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPSD1,Tryptase delta,39934,-0.00951251646159256,0.00387317159858945,-0.0171039327948279,-0.00192110012835724,0.014064140768007
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,39657,-0.00528696172022009,0.00215889676737164,-0.0095183993842685,-0.00105552405617167,0.014344011256998
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42181,0.0282509271757558,0.0115567041523247,0.00559978703719938,0.0509020673143122,0.0145159695988357
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,39966,-0.0165845552761994,0.00679515853951438,-0.0299030660136476,-0.00326604453875124,0.0146763078116386
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACTN2,Alpha-actinin-2,39575,0.0166930068845199,0.00683978378729107,0.0032870306614294,0.0300989831076104,0.0146795957000913
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INSL4,Early placenta insulin-like peptide,39919,-0.0123917344223394,0.00509396453297405,-0.0223759049069685,-0.00240756393771026,0.0150049691134906
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNNI3,"Troponin I, cardiac muscle",41900,-0.0214827826992945,0.00883289169581991,-0.0387952504231015,-0.00417031497548745,0.015023226655506
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPON2,Spondin-2,42070,-0.0089380915460233,0.00367781704595518,-0.0161466129560954,-0.00172957013595115,0.0151005138372861
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUP50,Nuclear pore complex protein Nup50,39575,0.0081598531508492,0.00335815880924962,0.00157786188471995,0.0147418444169785,0.0151206167511694
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39560,0.0080017521753913,0.00329871950940425,0.00153626193695897,0.0144672424138236,0.0152943155969842
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRC1,Macrophage mannose receptor 1,39990,-0.00729907144213721,0.00300955790099518,-0.0131978049280878,-0.00140033795618665,0.0153113116468527
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSBP1,Heat shock factor-binding protein 1,39638,-0.0246925948809046,0.0101889937030721,-0.044663022538926,-0.00472216722288318,0.0153895157072872
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39586,-0.0140755895719657,0.00581277268401212,-0.0254686240326295,-0.00268255511130198,0.0154729773122228
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",39575,-0.0161447433885992,0.0066686561941506,-0.0292153095291344,-0.00307417724806402,0.0154944591400875
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNLZ,DNL-type zinc finger protein,39586,0.0216202229419658,0.00894169176072694,0.00409450709094102,0.0391459387929906,0.0156260180414487
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFB,Complement factor B,39794,-0.00836030466160655,0.00346085521051943,-0.0151435808742246,-0.00157702844898846,0.0157219407562407
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA11,Serpin A11,42310,0.0105757390855205,0.00439409968026335,0.00196330371220435,0.0191881744588367,0.0161059176788391
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39657,0.00759426976313408,0.00316029028469383,0.00140010080513418,0.013788438721134,0.0162762593338184
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,41913,-0.010752803233445,0.0044775585193784,-0.0195288179314266,-0.0019767885354633,0.0163421645692715
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAS6,Growth arrest-specific protein 6,42236,0.00636698785569456,0.00265318025614957,0.0011667545536414,0.0115672211577477,0.0164192877748999
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42070,0.0099387348290628,0.0041433002319582,0.00181786637442472,0.0180596032837009,0.0164647238044652
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,41843,-0.0187232346387515,0.007816269286123,-0.0340431224395526,-0.00340334683795039,0.0166152124692337
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MANSC1,MANSC domain-containing protein 1,42181,0.00700403708361139,0.00292567344090232,0.00126971713944285,0.0127383570277799,0.0166796197649525
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EVI2B,Protein EVI2B,39560,0.0101160775979978,0.00422618799772159,0.00183274912246352,0.0183994060735322,0.0166976959268856
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLG,Plasminogen,39742,-0.00552577685423584,0.00230946044412821,-0.0100523193247271,-0.00099923438374454,0.0167427343257171
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL20,Interleukin-20,41913,0.0117188358959008,0.00490209220925689,0.00211073516575729,0.0213269366260443,0.0168356672454465
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39929,-0.0141286481970766,0.00591410718420893,-0.0257202982781261,-0.00253699811602708,0.0169117621135141
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42107,-0.0274919185703634,0.0115350050248943,-0.0501005284191562,-0.00488330872157068,0.0171697556850867
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39575,0.00524816824693948,0.00220427279975256,0.000927793559424469,0.00956854293445449,0.0172870360071427
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41900,0.00736855975687651,0.00309797129560679,0.0012965360174872,0.0134405834962658,0.0173967390641011
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA1,Annexin A1,39699,-0.0111764307358026,0.00470443954314666,-0.0203971322403701,-0.00195572923123519,0.0175316290834159
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42155,-0.0239226077352697,0.0100882972940962,-0.0436956704316982,-0.00414954503884116,0.0177384456908915
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNN,Tenascin-N,39966,-0.0108274435244848,0.00456778620077947,-0.0197803044780125,-0.00187458257095701,0.0177858277686008
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,41843,0.013458890226026,0.00570201452490031,0.00228294175722136,0.0246348386948306,0.0182709035376038
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42310,-0.0156122932414784,0.00665695139386646,-0.0286599179734567,-0.00256466850950017,0.0190279070830241
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42185,-0.0296919430214309,0.0126637806764058,-0.0545129531471862,-0.00487093289567561,0.0190600361929922
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,39934,0.0114133181850465,0.00486896951841647,0.00187013792895021,0.0209564984411428,0.0190905822684854
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNASE3,Eosinophil cationic protein,42081,-0.0268863170402278,0.0114802438017087,-0.0493875948915769,-0.00438503918887868,0.0191970450530978
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,41839,-0.00983966895358625,0.00420170804623461,-0.0180750167242061,-0.00160432118296641,0.0192044054142008
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,39575,-0.0172098442756285,0.00734914152636385,-0.0316141616673017,-0.00280552688395539,0.0192114096094635
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42217,-0.00669503704938194,0.002867367562296,-0.0123150774714821,-0.00107499662728178,0.0195627242826335
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP9,Caspase-9,39657,-0.0157749753156892,0.00675684282771814,-0.0290183872580167,-0.00253156337336161,0.0195786488616397
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,POMC,Pro-opiomelanocortin,39638,-0.0181263996484553,0.00777493245832253,-0.0333652672667675,-0.00288753203014317,0.0197507098217327
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DAND5,DAN domain family member 5,39657,0.0134756337230589,0.00578573272063328,0.00213559759061764,0.0248156698555001,0.0198709246904255
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42296,-0.00862717915879885,0.00370599162845262,-0.015890922750566,-0.00136343556703172,0.019931885074747
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYL6B,Myosin light chain 6B,39649,-0.0224561462553646,0.00964894107689457,-0.0413680707660779,-0.00354422174465123,0.0199663630116514
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEFL,Neurofilament light polypeptide,41797,-0.0115813275685687,0.00499235883247922,-0.021366350880228,-0.00179630425690944,0.0203662978016699
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QL2,Complement C1q-like protein 2,39657,0.0105540480990662,0.00455594735563147,0.00162439128202854,0.0194837049161039,0.0205468239445865
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MATN2,Matrilin-2,42144,-0.00721444436121352,0.00311765182678013,-0.0133250419417026,-0.00110384678072446,0.0206791270775711
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPM3,Tropomyosin alpha-3 chain,39575,0.0113402002927208,0.00490164028221318,0.00173298533958297,0.0209474152458586,0.0207106878454091
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NDRG1,Protein NDRG1,41839,-0.0160774231048232,0.0069583033741337,-0.0297156977181252,-0.00243914849152111,0.0208736912171791
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCAM,Basal cell adhesion molecule,42137,0.00596804320050503,0.00258330676918187,0.000904761932908574,0.0110313244681015,0.0208901636287675
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,39657,-0.00929275121976738,0.00402689249590418,-0.0171854605117396,-0.00140004192779518,0.0210357018000885
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,41791,-0.0140959285937753,0.00611459317724257,-0.0260805312211707,-0.00211132596637983,0.0211656137208464
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB6,Integrin beta-6,41913,0.00742474171707843,0.00322823550403969,0.00109740012916063,0.0137520833049962,0.0214671231883556
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL17RA,Interleukin-17 receptor A,42137,-0.0107130331199261,0.00466928721398811,-0.0198648360593428,-0.00156123018050941,0.0217849738604764
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,39919,-0.010454061439859,0.00457092665936446,-0.0194130776922134,-0.00149504518750469,0.0222096963880321
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,39919,-0.0116963236639572,0.00512221920959412,-0.0217358733147617,-0.00165677401315275,0.0224224086637037
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39934,-0.00756491723690998,0.00332726774119451,-0.0140863620096512,-0.00104347246416874,0.0230079213271111
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNW1,Interferon omega-1,39575,0.00849044324970993,0.00373580551755379,0.00116826443530449,0.0158126220641154,0.0230622536314057
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42070,0.0135302289753626,0.00595882393574268,0.00185093406130693,0.0252095238894183,0.0231856684061698
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,39638,-0.0146149451520909,0.00647437621975535,-0.0273047225428113,-0.00192516776137038,0.0240055582518262
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39649,-0.0128820651900547,0.00570680411180762,-0.0240674012491977,-0.00169672913091177,0.0240077239110368
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEMA4D,Semaphorin-4D,42249,-0.00713027944049602,0.00316635146716602,-0.0133363283161414,-0.000924230564850629,0.0243449693296542
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYH4,Myosin-4,39575,0.0109149710691793,0.00485143159090012,0.00140616515101508,0.0204237769873436,0.0244784904398357
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,39657,-0.00964572939824305,0.00428802200787609,-0.0180502525336802,-0.00124120626280592,0.0245029044667386
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAP,Prolyl endopeptidase FAP,42310,0.0065113700194368,0.0028949933961405,0.000837182963001423,0.0121855570758722,0.0245166583361159
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLXDC2,Plexin domain-containing protein 2,39929,-0.00651162911787528,0.00289597417800295,-0.012187738506761,-0.000835519728989502,0.0245627796922832
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATXN2,Ataxin-2,39586,-0.0252272094310457,0.0112220183931219,-0.0472223654815646,-0.00323205338052666,0.0245953015235746
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPMT,Thiopurine S-methyltransferase,41843,-0.0169224472085847,0.00753345557049572,-0.0316880201267563,-0.00215687429041309,0.0247008200836316
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PALLD,Palladin,39657,0.00903650898649308,0.00403389529630539,0.00113007420573452,0.0169429437672516,0.025101318394097
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PROK1,Prokineticin-1,42119,-0.011706306630987,0.00522829898257101,-0.0219537726368262,-0.00145884062514778,0.0251703096579396
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFRC,Transferrin receptor protein 1,42200,-0.00880605174682783,0.00394681818296252,-0.0165418153854344,-0.0010702881082213,0.025685613090837
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,39757,-0.00833694704612074,0.00374287549621912,-0.0156729830187102,-0.00100091107353127,0.0259392409934584
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1S,Complement C1s subcomponent,39979,0.0049615578259841,0.00222880670957396,0.000593096675219134,0.00933001897674906,0.0260266547721203
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39560,-0.0133710505222393,0.00600869362267468,-0.0251480900226816,-0.0015940110217969,0.0260824411595391
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SH3GL3,Endophilin-A3,39690,-0.0200803905044386,0.00902466776063999,-0.0377687393152929,-0.00239204169358421,0.0260975214656927
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOP56,Nucleolar protein 56,39575,-0.0263666097171969,0.0118600928129526,-0.0496123916305839,-0.00312082780380982,0.0262268591023006
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA5,Annexin A5,41780,-0.00709509919897624,0.00320435492539075,-0.0133756348527421,-0.000814563545210368,0.0268317168497696
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,REST,RE1-silencing transcription factor,39560,0.00801318815650664,0.00362063352116068,0.000916746455031705,0.0151096298579816,0.026904342917128
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RTKN2,Rhotekin-2,39575,0.01191980141997,0.00539157402725193,0.00135231632655622,0.0224872865133838,0.027068825077452
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,41913,-0.00854586387212767,0.00388961672380201,-0.0161695126507796,-0.000922215093475739,0.0280307127441493
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC12A2,Solute carrier family 12 member 2,39575,0.0061336851401104,0.00279652649368949,0.000652493212479011,0.0116148770677418,0.0283050383499514
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARFIP1,Arfaptin-1,39934,-0.0160782968958816,0.00733669446523053,-0.0304582180477334,-0.00169837574402974,0.028436587719835
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA4,Carbonic anhydrase 4,42310,0.00558507685508489,0.00255215206316728,0.000582858811277011,0.0105872948988928,0.0286587961463956
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GP6,Platelet glycoprotein VI,42115,-0.0202821190181949,0.00926923817679807,-0.0384498258447191,-0.0021144121916707,0.0286786029315681
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,39649,-0.0118138690339585,0.00541469404465144,-0.0224266693614753,-0.00120106870644166,0.0291440728936326
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERVV_1,,39575,0.0100625032216928,0.00461408414224669,0.00101889830288926,0.0191061081404963,0.0292176317007348
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,39934,-0.00672521599491558,0.00308460900441992,-0.0127710496435786,-0.000679382346252545,0.0292595026433865
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42114,-0.00615044437265414,0.00282553154141238,-0.0116884861938224,-0.000612402551485884,0.0295173067455404
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,39929,-0.00644338759549975,0.00296636144469618,-0.0122574560271043,-0.000629319163895243,0.0298648779616589
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42129,-0.00748784624220881,0.00344827366252682,-0.0142464626207614,-0.000729229863656254,0.0299124683946949
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BMP4,Bone morphogenetic protein 4,41992,0.0108029408809141,0.00497500356839484,0.00105193388686023,0.020553947874968,0.0299151343538811
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BLNK,B-cell linker protein,39657,-0.00954420273972995,0.0044280393270395,-0.0182231598207274,-0.000865245658732529,0.0311519404939124
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42310,0.00612153056961622,0.00284855810702623,0.000538356679844815,0.0117047044593876,0.0316524321541707
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39281,0.0251082121961382,0.0117076034906446,0.00216130935447474,0.0480551150378017,0.0320067495659894
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB2,Integrin beta-2,42079,0.00647248291916506,0.0030187195804575,0.000555792541468358,0.0123891732968618,0.0320414791425813
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,39638,-0.00724339271567531,0.00337867549244354,-0.0138655966808647,-0.000621188750485964,0.0320662313588357
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK8,Kallikrein-8,41668,-0.00826298945530514,0.00385828704627116,-0.0158252320659966,-0.000700746844613656,0.0322424082958612
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,39757,-0.00912472580182378,0.00426078827913921,-0.0174758708289366,-0.000773580774710925,0.0322506490824652
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP4,Caspase-4,39757,0.0375311704109899,0.0175814803076886,0.00307146900792028,0.0719908718140594,0.0328073230966138
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41900,-0.0199389838706962,0.00935703372536748,-0.0382787699724165,-0.00159919776897599,0.0331149590444714
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,39930,-0.0217522191359162,0.0102086553629324,-0.0417611836472637,-0.00174325462456877,0.0331301916158761
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",39649,-0.00884344781063699,0.0041540572102885,-0.0169853999428025,-0.000701495678471532,0.0332870712173563
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MILR1,Allergin-1,41913,-0.0114209503835875,0.00537438079267237,-0.0219547367372254,-0.000887164029949674,0.0335989050803873
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSHB,Thyrotropin subunit beta,42145,-0.0152099500138595,0.00717218887048361,-0.0292674402000073,-0.00115245982771159,0.0339664796104127
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GDF2,Growth/differentiation factor 2,42145,0.00788884566126697,0.0037222231277859,0.000593288330806598,0.0151844029917273,0.0340755902157547
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB5,Integrin beta-5,42181,0.00856406801095753,0.00404553678785283,0.000634815906765991,0.0164933201151491,0.0342849743647999
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41997,-0.016037606187864,0.00758012588175903,-0.0308946529161117,-0.0011805594596163,0.0343849826257416
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EVPL,Envoplakin,39757,0.007476879577731,0.00353721795251156,0.000543932390808345,0.0144098267646537,0.0345567014163659
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UPK3A,Uroplakin-3a,39586,0.0107978515914625,0.0051285601855814,0.000745873627722963,0.0208498295552021,0.0352760738059621
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THBD,Thrombomodulin,42145,-0.00654849906756872,0.00311346218376926,-0.0126508849477565,-0.000446113187380975,0.0354592380092851
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42217,-0.0101941233664102,0.00485894515137359,-0.0197176558631024,-0.000670590869717944,0.0359224994913966
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,39757,0.0175418365494573,0.00836718885858658,0.00114214638662759,0.033941526712287,0.0360600556530066
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39919,-0.0222142745696224,0.0106118769109735,-0.0430135533151305,-0.00141499582411423,0.0363409447950746
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TG,Thyroglobulin,39919,0.0230577403352896,0.0110863215005203,0.00132855019426985,0.0447869304763094,0.0375629455070842
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRP2BP,LRP2-binding protein,39649,-0.0170343221620361,0.00821649344966308,-0.0331386493233757,-0.000929995000696432,0.0381780608885158
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,39930,-0.0217004354580623,0.0104706819220483,-0.042222972025277,-0.00117789889084759,0.0382418671217173
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCDH1,Protocadherin-1,42264,-0.00448518221215815,0.00216782465266444,-0.00873411853138046,-0.000236245892935846,0.0385668809636632
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFHR2,Complement factor H-related protein 2,39904,-0.0124181805473891,0.00602426704783764,-0.0242257439611508,-0.000610617133627303,0.0392915635014363
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLA2G1B,Phospholipase A2,42299,0.00961437999149284,0.00468683564201163,0.000428182133150037,0.0188005778498356,0.0402510242358942
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",39541,0.00576841039141609,0.00281224105162883,0.000256417930223584,0.0112804028526086,0.0402732577543047
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL14,C-X-C motif chemokine 14,41913,-0.0123160431252707,0.00600671935205198,-0.0240892130552926,-0.000542873195248867,0.040347131161756
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,39575,-0.0216488681403286,0.0105659415070674,-0.0423581134941807,-0.000939622786476409,0.0404927475995023
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUSD4,Sushi domain-containing protein 4,39919,0.00835517362367516,0.00407813464803864,0.000362029713519434,0.0163483175338309,0.0405072916614882
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,39736,0.00568195123441313,0.00277751624734232,0.000238019389622185,0.0111258830792041,0.0408098265728955
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,39966,-0.00614343081405515,0.00300509882480549,-0.0120334245106739,-0.000253437117436401,0.0409433874760124
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPM1F,Protein phosphatase 1F,39958,-0.011495061723796,0.00564280378308086,-0.0225549571386344,-0.000435166308957475,0.0416612730913491
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42217,0.00768618252726014,0.00377449686864416,0.000288168664717582,0.0150841963898027,0.0417349077750322
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCRL3,Fc receptor-like protein 3,41913,-0.011457468422559,0.00562677698485505,-0.0224859513128749,-0.000428985532243053,0.0417460116314033
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39638,-0.0198232401841905,0.00974681440179035,-0.0389269964116996,-0.000719483956681432,0.041993880732791
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,41936,0.0359115839454804,0.0177540642870375,0.00111361794288687,0.070709549948074,0.0431214575036153
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39575,0.0108742826734718,0.00537691899025962,0.000335521452562958,0.0214130438943807,0.0431592189937392
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,39657,0.00896947847449386,0.00443534328629019,0.000276205633365089,0.0176627513156226,0.0431721042616702
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FBN2,Fibrillin-2,39649,-0.0127880025658313,0.0063528805961643,-0.0252396485343133,-0.000336356597349232,0.0441445707463568
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCN2,Transcobalamin-2,42286,-0.00637889130622371,0.00318250147345787,-0.0126165941942011,-0.00014118841824628,0.0450507504564168
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,39657,-0.00769261640186244,0.0038432348797433,-0.0152253567661593,-0.000159876037565573,0.045352228496012
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,41913,-0.0136780169015704,0.00684026272637987,-0.0270849318452749,-0.000271101957865814,0.0455601624397452
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP170,Centrosomal protein of 170 kDa,39638,-0.0163580276022395,0.00818234487632751,-0.0323954235598415,-0.000320631644637626,0.0456127273658637
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COPB2,Coatomer subunit beta',39575,-0.00910711417535491,0.00455626779381115,-0.0180373990512248,-0.000176829299485062,0.0456535212003892
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TLR1,Toll-like receptor 1,39657,-0.00565850681328326,0.00283163990247275,-0.0112085210221299,-0.000108492604436669,0.0457070291668344
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41482,0.00628887162377093,0.00315131752008549,0.000112289284403366,0.0124654539631385,0.0459949611321082
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42119,-0.0314097775621247,0.0157762654799728,-0.0623312579028714,-0.00048829722137796,0.0465063273763827
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42310,0.0085222063273143,0.00428933319565995,0.000115113263820795,0.0169292993908078,0.0469603225470601
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BPIFB2,BPI fold-containing family B member 2,39927,0.0128722578580091,0.00648030163888005,0.000170866645804216,0.025573649070214,0.0470166379590749
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRSS27,Serine protease 27,42107,-0.00839562679583187,0.00423257981892107,-0.0166914832409172,-9.9770350746568e-05,0.0473237877737167
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,39585,0.00722785079849056,0.00365173506067326,7.04500795709589e-05,0.0143852515174102,0.0478080416027603
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,39958,0.00804605530964388,0.00407609816306206,5.69029100422318e-05,0.0160352077092455,0.0484104688963887
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42310,-0.00569972218574629,0.00289131135697503,-0.0113666924454173,-3.27519260752392e-05,0.0487064820436194
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PKD1,Polycystin-1,39958,-0.00564812445441333,0.00287677879098896,-0.0112866108847517,-9.63802407496096e-06,0.0496298483076089
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39657,-0.0064633747813245,0.00329295766650382,-0.012917571807672,-9.1777549770097e-06,0.0496959531771213
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,39575,0.00807374968336138,0.00411542549173111,7.51571956840967e-06,0.0161399836471543,0.0498079553897104
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL22,Interleukin-22,39919,-0.0146144240846237,0.00745144171591695,-0.0292192498478209,-9.59832142648047e-06,0.0498699010489911
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42310,0.00618326458250887,0.00315917175760016,-8.71206238745644e-06,0.0123752412274052,0.0503392497453217
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCRN1,Secernin-1,42119,-0.0113897133502878,0.00582112527633535,-0.0227991188919051,1.96921913295216e-05,0.0504130570389425
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C7,Complement component C7,39722,-0.00688287445130153,0.00351789757215889,-0.013777953692733,1.22047901299042e-05,0.0504276621606167
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39930,-0.00741796810860971,0.00379653692519243,-0.0148591804819869,2.32442647674557e-05,0.0507402751215636
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL17D,Interleukin-17D,41913,-0.00698692123559682,0.00358195667538225,-0.014007556319346,3.37138481523976e-05,0.0511270449879014
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,39657,-0.0132976094503634,0.00682346569250763,-0.0266716022076783,7.63833069515711e-05,0.0513438789500104
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOX2,Transcription factor SOX-2,39915,0.00506329433094889,0.00260085419657651,-3.43798943410632e-05,0.0101609685562388,0.0515856710834514
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOLR2,Folate receptor beta,42249,-0.00594725539683208,0.00305858382777643,-0.0119420796992739,4.75689056097161e-05,0.0518620373656239
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41820,-0.00990159632274781,0.00509591738872702,-0.0198895944046528,8.64017591571536e-05,0.0520319326344435
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41843,-0.0160661898267029,0.00827270164377446,-0.0322806850485008,0.000148305395095073,0.0521494490403013
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDIA5,Protein disulfide-isomerase A5,39560,-0.0126424894184997,0.00651956339843536,-0.025420833679433,0.000135854842433596,0.0525072507179429
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39757,-0.0178875418931248,0.0092276003121781,-0.0359736385049939,0.00019855471874422,0.052589571602229
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPHS2,Podocin,39657,0.0208912294667776,0.0107807544938384,-0.000239049341145717,0.042021508274701,0.0526698473553428
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,39963,-0.00521787535468652,0.00270204138565606,-0.0105138764705724,7.81257611993571e-05,0.0534972130829009
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA12,Carbonic anhydrase 12,42070,-0.00665403387877647,0.00344754817216648,-0.0134112282962228,0.000103160538669832,0.0536182519144005
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41913,-0.0234740154914321,0.0121699926330914,-0.0473272010522913,0.000379170069427077,0.0537714827620763
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,XG,Glycoprotein Xg,42261,-0.00702236253333024,0.00364215062693653,-0.0141609777621258,0.000116252695465351,0.0538657153881386
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42223,-0.0129279778938791,0.00670814527722993,-0.0260759426372497,0.000219986849491597,0.0539747312127653
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NLGN1,Neuroligin-1,39649,0.0136866010418401,0.00710337956631944,-0.000236022908145995,0.0276092249918262,0.0540335218902981
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MELTF,Melanotransferrin,39958,0.00612165322115106,0.00318108659476341,-0.00011327650458523,0.0123565829468873,0.0543305918962952
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39736,-0.0181143105928485,0.00945147999668272,-0.0366392113863466,0.000410590200649659,0.055319661399373
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MPI,Mannose-6-phosphate isomerase,42070,-0.0171739475898879,0.00896512123574442,-0.0347455852119469,0.000397690032171192,0.0554320430773601
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZNF830,Zinc finger protein 830,39919,-0.0157349399129869,0.00821444178940913,-0.0318352458202288,0.00036536599425499,0.0554511973406255
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A11,Protein S100-A11,42027,-0.00932858672913484,0.00487479102204707,-0.0188831771323471,0.000226003674077423,0.0556876293850884
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TEX101,Testis-expressed protein 101,39649,-0.0124475829624434,0.00651327799105046,-0.0252136078249023,0.000318441900015469,0.0560164471647208
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PALM,Paralemmin-1,39859,0.00618453100010103,0.00323822757338327,-0.00016239504373018,0.0125314570439322,0.0561778311858691
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39575,-0.0176214022051993,0.00924327011496012,-0.0357382116305211,0.000495407220122566,0.0566239705339357
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HEBP1,Heme-binding protein 1,41900,0.0104183766065311,0.00547234664296176,-0.000307422813673975,0.0211441760267361,0.0569548678087666
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD276,CD276 antigen,42123,-0.00719189466746131,0.00377835522131747,-0.0145974709012436,0.00021368156632094,0.0570035996867958
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DLGAP5,Disks large-associated protein 5,39934,0.00995886156173687,0.00523476344120603,-0.000301274783026953,0.0202189979065007,0.0571380232470403
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GJA8,Gap junction alpha-8 protein,39560,-0.0125490523322275,0.00660086564270299,-0.0254867489919253,0.000388644327470376,0.0573122098720663
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC44A4,Choline transporter-like protein 4,39649,0.0137920463554729,0.00727638464724809,-0.000469667553133341,0.0280537602640792,0.058058463541737
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,39757,-0.0114893420868859,0.00606951100869385,-0.0233855836639259,0.000406899490154039,0.0583890333524658
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GUK1,Guanylate kinase,39575,0.00805239550184894,0.00426176203173486,-0.000300658080351388,0.0164054490840493,0.0588576006017011
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHPK,Sedoheptulokinase,39757,-0.00798858261204419,0.00423418267931517,-0.0162875806635019,0.000310415439413543,0.059228214622315
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FZD8,Frizzled-8,39586,-0.00859484004200904,0.00455937589841165,-0.0175312168028959,0.000341536718877789,0.0594438749878713
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRTN,Neurturin,41913,-0.00980893588357553,0.00520701760354704,-0.0200146903865277,0.000396818619376677,0.0596149481836498
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41900,-0.00546385759952162,0.00290111417952351,-0.0111500413913877,0.000222326192344462,0.059672688299089
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,39757,-0.00900014550124381,0.00478049705092634,-0.0183699197210594,0.000369628718571819,0.0597697641816607
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39586,-0.00902879806316033,0.00479731885173869,-0.0184315430125682,0.000373946886247497,0.059855521249832
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIF20B,Kinesin-like protein KIF20B,39586,0.0148794016212401,0.00791479140508008,-0.0006335895327169,0.030392392775197,0.0601415125938397
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLC,Galectin-10,42119,0.0133012014015763,0.00707740826729195,-0.000570518802315893,0.0271729216054685,0.0602129245560895
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39919,-0.0129585269961056,0.00690301406486848,-0.0264884345632478,0.000571380571036669,0.0605126343811067
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DRAXIN,Draxin,42016,-0.00838606571554086,0.00447161257401328,-0.0171504263606069,0.000378294929525172,0.060759309023682
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39979,0.00383388301122637,0.00204561948224226,-0.000175531173968463,0.0078432971964212,0.0609296126858384
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,39735,0.00995663013183468,0.00534184111736646,-0.000513378458203569,0.0204266387218729,0.0623627711412706
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",39958,-0.0151736165015586,0.00815180943044213,-0.0311511629852251,0.000803929982108013,0.0627163217447187
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MSLNL,Mesothelin-like protein,39649,0.00746281785114961,0.00400996304828257,-0.000396709723484226,0.0153223454257834,0.0627609759008927
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCG3,Secretogranin-3,42144,0.00650598438431341,0.00350176062052451,-0.000357466431914633,0.0133694352005415,0.0632023321318394
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LCP1,Plastin-2,39966,0.00939524337710737,0.00506148834317301,-0.000525273775511729,0.0193157605297265,0.063447856607754
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42145,0.00557129925898001,0.0030021510080712,-0.000312916716839548,0.0114555152347996,0.0635081731639684
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAMDC2,MAM domain-containing protein 2,39958,0.00697374895829925,0.00376207962046259,-0.000399927097807439,0.0143474250144059,0.0638086883587547
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CBLN1,Cerebellin-1,39586,0.0181472806061391,0.00980951580327289,-0.0010793703682758,0.0373739315805539,0.0643451401249968
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,41913,0.0070631535161187,0.00382387203054368,-0.000431635663746908,0.0145579426959843,0.0647518107319023
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,39743,0.010459504104699,0.00567555825289832,-0.000664590070981717,0.0215835982803797,0.0653696990013979
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HIP1,Huntingtin-interacting protein 1,39575,-0.00641515761629261,0.00348844835863152,-0.0132525163992104,0.000422201166625162,0.0659463564382226
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39966,0.0079268762951167,0.00431538840634624,-0.00053128498132194,0.0163850375715553,0.0662528306883244
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,39649,-0.0150234350474466,0.00818856101733538,-0.0310730146414239,0.00102614454653074,0.0665791568697318
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,39560,-0.0115444234316658,0.00629376232608911,-0.0238801975908004,0.000791350727468866,0.0666418677236104
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39757,-0.00720871358638496,0.00393600163056581,-0.0149232767822939,0.000505849609524016,0.0670553775338534
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEZ6,Seizure protein 6 homolog,39649,0.00606133945554907,0.00331134464679668,-0.000428896052172426,0.0125515749632706,0.0672055985817001
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42137,0.00683338414457685,0.0037334403464119,-0.000484158934390483,0.0141509272235442,0.0672243331435426
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL31,Interleukin-31,39657,0.0107650574359558,0.00588236309400196,-0.000764374228287996,0.0222944891001997,0.0672683818047051
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENO2,Gamma-enolase,42249,-0.0125405707247817,0.00685371895189167,-0.0259738598704894,0.000892718420925981,0.0673096005094749
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLHL41,Kelch-like protein 41,39934,-0.0101650924451601,0.00555649263946366,-0.0210558180185089,0.00072563312818864,0.0673647571930921
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39575,0.0127632910167337,0.00698537082022218,-0.000928035790901772,0.0264546178243692,0.0677049918715359
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39657,0.00660453682608388,0.00363378123285465,-0.000517674390311229,0.013726748042479,0.0691617712069307
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CBLN4,Cerebellin-4,42262,-0.00607149247766196,0.00334333396188858,-0.0126244270429636,0.000481442087639655,0.0693923724801971
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42016,0.0132931806697178,0.00732213751669787,-0.00105820886301008,0.0276445702024456,0.0694727762167868
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,41843,-0.0101879322423919,0.00561334686233469,-0.0211900920925679,0.000814227607784091,0.0695545243883929
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39736,0.00706458101015658,0.00389411625391372,-0.000567886847514318,0.0146970488678275,0.0696787675045782
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TEX33,Testis-expressed protein 33,39757,0.00740785389908128,0.00408571391053042,-0.000600145365558346,0.0154158531637209,0.0698415228983886
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HLA_A,,39934,-0.00628982053904707,0.00347677069469057,-0.0131042911006406,0.000524650022546441,0.0704621914889946
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DGKZ,Diacylglycerol kinase zeta,41913,-0.00685641766693409,0.00379465819750194,-0.0142939477340379,0.000581112400169707,0.0708066148149645
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42185,0.00827801930659211,0.00459600694239331,-0.000730154300498791,0.017286192913683,0.0717041026140706
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",41839,-0.00524880096986709,0.00292794710215631,-0.0109875772900935,0.000489975350359283,0.0730508210610266
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSR,"Glutathione reductase, mitochondrial",39949,-0.00434283094748872,0.00242836092325747,-0.00910241835707336,0.000416756462095918,0.0737414637524247
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,41843,0.00974881579593815,0.00546143627447203,-0.000955599302027023,0.0204532308939033,0.0742796821189986
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRD1,Bromodomain-containing protein 1,39757,-0.00573563391672377,0.0032231965524125,-0.0120530991594523,0.000581831326004727,0.0751872929249055
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHGB,Secretogranin-1,42210,-0.00790840965620837,0.00444914943888132,-0.0166287425564157,0.000811923243999011,0.0755066169450795
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AHNAK2,Protein AHNAK2,39638,-0.00585394676448415,0.00329767426551108,-0.0123173883248859,0.000609494795917563,0.075896654248462
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,39560,0.00879229174672373,0.00495331871208167,-0.000916212928956347,0.0185007964224038,0.0759206005683285
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FMR1,Synaptic functional regulator FMR1,41843,-0.00674426917142574,0.00380563955740296,-0.0142033227039355,0.000714784361084061,0.0763880684884692
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42230,-0.00416708667467123,0.00235530168268057,-0.00878347797272515,0.000449304623382687,0.0768767045250789
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,39586,0.0107365484951216,0.00608310242080043,-0.00118633224964728,0.0226594292398904,0.0775950615098995
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB2B,Ras-related protein Rab-2B,39919,-0.011643811492022,0.00660091861935294,-0.0245816119859537,0.00129398900190979,0.0777642801337867
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TTN,Titin,39575,-0.012921897742623,0.00733273384447013,-0.0272940560777845,0.00145026059253843,0.0780597944051149
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41843,-0.014535730585627,0.00825062034904376,-0.0307069464697527,0.00163548529849882,0.0781305146352989
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,39586,-0.0082789509655655,0.00471065250776219,-0.0175118298807794,0.000953927949648388,0.0788612233509328
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42070,-0.00431552525373747,0.00246660997642523,-0.00915008080753091,0.000519030300055972,0.0802140207563682
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,41843,-0.00847349115131955,0.00487131559518418,-0.0180212697178805,0.00107428741524144,0.0819759427480127
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,39560,-0.0154025887217683,0.00885769933744707,-0.0327636794231645,0.001958501979628,0.0820817169864087
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42119,-0.0166334933566758,0.00963095331260359,-0.0355101618493788,0.00224317513602725,0.084174898558169
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK1,Kallikrein-1,42016,0.0232097033896874,0.0134615554110263,-0.00317494521592405,0.0495943519952989,0.0847043046752564
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41843,-0.00853656908837522,0.00495289893884853,-0.0182442510085183,0.00117111283176789,0.084812447668419
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42119,-0.00777671750573997,0.00451415686618435,-0.0166244649634613,0.00107102995198136,0.0849584664184589
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,39958,-0.00548306286248958,0.00318341462703319,-0.0117225555314746,0.000756429806495468,0.0850271779377215
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCUN1D2,DCN1-like protein 2,39560,0.0145270952853766,0.00844198781706661,-0.00201920083607396,0.0310733914068271,0.0853127088350459
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YAP1,Transcriptional coactivator YAP1,39929,-0.00501000222911138,0.0029163332959009,-0.0107260154890771,0.000706011030854379,0.0858401019296221
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42119,0.00875546289211219,0.00509941110231159,-0.00123938286841852,0.0187503086526429,0.0860101737647149
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39649,0.0108190406086113,0.00630285010217561,-0.00153454559165291,0.0231726268088755,0.086092839902852
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPRR1B,Cornifin-B,39757,-0.015700993226894,0.009153037024979,-0.0336409457958528,0.00223895934206483,0.086302212732708
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42310,-0.00411490667950238,0.00240398436627784,-0.00882671603740694,0.000596902678402176,0.0869740760692049
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLPS,Colipase,42115,0.0132305387311234,0.00776151491082348,-0.00198203049409059,0.0284431079563374,0.0882857734230293
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,41960,-0.00544895604428497,0.0032031211966207,-0.0117270735896615,0.000829161501091601,0.0889400621038151
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,39906,-0.00687149038338947,0.00404833334130033,-0.0148062237323381,0.00106324296555918,0.0896556146707461
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39575,0.0150542401517176,0.00887149803894683,-0.00233389600461818,0.0324423763080534,0.0897397641572895
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MB,Myoglobin,42310,-0.010011376755673,0.00590190230169165,-0.0215791052669886,0.00155635175564263,0.0898524276197447
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39635,0.00699390318984645,0.00413252151623512,-0.00110583898197439,0.0150936453616673,0.0905968662750158
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLASP1,CLIP-associating protein 1,39560,-0.0134476123823489,0.00794837099422692,-0.0290264195310336,0.0021311947663359,0.0906991431423967
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NENF,Neudesin,39919,-0.0201013156006501,0.0118963608123157,-0.0434181827927888,0.00321555159148862,0.0911123428237935
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPLX2,Complexin-2,39560,0.00547019328779006,0.00324271082662466,-0.000885519932394267,0.0118259065079744,0.0916472208953455
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39934,-0.016552508053585,0.00981592721385005,-0.0357917253927311,0.00268670928556108,0.0917673188222998
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39736,0.0074325537585621,0.00442967183464139,-0.00124960303733502,0.0161147105544592,0.0933943579558316
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBP1,Retinol-binding protein 1,39649,-0.0124609604385962,0.00742798515422135,-0.02701981134087,0.00209789046367768,0.0934594787548949
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42310,0.00612523069699,0.00365584100907777,-0.00104021768080243,0.0132906790747824,0.0938659951692201
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,41936,0.00423057071343478,0.0025255470074447,-0.00071950142115683,0.00918064284802639,0.0939359668830577
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39966,-0.0111290377718396,0.0066593185314567,-0.0241813020934947,0.00192322654981558,0.0947101651472996
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PREB,Prolactin regulatory element-binding protein,41913,-0.00497956554736885,0.00297977114991947,-0.010819917001211,0.000860785906473315,0.0947207932809153
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39757,0.00614598062356082,0.00368373495614365,-0.00107413989048074,0.0133661011376024,0.0952624037400266
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRELP,Prolargin,42123,-0.00410220876013829,0.00246272223784524,-0.00892914434631496,0.00072472682603838,0.0957921099468595
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GNLY,Granulysin,42137,-0.00944850209065182,0.0056781279960375,-0.0205776329628853,0.00168062878158168,0.0961321571767452
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DEFB118,Beta-defensin 118,39586,-0.010024622931122,0.00603367905080968,-0.021850633870709,0.00180138800846496,0.096652737622698
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPB41L5,Band 4.1-like protein 5,39649,-0.0109183794118135,0.00657640749519134,-0.0238081381023885,0.00197137927876152,0.0968956382802065
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39757,-0.012152725226276,0.00732956837354928,-0.0265186792384326,0.00221322878588058,0.0973372935377303
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MKI67,Proliferation marker protein Ki-67,39657,-0.00707655834738135,0.00430646172957692,-0.0155172233373521,0.00136410664258941,0.100361327105998
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39575,-0.0116712069732415,0.00710630677270126,-0.025599568247736,0.00225715430125293,0.100541358313664
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39575,0.00544403393701194,0.00331654261300742,-0.00105638958448261,0.0119444574585065,0.100726745118336
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,39738,0.00912940367203977,0.00560078581932878,-0.00184813653384463,0.0201069438779242,0.103125140386101
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39575,0.0045355489381728,0.00278357508950573,-0.000920258237258428,0.00999135611360404,0.103257699532043
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRDT,Bromodomain testis-specific protein,39575,-0.0063041363564421,0.00387389182334569,-0.0138969643301997,0.00128869161731546,0.10369376454455
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42142,0.00652762736192387,0.00401844980887487,-0.00134853426347087,0.0144037889873186,0.104310688417305
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BGLAP,Osteocalcin,39966,-0.0144464181493435,0.00890015209373784,-0.0318907162530696,0.00299787995438269,0.104581803162068
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1R,Complement C1r subcomponent,39979,0.00321567138859169,0.00198642050008987,-0.000677712791584455,0.00710905556876784,0.105512177826486
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENSA,Alpha-endosulfine,39919,-0.00901101074485965,0.00561074934910718,-0.0200080794691097,0.00198605797939042,0.108296037266102
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPRING1,SREBP regulating gene protein,39560,-0.010525696929408,0.00656653864176929,-0.0233961126672758,0.00234471880845983,0.108979088973417
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MUC2,Mucin-2,39966,-0.0157028464567361,0.00980305973831162,-0.0349168435438269,0.00351115063035468,0.109220742071967
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41843,0.0059552415373969,0.00371939951316878,-0.00133478150841392,0.0132452645832077,0.109372016861422
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39657,-0.0075025281422299,0.00468925869755506,-0.0166934751894378,0.00168841890497801,0.109640673738388
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,41839,0.0143212804399183,0.00896204823791632,-0.00324433410639772,0.0318868949862343,0.110068645898133
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42262,0.0103323848283992,0.00647678388052709,-0.00236211157743389,0.0230268812342323,0.110669279370653
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41843,-0.00841353802092581,0.00527575820789194,-0.018754024108394,0.0019269480665424,0.11079105604582
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,39958,-0.00480257679147345,0.00301800528248121,-0.0107178671451366,0.00111271356218971,0.111568044142264
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42016,0.00857524167485961,0.00539307571036123,-0.00199518671744841,0.0191456700671676,0.111847864702548
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,39560,0.00511342478440424,0.0032212875513099,-0.00120029881616316,0.0114271483849716,0.112454233787525
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HLA_DRA,,42060,0.00607218634526818,0.00382570641103222,-0.00142619822035496,0.0135705709108913,0.112489356758613
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NXPH1,Neurexophilin-1,41839,-0.00649248012995306,0.0040919138183098,-0.0145126312138403,0.00152767095393415,0.112613322489796
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,39649,-0.00846685598945576,0.00534094746789602,-0.018935113026532,0.00200140104762044,0.112933101144875
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,39616,-0.00629366877764312,0.003970419510811,-0.0140756910188327,0.00148835346354643,0.112963347476946
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F2,Prothrombin,39979,0.00248785667548032,0.00157093916843139,-0.000591184094645193,0.00556689744560584,0.113295546472942
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,39922,-0.00335478884830787,0.00212126715270013,-0.00751247246760013,0.000802894770984395,0.113791169756755
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TREML1,Trem-like transcript 1 protein,39990,0.00885248337035555,0.00561442083943821,-0.00215178147494333,0.0198567482156544,0.114883074313932
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42137,-0.0195711829564952,0.0125019240455862,-0.0440749540858442,0.00493258817285379,0.117499945579811
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,39586,0.00486624237501375,0.00311439541763201,-0.00123797264354499,0.0109704573935725,0.118199084526999
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39575,0.00942996510226974,0.00607061163337365,-0.00246843369914261,0.0213283639036821,0.120361275071344
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VGF,Neurosecretory protein VGF,39934,-0.00496570579193767,0.00319779519857368,-0.0112333843811421,0.00130197279726675,0.120486183933537
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39575,0.00558534646905401,0.0036024933770198,-0.0014755405499048,0.0126462334880128,0.121071660030436
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42070,0.00423436344853114,0.00273370695208561,-0.00112370217755666,0.00959242907461893,0.121418282575839
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,39929,0.00619020329881721,0.00399638761997748,-0.00164271643633865,0.0140231230339731,0.121421751225329
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APPL2,DCC-interacting protein 13-beta,39736,-0.0185204577148152,0.011962519117981,-0.041966995186058,0.00492607975642746,0.121600845387663
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFIC,Nuclear factor 1 C-type,39934,-0.00748574846840405,0.00484602933215095,-0.0169839659594199,0.00201246902261182,0.122442421478481
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOSB,Protein fosB,41839,-0.00622452698249789,0.00405459775985763,-0.0141715385918189,0.00172248462682307,0.124764146345332
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42070,-0.00322200679345056,0.00209895978110215,-0.00733596796441077,0.000891954377509661,0.124795199237355
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42070,-0.0116853878656434,0.00762741405218191,-0.02663511940792,0.00326434367663312,0.125539786931651
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,41843,0.00775765318041436,0.00507239584948971,-0.00218424268458547,0.0176995490454142,0.126192568506335
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RGS8,Regulator of G-protein signaling 8,41913,0.0102642025636366,0.0067148809483016,-0.00289696409503458,0.0234253692223077,0.126393469171444
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,39657,-0.00488234575848568,0.00320210948958733,-0.0111584803580768,0.00139378884110548,0.127355573770724
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPB2,Carboxypeptidase B2,39959,0.00360163163579216,0.00237425910153988,-0.00105191620322601,0.00825517947481033,0.129307211673469
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39919,0.0121061316630584,0.00800136115253884,-0.00357653619591775,0.0277887995220345,0.130305284782746
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,39560,-0.00473597862951067,0.00313284553984548,-0.0108763558876078,0.00140439862858646,0.130634478231945
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,41839,0.00618056676491016,0.00409155025400319,-0.0018388717329361,0.0142000052627564,0.130922301082189
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CADPS,Calcium-dependent secretion activator 1,39649,0.00650372703959444,0.00431412417676633,-0.00195195634686756,0.0149594104260564,0.13170016015784
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFRA2,GDNF family receptor alpha-2,42070,-0.00329596653554187,0.00219896558267699,-0.00760593907758877,0.00101400600650503,0.13393044178557
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39966,-0.00584636862614569,0.00390183125268422,-0.0134939578814068,0.00180122062911538,0.134066133173419
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,39560,-0.00690494701258389,0.00461551634928954,-0.0159513590571914,0.00214146503202361,0.134674851915198
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPT1,Translationally-controlled tumor protein,41913,0.0100625127481881,0.00673248970998411,-0.00313316708338074,0.023258192579757,0.135037384335278
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",39934,0.00573691937636673,0.00383853410835178,-0.00178660747600276,0.0132604462287362,0.135057162304851
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDIA3,Protein disulfide-isomerase A3,39736,-0.00388461730479801,0.00260347167828893,-0.00898742179424431,0.00121818718464828,0.135703553320999
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOH,Beta-2-glycoprotein 1,42137,0.00574253469563649,0.00385138715626701,-0.00180618413064685,0.0132912535219198,0.13597685761402
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,39757,0.00662427557719178,0.00444709049186735,-0.00209202178686822,0.0153405729412518,0.136364241150303
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42070,-0.00382091649653433,0.00256622957936275,-0.00885072647208532,0.00120889347901667,0.136531236689534
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALCAM,CD166 antigen,42310,-0.00307752041063484,0.0020708087602679,-0.00713630558075992,0.000981264759490236,0.137263979757967
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,41913,-0.00869624426385983,0.00588915426154343,-0.020238986616485,0.0028464980887653,0.139792012822637
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,39911,-0.010912374156681,0.00742910271131281,-0.0254734154708541,0.00364866715749206,0.14189629885872
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCLRE1C,Protein artemis,39560,0.00471631833591324,0.00322042661199873,-0.00159571782360426,0.0110283544954307,0.143085763007622
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRYBB2,Beta-crystallin B2,39929,-0.0108054968391995,0.00739081178232025,-0.0252914879325472,0.00368049425414815,0.143764126717523
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,39649,-0.0126768702110956,0.00868458535352143,-0.0296986575039976,0.00434491708180637,0.144401574322731
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39934,-0.0107900047651777,0.00741493641719921,-0.0253232801428881,0.00374327061253278,0.145649460571319
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,41843,-0.006144499047423,0.00422949628253647,-0.0144343117611945,0.00214531366634849,0.146310415305932
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPM1A,Protein phosphatase 1A,41843,-0.00479374229273897,0.00330265261682067,-0.0112669414217075,0.00167945683622953,0.146669255125563
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,39586,0.005104998598798,0.00352074361135164,-0.00179565887945123,0.0120056560770472,0.147093373854421
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,39958,0.00427662029957333,0.00295940674170414,-0.00152381691416678,0.0100770575133134,0.148459131313545
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGA6,Integrin alpha-6,42119,-0.00772390932719853,0.00535562513376496,-0.0182209345893779,0.0027731159349808,0.149267717053316
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,39929,-0.0366679754690602,0.0254987991369376,-0.086645621777458,0.0133096708393375,0.150453860936785
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,39575,0.00544326950075599,0.00378652960906102,-0.00197832853300361,0.0128648675345156,0.150594495468188
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERC2,ERC protein 2,39649,-0.0111797549555928,0.00779703466594806,-0.026461942900851,0.00410243298966539,0.151644220231951
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39638,-0.00387965505970412,0.00270950377762991,-0.00919028246385874,0.00143097234445049,0.152209567491247
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,41843,0.00773588324983983,0.00540389985684653,-0.00285576046957938,0.018327526969259,0.152299934447666
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX5,Syntaxin-5,39657,-0.00601758707690166,0.00420886684968844,-0.014266966102291,0.00223179194848768,0.152819787062231
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP13,Collagenase 3,41839,0.00486006282262387,0.00340134665450525,-0.00180657662020642,0.0115267022654542,0.153066831462584
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,41843,-0.00713714854102006,0.00499664687362698,-0.0169305764133289,0.00265627933128881,0.153203903475516
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EBI3_IL27,Interleukin-27,42247,-0.00460544954308386,0.00322633847762506,-0.010929072959229,0.00171817387306126,0.153471975694605
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHGA,Chromogranin-A,39966,-0.0128105058907167,0.00898568449036428,-0.0304224474918307,0.00480143571039729,0.153994775064781
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42119,0.00852641630036527,0.00598551387619497,-0.00320519089697686,0.0202580234977074,0.154322365027913
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42117,-0.00499228440127272,0.00350979315435458,-0.0118714789838077,0.00188691018126227,0.154936989852304
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,39649,-0.0121287089440279,0.00856162677437601,-0.0289094974218049,0.00465207953374911,0.156617562051014
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39934,-0.0100988489379868,0.00713884223820155,-0.0240909797248618,0.00389328184888823,0.157203306049545
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAD1,Glutamate decarboxylase 1,39560,0.00392630913891104,0.00278586920713406,-0.00153399450707172,0.0093866127848938,0.158755366105083
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,39990,0.00394357132109106,0.00279995875705513,-0.00154434784273699,0.00943149048491912,0.159028390785797
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMMR,Hyaluronan mediated motility receptor,39541,-0.00720139346945823,0.00511421791729872,-0.0172252605873637,0.00282247364844725,0.159126214176717
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AFP,Alpha-fetoprotein,41976,0.00962023501380342,0.00685235134425856,-0.00381037362094336,0.0230508436485502,0.160362329671394
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39575,0.00541743313851003,0.00385898562735117,-0.00214617869109827,0.0129810449681183,0.160392112064728
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,41900,-0.00828312721586195,0.00591642859151061,-0.0198793272552227,0.00331307282349884,0.161530206737592
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42107,-0.00447621054048841,0.00320563525963493,-0.0107592556493729,0.00180683456839605,0.16263002821737
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,39586,-0.00645653231102183,0.00462683893042276,-0.0155251366146504,0.00261207199260678,0.162907740666752
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACTA2,"Actin, aortic smooth muscle",41900,-0.0063672095424185,0.00458890867999606,-0.0153614705552108,0.00262705147037377,0.165306040766552
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NLGN2,Neuroligin-2,39586,0.006866213334698,0.00495004420232666,-0.00283587330186226,0.0165682999712583,0.165438979392803
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PODXL2,Podocalyxin-like protein 2,42181,0.00414759616047921,0.0030081943925928,-0.00174846484900267,0.0100436571699611,0.167989619879794
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF16,Fibroblast growth factor 16,39657,-0.00677982966245904,0.00492067595742301,-0.0164243545390081,0.00286469521409005,0.168285252449744
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SYT1,Synaptotagmin-1,39929,0.00581977995335161,0.0042333701289456,-0.00247762549938176,0.014117185406085,0.169239496191594
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,39649,-0.0153314784362021,0.0111614474046375,-0.0372079153492915,0.00654495847688732,0.169590585035343
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STEAP4,Metalloreductase STEAP4,39586,-0.01058821798417,0.00770840357607409,-0.0256966889932752,0.00452025302493524,0.169595745231751
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,39649,-0.00533015547051964,0.00388132336075794,-0.0129375492576052,0.00227723831656592,0.169692244595532
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD82,CD82 antigen,39757,0.00602702667421806,0.0043900392184664,-0.00257745019397608,0.0146315035424122,0.169815149015269
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFP,Properdin,39979,-0.00342415516890923,0.00250157582735877,-0.00832724379053242,0.00147893345271397,0.171089048796058
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSP90B1,Endoplasmin,41774,0.0091590159420664,0.00669352637685273,-0.00396029575656495,0.0222783276406978,0.171229194948026
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLB,Beta-klotho,41839,0.0107669567565863,0.00787455055266098,-0.00466716232662919,0.0262010758398019,0.171551171010967
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPN1,Epsin-1,39757,-0.006262180027816,0.00458305156652673,-0.0152449610982084,0.00272060104257638,0.171847941933096
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFRA3,GDNF family receptor alpha-3,41989,-0.00398845776944664,0.00292535675866322,-0.00972215701642655,0.00174524147753326,0.172776566541683
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF9,Fibroblast growth factor 9,39539,0.00593378752018786,0.00435808941784726,-0.00260806773879277,0.0144756427791685,0.173365748361113
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",39575,-0.00557757748049923,0.00410522526080979,-0.0136238189916864,0.00246866403068796,0.174284428101223
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39638,0.00635312384257757,0.00467608748657255,-0.00281200763110463,0.0155182553162598,0.174288162545021
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL4,Interleukin-4,41913,0.0134668647254917,0.00991848197137468,-0.00597335993840265,0.0329070893893861,0.174564570973893
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTPN,Myotrophin,41900,0.00463559973525464,0.00341875922354419,-0.00206516834289197,0.0113363678134013,0.175144318463224
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IKZF2,Zinc finger protein Helios,41843,0.0126608984762807,0.00936368920102288,-0.00569193235772418,0.0310137293102855,0.176357730369041
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39657,-0.00400161290867394,0.00296145976925404,-0.00980607405641185,0.00180284823906398,0.176649454110621
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INHBB,Inhibin beta B chain,39736,0.00746836584171722,0.00553156346661998,-0.00337349855285795,0.0183102302362924,0.176999635907196
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGA2,Integrin alpha-2,39736,0.00493829705329733,0.00366640653105114,-0.0022478597475629,0.0121244538541576,0.178038611711483
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41839,-0.00696032783419015,0.00516926067313987,-0.0170920787535443,0.00317142308516398,0.178169463226114
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42145,-0.00248878780621951,0.00184898416345428,-0.0061127967665899,0.00113522115415088,0.178315429404762
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCARE,Photoreceptor cilium actin regulator,39586,0.0118548526866522,0.00881409181115613,-0.0054207672632138,0.0291304726365182,0.178656691714526
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,39586,0.00489408508124652,0.00365503747900015,-0.00226978837759377,0.0120579585400868,0.180599276695023
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB39B,Ras-related protein Rab-39B,39575,-0.0130661547580415,0.00977695038313838,-0.0322289775089928,0.00609666799290969,0.181438310584543
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39919,-0.00652698862196542,0.00488491058627073,-0.016101413371056,0.00304743612712522,0.181526084337036
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CYB5A,Cytochrome b5,39560,-0.0100581540501105,0.00753064539154222,-0.0248182190175333,0.00470191091731223,0.181698055073834
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAPPA,Pappalysin-1,41913,0.00664447904768174,0.00498497971270018,-0.00312608118921062,0.0164150392845741,0.182587459467414
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGB7,Integrin beta-7,42262,0.00646226650616964,0.00486014314068125,-0.0030636140495656,0.0159881470619049,0.183657363373045
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,41839,-0.00936919420737094,0.00704639626378514,-0.0231801308843898,0.00444174246964794,0.183658704106956
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FXN,"Frataxin, mitochondrial",42262,-0.0101681079161744,0.00765660837726953,-0.0251750603356227,0.00483884450327391,0.184194597749299
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEMA3G,Semaphorin-3G,39736,-0.00640246552793969,0.00482155491671435,-0.0158527131646998,0.00304778210882043,0.184243654779852
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPESP1,Sperm equatorial segment protein 1,39958,-0.00469418027155255,0.00354751885698095,-0.0116473172312352,0.00225895668813011,0.185785829541471
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCC,Netrin receptor DCC,39649,-0.00312381494162422,0.00236426161753214,-0.00775776771198721,0.00151013782873877,0.186440546629543
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,39757,0.00924864453240345,0.00700760310359017,-0.00448625755063328,0.0229835466154402,0.186928406302212
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39586,0.0085422337770882,0.00651488506904552,-0.00422694095824101,0.0213114085124174,0.189821936871367
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GBP6,Guanylate-binding protein 6,39575,0.00618852373884055,0.00473485395620319,-0.0030917900153177,0.0154688374929988,0.191235101527635
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,39560,0.00358498896324936,0.00275868815817221,-0.00182203982676817,0.0089920177532669,0.193790563962487
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRD2,Bromodomain-containing protein 2,39586,-0.00481851866803336,0.00370923412481469,-0.0120886175526701,0.00245158021660342,0.193950510488547
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PADI2,Protein-arginine deiminase type-2,41913,-0.00778109010180077,0.00599198441769586,-0.0195253795604847,0.00396319935688312,0.194109510638904
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39539,0.00737063180001413,0.00568732304626642,-0.00377652137066806,0.0185177849706963,0.195011239903093
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F11,Coagulation factor XI,39822,0.00428502682194536,0.00332213838584137,-0.00222636441430372,0.0107964180581944,0.197132812526284
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,41814,-0.00729841920098287,0.00567463260358894,-0.0184206991040172,0.00382386070205144,0.198413837577081
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF3,Fibroblast growth factor 3,39657,0.00400294791708276,0.00313425887499057,-0.00214019947789877,0.0101460953120643,0.201572825336178
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41839,-0.00922469833957603,0.00723634122543937,-0.0234079271414372,0.00495853046228514,0.202411682322014
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,39919,0.00825565828913484,0.00650276981407942,-0.00448977054646081,0.0210010871247305,0.204267405306084
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL7,Interleukin-7,42119,-0.0086077524144648,0.00679161088728941,-0.0219193097535521,0.00470380492462245,0.205030721707544
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ESPL1,Separin,39560,0.00712585518854031,0.00564581732918879,-0.00393994677666972,0.0181916571537503,0.206922511469248
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CYTH3,Cytohesin-3,39560,-0.00975263907702613,0.0077325034430918,-0.0249083458254861,0.00540306767143379,0.207244744004469
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CENPJ,Centromere protein J,39757,-0.0093682067554987,0.00744432284011391,-0.023959079522122,0.00522266601112457,0.208260311652799
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39638,-0.00368914853619502,0.0029321382027681,-0.00943613941362051,0.00205784234123046,0.208354402820301
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYOM1,Myomesin-1,39586,-0.00650421658273486,0.00518512598839361,-0.0166670635199863,0.00365863035451662,0.20972372240233
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRXN3,Neurexin-3,39649,-0.00475709663504276,0.00380325803803864,-0.0122114823895985,0.00269728911951297,0.211035717406301
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSC1,Hamartin,39657,0.00978877633273577,0.00783002890053365,-0.00555808031231018,0.0251356329777817,0.211268150629648
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGL1,Fibrinogen-like protein 1,39990,0.0085740229501391,0.00686667391748784,-0.00488465792813706,0.0220327038284153,0.211821414039735
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BEX3,Protein BEX3,39560,0.0061759135337135,0.00494816893919974,-0.003522497587118,0.015874324654545,0.212013414247491
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TJP3,Tight junction protein ZO-3,39586,0.00547028336138559,0.00440418804131814,-0.00316192519959798,0.0141024919223692,0.214239468192797
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRK1,Protein BRICK1,41839,0.00593263129867849,0.0047878821413421,-0.00345161769835202,0.015316880295709,0.215333021490089
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINB5,Serpin B5,41900,-0.00633895818723615,0.00512306258924663,-0.0163801608621596,0.00370224448768725,0.215983603274543
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42145,-0.0144158483622992,0.0116522582237281,-0.0372542744808063,0.0084225777562078,0.216044657955865
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LHB,Lutropin subunit beta,41843,0.0115145523923968,0.00932023124992718,-0.00675310085746049,0.0297822056422541,0.216690070606915
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39649,-0.00592064260123384,0.00480464175043761,-0.0153377404320916,0.00349645522962389,0.217872387868545
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,39757,0.00943101604071689,0.0076582732071467,-0.00557919944529064,0.0244412315267244,0.218169067822364
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,41913,-0.00448969017367139,0.00364692291986393,-0.0116376590966047,0.00265827874926191,0.218310970000508
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42178,-0.0063126709756351,0.00513639825413322,-0.0163800115537362,0.00375466960246602,0.21909036577322
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,39649,-0.00835709756950802,0.00681307495597819,-0.0217107244832253,0.00499652934420923,0.219989182270427
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCN1,Transcobalamin-1,39806,0.00462993478988737,0.0037757496715683,-0.0027705345663865,0.0120304041461612,0.220138173099683
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41839,-0.00675448362996255,0.00553080110059509,-0.0175948537871289,0.00408588652720383,0.222013619408825
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHIT1,Chitotriosidase-1,42207,-0.0201097113589041,0.0164681366156353,-0.0523872591255492,0.012167836407741,0.222058519164581
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39586,0.00630831352405293,0.00517282696067034,-0.00383042731886092,0.0164470543669668,0.222676913664993
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MDM1,Nuclear protein MDM1,39649,-0.00405440768697165,0.00332703735718422,-0.0105754009070527,0.00246658553310941,0.223012940687827
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,41976,-0.00379935471084401,0.00311971531300252,-0.00991399672432894,0.00231528730264093,0.223301314699405
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAPS,Calcyphosin,39929,0.0122189972405246,0.0100390066802112,-0.00745745585268934,0.0318954503337385,0.223571735534848
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39649,0.00990536140841669,0.00816483584902404,-0.00609771685567042,0.0259084396725038,0.225089478873594
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,41843,0.00725219865969475,0.00599279788920089,-0.00449368520313901,0.0189980825225285,0.226242024438993
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39575,-0.00518956416599434,0.00429256700996905,-0.0136029955055337,0.00322386717354499,0.226702256770638
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FSHB,Follitropin subunit beta,39638,0.00523985383486146,0.00434307648410633,-0.00327257607398694,0.0137522837437099,0.227656644548083
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,39990,-0.00334894540645627,0.00279602943420055,-0.00882916309748934,0.0021312722845768,0.23103912144866
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,39930,0.00554285890167164,0.00463314573330273,-0.0035381067356017,0.014623824538945,0.231585459423406
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39929,-0.00319929095032507,0.00267966737864866,-0.00845143901247645,0.0020528571118263,0.232536820343071
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,39649,-0.00969266239657825,0.0081575710701462,-0.0256815016940648,0.00629617690090829,0.234788059582744
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPP7,Dipeptidyl peptidase 2,42054,-0.00786675993708327,0.00662526613336162,-0.020852281558472,0.00511876168430549,0.235095667477919
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42293,-0.00751620955100829,0.00633201657774278,-0.0199269620433841,0.00489454294136757,0.235241617679323
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,39649,0.00452045289040731,0.00382840955738918,-0.00298322984207549,0.0120241356228901,0.237721417339176
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,39757,0.0102401158328536,0.00867476427704713,-0.00676242215015876,0.027242653815866,0.237846893921
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KCNIP4,Kv channel-interacting protein 4,41839,0.0063345968707546,0.00536854283370871,-0.00418774708331448,0.0168569408248237,0.23804243259153
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42262,0.00413043389688752,0.0035025182363034,-0.00273450184626715,0.0109953696400422,0.23830903193237
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GP5,Platelet glycoprotein V,39736,-0.00455601852493151,0.00387517402713536,-0.0121513596181168,0.00303932256825379,0.239742345404447
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39919,0.00548137819777226,0.00466488711381004,-0.00366180054529543,0.0146245569408399,0.240007783275396
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42137,-0.00442093627036543,0.0037653714945965,-0.0118010643997746,0.00295919185904372,0.240374181873018
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39657,-0.00555032573853945,0.00472962068486682,-0.0148203822808784,0.00371973080379952,0.240610816446896
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FADD,FAS-associated death domain protein,42145,-0.00940984178115612,0.00803751314676162,-0.0251633675488089,0.00634368398649665,0.241723715880009
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF7,Fibroblast growth factor 7,39560,0.00961408226275032,0.00822180672168749,-0.00650065891175716,0.0257288234372578,0.242292358390686
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39560,-0.00793370631153736,0.00679107206696446,-0.0212442075627877,0.00537679493971297,0.24272918911384
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLSPN,Claspin,41820,0.00436755853792733,0.00374458596674692,-0.00297182995689662,0.0117069470327513,0.243487454919366
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,39930,-0.00669783939769758,0.00576293418528097,-0.0179931904008483,0.00459751160545312,0.245167631833681
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39657,-0.00719362938920705,0.00620099095543952,-0.0193475716618685,0.00496031288345442,0.246042347701635
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBM19,Probable RNA-binding protein 19,39575,0.00588314781681739,0.00509230798590287,-0.00409777583555225,0.015864071469187,0.247992393710081
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLKB1,Plasma kallikrein,39759,-0.00298679702934274,0.00258587800073318,-0.00805511791077977,0.0020815238520943,0.248098065786804
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,41839,0.0073307983018842,0.0063650796223621,-0.00514475775794551,0.0198063543617139,0.249456380787548
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,39586,-0.0132266461357275,0.011504340482105,-0.0357751534806534,0.00932186120919836,0.250288689724207
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42119,0.00741292984429491,0.00644893160408817,-0.0052269760997179,0.0200528357883077,0.250377680715968
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OTOA,Otoancorin,39586,0.00639191062323065,0.00556372616618927,-0.00451299266250032,0.0172968139089616,0.250641084691018
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,39657,0.00502507077509741,0.0043772814541115,-0.00355440087496114,0.013604542425156,0.250997958550469
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,41992,-0.00405467921438684,0.00354602197213276,-0.011004882279767,0.00289552385099336,0.252874537056745
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,39638,0.00686728344366456,0.00600726777790861,-0.00490696140103631,0.0186415282883654,0.252995908398622
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42248,-0.00415333139695414,0.00364086684477003,-0.0112894304127034,0.00298276761879513,0.25399255562473
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42114,-0.00409285558805418,0.00359258715039291,-0.0111343264028243,0.00294861522671593,0.254619010909132
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPTX1,Neuronal pentraxin-1,42137,0.00499322601174874,0.00439508188331658,-0.00362113447955175,0.0136075865030492,0.255937351900541
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",39575,-0.00459002814211717,0.0040465908351325,-0.0125213461789769,0.00334128989474253,0.256695559471814
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZNF75D,Zinc finger protein 75D,39757,0.00733429073977217,0.00648022238352726,-0.00536694513194126,0.0200355266114856,0.257744471957652
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42016,-0.00550077180183506,0.00487127364549567,-0.0150484681470066,0.00404692454333646,0.25882244346443
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42247,-0.00803613332037208,0.00712452079581298,-0.0220001940801655,0.00592792743942135,0.259359081913217
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,39586,0.00666543088158089,0.00591532499463113,-0.00492860610789611,0.0182594678710579,0.259848610854922
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RUVBL1,RuvB-like 1,41843,-0.0116820367328007,0.0104255218614728,-0.0321160595812874,0.00875198611568607,0.26251128903838
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39586,0.0037232212644634,0.00333811042905766,-0.00281947517648962,0.0102659177054164,0.264717190669085
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A3,Protein S100-A3,39919,-0.00503977161400328,0.00451849552924318,-0.0138960228513199,0.00381647962331335,0.264717735308308
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,YY1,Transcriptional repressor protein YY1,39657,0.00328663838879536,0.0029515878855649,-0.00249847386691184,0.00907175064450256,0.265511369276535
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,41839,0.00634260911295301,0.0057002157393436,-0.00482981373616046,0.0175150319620665,0.265859077123709
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF3,Granulocyte colony-stimulating factor,41913,0.00560985048538439,0.0050439428296731,-0.00427627746077488,0.0154959784315437,0.266074188203182
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PAEP,Glycodelin,42016,0.0122318650373364,0.0110120204657123,-0.00935169507545969,0.0338154251501325,0.266685585780221
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TOP1,DNA topoisomerase 1,39930,-0.014171528774473,0.0127665747335162,-0.0391940152521647,0.0108509577032188,0.267001293122156
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK7,Kallikrein-7,39475,-0.00466084741440496,0.00420368638568194,-0.0129000727303416,0.00357837790153164,0.267561524354159
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,39990,-0.00860326283134697,0.00776493862651628,-0.0238225425393189,0.00661601687662493,0.267901295080925
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42179,-0.00671524858426155,0.00608643723125498,-0.0186446655575213,0.00521416838899821,0.269910582424903
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSLP,Thymic stromal lymphopoietin,41900,-0.00699022339700659,0.00633653073788065,-0.0194098236432527,0.00542937684923949,0.26997654193101
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINA7,Thyroxine-binding globulin,39979,-0.00213544625133086,0.00193931036264068,-0.0059364945621066,0.00166560205944488,0.270860359611171
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP6,Gastrotropin,41881,-0.00656624928789386,0.00597929239952268,-0.0182856623909583,0.00515316381517059,0.272152380278882
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EDNRB,Endothelin receptor type B,39657,-0.00508858518479474,0.00463719947848774,-0.0141774961626307,0.00400032579304123,0.272516621161708
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PCNA,Proliferating cell nuclear antigen,39560,0.00746068023144879,0.00682064481189331,-0.00590778359986209,0.0208291440627597,0.274050090284203
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COPE,Coatomer subunit epsilon,41839,0.00530091474413982,0.00489025329039439,-0.00428398170503318,0.0148858111933128,0.278395402918402
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,39560,0.00780539157722012,0.00721981912704431,-0.00634545391178673,0.021956237066227,0.279673641194682
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TP73,Tumor protein p73,39649,0.00391662153598341,0.00362424868023186,-0.00318690587727103,0.0110201489492378,0.279866940642387
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,39586,-0.00554897750079015,0.00513567540163199,-0.0156149012879889,0.00451694628640856,0.279953684914753
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,41913,-0.00740675808993832,0.00689575095519473,-0.02092242996212,0.00610891378224335,0.282795252904881
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINC1,Antithrombin-III,39959,-0.00163770141237003,0.00152827807107563,-0.00463312643167827,0.0013577236069382,0.283922902805941
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRYGD,Gamma-crystallin D,39929,-0.0110947217178412,0.0103619074117135,-0.0314040602447997,0.00921461680911724,0.284317279946164
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAPT,Microtubule-associated protein tau,41839,0.00594824760769478,0.00556967175062347,-0.00496830902352723,0.0168648042389168,0.285553090869394
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLAMF7,SLAM family member 7,42119,-0.00670117489875004,0.0062778404116443,-0.0190057421055729,0.00560339230807279,0.285795351402453
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KHDC3L,KH domain-containing protein 3,39560,0.00756189191212025,0.00709880075684368,-0.00635175757129337,0.0214755413955339,0.286793008482587
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMBN,Ameloblastin,41913,0.00305875741441426,0.00287491330421687,-0.00257607266185081,0.00869358749067934,0.287371687164508
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39657,-0.00557932065813148,0.00525575055182043,-0.0158805917396995,0.00472195042343656,0.288456410973794
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GZMB,Granzyme B,42119,-0.00757330485493752,0.00713446539257456,-0.0215568570243837,0.00641024731450863,0.288477249055059
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTO1,Protein LTO1 homolog,41913,0.00459994834261354,0.00434060756105287,-0.00390764247705008,0.0131075391622772,0.289278678220548
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42070,-0.003814258635533,0.00360619565374412,-0.0108824021168715,0.00325388484580548,0.290213037478525
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VWF,von Willebrand factor,42310,0.00819635602453605,0.00779076225122988,-0.00707353798787452,0.0234662500369466,0.292790170720681
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ECE1,Endothelin-converting enzyme 1,41839,0.00391210024016403,0.00372341965721518,-0.00338580228797772,0.0112100027683058,0.293427517270701
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FRMD7,FERM domain-containing protein 7,39649,0.00377294163247761,0.00359451702110979,-0.00327231172889758,0.0108181949938528,0.293907539749844
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,41843,-0.0051474697099581,0.00490579100516841,-0.0147628200800882,0.00446788066017198,0.29407579494464
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42185,-0.00319267357075072,0.00304667003624029,-0.0091641468417817,0.00277879970028025,0.294693035154096
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRIM26,Tripartite motif-containing protein 26,39560,-0.0063351988467944,0.00607411779906436,-0.0182404697329605,0.00557007203937174,0.296979381037027
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAP1A,Ras-related protein Rap-1A,39657,0.00762982837828004,0.00731801007586468,-0.00671347137041473,0.0219731281269748,0.297151884199713
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPGN,Epigen,39919,0.00509880734395056,0.00490182077123021,-0.00450876136766065,0.0147063760555618,0.298275522497653
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CORO6,Coronin-6,39586,-0.0042831165108469,0.0041342626893277,-0.0123862713819292,0.00382003836023538,0.300222647390295
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39919,-0.00529879435865451,0.00511671668321654,-0.0153275590577589,0.0047299703404499,0.300417979012732
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MUCL3,Mucin-like protein 3,39560,0.00465754446236756,0.00450799024490647,-0.00417811641764912,0.0134932053423842,0.301544636570192
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SDHB,Succinate dehydrogenase,39930,-0.00717057371744714,0.00694835537495865,-0.0207893502523661,0.00644820281747182,0.302102844575224
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DHODH,Dihydroorotate dehydrogenase,39575,-0.00507173909661209,0.0049196881085285,-0.0147143277893279,0.00457084959610377,0.302607323817515
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HRAS,GTPase Hras,39750,-0.0108208843444653,0.0104994105970692,-0.031399729114721,0.00975796042579029,0.302742221640435
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39934,-0.0053201708931902,0.00522015202805547,-0.0155516688681789,0.00491132708179852,0.308148698338316
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,39757,0.00294421413293576,0.00289742865197652,-0.00273474602493823,0.00862317429080974,0.309581310008752
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42145,-0.00492384749493852,0.00484987234638476,-0.0144295972938527,0.00458190230397562,0.31000337197222
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MANSC4,MANSC domain-containing protein 4,39575,0.00728327725716283,0.00719705616669198,-0.00682295282955345,0.0213895073438791,0.311569901909152
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42217,-0.00342402293537782,0.00338998415160681,-0.0100683918725272,0.00322034600177153,0.312493600854097
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39757,-0.00512884102857183,0.00508385903731956,-0.0150932047417182,0.00483552268457451,0.313069414586235
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39649,-0.00506729918416353,0.00502428585001207,-0.0149148994501872,0.00478030108186013,0.313207264673213
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39958,0.0036552367341541,0.00362592063630011,-0.00345156771299411,0.0107620411813023,0.313435062986801
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",39575,-0.00587049407207855,0.00584604975978599,-0.0173287516012591,0.005587763457102,0.315313354342895
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",39560,-0.00510767239457734,0.00509980694344589,-0.0151032940037313,0.0048879492145766,0.316586809889963
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC1A4,Neutral amino acid transporter A,39649,-0.00536956993797678,0.0053731082495539,-0.0159008621071024,0.00516172223114886,0.317651183891474
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZNF174,Zinc finger protein 174,39657,0.00387648266130026,0.00389129537998738,-0.00375045628347501,0.0115034216060755,0.319177999759293
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTNL10,Butyrophilin-like protein 10,39560,0.00420156509780236,0.00421894129701392,-0.00406755984434493,0.0124706900399496,0.319329767409991
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39575,0.00415827574517501,0.00418175783050441,-0.00403796960261363,0.0123545210929636,0.3200575670896
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,39649,-0.00384711857785805,0.00388220281654917,-0.0114562360982944,0.00376199894257832,0.321725445165652
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL13,Interleukin-13,41913,0.00505352486895511,0.00510701785479239,-0.00495623012643797,0.0150632798643482,0.322424038503949
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41839,-0.00783700442135378,0.00797561734448616,-0.0234692144165466,0.00779520557383908,0.32581224962586
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39586,0.00337264970692222,0.00343318296058125,-0.00335638889581704,0.0101016883096615,0.325940128303545
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42223,-0.00424193172707609,0.00432343397098841,-0.0127158623102134,0.00423199885606119,0.326536829198719
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,39934,0.0076748396699473,0.00787954837494942,-0.00776907514495356,0.0231187544848482,0.330067272335416
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RCC1,Regulator of chromosome condensation,39919,-0.00535889156662767,0.00551827004005732,-0.01617470084514,0.00545691771188467,0.331510254010727
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ECM1,Extracellular matrix protein 1,39720,0.00373876622867164,0.00385394499834779,-0.00381496596809003,0.0112924984254333,0.332010741396394
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,39757,-0.00539240560148668,0.00556331848018774,-0.0162965098226546,0.0055116986196813,0.332427210023691
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42016,-0.00411300081902213,0.00424487758650288,-0.0124329608885678,0.00420695925052351,0.332596221979284
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOLR3,Folate receptor gamma,42132,-0.0195381267677999,0.0202135666993098,-0.0591567174984471,0.0200804639628472,0.333768899233563
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,39586,0.00723645466118177,0.00749061404731287,-0.00744514887155145,0.021918058193915,0.334030610925135
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STX1B,Syntaxin-1B,39649,-0.00409748926734026,0.00424663305420156,-0.0124208900535753,0.0042259115188948,0.334626277199768
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK4,Kallikrein-4,42262,0.0063254345234561,0.00659493373039103,-0.00660063558811032,0.0192515046350225,0.337507502775663
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,39757,0.00773417982730695,0.00807947342639847,-0.00810158808843406,0.023569947743048,0.338455338826634
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DUSP29,Dual specificity phosphatase 29,39649,0.00674057984830507,0.00712252123833052,-0.00721956177882274,0.0207007214754329,0.343977774853932
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL36A,Interleukin-36 alpha,39657,0.00573511163151978,0.00607868029001819,-0.00617910173691587,0.0176493249999554,0.345456193446381
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYO6,Unconventional myosin-VI,39934,-0.00373840185343565,0.003964588167257,-0.0115089946612594,0.00403219095438808,0.345727423148194
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41662,0.0061608645219801,0.00657893036335775,-0.00673383899020108,0.0190555680341613,0.349056887720309
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,39575,0.00734656087391298,0.007913059774466,-0.00816303628404038,0.0228561580318663,0.353215544188695
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39657,0.00417925264963404,0.00451747283124969,-0.00467499409961535,0.0130334993988834,0.354918133141732
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39575,-0.00392648930806978,0.00425502033191401,-0.0122663291586212,0.00441335054248169,0.356137049683072
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39649,-0.0053272390114774,0.0057783248992074,-0.0166527558139239,0.0059982777909691,0.356582697564624
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RILPL2,RILP-like protein 2,39958,-0.00961616552329536,0.0104553181299112,-0.0301085890579213,0.0108762580113306,0.357728615461628
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,39649,0.00352239234839298,0.00383020985604318,-0.00398481896945165,0.0110296036662376,0.357783974013486
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CORO1A,Coronin-1A,41883,-0.00858116636403286,0.00933525056692665,-0.0268782574752091,0.00971592474714337,0.3579962326484
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39586,-0.00570145800292342,0.00622075009327649,-0.0178941281857453,0.0064912121798985,0.359412981522566
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,39919,-0.00503671680837576,0.00550424853543716,-0.0158250439378326,0.00575161032108108,0.360179707022384
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,39575,0.0102388087483486,0.0112198969226357,-0.0117521892200174,0.0322298067167145,0.361495000649345
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,F13B,Coagulation factor XIII B chain,39925,-0.00246628731117415,0.00270672709480106,-0.00777147241698423,0.00283889779463593,0.362225438371517
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENG,Endoglin,42310,0.00165555731320608,0.00181811826423598,-0.00190795448469645,0.00521906911110861,0.362528319121337
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PFDN4,Prefoldin subunit 4,39560,0.00507603908111251,0.00558343738243751,-0.00586749818846501,0.01601957635069,0.363304462569464
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FH,"Fumarate hydratase, mitochondrial",39586,-0.00791502519726981,0.00871335632897368,-0.0249932036020582,0.00916315320751859,0.363698228339349
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,39560,-0.0073961827680103,0.00816258382311371,-0.0233948470613132,0.00860248152529257,0.364898593433044
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TGFBR1,TGF-beta receptor type-1,39657,-0.00210644997763697,0.00232624244521043,-0.00666588517024942,0.00245298521497548,0.36521176704946
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAG,Myelin-associated glycoprotein,39649,0.00465564733703392,0.00514500598813253,-0.00542856439970584,0.0147398590737737,0.365545159492609
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AHCY,Adenosylhomocysteinase,42145,-0.00640403587861734,0.0070851418723412,-0.0202909139484061,0.00748284219117141,0.366081259395259
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,39575,0.00563180745460081,0.00623118787788433,-0.00658132078605248,0.0178449356952541,0.366116205228987
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39586,0.00546547979190663,0.00605092323140495,-0.00639432974164707,0.0173252893254603,0.366414488024976
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,39649,0.00400774217176186,0.00444366189578906,-0.0047018351439847,0.0127173194875084,0.367129231518871
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INSR,Insulin receptor,39657,0.00162975696251465,0.00181353876509422,-0.00192477901707002,0.00518429294209931,0.368852706888671
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",39575,0.00383539429960707,0.00427550812567192,-0.00454460162670989,0.012215390225924,0.369705707188309
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,39657,-0.00280417680850648,0.0031266889898114,-0.00893248722853682,0.00332413361152387,0.369817501493553
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,39560,0.00368947055893198,0.00413192714954129,-0.00440910665416894,0.0117880477720329,0.371920894881236
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GKN1,Gastrokine-1,41538,-0.00265456449308704,0.00298727186210219,-0.00850961734280734,0.00320048835663326,0.374221164846492
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,39657,0.00429281571775335,0.00485427950344414,-0.00522157210899716,0.0138072035445039,0.376533911236037
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,41920,-0.00267255073202321,0.00302438189153028,-0.00860033923942255,0.00325523777537614,0.376891187694161
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RELB,Transcription factor RelB,39657,-0.00438493530940358,0.00496364809979382,-0.0141136855849995,0.0053438149661923,0.377034111591837
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,39657,-0.00583278443823224,0.00662523485816623,-0.0188182447602381,0.00715267588377358,0.378667703397472
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,39586,-0.00486806930912722,0.00553260826984943,-0.0157119815180321,0.00597584289977766,0.378939850813141
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNAP25,Synaptosomal-associated protein 25,39586,-0.00448145978775166,0.00509802783738774,-0.0144735943490316,0.00551067477352831,0.379389306787634
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TUBB3,Tubulin beta-3 chain,39586,0.00265780383757883,0.00303085001573705,-0.0032826621932658,0.00859826986842346,0.380550908373255
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA11,Carbonic anhydrase-related protein 11,41843,-0.00281609536405793,0.00321495636127096,-0.009117409832149,0.00348521910403314,0.381080824762892
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CPA4,Carboxypeptidase A4,39518,0.00408717112079682,0.00466735640434275,-0.00506084743171498,0.0132351896733086,0.381216240980518
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFNB2,Ephrin-B2,39649,-0.005356709937437,0.00611830898156627,-0.0173485955413069,0.00663517566643288,0.381309348685503
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MARCO,Macrophage receptor MARCO,42145,-0.00238303785943247,0.00272217300675654,-0.00771849695267528,0.00295242123381034,0.38136230999503
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ABHD14B,Protein ABHD14B,41976,-0.00514242186593526,0.00587573941407087,-0.0166588711175142,0.00637402738564365,0.381483147546077
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39919,-0.00430110144438368,0.00498904522697442,-0.0140796300892535,0.00547742720048617,0.388645731008547
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42123,-0.00266937299663797,0.0030969552369381,-0.00873940526103664,0.0034006592677607,0.388738769499067
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39757,-0.00599136775946975,0.00696140086444241,-0.0196357134537769,0.00765297793483738,0.389446317525086
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL25,Interleukin-25,39510,0.00312653004062146,0.00363387361384399,-0.00399586224251275,0.0102489223237557,0.389595804753892
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LEG1,Protein LEG1 homolog,39398,0.00641501046548675,0.00746021147681414,-0.00820700402906896,0.0210370249600425,0.389865134695442
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDCL2,Phosducin-like protein 2,39560,-0.00474490979007756,0.00552411579486883,-0.0155721767480205,0.00608235716786535,0.390389830827378
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,39638,-0.00365261809574522,0.0042583955934183,-0.0119990734588451,0.00469383726735466,0.391051835658298
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPHS1,Nephrin,39657,0.00302152857528696,0.00352399803520638,-0.00388550757371754,0.00992856472429145,0.391234187153199
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,39560,-0.00472720589959085,0.00551376115057465,-0.0155341777547172,0.00607976595553547,0.391271955369869
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,39757,-0.00357669090019513,0.00417494346918009,-0.0117595800997881,0.00460619829939784,0.391626874802785
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,39894,0.00347218875826149,0.00405517038569009,-0.00447594519769109,0.0114203227142141,0.391884616329806
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TERF1,Telomeric repeat-binding factor 1,39657,0.00262866603183482,0.00307692994386546,-0.00340211665814149,0.00865944872181113,0.392949234099281
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHD,SH2 domain-containing adapter protein D,39554,-0.00745391152227858,0.00872969843306054,-0.0245641204510772,0.00965629740652008,0.393203063552104
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLINT1,Clathrin interactor 1,39560,0.00450248439275746,0.00528681108249831,-0.00585966532893923,0.0148646341144542,0.39442995527704
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL3,Interleukin-3,39560,0.00549143793389227,0.00647885073772599,-0.00720710951205068,0.0181899853798352,0.396682374420412
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENOPH1,Enolase-phosphatase E1,39919,0.00476573102377373,0.00564318812921401,-0.00629491770948572,0.0158263797570332,0.398402107025273
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39638,-0.00228764722345905,0.00271192835427852,-0.00760302679784494,0.00302773235092685,0.398939181819803
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41913,0.00477057461072549,0.00565967256996557,-0.00632238362640702,0.015863532847858,0.39929589953
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PXDNL,Peroxidasin-like protein,39919,0.00502766488693901,0.00605671436813421,-0.00684349527460404,0.0168988250484821,0.406501033776982
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCN,Decorin,41900,0.00200820431120761,0.00242046671940635,-0.00273591045882883,0.00675231908124406,0.406736612896727
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYOM2,Myomesin-2,39575,0.00486319439331502,0.00590235580769271,-0.0067054229897627,0.0164318117763927,0.409990848030899
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTC,Probetacellulin,41843,-0.00635716359181468,0.00772677925726836,-0.0215016509360607,0.00878732375243131,0.410668231467638
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42296,0.00318786889219893,0.00387537765827038,-0.00440787131801102,0.0107836091024089,0.410752281316169
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WNT9A,Protein Wnt-9a,41913,-0.0025159994086388,0.00306273216918815,-0.00851895446024758,0.00348695564296999,0.411382754108
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTF,Ciliary neurotrophic factor,39586,0.00300374713815898,0.00365880576579518,-0.00416751216279956,0.0101750064391175,0.411684693616105
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TP53BP1,TP53-binding protein 1,39657,-0.00745024113898636,0.00909948395875369,-0.0252852296981436,0.0103847474201709,0.412944284876574
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCP11,T-complex protein 11 homolog,39757,0.00500252503746303,0.00612786517165496,-0.00700809069898069,0.0170131407739068,0.414313466833306
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39575,-0.00416853703377202,0.00512243846604226,-0.0142085164272149,0.00587144235967081,0.415788754666879
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,39586,0.00356217422119143,0.0043788571552441,-0.005020385803087,0.0121447342454699,0.415952489100266
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCN3B,Sodium channel subunit beta-3,39586,0.00401043851695797,0.00493298236746894,-0.00565820692328115,0.0136790839571971,0.416244526184588
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39990,0.00316080167416765,0.00390597248644064,-0.004494904399256,0.0108165077475913,0.418403952831828
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CXCL3,C-X-C motif chemokine 3,42129,-0.00810258646120648,0.0100323514309986,-0.0277659952659637,0.0115608223435507,0.419308714628813
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MLLT1,Protein ENL,39560,0.00564853621983255,0.00701905270544878,-0.00810880708284705,0.0194058795225121,0.420985235303354
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,39586,0.00475424800833063,0.00591020900098712,-0.00682976163360412,0.0163382576502654,0.421175994686273
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39934,-0.00205527232142183,0.00255892596164102,-0.00707076720623824,0.00296022256339457,0.42188886345203
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA13,Carbonic anhydrase 13,41967,-0.00889550155623752,0.0111080845125613,-0.0306673472008576,0.0128763440883826,0.423253984882529
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42310,-0.00590271125319647,0.00737383595845078,-0.02035542973176,0.00855000722536706,0.423438524072406
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLC13A1,Solute carrier family 13 member 1,39919,-0.00507488161500019,0.00635677168178755,-0.0175341541113038,0.00738439088130341,0.424688454018691
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,39560,0.00213057521157973,0.00268818567330007,-0.0031382687080884,0.00739941913124786,0.428045571559062
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRTN3,Myeloblastin,41800,-0.004004937078568,0.0050581166505691,-0.0139188457136834,0.00590897155654744,0.428500717569804
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RBM25,RNA-binding protein 25,39560,0.00392035426885745,0.00495332841772012,-0.00578816942987398,0.0136288779675889,0.428693565860202
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EXTL1,Exostosin-like 1,39575,-0.00397797408427967,0.00504032430661111,-0.0138570097252374,0.0059010615566781,0.429994763820586
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39979,-0.00151979870667334,0.00193880144234585,-0.00531984953367121,0.00228025212032453,0.433123503374056
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMEM25,Transmembrane protein 25,39934,-0.00388012679349644,0.00496525630712851,-0.0136120291554683,0.00585177556847544,0.434550969164047
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SKIV2L,Helicase SKI2W,39575,-0.00326019884606692,0.0041908263519117,-0.0114742184958138,0.00495382080368,0.436622928713345
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,39575,0.00455042598758171,0.00586672350550241,-0.00694835208320302,0.0160492040583664,0.437982257873474
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,41843,-0.00317106773932068,0.00411384776370399,-0.0112342093561805,0.00489207387753915,0.440822828086827
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42082,0.00274280269509557,0.00355948216600385,-0.00423378235027198,0.00971938774046313,0.440979928607715
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FABP9,Fatty acid-binding protein 9,42119,0.00455941142648875,0.00592861880730911,-0.0070606814358371,0.0161795042888146,0.441876349831513
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMA1,Laminin subunit alpha-1,39575,0.00420852586462807,0.00547339286299947,-0.0065193241468509,0.014936375876107,0.441965525346112
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,39649,-0.00561123511606294,0.00730998983307367,-0.0199388151888873,0.00871634495676145,0.442734199201844
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,39586,-0.00406678623581958,0.00530155913442811,-0.0144578421392987,0.00632426966765952,0.443043006795618
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39560,-0.00420101112503487,0.0054896780327004,-0.0149607800691276,0.00655875781905791,0.444135372304088
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,41900,0.00274027894419765,0.00358586789180156,-0.00428802212373341,0.00976858001212871,0.444768485844422
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42145,0.00254792532491825,0.00333696925155415,-0.00399253440812789,0.00908838505796439,0.445151888757787
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL9,Interleukin-9,39757,0.00453693364778727,0.00594918329998437,-0.00712346562018209,0.0161973329157566,0.445709436921726
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,41900,0.00609498366552977,0.00799551661025098,-0.00957622889056215,0.0217661962216217,0.445894391221351
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEO1,Neogenin,39934,-0.00181398182338213,0.00239345838264182,-0.00650516025336008,0.00287719660659583,0.448531681641707
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF20,Fibroblast growth factor 20,39657,0.00344602492909441,0.00456702641651702,-0.00550534684727894,0.0123973967054678,0.450538369949479
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CALCB,Calcitonin gene-related peptide 2,39929,0.00323564412747067,0.00429319900612826,-0.00517902592454071,0.0116503141794821,0.451064625223283
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NME1,Nucleoside diphosphate kinase A,39657,0.00172307512727769,0.00232165377727899,-0.00282736627618913,0.0062735165307445,0.457996625738128
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39657,-0.00677097138966871,0.00914393489066364,-0.0246930837753694,0.011151140996032,0.459019840387683
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39575,-0.00370533598681814,0.005017227773309,-0.0135391024225038,0.00612843044886751,0.460212744720592
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42063,-0.00230538123789332,0.00312516174368032,-0.00843069825550674,0.0038199357797201,0.460719466328733
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MTR,Methionine synthase,39575,-0.00509708883261433,0.00691805422753078,-0.0186564751185747,0.008462297453346,0.461271471080216
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CST6,Cystatin-M,41864,-0.00384446137678543,0.00522969912861809,-0.0140946716688769,0.00640574891530602,0.462278835196666
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FZD10,Frizzled-10,39649,-0.00463743394517829,0.00630869992030663,-0.0170024857889793,0.0077276178986227,0.462303015594533
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPR15L,Protein GPR15L,39930,-0.00485204636217545,0.00660077349717732,-0.017789562416643,0.0080854696922921,0.462310621658666
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GHRL,Appetite-regulating hormone,42145,0.00643021750122244,0.00875090655730616,-0.0107215593510976,0.0235819943535425,0.462470453087687
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,39586,-0.00461886823664232,0.00630132867394709,-0.0169694724375786,0.00773173596429398,0.4635746187267
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPR101,Probable G-protein coupled receptor 101,39586,0.0045041674102931,0.00615287922457157,-0.00755547586986717,0.0165638106904534,0.464158410103476
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41619,-0.00294380917321333,0.00402221448673758,-0.010827349567219,0.00493973122079232,0.464250308940841
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCARF2,Scavenger receptor class F member 2,42249,0.00218265071649489,0.002994724707416,-0.00368700971004048,0.00805231114303025,0.46611703787098
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL5,Interleukin-5,41913,-0.0105001527643605,0.0145176349418832,-0.0389547172504515,0.0179544117217306,0.46952744881023
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AOC3,Membrane primary amine oxidase,42217,-0.00225092764801882,0.00312201318055854,-0.00837007348191354,0.00386821818587591,0.470930534905803
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39966,-0.0105596710081545,0.0146504152082157,-0.0392744848162572,0.0181551427999482,0.471062027572945
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42126,-0.0016849032719885,0.00233916484950916,-0.00626966637702646,0.00289985983304946,0.471352006806972
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GC,Vitamin D-binding protein,39979,-0.00196135375839664,0.00272848549440501,-0.00730918532743046,0.00338647781063717,0.472252181221794
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42087,0.00651664903173993,0.00908450087070493,-0.0112889726748417,0.0243222707383216,0.473178576269579
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,39736,-0.00397629869928785,0.0055550272857351,-0.0148641521793287,0.00691155478075295,0.47412873042496
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39336,-0.00392294135241859,0.00548440703641798,-0.0146723791437978,0.00682649643896064,0.474445438670375
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APOB,Apolipoprotein B-100,39990,0.0017278392605231,0.00241565803265271,-0.00300685048347621,0.00646252900452241,0.47445904692699
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP112,Centrosomal protein of 112 kDa,39575,0.0033566143667578,0.00470181243235151,-0.00585893800065116,0.0125721667341668,0.475305451994277
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39575,0.00464792302806622,0.00651770647803006,-0.0081267816688727,0.0174226277250051,0.475785130236488
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HK2,Hexokinase-2,41900,0.00204525950312091,0.00287216538869792,-0.00358418465872701,0.00767470366496883,0.476417386607955
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASQ2,Calsequestrin-2,39575,0.00356953717152335,0.00503907126688295,-0.00630704251156722,0.0134461168546139,0.478729297975775
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRR5,Proline-rich protein 5,39657,0.00350453111291725,0.00499306175777614,-0.00628186993232398,0.0132909321581585,0.482768660140763
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SSB,Lupus La protein,41839,-0.0043541798531939,0.00620626127008235,-0.0165184519425553,0.00781009223616751,0.482954357611894
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39424,-0.00802031020178559,0.0114851181985344,-0.0305311418709131,0.0144905214673419,0.484990873556913
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RGS10,Regulator of G-protein signaling 10,39934,-0.00437501754240049,0.00630856752189387,-0.0167398098853125,0.00798977480051149,0.488007455268619
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPSG1,Tryptase gamma,39657,0.00191912877506737,0.00277261394917384,-0.00351519456531335,0.0073534521154481,0.488843168420971
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDIA2,Protein disulfide-isomerase A2,39560,0.00291532223214034,0.00422802982215019,-0.00537161621927402,0.0112022606835547,0.490509036780272
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK10,Kallikrein-10,42138,-0.00296468840101209,0.00430573384244618,-0.0114039267322066,0.00547454993018242,0.491121895467231
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMY2A,Pancreatic alpha-amylase,41665,-0.00354449351363868,0.00514860823733958,-0.0136357656588243,0.00654677863154691,0.491189718925136
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BSND,Barttin,39560,-0.0024433163153186,0.00354977908305285,-0.00940088331810218,0.00451425068746498,0.491277851285604
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ACTN4,Alpha-actinin-4,41913,0.00227926936599573,0.00331526566202996,-0.004218651331583,0.00877719006357446,0.491775074815039
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MN1,Transcriptional activator MN1,39649,0.00427173595045732,0.006229528664701,-0.00793814023235664,0.0164816121332713,0.492901694655028
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39560,-0.00243224780653288,0.0035495022735776,-0.00938927226274498,0.00452477664967923,0.493209312535359
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMA1,Proteasome subunit alpha type-1,41843,-0.00332981048124392,0.00487717381355868,-0.0128890711558189,0.00622945019333108,0.494787130530591
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYL3,Myosin light chain 3,39638,-0.00566354033818212,0.008319806514794,-0.0219703611071784,0.0106432804308141,0.496056746824597
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA7,Carbonic anhydrase 7,39757,0.00239445443925794,0.00355517076387807,-0.00457368025794307,0.00936258913645896,0.500634805098822
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41843,-0.00891428491398796,0.0133027804311813,-0.0349877345591034,0.0171591647311274,0.502801333000941
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,39649,-0.00213166908078201,0.00318600110481229,-0.0083762312462141,0.00411289308465008,0.503462538419009
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZPR1,Zinc finger protein ZPR1,39586,0.00681635075092759,0.0102039811372819,-0.0131834522781449,0.0268161537800001,0.504141911042625
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNTN2,Contactin-2,42262,0.00309472639701462,0.00463716307277485,-0.00599411322562408,0.0121835660196533,0.504543945100079
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RALB,Ras-related protein Ral-B,39657,-0.00209216709338764,0.00313802908718541,-0.00824270410427105,0.00405836991749577,0.504968915179274
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,41913,0.00216000153418752,0.00324805669108882,-0.00420618958034656,0.0085261926487216,0.506053380770075
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EXOSC10,Exosome component 10,39575,0.00409403546136647,0.00617322187098985,-0.00800547940577364,0.0161935503285066,0.507221097637207
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,39757,-0.00288371527420071,0.00435082043619888,-0.0114113233291505,0.00564389278074909,0.507473598596639
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,39929,-0.00267974856170456,0.0040595994667232,-0.010636563516482,0.00527706639307292,0.509201979411734
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMOD4,Tropomodulin-4,39560,-0.00279547409615338,0.00423638321833831,-0.0110987852040965,0.00550783701178971,0.509349320497795
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RLN1,Prorelaxin H1,39934,-0.00309180136011582,0.00469531304946342,-0.0122946149370641,0.00611101221683249,0.510238793466332
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1B,Interleukin-1 beta,41825,-0.00390103639000456,0.00592839228493704,-0.0155206852684812,0.00771861248847204,0.51053286408705
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL21R,Interleukin-21 receptor,39657,-0.00376830694332997,0.00572925268628957,-0.0149976422084575,0.00746102832179759,0.510724708421467
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,39657,0.00295930890888654,0.00450115011019721,-0.00586294530709999,0.0117815631248731,0.510901330573333
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,39657,-0.00252454697888897,0.0038412975566044,-0.0100534901898336,0.00500439623205565,0.511058268572123
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DNM1,Dynamin-1,39930,-0.00799701720149206,0.0122480613383466,-0.0320032174246514,0.0160091830216673,0.513820418491345
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,39919,-0.00237065846853372,0.0036661423417537,-0.00955629745837097,0.00481498052130352,0.517880867469088
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39638,-0.00247514658085202,0.00383153926451122,-0.00998496353929402,0.00503467037758998,0.518297480997697
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP152,Centrosomal protein of 152 kDa,39560,0.00285760046368142,0.00444861556158815,-0.00586168603703135,0.0115768869643942,0.520654685272353
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,H2AP,Huntingtin-interacting protein M,39560,0.00341393738748393,0.00532967982834358,-0.00703223507606949,0.0138601098510374,0.521827147381505
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,39560,-0.00377219877777469,0.00594080645352246,-0.0154161794266787,0.00787178187112934,0.525465089091053
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39757,0.00459073347001662,0.00723089112150863,-0.0095818131281403,0.0187632800681735,0.525521025412508
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HGFAC,Hepatocyte growth factor activator,39897,0.00181926932726909,0.0028667833507923,-0.00379962604028381,0.00743816469482198,0.525700219134923
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD14,Monocyte differentiation antigen CD14,41932,-0.00274759583713161,0.00434303804145458,-0.0112599503983826,0.00576475872411937,0.52697716568301
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRTG,Protogenin,42262,-0.00163606234381908,0.00258845864649994,-0.00670944129095897,0.00343731660332081,0.527357952225732
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39958,-0.00351115873319463,0.00555674059330564,-0.0144023702960737,0.00738005282968442,0.52748206944721
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39575,-0.00437536261667989,0.00692841531368866,-0.0179550566315097,0.00920433139814988,0.527720353724513
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPR158,Probable G-protein coupled receptor 158,39934,0.00231458084551837,0.00367365479747551,-0.00488578255753363,0.00951494424857038,0.528675527289117
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LAMA4,Laminin subunit alpha-4,42185,-0.0022440532049387,0.00359863216561883,-0.00929737224955161,0.0048092658396742,0.532910603388516
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39575,0.00326158479247403,0.00524064559508471,-0.007010080573892,0.0135332501588401,0.533716023510692
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MORN4,MORN repeat-containing protein 4,39560,-0.00512530121957019,0.00828004864211509,-0.0213541965581158,0.0111035941189754,0.535933113930355
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OSTN,Osteocrin,39649,-0.0026403044235514,0.00427925967774219,-0.0110276533919261,0.00574704454482329,0.537247253914788
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNL2,Interferon lambda-2,39586,-0.0038153319579481,0.0061982005780675,-0.0159638050909604,0.0083331411750642,0.538201159259297
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL33,Interleukin-33,41913,-0.00255008246834991,0.00414545559448514,-0.0106751754335408,0.00557501049684096,0.538465309275501
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39575,-0.00405351722257084,0.00665661437141892,-0.0171004813905519,0.00899344694541025,0.542572982999138
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN7,Septin-7,39757,0.00343006765405575,0.0056373256323138,-0.0076190905852793,0.0144792258933908,0.542897107902621
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SULT1A1,Sulfotransferase 1A1,42249,-0.00821666877073531,0.0135329813279133,-0.0347413121734453,0.0183079746319747,0.543755627815354
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLSTN1,Calsyntenin-1,41839,0.00324340339541258,0.00534225310122536,-0.00722741268298913,0.0137142194738143,0.543779865163826
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39638,-0.00201528029857227,0.00333199893377714,-0.00854599820877546,0.00451543761163093,0.545306907068241
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39649,-0.00357947116710482,0.00594156673935898,-0.0152249419762484,0.00806599964203878,0.546889879518487
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,39560,-0.00583116508664837,0.00968292674491689,-0.0248097015066855,0.0131473713333887,0.547046146358581
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PZP,Pregnancy zone protein,39979,0.00210945818704376,0.00350622515105994,-0.00476274310903372,0.00898165948312124,0.547430931080856
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,39638,0.00150381704199941,0.00249997958170901,-0.00339614293815024,0.00640377702214906,0.547498238443304
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,39575,0.00249187642985715,0.00414723414887387,-0.00563670250193563,0.0106204553616499,0.547950573045151
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LMNB1,Lamin-B1,39908,0.00388212751703889,0.00646506736215844,-0.00878940451279166,0.0165536595468694,0.548200082468042
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",39934,-0.00263706826281894,0.00441239936726323,-0.0112853710226549,0.00601123449701699,0.550085770255065
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DUOX2,Dual oxidase 2,41900,0.00440116889331116,0.0073954368581313,-0.0100938873486262,0.0188962251352485,0.551773701013141
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMY2B,Alpha-amylase 2B,41300,-0.0031277217739878,0.00527042855292706,-0.0134577617377248,0.00720231818974923,0.55289238760196
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,39919,-0.00223416251653647,0.0037657948782838,-0.00961512047797273,0.00514679544489978,0.553007104416413
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CAPN3,Calpain-3,39919,0.00244627036485624,0.00412961444426881,-0.00564777394591064,0.0105403146756231,0.553612955971649
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HBZ,Hemoglobin subunit zeta,39958,-0.0066769702260118,0.0113584537323829,-0.0289395395414823,0.0155855990894587,0.556650387459749
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39575,-0.00297085151417892,0.00507138664967898,-0.0129107693475497,0.00696906631919187,0.55801756776437
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,APCS,Serum amyloid P-component,39870,-0.0020159899219902,0.00344195197675631,-0.00876221579643256,0.00473023595245217,0.558081315203771
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39560,0.00363802093893264,0.00621886274115767,-0.0085509500337364,0.0158269919116017,0.558561247872017
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDC25A,M-phase inducer phosphatase 1,39560,0.00247875213494369,0.00423759781478132,-0.00582693958202769,0.0107844438519151,0.558598251247021
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LTB,Lymphotoxin-beta,39919,-0.0021288207455917,0.00364204315717383,-0.00926722533365241,0.00500958384246901,0.558887023757003
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGM2,Phosphoglucomutase-2,39649,0.00372600889706389,0.00641959408903451,-0.00885639551744376,0.0163084133115715,0.561648708794254
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCN2B,Sodium channel subunit beta-2,39649,0.00172901616672743,0.00298344690377856,-0.00411853976467854,0.00757657209813341,0.562239088804499
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NCLN,Nicalin,41913,0.00311845667897328,0.00538180782911382,-0.0074298866660898,0.0136668000240364,0.56229937386287
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MSMB,Beta-microseminoprotein,42103,-0.00423412716258991,0.00734744457732417,-0.0186351185341453,0.0101668642089655,0.564440896990133
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39638,0.00466574603255063,0.0081055518911841,-0.0112211356741702,0.0205526277392715,0.564881437496032
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENPEP,Glutamyl aminopeptidase,39575,0.00258641173332174,0.00449391739597222,-0.0062216663627838,0.0113944898294273,0.564940576575943
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42249,-0.00423890086823336,0.00738722277733477,-0.0187178575118095,0.0102400557753428,0.566102302734996
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL28,C-C motif chemokine 28,42075,-0.00353324985364622,0.00619828174143122,-0.0156818820668514,0.00861538235955896,0.56866211495276
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RASA1,Ras GTPase-activating protein 1,41839,0.00195661532134917,0.00343627072818393,-0.00477847530589133,0.00869170594858967,0.569093830538603
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",39638,-0.00528595470007724,0.0093157903135591,-0.0235449037146531,0.0129729943144986,0.57044120951935
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGFL4,Insulin growth factor-like family member 4,39657,0.00428877730006846,0.00756416092520242,-0.0105369781133283,0.0191145327134652,0.570734847823926
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL11,Interleukin-11,41913,0.00359280438258438,0.00640234193286832,-0.00895578580583752,0.0161413945710063,0.574690867264342
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39560,-0.00157630443247201,0.00282146320223906,-0.00710637230886057,0.00395376344391655,0.57638927785684
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SFRP1,Secreted frizzled-related protein 1,41968,-0.00251620889445345,0.004522666059038,-0.0113806343701679,0.00634821658126102,0.577977353548016
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42145,0.00165792728420747,0.00298386748315087,-0.00419045298276823,0.00750630755118316,0.578472767498854
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD177,CD177 antigen,42123,0.00749813524616834,0.0135520985090443,-0.0190639778315586,0.0340602483238952,0.580079315674945
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPTN,Neuroplastin,41843,-0.00455833654904987,0.00824959643838091,-0.0207275455682765,0.0116108724701767,0.580579083753441
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,39966,0.001565051599424,0.00285469255412481,-0.00403014580666062,0.00716024900550862,0.583539100594999
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39930,-0.00601283144382774,0.0110092849073694,-0.0275910298622718,0.0155653669746163,0.584966688084092
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,VIT,Vitrin,39958,-0.00221546091996077,0.00406621689156608,-0.0101852460274303,0.00575432418750875,0.585870319790768
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENAH,Protein enabled homolog,41913,-0.00274580795655021,0.005063657030351,-0.0126705757360382,0.00717895982293774,0.587649939354622
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,41900,-0.00271785288790515,0.0050320162941942,-0.0125806048245258,0.00714489904871548,0.589128769925063
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,39586,0.00285263515886833,0.00529294223381344,-0.00752153161940602,0.0132268019371427,0.589931762367212
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,39560,-0.00177121035126847,0.00330064488506966,-0.00824047432600501,0.00469805362346807,0.591537189124656
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42310,0.000901422387278582,0.00169764070682184,-0.00242595339809223,0.0042287981726494,0.595437515213907
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,STAM,Signal transducing adapter molecule 1,39919,0.00203147307096228,0.00382882617600603,-0.00547302623400954,0.0095359723759341,0.59572488703447
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP290,Centrosomal protein of 290 kDa,39757,-0.00297661900601796,0.00561895848352734,-0.0139897776337315,0.00803653962169562,0.596298809815752
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,39586,0.00210063513195503,0.00396562748674353,-0.00567199474206229,0.00987326500597234,0.596323263778355
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,39919,-0.00300252321608242,0.00568594773757238,-0.0141469807817243,0.00814193434955945,0.597467842408396
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39757,-0.00353803958146136,0.00670912355676895,-0.0166879217527285,0.00961184258980578,0.597962775119592
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,S100A16,Protein S100-A16,41814,-0.00338095982462268,0.00641722953213205,-0.0159587297076015,0.00919681005835613,0.59830200828317
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP350,Centrosome-associated protein 350,39560,0.00203471995055595,0.00386720310633882,-0.00554499813786813,0.00961443803898003,0.598796247370055
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOS,Proto-oncogene c-Fos,39539,0.00200637039547767,0.00381844858188899,-0.00547778882502475,0.0094905296159801,0.599287134316835
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39649,-0.00574380039961445,0.0109710450810987,-0.0272470487585679,0.015759447959339,0.600607788818982
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,39586,0.00335671078637019,0.00641507828570976,-0.00921684265362093,0.0159302642263613,0.60080855844752
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,39586,0.00399478228193165,0.00766214249904063,-0.011023017016188,0.0190125815800513,0.602122187165622
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ISM2,Isthmin-2,39966,0.00236467857602599,0.00458751509602674,-0.00662685101218641,0.0113562081642384,0.606241937354925
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MAGEA3,Melanoma-associated antigen 3,39757,-0.00468852631502162,0.0091295916234325,-0.0225825258969493,0.0132054732669061,0.607574934731077
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,39757,-0.00242551117229906,0.00472660238206439,-0.0116896518411453,0.00683862949654715,0.607848396143158
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN7,Tetraspanin-7,39586,-0.00527068798146314,0.0103303934921387,-0.025518259226055,0.0149768832631287,0.609913382385888
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPC1,Glypican-1,42262,-0.00155531243002212,0.00311360757110275,-0.0076579832693835,0.00454735840933927,0.617420426340054
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN3,Neuronal-specific septin-3,39934,0.00409568498243352,0.00829750078582385,-0.0121674165577812,0.0203587865226483,0.621594979657256
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,39575,0.00179397432436537,0.00364223078875696,-0.00534479802159828,0.00893274667032901,0.622341689275956
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39730,0.00323242783636213,0.00656767642585003,-0.00964021795830393,0.0161050736310282,0.622607313915152
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK6,Kallikrein-6,42158,-0.00159326167239114,0.00325224677961237,-0.00796766536043138,0.0047811420156491,0.624215641386868
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39586,-0.00320403992968523,0.00654928730900468,-0.0160406430553344,0.00963256319596395,0.624695978688838
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IMPA1,Inositol monophosphatase 1,42016,0.00313949610505934,0.00642829049213715,-0.00945995325952948,0.0157389454696482,0.625283444444488
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CES2,Cocaine esterase,42070,-0.00286318687344295,0.0058629508070568,-0.0143545704552743,0.00862819670838837,0.625308107486721
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42122,-0.00302111555785483,0.00619992165452055,-0.0151729620007151,0.00913073088500545,0.626065791371049
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL17F,Interleukin-17F,41913,0.00372056693375108,0.00771270512808284,-0.0113963351172913,0.0188374689847935,0.629533621686518
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TBR1,T-box brain protein 1,39649,0.00242988170198197,0.00507388863814871,-0.00751494002878949,0.0123747034327534,0.632019748017509
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAT1,Diamine acetyltransferase 1,39575,0.0024499643760362,0.00512241557671272,-0.00758997015432074,0.0124898989063931,0.632458309109952
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,39586,-0.00579736687399237,0.012442924390024,-0.0301854986784394,0.0185907649304546,0.641284329067118
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42081,-0.00129773997506795,0.00280999541612267,-0.00680533099066838,0.00420985104053248,0.644210740749978
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,39575,0.00208688268367371,0.00452054379048799,-0.00677338314568275,0.0109471485130302,0.64434566388265
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL36G,Interleukin-36 gamma,39624,-0.00327778931948414,0.00710762670671863,-0.0172087376646527,0.0106531590256844,0.644689262965914
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EPHA10,Ephrin type-A receptor 10,41839,0.0031852956126242,0.00693144185495209,-0.0104003304230819,0.0167709216483303,0.645851823435288
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39560,0.00396283232858676,0.00863339425787987,-0.0129586204168578,0.0208842850740313,0.646234587970545
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNPY2,Protein canopy homolog 2,41900,0.00293549892024914,0.00640728424991385,-0.009622778209582,0.0154937760500803,0.646851980167203
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41843,-0.00596650420109699,0.0130388478370693,-0.0315226459617527,0.0195896375595588,0.647251349826037
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,39657,-0.00196461391181538,0.0043164117381475,-0.0104247809185845,0.00649555309495372,0.649010413917568
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39575,0.00222558774312385,0.00490886331492539,-0.00739578435412991,0.0118469598403776,0.650283029434377
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39575,0.00242381554667918,0.00534970931279135,-0.00806161470639187,0.0129092457997502,0.650504231759836
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42070,0.00178806346401675,0.003961394087764,-0.0059762689480007,0.00955239587603419,0.651728528251005
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RRP15,RRP15-like protein,39586,0.00433715458990561,0.00965648198260018,-0.0145895500959908,0.023263859275802,0.653336368946447
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM171B,Protein FAM171B,39919,0.00125488713697405,0.00281064520128941,-0.0042539774575532,0.0067637517315013,0.655261598394883
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42296,-0.0030897119829033,0.00695064525004015,-0.016712976672982,0.0105335527071754,0.656672536027678
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,39575,0.00476065465984673,0.0107170633777085,-0.016244789560462,0.0257660988801555,0.656897636907548
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ESR1,Estrogen receptor,39657,0.00266799041822748,0.0060481212134015,-0.00918632716003945,0.0145223079964944,0.659129580998188
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39586,0.00303264954162824,0.00688288634573217,-0.0104578076960068,0.0165231067792633,0.65950603133595
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,39575,-0.00231970928562107,0.00527175013047022,-0.0126523395413427,0.00801292097010057,0.659926644338396
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,39575,-0.00152324766015249,0.00347357171874801,-0.00833144822889858,0.0052849529085936,0.661014462030408
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,39560,-0.0029210382897307,0.00671786125084607,-0.016088046341389,0.0102459697619276,0.66370403984544
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRC1,Protein regulator of cytokinesis 1,39919,-0.00201232593813142,0.00466853907356254,-0.011162662522314,0.00713801064605116,0.666447672576916
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39930,-0.00778722536845519,0.0182155949950807,-0.0434897915588134,0.027915340821903,0.669020970606591
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SUMF1,Formylglycine-generating enzyme,39657,0.00298391302042523,0.00699159649305109,-0.0107196161059549,0.0166874421468054,0.669543772226639
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39919,0.00266805393394309,0.0062772034498628,-0.009635264827788,0.0149713726956742,0.670816596318083
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,39657,-0.00470382537144156,0.0110735480020613,-0.0264079794554817,0.0170003287125986,0.671005083664207
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,39757,-0.00290595962882915,0.00692042832534946,-0.0164699991465141,0.0106580798888558,0.674559016630653
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARTN,Artemin,41913,-0.00199131395826781,0.00475055437336362,-0.0113024005300605,0.00731977261352488,0.675094953889873
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MUC16,Mucin-16,42070,-0.00837934735706872,0.0201099055045562,-0.0477947621459988,0.0310360674318614,0.676920873201634
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DKKL1,Dickkopf-like protein 1,42070,-0.00367385568302037,0.00882287261819873,-0.0209666860146899,0.0136189746486491,0.677123007317499
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PFDN6,Prefoldin subunit 6,39649,0.00283960057690995,0.00685866881746675,-0.0106033903053249,0.0162825914591448,0.678870217513471
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39575,0.00295683958946463,0.0072258265185807,-0.0112057803869535,0.0171194595658828,0.682397693083688
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,METAP1,Methionine aminopeptidase 1,41839,-0.00124529169319569,0.00306088375164089,-0.00724462384641183,0.00475404046002044,0.684131663602121
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41900,0.00134282335536979,0.00331350458151732,-0.00515164562440416,0.00783729233514374,0.685294589934838
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHH,Sonic hedgehog protein,39657,-0.00182719880504436,0.00451437733254192,-0.0106753783768265,0.00702098076673781,0.685668368925388
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GM2A,Ganglioside GM2 activator,39733,0.00164181665485843,0.00407181429814457,-0.00633893936950494,0.00962257267922179,0.686797799464073
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MEP1B,Meprin A subunit beta,42145,0.00484906827212199,0.0120766395710618,-0.0188211452871591,0.0285192818314031,0.688040240455452
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LMOD2,Leiomodin-2,39586,-0.00259594137376321,0.00651116739781783,-0.0153578294734861,0.0101659467259597,0.690128927978089
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,41900,-0.00144851161599181,0.0036397148098146,-0.00858235264322842,0.0056853294112448,0.690655788555183
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKCQ,Protein kinase C theta type,41913,-0.00178237865633975,0.00449483603153829,-0.0105922572781548,0.0070274999654753,0.691713655712178
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PGR,Progesterone receptor,39657,0.00419415076933051,0.0106050434156702,-0.0165917343253831,0.0249800358640441,0.692491563645602
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,41843,-0.0021703744198092,0.00553498859263306,-0.01301895206137,0.0086782032217516,0.694976569094083
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK15,Kallikrein-15,39900,0.00218087522233288,0.00556562030940211,-0.00872774058409526,0.013089491028761,0.695178176689351
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PITHD1,PITH domain-containing protein 1,39539,0.00318610788897961,0.00816862178817144,-0.0128243908158364,0.0191966065937956,0.696512875089795
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PYDC1,Pyrin domain-containing protein 1,39638,-0.0016967280674033,0.00436702348346226,-0.0102560940949893,0.00686263796018272,0.697629922352246
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAGE2A,G antigen 2A,39560,0.00268414476501881,0.00691425771160301,-0.0108678003497231,0.0162360898797607,0.697872370795049
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARG2,"Arginase-2, mitochondrial",39919,0.00171980795593654,0.00446398500558897,-0.00702960265501784,0.0104692185668909,0.700049860440442
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,39990,0.00116280959547448,0.00302021464474245,-0.00475681110822072,0.00708243029916967,0.700237991566847
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ROBO4,Roundabout homolog 4,39638,-0.000740757943642798,0.00193154148668917,-0.00452657925755358,0.00304506337026798,0.701351933844083
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD109,CD109 antigen,42137,-0.00137259207929427,0.00359128470171558,-0.00841151009465681,0.00566632593606827,0.70231838839461
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,41839,-0.00342203400869556,0.00905327937665244,-0.0211664615869343,0.0143223935695432,0.705445318691284
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,39736,0.00145500844005352,0.00395396853555732,-0.00629476988963882,0.00920478676974586,0.712890030918843
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RPA2,Replication protein A 32 kDa subunit,39657,0.00118399193054293,0.00327646079867734,-0.00523787123486465,0.00760585509595051,0.717834956254773
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RGMA,Repulsive guidance molecule A,42249,0.00121416505887324,0.00338667181507116,-0.00542371169866623,0.00785204181641271,0.719965165490848
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NOS2,"Nitric oxide synthase, inducible",39575,0.00152832031958097,0.00426914142221758,-0.00683919686796549,0.00989583750712743,0.72035586195266
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41701,0.00317930805544253,0.00889513939875451,-0.0142551651661163,0.0206137812770014,0.7207825468442
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH23,Cadherin-23,39929,-0.00100248175676209,0.00282827937178682,-0.00654590932546427,0.00454094581194008,0.723008760588052
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39757,-0.00256802523161659,0.0073066759250428,-0.0168891100447005,0.0117530595814673,0.725247766345544
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PVALB,Parvalbumin alpha,42208,0.00411961395953445,0.0117785375592326,-0.0189663196565615,0.0272055475756304,0.726527249535246
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MYH7B,Myosin-7B,39560,-0.00158680887303489,0.00453744667535491,-0.0104802043567305,0.00730658661066073,0.726560024484304
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HDAC8,Histone deacetylase 8,39657,0.0022121691952213,0.00637127245674474,-0.0102755248199984,0.014699863210441,0.728440204016214
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,39575,-0.00171348614574195,0.00493668137102851,-0.0113893816329578,0.00796240934147393,0.728528320572177
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,39930,0.00607867477957117,0.0175764572434818,-0.0283711814176533,0.0405285309767956,0.729467980630155
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CASP8,Caspase-8,42224,-0.00221087265188227,0.00643959434801107,-0.014832477573984,0.0104107322702194,0.731359398652525
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EP300,Histone acetyltransferase p300,39657,0.00111840804771972,0.00325826980634215,-0.0052678007727109,0.00750461686815033,0.731415316816352
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SAG,S-arrestin,39586,-0.00189635973035752,0.00553659542854279,-0.0127480867703014,0.00895536730958636,0.731970895816096
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,41992,0.0014599819770324,0.00426497766205322,-0.00689937424059191,0.00981933819465671,0.732116371244693
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TET2,Methylcytosine dioxygenase TET2,39750,-0.00363816772219737,0.0106441221379803,-0.0245006471126387,0.0172243116682439,0.732507372061707
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF6,Fibroblast growth factor 6,39657,0.00140692122556228,0.00413470952954272,-0.00669710945234146,0.00951095190346602,0.733659013013432
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLI2,Zinc finger protein GLI2,39657,0.00119357389898527,0.00351234124282949,-0.00569061493696052,0.00807776273493107,0.733996374954459
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,39657,-0.00211432624041004,0.0062256755678992,-0.0143166503534925,0.0100879978726724,0.734153725409445
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SERPINF2,Alpha-2-antiplasmin,39786,0.000477473014929249,0.00141331815427036,-0.00229263056744066,0.00324757659729915,0.73549137884842
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANXA4,Annexin A4,42088,-0.00255935715101184,0.00762832396108905,-0.0175108721147464,0.0123921578127227,0.737247778100724
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,39649,0.00126504842685135,0.00379070791597148,-0.00616473908845275,0.00869483594215545,0.738594525243512
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",41839,0.00145875241347985,0.0043940404263327,-0.00715356682213224,0.0100710716490919,0.739906373319186
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,39757,-0.00281366086258626,0.00848288628593181,-0.0194401179830126,0.0138127962578401,0.740132047590487
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GH2,Growth hormone variant,41843,0.0056189300581382,0.0170763788814828,-0.0278507725495681,0.0390886326658445,0.742125419076348
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,39560,0.00191134746180078,0.00582267150482142,-0.00950108868764921,0.0133237836112508,0.742721705001887
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PFDN2,Prefoldin subunit 2,41839,0.00188699480262627,0.00581681812208042,-0.00951396871665137,0.0132879583219039,0.745637871811885
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39560,-0.00184506629140937,0.00570473301329375,-0.0130263429974651,0.00933621041464637,0.746377841712885
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,39586,-0.00103482168663757,0.00320925733371555,-0.00732496606072004,0.0052553226874449,0.747118735037405
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CREG1,Protein CREG1,41960,0.00136921082498176,0.00425412376953986,-0.00696887176331636,0.00970729341327989,0.747567613100202
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,39575,-0.00165660628780931,0.00517179429231461,-0.0117933231007459,0.00848011052512733,0.748735211811726
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRR4,Proline-rich protein 4,39652,0.00237280382596471,0.00752331000381064,-0.0123728837815042,0.0171184914334336,0.752468780383583
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TLR4,Toll-like receptor 4,39657,0.000936821666956295,0.00300405391563702,-0.00495112400769225,0.00682476734160485,0.755158517272922
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39919,-0.00293287043510831,0.00944062442042014,-0.0214364942991318,0.0155707534289152,0.756061120367186
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,39930,0.00080225331468913,0.00260396884235739,-0.00430152561633135,0.00590603224570961,0.75802052075436
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRX,Cone-rod homeobox protein,41900,0.0034783136681543,0.0113152565062691,-0.0186995890841332,0.0256562164204418,0.758543484458406
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41839,-0.00144005191846067,0.00473028971754728,-0.0107114197648533,0.00783131592793199,0.760803518645909
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CA8,Carbonic anhydrase-related protein,39657,-0.000847456435928669,0.00281907303370099,-0.00637283958198262,0.00467792671012528,0.763713528554068
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42123,0.000742995221550213,0.00247420205128016,-0.0041064407989589,0.00559243124205932,0.763955308859563
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NECTIN1,Nectin-1,39657,-0.00104395201190667,0.00349238517030311,-0.00788902694570077,0.00580112292188743,0.765004904768852
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,39560,0.00105460316586899,0.0035361016641346,-0.00587615609583481,0.0079853624275728,0.765526466992878
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SOX9,Transcription factor SOX-9,39649,0.000870474103041568,0.00292275688423007,-0.00485812939004937,0.00659907759613251,0.765841278889173
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GBP2,Guanylate-binding protein 2,41913,-0.00189477346908241,0.00637363145195984,-0.0143870911149237,0.0105975441767589,0.766254955070869
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCARB1,Scavenger receptor class B member 1,41839,0.0017238694402754,0.00585674968940446,-0.00975535995095734,0.0132030988315081,0.768503541839363
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,39930,0.00174690025121026,0.00596708722342387,-0.00994859070670054,0.013442391209121,0.769714066417087
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39757,-0.00171694243655505,0.00587401893860941,-0.0132300195562295,0.00979613468311939,0.770067027787604
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39736,-0.001978278918269,0.00676915092900688,-0.0152458147391225,0.0112892569025845,0.770101543787405
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMIGO1,Amphoterin-induced protein 1,39649,-0.0015465992425811,0.00536492769031963,-0.0120618575156076,0.00896865903044537,0.773138124041907
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DLL4,Delta-like protein 4,39638,-0.00269113143065522,0.00933685634471342,-0.0209913698662935,0.0156091070049831,0.77317861238646
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,39649,0.00111278358497597,0.00386715904211985,-0.00646684813757894,0.00869241530753089,0.773541813654186
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42070,-0.00159208125223739,0.00560238294620472,-0.0125727518267986,0.00938858932232387,0.776277347714895
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GSAP,Gamma-secretase-activating protein,41843,-0.00251946688357235,0.00887495190144282,-0.0199143726104003,0.0148754388432556,0.776502849691678
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DENND2B,DENN domain-containing protein 2B,39575,-0.00147154270890675,0.00518893498419411,-0.0116418552779272,0.00869876986011371,0.776728084226136
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTSH,Pro-cathepsin H,41865,0.00221667708949726,0.00785319677626847,-0.0131755885919889,0.0176089427709835,0.7777452613072
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39757,0.00152357610857448,0.00546257918557888,-0.00918307909516013,0.0122302313123091,0.78031791870781
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK12,Kallikrein-12,41843,-0.0039159054125499,0.014053850393448,-0.031461452183708,0.0236296413586082,0.780528710152181
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41839,-0.000876537125569024,0.0031835255635124,-0.00711624723005332,0.00536317297891527,0.783062905055765
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BLMH,Bleomycin hydrolase,42310,-0.000883875772351287,0.0032514635377474,-0.00725674430633618,0.00548899276163361,0.785749631507745
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,39586,0.00215634352778238,0.00801918820530641,-0.0135612653546182,0.0178739524101829,0.788013239136245
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DBH,Dopamine beta-hydroxylase,39978,0.00323143484789219,0.0120781380294155,-0.0204417156897622,0.0269045853855466,0.789055095903902
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41839,0.00141545533029441,0.00536866403773613,-0.0091071261836684,0.0119380368442572,0.792052717215553
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IFNGR1,Interferon gamma receptor 1,42185,0.000599833654817357,0.00227588949708121,-0.00386090975946182,0.00506057706909653,0.792122907550834
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41913,0.000966966602411373,0.00387403417892114,-0.00662614038827406,0.00856007359309681,0.802899018017886
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TLR2,Toll-like receptor 2,39757,0.000607979951704179,0.00245236145792418,-0.00419864850582722,0.00541460840923558,0.804203865117242
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,39638,0.00693600756603535,0.0282241623004996,-0.0483833505429439,0.0622553656750146,0.805882536489839
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,39586,-0.00184099454752354,0.00750775244100847,-0.0165561893319001,0.0128742002368531,0.806296498765771
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FRZB,Secreted frizzled-related protein 3,41973,0.000631139583066864,0.00259503393683631,-0.0044551269331323,0.00571740609926603,0.807846039096609
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL26,C-C motif chemokine 26,42119,-0.00222508149944183,0.00944413168055691,-0.0207355795933334,0.0162854165944497,0.8137430204925
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPM1B,Protein phosphatase 1B,39657,0.00153718127919612,0.00652794541018232,-0.0112575917247612,0.0143319542831535,0.813842856288977
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39638,0.00176991264871089,0.0075578124829582,-0.0130433998178872,0.016583225115309,0.814847106702342
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENO1,Alpha-enolase,42119,0.0019086305948644,0.00828644782593127,-0.0143328071439609,0.0181500683336897,0.817837610412214
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEPTIN9,Septin-9,42070,0.000685817401529555,0.0030291941693992,-0.00525140317049288,0.00662303797355199,0.820891750064486
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ALMS1,Alstrom syndrome protein 1,39757,-0.00105496008490606,0.00470480784364701,-0.0102763834584542,0.00816646328864207,0.822582277972876
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,41913,-0.00103909185885815,0.00465974637021586,-0.0101721947444812,0.00809401102676494,0.8235442025445
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,39757,-0.00144964302960821,0.00650465567207786,-0.0141987681468808,0.0112994820876644,0.823646697906897
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD33,Myeloid cell surface antigen CD33,42181,0.00185210423304388,0.00836669494181142,-0.0145466178529065,0.0182508263189943,0.824810564757725
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,39649,-0.00163504508345655,0.0073894771059286,-0.0161184202110766,0.0128483300441635,0.824888879473795
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,39586,0.00214219658343614,0.00973365051603482,-0.0169357584279921,0.0212201515948644,0.825811757511389
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,39649,-0.000940415963251904,0.00427868398406952,-0.00932663657202817,0.00744580464552436,0.826038038376909
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39575,-0.000987906557144201,0.00451245976673111,-0.00983232769993717,0.00785651458564877,0.826709728241486
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,39657,0.00125279507427745,0.00573308896103307,-0.00998405928934736,0.0124896494379023,0.827027945503681
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,39575,0.00160735415929611,0.00735876954568716,-0.0128158341502507,0.0160305424688429,0.827100470083358
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,39757,-0.000966074630124879,0.00446903540033624,-0.00972538401478391,0.00779323475453415,0.828858622743237
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,HDAC9,Histone deacetylase 9,39586,-0.00152601014288457,0.00706484057139845,-0.0153730976628255,0.0123210773770564,0.828991252471885
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1A,Interleukin-1 alpha,41913,0.00130417482760743,0.00608157472710077,-0.0106157116375101,0.0132240612927249,0.830201858282756
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,39892,-0.00102375264755969,0.00480815278803712,-0.0104477321121124,0.00840022681699306,0.831393083225329
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,39586,0.00123943877394513,0.0058280146679157,-0.0101834699751696,0.0126623475230599,0.831588997082114
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42119,-0.000743527129909957,0.00351789466740705,-0.00763860067802778,0.00615154641820787,0.832612899121303
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EGFLAM,Pikachurin,39930,-0.000686010371927553,0.00327175227950129,-0.00709864483975008,0.00572662409589498,0.833923745971629
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,39638,0.000858363872220171,0.00409859739895562,-0.00717488702973284,0.00889161477417318,0.834117465103859
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42166,-0.0019743436198411,0.00945434552156269,-0.020504860842104,0.0165561736024218,0.834584693706311
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,UNG,Uracil-DNA glycosylase,39919,-0.000778183345440592,0.00372835676897202,-0.00808576261262575,0.00652939592174456,0.834670431055416
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,39575,-0.000713601852413798,0.00345632501918491,-0.00748799889001623,0.00606079518518863,0.836433405536739
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39575,0.00111089909628002,0.00538321777011481,-0.009440207733145,0.0116620059257051,0.836510889753488
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,39586,0.000876507018481339,0.00426539725107865,-0.00748367159363281,0.00923668563059548,0.837191187669373
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42119,0.000779466338392342,0.00385848915952703,-0.00678317241428063,0.00834210509106532,0.839909323670517
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH22,Cadherin-22,39757,0.000589673517752542,0.0029206236164405,-0.00513474877047084,0.00631409580597592,0.839998687563818
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TEF,Thyrotroph embryonic factor,39575,0.000912374222941829,0.00453547881194084,-0.00797716424846222,0.00980191269434588,0.840574212025559
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,41802,0.000613425845518269,0.00307158465866076,-0.00540688008545683,0.00663373177649336,0.841710551450907
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITGAX,Integrin alpha-X,39757,0.00108945994244034,0.0054717950413057,-0.00963525833851883,0.0118141782233995,0.842184496892413
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39649,-0.000657371308862002,0.00331842314835895,-0.00716148067964554,0.00584673806192154,0.842972430087918
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,39575,0.000719984576352411,0.00374657771564747,-0.00662330774631663,0.00806327689902145,0.847611609554722
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42249,0.000941053201039525,0.0049166130471694,-0.0086955083714125,0.0105776147734916,0.848212921812949
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GPC5,Glypican-5,42016,-0.00113052322244167,0.00592288856587887,-0.0127393848115643,0.0104783383666809,0.84862749114876
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39649,-0.000839978662183167,0.00442028637063968,-0.00950373994863694,0.0078237826242706,0.849290594577018
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CLSTN3,Calsyntenin-3,39929,0.00060424786933129,0.00319802416765365,-0.00566387949926987,0.00687237523793245,0.850139996315096
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39657,-0.00124038462715283,0.00659234248168956,-0.0141613758912644,0.0116806066369587,0.850758311364209
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C5,Complement C5,39979,0.000297167218676745,0.00158753353108511,-0.00281439850225008,0.00340873293960357,0.851516574396068
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH6,Cadherin-6,42145,-0.000755032858902307,0.00410100739768656,-0.00879300735836796,0.00728294164056335,0.853930608916577
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ICOSLG,ICOS ligand,42070,-0.000370253049727707,0.00201421685029266,-0.00431811807630133,0.00357761197684592,0.854157546281903
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SCIN,Adseverin,39586,-0.00143458361446068,0.00781351540855919,-0.0167490738152367,0.0138799065863153,0.854328423887837
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BTLA,B- and T-lymphocyte attenuator,39560,0.00166232947850965,0.00906496586955159,-0.0161050036258115,0.0194296625828308,0.854503602596803
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,39657,0.000476342501898286,0.00259837325474138,-0.00461646907739482,0.00556915408119139,0.85454767183847
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,39934,0.000650722384205836,0.00359971291633821,-0.00640471493181705,0.00770615970022872,0.856550846547058
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NRN1,Neuritin,39934,0.000664125875743111,0.00368453135019905,-0.00655755557064703,0.00788580732213325,0.856961851744055
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TAP1,Antigen peptide transporter 1,39757,-0.00110662264417208,0.00618137871012425,-0.0132221249160156,0.0110088796276714,0.857921154635443
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMEM132A,Transmembrane protein 132A,39638,-0.00118340730907119,0.00664488380278676,-0.0142073795625332,0.0118405649443909,0.858653205392925
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP1B4,Protein ATP1B4,39560,-0.000781416380686136,0.00443071366071839,-0.00946561515569419,0.00790278239432192,0.860011598887597
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CEP164,Centrosomal protein of 164 kDa,41913,-0.0011306713695084,0.00654091718958434,-0.0139508690610937,0.0116895263220769,0.862763089104589
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42016,0.000524420577632673,0.00303517753899212,-0.00542452739879188,0.00647336855405722,0.862826290693276
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KLK13,Kallikrein-13,41839,-0.000815538339973171,0.00472740089718196,-0.0100812440984498,0.00845016741850348,0.86303684101306
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39934,-0.000676014231036129,0.00402589514939568,-0.00856676872385167,0.00721474026177941,0.866651963693002
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,39560,0.000856898115527928,0.00517176749919035,-0.00927976618288516,0.010993562413941,0.868405804520226
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39560,-0.000946847077612563,0.00573103266046563,-0.0121796710921252,0.0102859769369001,0.868778559324968
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FAM171A2,Protein FAM171A2,39934,0.00269211398310082,0.0165476709910877,-0.029741321159431,0.0351255491256326,0.870766687471914
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39586,-0.000872089414250939,0.00568109000250382,-0.0120070258191584,0.0102628469906566,0.878000966396592
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TAGLN3,Transgelin-3,39560,0.000958455250278699,0.00634908752059304,-0.0114857562900837,0.0134026667906411,0.880010420747382
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,C1RL,Complement C1r subcomponent-like protein,39958,-0.000311365152323315,0.00208337505703528,-0.00439478026411246,0.00377204995946583,0.881199414946918
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PLXDC1,Plexin domain-containing protein 1,41843,-0.000504763210195018,0.00339322898912358,-0.00715549202887724,0.0061459656084872,0.881748427140778
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SEMA6C,Semaphorin-6C,39657,0.000402800448837844,0.00273089782672834,-0.00494975929154971,0.0057553601892254,0.882742086518727
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RAB6B,Ras-related protein Rab-6B,41839,-0.000722012794341805,0.00499280515706961,-0.0105079109021982,0.00906388531351463,0.885020490140013
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39649,0.000825377982957114,0.00572134282913578,-0.010388453962149,0.0120392099280632,0.885295438898057
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,EFHD1,EF-hand domain-containing protein D1,39934,0.000536847236400926,0.00381407525092819,-0.00693874025541834,0.00801243472822019,0.888066601149817
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,41900,-0.000837089105275992,0.00613744355065948,-0.0128664784645686,0.0111923002540166,0.891514633450369
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF12,Fibroblast growth factor 12,39657,-0.000653281676345484,0.00479750902882611,-0.0100563993728447,0.00874983602015368,0.891688566977764
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,39586,0.0010839164530049,0.00803813200970238,-0.0146708222860118,0.0168386551920216,0.89273546577435
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39560,-0.000610317486476615,0.00465449477355254,-0.0097331272426396,0.00851249226968637,0.895679365220518
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AFAP1,Actin filament-associated protein 1,39736,-0.00115637674630877,0.00885495187363921,-0.0185120824186416,0.0161993289260241,0.896101246023238
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PSCA,Prostate stem cell antigen,39930,0.00356250699395094,0.0275001277344767,-0.0503377433656235,0.0574627573535253,0.896928634868421
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCL24,C-C motif chemokine 24,42166,-0.00112081603310119,0.00866505421271887,-0.0181043222900302,0.0158626902238278,0.897083424145193
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEDD9,Enhancer of filamentation 1,39657,0.000462477493872902,0.00358307329312344,-0.00656034616064903,0.00748530114839484,0.897302349787793
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,39966,-0.000410548254345522,0.00319797746135288,-0.00667858407859716,0.00585748756990612,0.897852531571226
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CTNNA1,Catenin alpha-1,39586,0.000458221481275454,0.00358100620239245,-0.00656055067541375,0.00747699363796466,0.898183870182849
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,39757,-0.000726741715733856,0.00569751864828529,-0.011893878266373,0.0104403948349053,0.898504176506051
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,39657,-0.000581417882477379,0.00477917857096848,-0.00994860788157561,0.00878577211662085,0.903173318294671
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42224,0.000443807042392268,0.00371599520015897,-0.00683954354991931,0.00772715763470384,0.904935232973857
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL24,Interleukin-24,41913,-0.000602041035903883,0.00506772018079034,-0.0105347725902529,0.00933069051844517,0.905436245442365
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NTF4,Neurotrophin-4,41843,-0.000466902672517412,0.00398916187098803,-0.00828565993965395,0.00735185459461913,0.906827912423631
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,JUN,Transcription factor AP-1,41913,-0.000589429183328289,0.0050737902985865,-0.0105340581685578,0.00935519980190124,0.907518476682799
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42272,0.000577111254744043,0.00501947302665102,-0.00926105587749196,0.01041527838698,0.908467045622163
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,FGF5,Fibroblast growth factor 5,41913,0.000408328834515798,0.00358288025132128,-0.00661411645807391,0.0074307741271055,0.909265954694692
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",39657,0.000350400718593516,0.00311486483136252,-0.00575473435087702,0.00645553578806405,0.910434503486012
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ITM2A,Integral membrane protein 2A,42119,0.000725018741057323,0.00652769572258677,-0.0120692648752127,0.0135193023573274,0.911563995958665
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CCNE1,G1/S-specific cyclin-E1,39657,0.00105926126319678,0.00969387503273498,-0.0179407338009638,0.0200592563273573,0.912989379492573
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KDM3A,Lysine-specific demethylase 3A,39657,0.00102401199374597,0.00938260420228328,-0.0173658922427293,0.0194139162302212,0.913093888381621
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MSLN,Mesothelin,42048,0.000668081883141178,0.00612591041407181,-0.0113387025284396,0.0126748662947219,0.913157810783761
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39586,0.000816390281768767,0.00791303508607266,-0.0146931584869337,0.0163259390504712,0.917829686555922
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39575,0.000531030288432647,0.00526135192206719,-0.00978121947881904,0.0108432800556843,0.919607564176856
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,39930,-0.000278010991644589,0.00276918893550707,-0.00570562130523845,0.00514959932194927,0.920033011854176
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TNPO1,Transportin-1,39757,-0.000373085781375798,0.00375925420455107,-0.0077412240222959,0.0069950524595443,0.920945825507683
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PTTG1,Securin,39757,0.000434510332233857,0.00440930801605645,-0.00820773337923677,0.00907675404370449,0.921502198389136
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41976,-0.000419631567741143,0.00429388783813717,-0.00883565173048999,0.0079963885950077,0.92215002339946
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TPBGL,Trophoblast glycoprotein-like,39649,0.000393482417111222,0.0042985728555941,-0.00803172037985321,0.00881868521407565,0.927066836517353
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,THBS4,Thrombospondin-4,42189,0.000423513629609677,0.00478236290954161,-0.00894991767309188,0.00979694493231124,0.929434969117062
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,39657,0.000517376253283599,0.00604239468565809,-0.0113257173306063,0.0123604698371735,0.931766573464246
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDC123,Cell division cycle protein 123 homolog,39560,-0.000568375274227585,0.00664080457850046,-0.0135843522480885,0.0124476016996333,0.931795250995462
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TSPAN15,Tetraspanin-15,39575,0.000445757777326862,0.00532577130739241,-0.00999275398516227,0.010884269539816,0.933297869243062
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHP1,Calcineurin B homologous protein 1,39586,-0.000614246455301435,0.00781545837019351,-0.0159325448608807,0.0147040519502778,0.937357162437312
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,MMP15,Matrix metalloproteinase-15,39958,-0.000381623031509068,0.00514482276202626,-0.0104654756450805,0.0097022295820624,0.94087154689176
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDAN1,Codanin-1,39929,-0.000158605564881878,0.00231043055390074,-0.00468704945052733,0.00436983832076357,0.94527132234692
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,39586,-0.000486698964653287,0.00733984962384685,-0.0148728042273931,0.0138994062980865,0.947132929610601
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GBA,Lysosomal acid glucosylceramidase,39649,0.000386503171563054,0.00586458736762429,-0.0111080880689805,0.0118810944121067,0.947454985985038
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,41900,-0.000229352191867286,0.00348286004199449,-0.0070557578741765,0.00659705349044192,0.947496898983681
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NXPE4,NXPE family member 4,39575,-0.000213095366666054,0.00338830471465254,-0.00685417260738504,0.00642798187405293,0.949854095597341
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39966,-0.000172866346166906,0.00275222545889031,-0.0055672282455919,0.00522149555325809,0.949919177699119
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42145,-0.000251321803221992,0.00413755904568634,-0.00836093753276722,0.00785829392632324,0.951565926478611
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,BRD3,Bromodomain-containing protein 3,39575,0.000291776494443833,0.00502982606122458,-0.00956668258555635,0.010150235574444,0.953742307552996
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IL2,Interleukin-2,41913,0.000160165826085066,0.0033608666876032,-0.0064271328816172,0.00674746453378734,0.961991029856098
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,JCHAIN,Immunoglobulin J chain,41913,-0.00029061261438433,0.00644100221479432,-0.0129149769553812,0.0123337517266125,0.964013005605695
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,39649,-0.000172657682592387,0.00388031327942238,-0.00777807171026026,0.00743275634507548,0.964509995853588
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD5L,CD5 antigen-like,39925,-0.000210574353793192,0.00507170822128845,-0.0101511224675186,0.00972997375993218,0.96688254790802
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PMCH,Pro-MCH,39575,0.000350114331285492,0.00873902266543763,-0.0167783700929723,0.0174785987555433,0.968043367074195
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,TXK,Tyrosine-protein kinase TXK,39757,0.000297837417785546,0.00775836954285497,-0.0149085668862102,0.0155042417217813,0.969378077359433
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39090,0.000223957643977789,0.0059835935628143,-0.0115038857391382,0.0119518010270938,0.970143966163569
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDSN,Corneodesmosin,42246,0.000160556265283147,0.00460845651391334,-0.00887201850198699,0.00919313103255329,0.972208242456223
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,NEB,Nebulin,39575,0.000142969939287682,0.00421512946391828,-0.00811868380999215,0.00840462368856752,0.972942933454528
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,ROBO2,Roundabout homolog 2,42249,-6.36999111072482e-05,0.00238311819577927,-0.00473461157483462,0.00460721175262012,0.978675756465797
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CGA,Glycoprotein hormones alpha chain,42137,0.000167407030018841,0.00651142737803713,-0.0125949906309339,0.0129298046909716,0.979489243165291
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CFD,Complement factor D,39979,-3.51904405688089e-05,0.00213893276601296,-0.00422749866195422,0.0041571177808166,0.986873815730211
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DSG3,Desmoglein-3,42196,6.06446920490864e-05,0.00369889995131403,-0.00718919921252642,0.00731048859662459,0.986919244493683
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,39934,4.49392557172565e-05,0.00287463473490119,-0.00558934482468908,0.00567922333612359,0.987527428636223
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,SHC1,SHC-transforming protein 1,39560,0.000158690247618791,0.0123768128205389,-0.0240998628806374,0.024417243375875,0.98977037602883
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CD55,Complement decay-accelerating factor,41714,3.0134617176465e-05,0.00278058177419821,-0.00541980566025202,0.00548007489460495,0.991353242343827
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,OMP,Olfactory marker protein,39586,-5.24697361664182e-05,0.00507731653865945,-0.0100040101519389,0.0098990706796061,0.99175487795392
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42085,0.000172439296090169,0.0202329837016855,-0.0394842087592133,0.0398290873513937,0.993200091610712
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,IGLON5,IgLON family member 5,39560,7.25981225300037e-05,0.00980201938192115,-0.0191393598660355,0.0192845561110955,0.9940907002962
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39586,-3.78154821203749e-05,0.00569990313143028,-0.0112096256197237,0.011133994655483,0.99470666769414
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,DEFB116,Beta-defensin 116,39586,3.28905816935234e-05,0.00795031787653074,-0.0155497324563067,0.0156155136196938,0.996699224396831
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,CDH4,Cadherin-4,39586,1.08488929476413e-05,0.00492607998862866,-0.00964426788476452,0.00966596567065981,0.998242829952563
NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,39757,1.45948776858349e-05,0.00725085935931979,-0.014197089466581,0.0142262792219526,0.998394016736665
